FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sanches, K
   Caruso, IP
   Almeida, FCL
   Melo, FA
AF Sanches, Karoline
   Caruso, Icaro P.
   Almeida, Fabio C. L.
   Melo, Fernando A.
TI The dynamics of free and phosphopeptide-bound Grb2-SH2 reveals two
   dynamically independent subdomains and an encounter complex with fuzzy
   interactions
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SH2 DOMAIN; PROTEIN; BINDING; RECEPTOR; ASSIGNMENT; INTEGRATION;
   BACKBONE; SYSTEM; SITE; N-15
AB The growth factor receptor-bound protein 2 (Grb2) is a key factor in the regulation of cell survival, proliferation, differentiation, and metabolism. In its structure, the central Src homology 2 (SH2) domain is flanked by two Src homology 3 (SH3). SH2 is the most important domain in the recognition of phosphotyrosines. Here, we present the first dynamical characterization of Grb2-SH2 domain in the free state and in the presence of phosphopeptide EpYINSQV at multiple timescales, which revealed valuable information to the understanding of phophotyrosine sensing mechanism. Grb2-SH2 presented two dynamically independent subdomains, subdomain I involved in pY recognition and subdomain II is the pY+2 specificity pocket. Under semi-saturated concentrations of pY-pep we observed fuzzy interactions, which led to chemical exchange observed by NMR. This information was used to describe the encounter complex. The association with pY-pep is dynamic, involving fuzzy interactions and multiple conformations of pY-pep with negative and hydrophobic residues, creating an electrostatic-potential that drives the binding of pY-pep. The recognition face is wider than the binding site, with many residues beyond the central SH2 binding site participating in the association complex, which contribute to explain previously reported capability of Grb2 to recognize remote pY.
C1 [Caruso, Icaro P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Rio De Janeiro, Brazil.
   [Caruso, Icaro P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.
   [Sanches, Karoline; Caruso, Icaro P.; Melo, Fernando A.] Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat CMIB, Sao Jose Do Rio Preto, SP, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.; Melo, FA (corresponding author), Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat CMIB, Sao Jose Do Rio Preto, SP, Brazil.
EM falmeida@bioqmed.ufrj.br; fernando.melo@unesp.br
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [215141, 210361, 239229, 204432];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [442951/2014-0, 309564/2017-4, 457773/2014-6]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/17630-0, 2017/20642-8];
   UNESP-PROPG [09/2017, 12/2017]; INBEB-INCT; CNPqNational Council for
   Scientific and Technological Development (CNPq); FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX We thank the National Center of Nuclear Magnetic Resonance (CNRMN, UFRJ,
   Rio de Janeiro-Brazil) and the Mutiuser Center of Molecular Inovation
   (CMIB, UNESP, Sao Jose do Rio Preto, Brazil) for the NMR spectra
   acquisition, and NMRbox (National Center for Biomolecular NMR Data
   Processing and Analysis, a Biomedical Technology Research
   Resource-BTRR). We thank Professor John Ladbury for kindly providing the
   plasmid of Grb2-SH2. We also thank Prof. Dmitry Korzhnev for discussion
   of the results and Prof. Ana Paula Valente for the paper review and
   suggestions. The work was supported by FAPERJ grants 215141, 210361,
   239229, and 204432, CNPq Grants 309564/2017-4 and 457773/2014-6 awarded
   to FCLA. FAPESP Grants (2014/17630-0, 2017/20642-8), CNPq Grant
   442951/2014-0 and UNESP-PROPG grants (09/2017, 12/2017) awarded to FAM.
   We also thank INBEB-INCT for funding. KS is funded by CNPq scholarship
   and IPC is funded by a postdoctoral fellowship by FAPERJ. The authors
   declare no conflict of interest.
CR Ahmed Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8354
   Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086
   Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V462, P47, DOI 10.1016/j.abb.2007.03.010
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W., 2002, CCP4 NEWSL PROTEIN C
   Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Finerty PJ, 2005, BIOCHEMISTRY-US, V44, P694, DOI 10.1021/bi048641k
   Hosoe Y, 2019, BIOPHYS PHYSICOBIOL, V16, P80, DOI 10.2142/biophysico.16.0_80
   Huang WYC, 2017, J AM CHEM SOC, V139, P18009, DOI 10.1021/jacs.7b09387
   Huculeci R, 2016, STRUCTURE, V24, P1947, DOI 10.1016/j.str.2016.08.016
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   Ijaz M, 2017, PROTEIN PEPTIDE LETT, V24, P1084, DOI 10.2174/0929866525666171123213148
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kay LE, 1996, BIOCHEMISTRY-US, V35, P361, DOI 10.1021/bi9522312
   Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x
   Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033
   Lindfors HE, 2012, IUBMB LIFE, V64, P538, DOI 10.1002/iub.1038
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B
   Machado LESF, 2018, BIOCHEMISTRY-US, V57, P5797, DOI 10.1021/acs.biochem.8b00753
   Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005
   Maciejewski MW, 2017, BIOPHYS J, V112, P1529, DOI 10.1016/j.bpj.2017.03.011
   MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0
   MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152
   Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004
   Momin M, 2017, J PHYS CHEM B, V121, P6131, DOI 10.1021/acs.jpcb.7b03470
   Morando MA, 2019, BIOCHEMISTRY-US, V58, P2488, DOI 10.1021/acs.biochem.9b00194
   Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176
   Papaioannou D, 2016, PROTEIN SCI, V25, P627, DOI 10.1002/pro.2856
   Pascal SM, 1995, BIOCHEM SOC T, V23, P729, DOI 10.1042/bst0230729
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017
   ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0
   Sanches K, 2019, BIOMOL NMR ASSIGN, V13, P295, DOI 10.1007/s12104-019-09894-x
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   Sanz-Hernandez M, 2017, J BIOMOL NMR, V69, P147, DOI 10.1007/s10858-017-0145-2
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Senior MM, 1998, J BIOMOL NMR, V11, P153, DOI 10.1023/A:1008250309874
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Tari AM, 2001, SEMIN ONCOL, V28, P142, DOI 10.1053/sonc.2001.28555
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vidal M, 2001, CRIT REV ONCOL HEMAT, V40, P175, DOI 10.1016/S1040-8428(01)00142-1
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396
   Zurini M, 2002, J MED CHEM, V42, P971
NR 58
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2020
VL 10
IS 1
AR 13040
DI 10.1038/s41598-020-70034-w
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MV5JW
UT WOS:000556395100037
PM 32747626
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bartkevihi, L
   Martins, B
   de Oliveira, DMP
   Pires, JRM
   Anobom, CD
   Almeida, FCL
AF Bartkevihi, Leonardo
   Martins, Bruna
   de Oliveira, Danielle Maria Perpetua
   Pires, Jose Ricardo M.
   Anobom, Cristiane Dinis
   Almeida, Fabio C. L.
TI Backbone assignment of ribose-5-phosphate isomerase of Mycobacterium
   tuberculosis (MtRpiB)
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE RpiB; Mycobacterium tuberculosis; Pentose phosphate pathway; NMR;
   Inhibition
ID PROTEIN BACKBONE; TORSION ANGLES; NMR
AB Tuberculosis is one of the deadliest diseases worldwide affecting approximately 10 million people in 2018. This classifies tuberculosis as epidemic in several countries and leads to an increasing number of multidrug-resistant strains. Thus, the development of new drugs is essential to effective treatments. A potential drug target is the ribose-5-phosphate isomerase, a ubiquitous enzyme important to nucleotide and cofactor biosynthesis. Here, we report the backbone assignment of ribose-5-phosphate isomerase of Mycobacterium tuberculosis (MtRpiB) that has been performed by triple resonance sequential approach using a [C-13, N-15, H-2]-labeled protein. This is the first ribose-5-phosphate isomerase, an enzyme previously classified as highly druggable, to be assigned. These data will be important to further screening studies to find inhibitors and determine their interaction with MtRpiB.
C1 [Bartkevihi, Leonardo; Pires, Jose Ricardo M.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Rio De Janeiro, Brazil.
   [Bartkevihi, Leonardo; Pires, Jose Ricardo M.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.
   [Martins, Bruna; de Oliveira, Danielle Maria Perpetua; Anobom, Cristiane Dinis] Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, Brazil.; Anobom, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil.
EM anobom@iq.ufrj.br; falmeida@bioqmed.ufrj.br
RI Oliveira, Danielle/B-5299-2015; Almeida, Fabio/O-4989-2018
OI Oliveira, Danielle/0000-0002-9889-5556; Almeida,
   Fabio/0000-0001-6046-7006
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [239229, 204432, 225356]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [309564/2017-4]; INBEB-INCT
FX This work was funded by FAPERJ Grants 239229 and 204432, awarded to FCLA
   and 225356 awarded to CDAB and CNPq Grant 309564/2017-4, awarded to
   FCLA. We also thank to INBEB-INCT for funding. LB is funded by CNPq
   scholarship, CDAB and LFCS is funded by FAPERJ. The authors declare no
   conflict of interest.
CR Capriles PVSZ, 2015, J MOL GRAPH MODEL, V55, P134, DOI 10.1016/j.jmgm.2014.11.002
   DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Faria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26937
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   Roos AK, 2005, J BIOL CHEM, V280, P6416, DOI 10.1074/jbc.M412018200
   Roos AK, 2004, J MOL BIOL, V335, P799, DOI 10.1016/j.jmb.2003.11.021
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996
   Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   World Health Organization, 2019, GLOB TUB REP 2018 GL
NR 14
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD APR
PY 2020
VL 14
IS 1
BP 119
EP 122
DI 10.1007/s12104-020-09931-0
EA FEB 2020
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA KU1DG
UT WOS:000515929100002
PM 32030620
DA 2020-12-01
ER

PT J
AU do Nascimento, MA
   Gotardo, LE
   Bastos, EM
   Almeida, FCL
   Leao, RAC
   de Souza, ROMA
   Wojcieszak, R
   Itabaiana, I
AF do Nascimento, Marcelo Avelar
   Gotardo, Larissa Ester
   Bastos, Eduardo Miguez
   Almeida, Fabio C. L.
   Leao, Raquel A. C.
   de Souza, Rodrigo O. M. A.
   Wojcieszak, Robert
   Itabaiana, Ivaldo, Jr.
TI Regioselective Acylation of Levoglucosan Catalyzed by Candida Antarctica
   (CaLB) Lipase Immobilized on Epoxy Resin
SO SUSTAINABILITY
LA English
DT Article
DE levoglucosan; CaLB; lipase; immobilization; NOEdiff;
   transesterification; esters
ID FUNCTIONALIZED SILICA; CHEMISTRY
AB Every year, a large amount of residual agroindustrial waste has been generated and only around 10% is in fact reused. The development of new strategies for biomass valorization is important to add value to these commodities, since biomass is an excellent alternative feedstock to obtain chemicals of interest from renewable resources. The major compound of pyrolytic treatment of lignocellulosic biomass is levoglucosan (1,6-anhydroglucopyranose), an anhydro-sugar that can be transformed into glucose and is greatly valued in the most diverse industrial sectors as a surfactant, emulsifier, or even a lubricant. In this work, levoglucosan was acylated by lipase-catalyzed transesterification in acetonitrile with great conversions and selectivities with different acyl donors such as ethyl esters of lauric, palmitic, stearic, and oleic acids prepared in situ in an integrated strategy mediated by commercial lipases Novozym435 (N435), PSIM, and the home-made biocatalyst CaLB_epoxy. As a result, all biocatalyst generated mostly monoesters, with N435 being more selective to produce lauric esters (99% at 50 degrees C) and PSIM to produce oleic esters (97% at 55 degrees C) while CaLB_epoxy was more selective to produce oleic esters of levoglucosan (83% at 55 degrees C). This is the first report in the literature on the production of high selectivity levoglucosan esters.
C1 [do Nascimento, Marcelo Avelar; Gotardo, Larissa Ester; Leao, Raquel A. C.; de Souza, Rodrigo O. M. A.] Univ Fed Rio de Janeiro, Chem Inst, BOSS Grp Biocatalysis & Organ Synth Grp, BR-21941909 Rio De Janeiro, Brazil.
   [Bastos, Eduardo Miguez] Univ Fed Rio de Janeiro, Inst Macromol Prof Eloisa Mano, BR-21941598 Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO I 1, BR-21941905 Rio De Janeiro, Brazil.
   [Leao, Raquel A. C.] Univ Fed Rio de Janeiro, Pharm Sch, BR-21941170 Rio De Janeiro, Brazil.
   [Wojcieszak, Robert] Univ Lille, Univ Artois, CNRS, Cent Lille,ENSCL,UCCS,UMR 8181, F-59000 Lille, France.
   [Itabaiana, Ivaldo, Jr.] Univ Fed Rio de Janeiro, Sch Chem, Dept Biochem Engn, BR-21941910 Rio De Janeiro, Brazil.
RP Itabaiana, I (corresponding author), Univ Fed Rio de Janeiro, Sch Chem, Dept Biochem Engn, BR-21941910 Rio De Janeiro, Brazil.
EM marceloavelar@id.uff.br; gotardolarissa@gmail.com; emiguez54@gmail.com;
   falmeida@bioqmed.ufrj.br; capelaleao@gmail.com; souzarod@gmail.com;
   robert.wojcieszak@univ-lille.fr; ivaldo@eq.ufrj.br
RI Itabaiana, Ivaldo/A-6308-2014; Wojcieszak, Robert/AAC-9099-2020
OI Itabaiana, Ivaldo/0000-0003-0725-0881; Wojcieszak,
   Robert/0000-0002-8956-5846
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors thank CAPES, CNPq, and FAPERJ for financial support. LIA
   CNRS France-Brazil "Energy & Environment" is also acknowledged.
CR Aguillon AR, 2019, MOL CATAL, V467, P128, DOI 10.1016/j.mcat.2019.01.034
   Babaki M, 2015, BIOCHEM ENG J, V101, P23, DOI 10.1016/j.bej.2015.04.020
   Boissiere-Junot N, 1998, J CARBOHYD CHEM, V17, P99, DOI 10.1080/07328309808005771
   de Souza SP, 2018, J CHEM TECHNOL BIOT, V93, P105, DOI 10.1002/jctb.5327
   do Nascimento MA, 2019, ACS OMEGA, V4, P860, DOI 10.1021/acsomega.8b02420
   Fathi Z, 2018, INT J BIOL MACROMOL, V117, P218, DOI 10.1016/j.ijbiomac.2018.05.156
   Galletti P, 2007, GREEN CHEM, V9, P987, DOI 10.1039/b702031g
   Hoi LWS, 2013, IND CROP PROD, V47, P1, DOI 10.1016/j.indcrop.2013.02.017
   HUNTER BK, 1983, J CHEM SOC PERK T 1, P657, DOI 10.1039/p19830000657
   Junior II, 2012, ORG PROCESS RES DEV, V16, P1098, DOI 10.1021/op200132y
   Ortiz AL, 2013, INT J HYDROGEN ENERG, V38, P12580, DOI 10.1016/j.ijhydene.2013.06.059
   Manzocco L, 2012, FOOD RES INT, V49, P778, DOI 10.1016/j.foodres.2012.09.011
   Mateo C, 2003, BIOMACROMOLECULES, V4, P772, DOI 10.1021/bm0257661
   Morais A, 2013, SUST CHEM P, V1, P18, DOI DOI 10.1186/2043-7129-1-18
   Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015
   Rocha IM, 2013, J CHEM ENG DATA, V58, P1813, DOI 10.1021/je400207t
   Rotticci D., 2000, THESIS
   Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001
   Schummer C, 2009, TALANTA, V77, P1473, DOI 10.1016/j.talanta.2008.09.043
   Tang SLY, 2005, GREEN CHEM, V7, P761, DOI 10.1039/b513020b
   TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206
   TURNER MK, 1995, TRENDS BIOTECHNOL, V13, P253, DOI 10.1016/S0167-7799(00)88959-3
   Uriarte I, 2018, CHEMPHYSCHEM, V19, P766, DOI 10.1002/cphc.201701242
   Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013
   Zdrahal Z, 2002, ENVIRON SCI TECHNOL, V36, P747, DOI 10.1021/es015619v
NR 25
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD NOV
PY 2019
VL 11
IS 21
AR 6044
DI 10.3390/su11216044
PG 14
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA JT7ZZ
UT WOS:000501205200173
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Lixa, C
   Clarkson, MW
   Iqbal, A
   Moon, TM
   Almeida, FCL
   Peti, W
   Pinheiro, AS
AF Lixa, Carolina
   Clarkson, Michael W.
   Iqbal, Anwar
   Moon, Thomas M.
   Almeida, Fabio C. L.
   Peti, Wolfgang
   Pinheiro, Anderson S.
TI Retinoic Acid Binding Leads to CRABP2 Rigidification and Dimerization
SO BIOCHEMISTRY
LA English
DT Article
ID BACKBONE DYNAMICS; PROTEIN-II; NMR-SPECTROSCOPY; ESCHERICHIA-COLI;
   LIGAND-BINDING; FATTY-ACID; DOMAIN; LOCALIZATION; ACTIVATION; EXPRESSION
AB Cellular retinoic acid-binding protein 2 (CRABP2) delivers all-trans retinoic acid (atRA) to retinoic acid receptors (RARs), allowing for the activation of specific gene transcription. The structural similarities between free and atRA-bound CRABP2 raise the questions of how atRA binding occurs and how the atRA:CRABP2 complex is recognized by downstream binding partners. Thus, to gain insights into these questions, we conducted a detailed atRA-CRABP2 interaction study using nuclear magnetic resonance spectroscopy. The data showed that free CRABP2 displays widespread intermediate-time scale dynamics that is effectively suppressed upon atRA binding. This effect is mirrored by the fast-time scale dynamics of CRABP2. Unexpectedly, CRABP2 rigidification in response to atRA binding leads to the stabilization of a homodimerization interface, which encompasses residues located on helix alpha 2 and the beta C-beta D loop as well as residues on strands beta I-beta A and the beta H-beta I loop. Critically, this rigidification also affects CRABP2's nuclear localization signal and RAR-binding motif, suggesting that the loss of conformational entropy upon atRA binding may be the key for the diverse cellular functions of CRABP2.
C1 [Lixa, Carolina; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Clarkson, Michael W.; Moon, Thomas M.; Peti, Wolfgang] Univ Arizona, Coll Med, Dept Chem & Biochem, Tucson, AZ 85721 USA.
   [Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM pinheiro@iq.ufrj.br
RI Pinheiro, Anderson S/B-6350-2014; Moon, Thomas/F-4896-2013; Almeida,
   Fabio/O-4989-2018
OI Moon, Thomas/0000-0003-1568-8808; Clarkson, Michael
   W/0000-0002-4323-3424; Almeida, Fabio/0000-0001-6046-7006; Pinheiro,
   Anderson/0000-0001-5118-6931
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brown University; Coordenacao de Aperfeicoamento de
   Nivel Superior (CAPES) PDSE scholarship
FX This work was supported by grants from Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho
   Nacional Cientifico e Tecnologico (CNPq), and a Brazil Initiative
   Collaboration Grant from Brown University to A.S.P. C.L. was the
   recipient of a Coordenacao de Aperfeicoamento de Nivel Superior (CAPES)
   PDSE scholarship to conduct part of her doctoral research as a Visiting
   Student at the University of Arizona.
CR Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a
   BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89
   BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005
   Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340
   Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002
   CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   FIORELLA PD, 1993, J BIOL CHEM, V268, P21545
   Ghaffari H, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0088-7
   Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040
   Horvath G, 2017, FEBS J, V284, P3637, DOI [10.1111/febs.14263, 10.1111/febs.14264]
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Keller R, 2004, COMPUTER AIDED RESON
   KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1
   Krishnan VV, 2000, BIOCHEMISTRY-US, V39, P9119, DOI 10.1021/bi000296l
   Kumar GS, 2018, P NATL ACAD SCI USA, V115, P4655, DOI 10.1073/pnas.1721441115
   Long D, 2010, BIOPHYS J, V98, P3054, DOI 10.1016/j.bpj.2010.03.047
   Majumdar A, 2011, J BIOL CHEM, V286, P42749, DOI 10.1074/jbc.M111.293464
   Manor D, 2003, CANCER RES, V63, P4426
   Menozzi I, 2017, J STRUCT BIOL, V197, P330, DOI 10.1016/j.jsb.2016.12.012
   NAPOLI JL, 1993, J NUTR, V123, P362, DOI 10.1093/jn/123.suppl_2.362
   Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004
   Nelson CH, 2016, FEBS LETT, V590, P2527, DOI 10.1002/1873-3468.12303
   NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9
   Penzes P, 1999, BIOCHEMISTRY-US, V38, P2088, DOI 10.1021/bi982228t
   Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024
   Ragona L, 2014, BBA-PROTEINS PROTEOM, V1844, P1268, DOI 10.1016/j.bbapap.2014.04.011
   Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026
   STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003
   THOMPSON JR, 1995, J MOL BIOL, V252, P433, DOI 10.1006/jmbi.1995.0509
   Vaezeslami S, 2006, J MOL BIOL, V363, P687, DOI 10.1016/j.jmb.2006.08.059
   Venditti V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6960
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wang L, 1999, BBA-PROTEIN STRUCT M, V1433, P240, DOI 10.1016/S0167-4838(99)00127-2
   Wang LC, 1998, BIOCHEMISTRY-US, V37, P12727, DOI 10.1021/bi9808924
   Wang LC, 1998, BIOCHEMISTRY-US, V37, P13021, DOI 10.1021/bi981021x
   Zhang W, 2016, J CELL SCI, V129, P4025, DOI 10.1242/jcs.192096
NR 39
TC 1
Z9 1
U1 2
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 15
PY 2019
VL 58
IS 41
BP 4183
EP 4194
DI 10.1021/acs.biochem.9b00672
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JF2ML
UT WOS:000491219400002
PM 31566355
DA 2020-12-01
ER

PT J
AU Sanches, K
   Caruso, IP
   Almeida, FCL
   Melo, FA
AF Sanches, Karoline
   Caruso, Icaro P.
   Almeida, Fabio C. L.
   Melo, Fernando A.
TI NMR assignment of free H-1, N-15 and C-13-Grb2-SH2 domain
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Grb2; SH2 domain; Assignment; Isotopic labeled; NMR
ID SIDE-CHAIN; SEQUENTIAL ASSIGNMENT; SH3 DOMAIN; RECEPTOR; PROTEINS; RAS;
   SPECTROSCOPY; BACKBONE; BINDS; C-13
AB Growth factor receptor-bound protein 2 (Grb2) is an adaptor protein composed of three domains, an N-terminal SH3 (nSH3), SH2 and a C-terminal SH3 (cSH3) domains. This multi-domain protein has been reported to be a key factor in many signaling pathways related to controlling cell survival, differentiation, and growth. The Grb2-SH2 domain has been a focus for the study of the interaction with peptides and small molecules to act as inhibitors in uncontrolled cell growth, and consequently inhibit tumor proliferation. Here we describe the almost complete assignment of the free SH2 domain at pH 7. This work prepares the ground for further structural studies, backbone dynamics, mapping of interactions and drug screening and development. TalosN secondary structure prediction showed great similarity with the available structures in the PDB.
C1 [Sanches, Karoline; Caruso, Icaro P.; Melo, Fernando A.] Sao Paulo State Univ UNESP, CMIB, Dept Phys, Sao Paulo, Brazil.
   [Caruso, Icaro P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Rio De Janeiro, Brazil.
   [Caruso, Icaro P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance, Rio De Janeiro, Brazil.
RP Melo, FA (corresponding author), Sao Paulo State Univ UNESP, CMIB, Dept Phys, Sao Paulo, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem IBqM, Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance, Rio De Janeiro, Brazil.
EM falmeida@bioqmed.ufrj.br; fernando.melo@unesp.br
RI Melo, Fernando A/A-6242-2013; Almeida, Fabio/O-4989-2018
OI Melo, Fernando A/0000-0002-8676-3150; Almeida, Fabio/0000-0001-6046-7006
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/17630-0, 2017/20642-8, 2009/53989-4]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [442951/2014-0,
   309564/2017-4, 131968/2017-3]; UNESP-PROPG Grants [09/2017, 12/2017];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [239229, 204432]; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P41GM111135]; INBEB-INCT; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135,
   P41GM111135, P41GM111135, P41GM111135, P41GM111135, P41GM111135] Funding
   Source: NIH RePORTER
FX This work was supported by FAPESP Grants Nos. (2014/17630-0,
   2017/20642-8), CNPq Grants No. 442951/2014-0, UNESP-PROPG Grants Nos.
   (09/2017, 12/2017) awarded to FAM; FAPESP Grants No. 2009/53989-4; and
   by FAPERJ Grants Nos. (239229, 204432) and CNPq Grants No. 309564/2017-4
   awarded to FCLA. We thank NMRbox: National Center for Biomolecular NMR
   Data Processing and Analysis, a Biomedical Technology Research Resource
   (BTRR), which is supported by NIH Grants No. P41GM111135 (NIGMS). We
   also thank INBEB-INCT for funding. The assignment was deposit at the
   Biomagnetic Resonance Data Bank (BMRB ID 27781). KS is funded by CNPq
   scholarship (131968/2017-3) and IPC is funded by a postdoctoral
   fellowship by FAPERJ.
CR Ahmed Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8354
   CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421
   Gal M, 2011, J BIOMOL NMR, V51, P497, DOI 10.1007/s10858-011-9580-7
   Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI [10.1517/14728222.12.8.1021, 10.1517/14728222.12.8.1021 ]
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   Lewitzky M, 2001, ONCOGENE, V20, P1052, DOI 10.1038/sj.onc.1204202
   Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033
   LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P
   LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B
   Maciejewski MW, 2017, BIOPHYS J, V112, P1529, DOI 10.1016/j.bpj.2017.03.011
   MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522
   Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004
   ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Senior MM, 1998, J BIOMOL NMR, V11, P153, DOI 10.1023/A:1008250309874
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Thornton KH, 1996, BIOCHEMISTRY-US, V35, P11852, DOI 10.1021/bi952615s
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wang YS, 1996, J BIOMOL NMR, V7, P89
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
   Zhang Y, 1995, THESIS
NR 26
TC 1
Z9 1
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD OCT
PY 2019
VL 13
IS 2
BP 295
EP 298
DI 10.1007/s12104-019-09894-x
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA IU6IU
UT WOS:000483690800007
PM 31028611
DA 2020-12-01
ER

PT J
AU Sales, EM
   Sousa, GS
   Belouezzane, C
   Almeida, FCL
   Figueroa-Villar, JD
AF Sales, Edijane M.
   Sousa, Gileno S.
   Belouezzane, Chiraz
   Almeida, Fabio C. L.
   Figueroa-Villar, Jose D.
TI Expression, purification and spectrophotometric analysis of nucleoside
   hydrolase from Leishmania chagasi (LcNH)
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Nucleoside hydrolase; Leishmania chagasi; NMR; Luminescence
ID INHIBITORS; DONOVANI; SPECIFICITY; DOCKING; DESIGN
AB Leishmaniasis represents an important public health problem in several countries. The main target in this study is the nucleoside hydrolase Leishmania chagasi (LcNH) that is responsible for causing visceral leishmaniasis, principally in Brazil. Nucleoside hydrolase enzymes are members of this pathway, hydrolyzing the N-glycosidic bond of ribonucleosides for the synthesis of nucleic acids. We present here for the first time, the expression and purification protocols to obtain the enzymes LcNH1 and LcNH2 that can be employed to explore novel strategies to produce nucleoside hydrolase inhibitors for use in chemotherapy. Protein integrity was also confirmed by SDS-PAGE gel, mass spectrometry and enzymatic activity.
C1 [Sales, Edijane M.; Belouezzane, Chiraz; Figueroa-Villar, Jose D.] Inst Mil Engn, BR-22290270 Rio De Janeiro, Brazil.
   [Sousa, Gileno S.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, BR-21941920 Rio De Janeiro, Brazil.
   [Belouezzane, Chiraz] Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.
RP Sales, EM (corresponding author), Inst Mil Engn, BR-22290270 Rio De Janeiro, Brazil.
EM edijanematos@gmail.com
RI sales, edijane EMS matos/M-3084-2017
OI sales, edijane EMS matos/0000-0002-8868-5176
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); INBEB
FX We would like to thank the financial support afforded by the Brazilian
   financial agencies CAPES, CNPq, INBEB and Prof. Fabio Silva Miranda
   (Universidade Federal Fluminense) for laboratory facilities.
CR Carrillo E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00750
   Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5
   Soares SFDX, 2013, BIOORGAN MED CHEM, V21, P5923, DOI 10.1016/j.bmc.2013.05.063
   DYGERT S, 1965, ANAL BIOCHEM, V13, P367, DOI 10.1016/0003-2697(65)90327-1
   Neto DCF, 2017, RSC ADV, V7, P33944, DOI 10.1039/c7ra04180b
   Figueroa-Villar JD, 2017, CHEM-BIOL INTERACT, V263, P18, DOI 10.1016/j.cbi.2016.12.004
   Franca TCC, 2008, J BRAZIL CHEM SOC, V19, P64, DOI 10.1590/S0103-50532008000100011
   Jain K, 2015, J IMMUNOL METHODS, V422, P1, DOI 10.1016/j.jim.2015.03.017
   Kumar R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003198
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Magana-Ortiz D., 2017, CURR MICROBIOL, V31, P1
   Marzochi M. C. A., 1981, J BRAS MED, V41, P68
   Nico D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000866
   PARKIN DW, 1991, J BIOL CHEM, V266, P20658
   Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713
   Petronilho ED, 2016, J ENZYM INHIB MED CH, V31, P1069, DOI 10.3109/14756366.2015.1094468
   Renno MN, 2012, EUR J MED CHEM, V56, P301, DOI 10.1016/j.ejmech.2012.07.052
   Santana DM, 2002, MOL BIOCHEM PARASIT, V120, P315, DOI 10.1016/S0166-6851(02)00010-5
   Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114
   Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002
   WHO, 2016, LEISHMANIASIS
NR 21
TC 1
Z9 1
U1 2
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD SEP
PY 2019
VL 161
BP 40
EP 48
DI 10.1016/j.pep.2019.04.009
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA IA9QW
UT WOS:000469892900005
PM 31034876
DA 2020-12-01
ER

PT J
AU De Paula, VS
   Sgourakis, NG
   Francischetti, IMB
   Almeida, FCL
   Monteiro, RQ
   Valente, AP
AF De Paula, Viviane S.
   Sgourakis, Nikolaos G.
   Francischetti, Ivo M. B.
   Almeida, Fabio C. L.
   Monteiro, Robson Q.
   Valente, Ana Paula
TI NMR structure determination of Ixolaris and factor X(a) interaction
   reveals a noncanonical mechanism of Kunitz inhibition
SO BLOOD
LA English
DT Article
ID FACTOR PATHWAY INHIBITOR; HEPARIN-BINDING EXOSITE; TORSION ANGLE
   DYNAMICS; TISSUE-FACTOR; FACTOR-XA; ANTICOAGULANT PROTEIN;
   CRYSTAL-STRUCTURE; SALIVARY-GLAND; FACTOR-VIIA; WEB SERVER
AB Ixolaris is a potent tick salivary anticoagulant that binds coagulation factor Xa (FXa) and zymogen FX, with formation of a quaternary tissue factor (TF)/FVIIa/ FX(a)/Ixolaris inhibitory complex. Ixolaris blocks TF-induced coagulation and PAR2 signaling and prevents thrombosis, tumor growth, and immune activation. We present a high-resolution structure and dynamics of Ixolaris and describe the structural basis for recognition of FX. Ixolaris consists of 2 Kunitz domains (K1 and K2) in which K2 is strikingly dynamic and encompasses several residues involved in FX binding. This indicates that the backbone plasticity of K2 is critical for Ixolaris biological activity. Notably, a nuclear magnetic resonance-derived model reveals a mechanism for an electrostatically guided, high-affinity interaction between Ixolaris and FX heparin-binding (pro) exosite, resulting in an allosteric switch in the catalytic site. This is the first report revealing the structure-function relationship of an anticoagulant targeting a zymogen serving as a scaffold for TF inhibition.
C1 [De Paula, Viviane S.; Sgourakis, Nikolaos G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.
   [De Paula, Viviane S.; Almeida, Fabio C. L.; Valente, Ana Paula] Ctr Biol Estrutural Bioimagem, Rio De Janeiro, Brazil.
   [Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
RP De Paula, VS (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.; Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Rio De Janeiro, Brazil.
EM vsilvade@ucsc.edu; vsilvade@ucsc.edu
RI DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; De Paula, Viviane/L-1947-2013;
   Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018
OI De Paula, Viviane/0000-0003-3171-6477; Valente, Ana
   Paula/0000-0001-7219-1123; Monteiro, Robson/0000-0002-5260-2332;
   Sgourakis, Nikolaos/0000-0003-3655-3902; Almeida,
   Fabio/0000-0001-6046-7006
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq)
FX This work was supported by grants from Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico. The authors acknowledge the
   University of California, Santa Cruz Baker cluster for providing access
   to the computer resources. The authors also thank the facilities of
   National Center of Nuclear Magnetic Resonance (Federal University of Rio
   de Janeiro, Rio de Janeiro) for the NMR time.
CR Augustsson C, 2018, J THROMB HAEMOST, V16, P893, DOI 10.1111/jth.14000
   Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926
   Carneiro-Lobo TC, 2012, J THROMB HAEMOST, V10, P1849, DOI 10.1111/j.1538-7836.2012.04864.x
   Carneiro-Lobo TC, 2009, J THROMB HAEMOST, V7, P1855, DOI 10.1111/j.1538-7836.2009.03553.x
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   De Paula VS, 2017, BIOMOL NMR ASSIGN, V11, P293, DOI 10.1007/s12104-017-9766-3
   De Paula VS, 2017, PROTEIN EXPRES PURIF, V139, P49, DOI 10.1016/j.pep.2017.07.012
   De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dockal M, 2014, J BIOL CHEM, V289, P1732, DOI 10.1074/jbc.M113.533836
   Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x
   Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x
   Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237
   Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014
   Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   Hackeng TM, 2009, ARTERIOSCL THROM VAS, V29, P2015, DOI 10.1161/ATVBAHA.108.177436
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314
   Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221
   Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109
   Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245
   Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83
   Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308
   Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738
   Murakami MT, 2007, J MOL BIOL, V366, P602, DOI 10.1016/j.jmb.2006.11.040
   Nazareth RA, 2006, THROMB HAEMOSTASIS, V96, P7, DOI 10.1160/TH06-02-0105
   Peraramelli S, 2012, THROMB HAEMOSTASIS, V108, P266, DOI 10.1160/TH11-12-0902
   Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x
   PETERSEN LC, 1992, THROMB HAEMOSTASIS, V67, P537
   Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649
   Rezaie AR, 2000, TRENDS CARDIOVAS MED, V10, P333, DOI 10.1016/S1050-1738(01)00070-6
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   Rios-Steiner JL, 2007, J MOL BIOL, V371, P774, DOI 10.1016/j.jmb.2007.05.042
   Ruf W, 2012, THROMB RES, V130, pS84, DOI 10.1016/j.thromres.2012.08.285
   Schechter ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5441
   Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5
   Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118
   Van den Berg YW, 2011, J THROMB HAEMOST, V9, P2311, DOI 10.1111/j.1538-7836.2011.04502.x
   van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x
   Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048
   Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022
   Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764
   Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042
   ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451
NR 49
TC 3
Z9 3
U1 1
U2 3
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD AUG 22
PY 2019
VL 134
IS 8
BP 699
EP 708
DI 10.1182/blood.2018889493
PG 10
WC Hematology
SC Hematology
GA IS5SU
UT WOS:000482213600006
PM 31133602
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Pinheiro-Aguiar, R
   do Amaral, VSG
   Pereira, IB
   Kurtenbach, E
   Almeida, FCL
AF Pinheiro-Aguiar, Ramon
   do Amaral, Virginia S. G.
   Pereira, Iuri B.
   Kurtenbach, Eleonora
   Almeida, Fabio C. L.
TI Nuclear magnetic resonance solution structure of Pisum sativum defensin
   2 provides evidence for the presence of hydrophobic surface-clusters
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE antimicrobial peptides; NMR; Pisum sativum defensin 2; Psd1; Psd2; plant
   defensins
AB Pisum sativum defensin 2 (Psd2) is a small (4.7 kDa) antifungal peptide whose structure is held together by four conserved disulfide bridges. Psd2 shares the cysteine-stabilized alpha-beta (CS alpha beta) fold, which lacks a regular hydrophobic core. All hydrophobic residues are exposed to the surface, except for leucine 6. They are clustered in the surface formed by two loops, between beta 1 and alpha-helix and beta 2 and beta 3 sheets. The observation of surface hydrophobic clusters reveals a remarkable evolution of the CS alpha beta fold to expose and reorganize hydrophobic residues, which facilitates creating versatile binding sites.
C1 [Pinheiro-Aguiar, Ramon; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [do Amaral, Virginia S. G.; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Pereira, Iuri B.] Univ Fed Rio de Janeiro, Campus Macae Prof Aloisio Teixeira, Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.; Kurtenbach, E (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM kurten@biof.ufrj.br; falmeida@bioqmed.ufrj.br
RI Pereira, Iuri Bastos/Y-3677-2019; Almeida, Fabio/O-4989-2018
OI Pereira, Iuri Bastos/0000-0002-6323-2883; Almeida,
   Fabio/0000-0001-6046-7006; Aguiar, Ramon/0000-0002-6387-7366
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [209306/2013-2, 457773/2014-6]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro [203059, 204361, 204432, 210361,
   215141]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Grant/Award Numbers: 209306/2013-2, 457773/2014-6; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Grant/Award Numbers: 203059, 204361, 204432, 210361, 215141
CR Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Boto A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020311
   Cabral KMS, 2003, PROTEIN EXPRES PURIF, V31, P115, DOI 10.1016/S1046-5928(03)00136-0
   Cools TL, 2017, FUTURE MICROBIOL, V12, P441, DOI 10.2217/fmb-2016-0181
   de Medeiros LN, 2014, BIOPOLYMERS, V102, P456, DOI 10.1002/bip.22570
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y
   Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767
   Felicio MR, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00005
   Gomes-Neto F, 2013, MOLECULES, V18, P10056, DOI 10.3390/molecules180810056
   Amaral VSG, 2019, BBA-BIOMEMBRANES, V1861, P713, DOI 10.1016/j.bbamem.2018.12.020
   Machado LESF, 2018, BIOCHEMISTRY-US, V57, P5797, DOI 10.1021/acs.biochem.8b00753
   Rollin-Pinheiro R, 2016, FUTURE MED CHEM, V8, P1469, DOI 10.4155/fmc-2016-0053
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701
NR 15
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD JAN
PY 2020
VL 88
IS 1
BP 242
EP 246
DI 10.1002/prot.25783
EA AUG 2019
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ND2JY
UT WOS:000479307100001
PM 31294889
DA 2020-12-01
ER

PT J
AU Pinheiro, GMS
   Amorim, GC
   Iqbal, A
   Almeida, FCL
   Ramosa, CHI
AF Pinheiro, Glaucia M. S.
   Amorim, Gisele C.
   Iqbal, Anwar
   Almeida, Fabio C. L.
   Ramosa, C. H. I.
TI Solution NMR investigation on the structure and function of the isolated
   J-domain from Sis1: Evidence of transient inter-domain interactions in
   the full-length protein
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE J-domain; Heat shock protein; Protein-protein interaction; Hsp70;
   Chaperone; NMR
ID PEPTIDE-BINDING FRAGMENT; CRYSTAL-STRUCTURE; HSP70; HSP40; CHAPERONE;
   HOMOLOG; FAMILY; REGION; DNAK
AB J-domain/Hsp40 proteins cooperate in aiding with folding in the cell by binding partially folded client proteins and delivering them to be folded by Hsp70. The delivery occurs concomitantly to the stimulation of the ATPase activity of Hsp70 via the N-terminally located J-domain. Although several lines of investigation have been used to study J-domain proteins, the presence of highly flexible domains (G/F- and G/M-rich) hold up obtaining a detailed full-length structure. In this work, we present the high-resolution structure of the J-domain and the N-terminal part of the G/F domain of Sis1, solved by NMR, and used chemical-shift perturbation approaches to further study the structure/function relationship of the Sis1/Hsp70 interaction. When the J-domain was compared to the full-length protein and to a G/M domain deletion mutant, an internal interaction patch formed by hydrophobic and positively charged residues (V2, D9, R27, T39, F52 and R73) was identified. Curiously, the same patch is protected by internal contacts in the full-length protein and, in combination with the loop containing the conserved HPD motif, participates in the interaction with Hsp70. Combined, these results suggest that the J-domain in the full-length Sis1 is in a transient intermediate conformation, in which its interacting patch is protected and, at the same time, also in a favorable condition to bind Hsp70, facilitating the interaction between the two proteins. Finally, 1D NMR experiments showed that the addition of ATP is followed by the disruption of the J-domain/Hsp70 complex, a necessary step for aiding the folding of the client protein.
C1 [Pinheiro, Glaucia M. S.; Ramosa, C. H. I.] Univ Campinas UNICAMP, Inst Chem, Campinas, SP, Brazil.
   [Amorim, Gisele C.; Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem & Nucl Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil.
   [Amorim, Gisele C.] Univ Fed Rio de Janeiro, Nucleo Multidiscipliner Pesquisa Biol, Campus Duque Caxias, Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.; Ramosa, C. H. I.] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
   [Iqbal, Anwar] Gomal Univ, Inst Chem Sci, Dera Ismail Khan, KP, Pakistan.
RP Ramosa, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, CHIR, POB 6154, BR-13083970 Campinas, SP, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem & Nucl Struct Biol & Bioimaging, FCLA, Rio De Janeiro, RJ, Brazil.
EM falmeida@bioqmed.ufrj.br; cramos@iqm.unicamp.br
RI Ramos, CH/C-1571-2012; Amorim, Gisele/O-9231-2019
OI Ramos, CH/0000-0002-7246-9081; Amorim, Gisele/0000-0003-4348-9515
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50161-8,
   2017/26131-5, 2017/01074-9, 2018/11948-9]; Conselho Nacional de Pesquisa
   e Desenvolvimento (CNPq)National Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; INBEB
FX Research in the laboratory of CHIR is supported by grants from Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2012/50161-8,
   2017/26131-5, 2017/01074-9 and 2018/11948-9), Conselho Nacional de
   Pesquisa e Desenvolvimento (CNPq), CAPES and INBEB.
CR Alderson TR, 2016, STRUCTURE, V24, P1014, DOI 10.1016/j.str.2016.05.011
   Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006
   Borges JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050927
   CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609
   CYR DM, 1994, J BIOL CHEM, V269, P9798
   Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108
   Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200
   Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022
   Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679
   Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003
   Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618
   LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623
   Mao BC, 2014, J AM CHEM SOC, V136, P1893, DOI 10.1021/ja409845w
   Nillegoda NB, 2017, ELIFE, V6, DOI 10.7554/eLife.24560
   Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884
   Pinheiro G. M. S., 2018, BIOMOL NMR ASSIGN, V30, P1
   Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6
   Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019
   Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2
   Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40
   Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223
   Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   WALL D, 1994, J BIOL CHEM, V269, P5446
   Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172
   Yan W, 1999, MOL CELL BIOL, V19, P7751
   Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007
NR 31
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2019
VL 669
BP 71
EP 79
DI 10.1016/j.abb.2019.05.020
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IF3MS
UT WOS:000472985500009
PM 31141701
DA 2020-12-01
ER

PT J
AU Morando, MA
   Barbosa, GM
   Cruz-Oliveira, C
   Da Poian, AT
   Almeida, FCL
AF Morando, Maria A.
   Barbosa, Glauce M.
   Cruz-Oliveira, Christine
   Da Poian, Andrea T.
   Almeida, Fabio C. L.
TI Dynamics of Zika Virus Capsid Protein in Solution: The Properties and
   Exposure of the Hydrophobic Cleft Are Controlled by the alpha-Helix 1
   Sequence
SO BIOCHEMISTRY
LA English
DT Article
ID N-TERMINAL REGION; NMR-SPECTROSCOPY; TEMPERATURE COEFFICIENTS;
   CHEMICAL-SHIFTS; TORSION ANGLES; ASSIGNMENT; RELAXATION; H-1; INFECTION;
   BACKBONE
AB Zika virus (ZIKV) became an important public health concern because infection was correlated to the development of microcephaly and other neurological disorders. Although the structure of the virion has been determined by cryo-electron microscopy, information about the nucleocapsid is lacking. We used nuclear magnetic resonance to determine the solution structure and dynamics of full length ZIKV capsid protein (ZIKVC). Although most of the protein is structured as described for the capsid proteins of Dengue and West Nile viruses and for truncated ZIKVC (residues 23-98), here we show important differences in the alpha-helix 1 and N-terminal intrinsically disordered region (IDR). We distinguished two dynamical regions in the ZIKVC IDR, a highly flexible N-terminal end and a transitional disordered region, indicating that it contains ordered segments rather than being completely flexible. The unique size and orientation of alpha-helix 1 partially occlude the protein hydrophobic cleft. Measurements of the dynamics of alpha-helix 1, surface exposure, and thermal susceptibility of each backbone amide H-1 in protein structure revealed the occlusion of the hydrophobic cleft by alpha 1/alpha 1' and supported alpha-helix 1 positional uncertainty. On the basis of the findings described here, we propose that the dynamics of ZIKVC structural elements responds to a structure-driven regulation of interaction of the protein with intracellular hydrophobic interfaces, which would have an impact on the switches that are necessary for nucleocapsid assembly. Subtle differences in the sequence of alpha-helix 1 have an impact on its size and orientation and on the degree of exposure of the hydrophobic cleft, suggesting that alpha-helix 1 is a hot spot for evolutionary adaptation of the capsid proteins of flaviviruses.
C1 [Morando, Maria A.; Barbosa, Glauce M.; Cruz-Oliveira, Christine; Da Poian, Andrea T.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Program Struct Biol, Inst Med Biochem Leopoldo De Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Morando, Maria A.; Cruz-Oliveira, Christine; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, Brazil.
   [Morando, Maria A.] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, BR-21040361 Rio De Janeiro, Brazil.
RP Da Poian, AT; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Program Struct Biol, Inst Med Biochem Leopoldo De Meis, BR-21941902 Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, Brazil.
EM dapoian@bioqmed.ufrj.br; falmeida@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [201167, 201316, 215141, 210361, 239229,
   204432]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [306669/2013-7, 309564/2017-4, 457773/2014-6];
   FINEPCiencia Tecnologia e Inovacao (FINEP) [0267/16]; Capes-CDTS-Fiocruz
   visiting research scholarship [001/2012]; FAPERJ Senior Postdoc (PDS)
   scholarship [201.849/2017]
FX The work presented here was funded by FAPERJ Grants 215141, 210361,
   239229, and 204432, awarded to F.C.L.A., FAPERJ Grants 201167 and
   201316, awarded to A.T.D.P., CNPq Grants 309564/2017-4 and
   457773/2014-6, awarded to F.C.L.A., CNPq Grant 306669/2013-7, awarded to
   A.T.D.P., and FINEP Grant 0267/16, awarded to A.T.D.P. and F.C.L.A.
   M.A.M. is funded by a Capes-CDTS-Fiocruz visiting research scholarship
   (001/2012). C.C.-O. is funded by a FAPERJ Senior Postdoc (PDS)
   scholarship (201.849/2017).
CR ANDERSEN NH, 1992, BIOCHEMISTRY-US, V31, P1280, DOI 10.1021/bi00120a003
   Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cierpicki T, 2002, J MAGN RESON, V157, P178, DOI 10.1006/jmre.2002.2597
   Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hong JB, 2013, J BIOMOL NMR, V55, P71, DOI 10.1007/s10858-012-9689-3
   Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   Khazanov N, 2011, J MOL BIOL, V408, P335, DOI 10.1016/j.jmb.2011.01.059
   Krepel D, 2017, PHYS CHEM CHEM PHYS, V19, P30562, DOI 10.1039/c7cp05251k
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tomlinson JH, 2012, J BIOMOL NMR, V52, P57, DOI 10.1007/s10858-011-9583-4
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
NR 46
TC 6
Z9 6
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 21
PY 2019
VL 58
IS 20
BP 2488
EP 2498
DI 10.1021/acs.biochem.9b00194
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IA1FE
UT WOS:000469303900003
PM 31034208
DA 2020-12-01
ER

PT J
AU Andrade, GC
   Silva, LFC
   Oliveira, DMP
   Pires, JRM
   Almeida, FCL
   Anobom, CD
AF Andrade, Guilherme Caldas
   Correa Silva, Luis Felipe
   Perpetua Oliveira, Danielle Maria
   Pires, Jose Ricardo M.
   Almeida, Fabio C. L.
   Anobom, Cristiane Dinis
TI Backbone and side chain H-1, N-15 and C-13 assignments of a putative
   peptidyl prolyl cis-trans isomerase FKBP12 from Mycobacterium
   tuberculosis
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE FKBP; Mycobacterium tuberculosis; NMR; Assignment
ID SEQUENTIAL ASSIGNMENT; NMR-SPECTROSCOPY; PROTEINS
AB FK506 Binding Proteins (FKBPs) are a family of highly conserved and important proteins that possess a peptidyl cis-trans isomerase (PPIases) domain. Human FKBP12 is a prototype of this family and it is involved in many diseases due to its interaction with the immunosuppressive drugs FK506 and rapamycin. They inhibit calcineurin and mTOR complex, respectively, leading to parasite death by inhibiting cell proliferation through cytokinesis blockade being an important target to find new drugs. Tuberculosis is a disease that causes important impacts on public health worldwide. In this context, MtFKBP12 is a putative peptidyl prolyl cis-trans isomerase from Mycobacterium tuberculosis and here we report the NMR chemical shift assignment for H-1, N-15 and C-13 nuclei in the backbone and side chains of the MtFKBP12. This lays the foundation for further structural studies, backbone dynamics, mapping of interactions and drug screening and development. We have found through the NMR spectrum that the protein is well folded with narrow peaks and almost none overlap in N-15-HSQC. Prediction of secondary structure using Talos-N server showed great similarity with other proteins from this family.
C1 [Andrade, Guilherme Caldas; Correa Silva, Luis Felipe; Perpetua Oliveira, Danielle Maria; Anobom, Cristiane Dinis] Univ Fed Rio de Janeiro, Inst Chem, Ave Carlos Chagas Filho,373 CCS Anexo CNRMN, BR-21941920 Rio De Janeiro, RJ, Brazil.
   [Pires, Jose Ricardo M.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem IBqM, Ave Carlos Chagas Filho,373 CCS Anexo CNRMN, BR-21941920 Rio De Janeiro, RJ, Brazil.
   [Pires, Jose Ricardo M.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, CNRMN, Rio De Janeiro, Brazil.
RP Anobom, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Ave Carlos Chagas Filho,373 CCS Anexo CNRMN, BR-21941920 Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem IBqM, Ave Carlos Chagas Filho,373 CCS Anexo CNRMN, BR-21941920 Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, CNRMN, Rio De Janeiro, Brazil.
EM falmeida@bioqmed.ufrj.br; anobom@iq.ufrj.br
RI Oliveira, Danielle/B-5299-2015; Bom, Cristiane Dinis Ano/X-9461-2019;
   Almeida, Fabio/O-4989-2018
OI Oliveira, Danielle/0000-0002-9889-5556; Almeida,
   Fabio/0000-0001-6046-7006; Pires, Jose Ricardo/0000-0001-6610-8530;
   Andrade, Guilherme/0000-0002-9761-9226
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [239229, 204432]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [309564/2017-4];
   INBEB-INCT; CAPES scholarshipCAPES; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was funded by FAPERJ Grants 239229 and 204432, awarded to
   FCLA, CNPq Grant 309564/2017-4, awarded to FCLA. We also thank to
   INBEB-INCT for funding. The assignment was deposit at the Biomagnetic
   Resonance Data Bank (BMRB ID 27690). GCA is funded by CAPES scholarship
   and LFCS is funded by FAPERJ.
CR Brasseur A, 2013, EUKARYOT CELL, V12, P168, DOI 10.1128/EC.00077-12
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   do Aido-Machado R, 2014, BIOMOL NMR ASSIGN, V8, P133, DOI 10.1007/s12104-013-9468-4
   Gal M, 2011, J BIOMOL NMR, V51, P497, DOI 10.1007/s10858-011-9580-7
   Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862
   Greenstein RJ, 2014, INT J INFECT DIS, V26, P37, DOI 10.1016/j.ijid.2014.01.026
   Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H
   LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P
   MORO A, 1995, EMBO J, V14, P2483, DOI 10.1002/j.1460-2075.1995.tb07245.x
   Mustafi SM, 2013, BIOCHEM J, V453, P371, DOI 10.1042/BJ20130276
   Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531
   Tong M, 2015, CURR MOL PHARM
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   WHO, 2017, GLOB TUB REP 2017
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
   Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6
NR 23
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD APR
PY 2019
VL 13
IS 1
BP 239
EP 243
DI 10.1007/s12104-019-09884-z
PG 5
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA HS1VE
UT WOS:000463649500045
PM 30879170
DA 2020-12-01
ER

PT J
AU Rona, GB
   Almeida, NP
   Santos, GC
   Fidalgo, TKS
   Almeida, FCL
   Eleutherio, ECA
   Pinheiro, AS
AF Rona, Germana B.
   Almeida, Natalia P.
   Santos, Gilson C., Jr.
   Fidalgo, Tatiana K. S.
   Almeida, Fabio C. L.
   Eleutherio, Elis C. A.
   Pinheiro, Anderson S.
TI H-1 NMR metabolomics reveals increased glutaminolysis upon
   overexpression of NSD3s or Pdp3 in Saccharomyces cerevisiae
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE cancer; metabolomics; NMR; NSD3s; Pdp3; Saccharomyces cerevisiae
ID CHOLINE PHOSPHOLIPID-METABOLISM; BREAST-CANCER; PWWP DOMAIN; ARGININE
   DEPRIVATION; YEAST; AMPLIFICATION; CELLS; SPECTROSCOPY; METHYLATION;
   EXPRESSION
AB NSD3s, the proline-tryptophan-tryptophan-proline (PWWP) domain-containing, short isoform of the human oncoprotein NSD3, displays high transforming properties. Overexpression of human NSD3s or the yeast protein Pdp3 in Saccharomyces cerevisiae induces similar metabolic changes, including increased growth rate and sensitivity to oxidative stress, accompanied by decreased oxygen consumption. Here, we set out to elucidate the biochemical pathways leading to the observed metabolic phenotype by analyzing the alterations in yeast metabolome in response to NSD3s or Pdp3 overexpression using H-1 nuclear magnetic resonance (NMR) metabolomics. We observed an increase in aspartate and alanine, together with a decrease in arginine levels, on overexpression of NSD3s or Pdp3, suggesting an increase in the rate of glutaminolysis. In addition, certain metabolites, including glutamate, valine, and phosphocholine were either NSD3s or Pdp3 specific, indicating that additional metabolic pathways are adapted in a protein-dependent manner. The observation that certain metabolic pathways are differentially regulated by NSD3s and Pdp3 suggests that, despite the structural similarity between their PWWP domains, the two proteins act by unique mechanisms and may recruit different downstream signaling complexes. This study establishes for the first time a functional link between the human oncoprotein NSD3s and cancer metabolic reprogramming.
C1 [Rona, Germana B.; Almeida, Natalia P.; Eleutherio, Elis C. A.; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Santos, Gilson C., Jr.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Med Biochem Inst, Struct Biol Program, Natl Ctr Nucl Magnet Resonance Jiri Jonas CNRMN, Rio De Janeiro, Brazil.
   [Santos, Gilson C., Jr.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging I CENABIO I, Rio De Janeiro, Brazil.
   [Fidalgo, Tatiana K. S.] Univ Estado Rio De Janeiro, Sch Dent, Dept Prevent & Community Dent, Rio De Janeiro, Brazil.
RP Eleutherio, ECA; Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM eliscael@iq.ufrj.br; pinheiro@iq.ufrj.br
RI da Silva Fidalgo, Tatiana Kelly/I-4969-2014; Eleutherio, Elis C
   A/J-5468-2013; Pinheiro, Anderson S/B-6350-2014; Almeida,
   Fabio/O-4989-2018
OI da Silva Fidalgo, Tatiana Kelly/0000-0003-1340-9967; Eleutherio, Elis C
   A/0000-0001-5842-2714; Pinto de Almeida, Natalia/0000-0002-8851-8669;
   Costa dos Santos Junior, Gilson/0000-0002-2038-2267; Pinheiro,
   Anderson/0000-0001-5118-6931; Almeida, Fabio/0000-0001-6046-7006
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Brown University; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
FX Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); Brown University, Grant/Award Number: Brazil
   Initiative Collaboration Grant; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)
CR Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659
   Airoldi C, 2015, MOL BIOSYST, V11, P379, DOI 10.1039/c4mb00452c
   Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749
   Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007
   Alvarez-Venegas R, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-101
   Belkic K, 2017, ISR MED ASSOC J, V19, P517
   Conde VR, 2015, EXP CELL RES, V335, P91, DOI 10.1016/j.yexcr.2015.04.007
   Dastidar RG, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-30
   DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358
   DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003
   Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202
   Elkhaled A, 2014, NMR BIOMED, V27, P578, DOI 10.1002/nbm.3097
   Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Gilbert TM, 2014, MOL CELL PROTEOMICS, V13, P2883, DOI 10.1074/mcp.M114.038224
   Glunde K, 2015, EXPERT REV MOL DIAGN, V15, P735, DOI 10.1586/14737159.2015.1039515
   Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021
   Hu JM, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0982-5
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Icard P, 2012, BBA-REV CANCER, V1826, P423, DOI 10.1016/j.bbcan.2012.07.001
   Irish JC, 2016, MOL ONCOL, V10, P850, DOI 10.1016/j.molonc.2016.02.003
   Jacobs MA, 2004, J MAGN RESON IMAGING, V19, P68, DOI 10.1002/jmri.10427
   Jones DH, 2017, MOL CLIN ONCOL, V7, P301, DOI 10.3892/mco.2017.1289
   Kurhanewicz J, 2002, J MAGN RESON IMAGING, V16, P451, DOI 10.1002/jmri.10172
   Loening NM, 2005, NMR BIOMED, V18, P413, DOI 10.1002/nbm.973
   Massari F, 2016, CANCER TREAT REV, V45, P46, DOI 10.1016/j.ctrv.2016.03.005
   Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5
   Mori N, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00262
   Natter K, 2013, BBA-MOL CELL BIOL L, V1831, P314, DOI 10.1016/j.bbalip.2012.09.003
   Pereira MD, 2003, BBA-GEN SUBJECTS, V1620, P245, DOI 10.1016/S0304-4165(03)00003-5
   Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761
   Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042
   Robinette SL, 2008, ANAL CHEM, V80, P3606, DOI 10.1021/ac702530t
   Rona GB, 2017, ONCOTARGET, V8, P54068, DOI 10.18632/oncotarget.11253
   Rona Germana B, 2016, Biophys Rev, V8, P63, DOI 10.1007/s12551-015-0190-6
   Saloura V, 2017, SCI REP-UK, V7, DOI 10.1038/srep40664
   Saloura V, 2016, ONCOTARGET, V7, P42527, DOI 10.18632/oncotarget.9897
   Seyfried Thomas N, 2015, Front Cell Dev Biol, V3, P43, DOI 10.3389/fcell.2015.00043
   Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6
   Stewart JD, 2012, P NATL ACAD SCI USA, V109, P8155, DOI 10.1073/pnas.1117654109
   Suman S, 2018, J PHARMACEUT BIOMED, V160, P38, DOI 10.1016/j.jpba.2018.07.024
   Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694
   Tian Y, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0255-y
   Trousil S, 2014, CANCER RES, V74, P6867, DOI 10.1158/0008-5472.CAN-13-2409
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Vicente-Munoz S, 2014, FEBS OPEN BIO, V4, P996, DOI 10.1016/j.fob.2014.11.001
   Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200
   Wheatley DN, 2005, SEMIN CANCER BIOL, V15, P247, DOI 10.1016/j.semcancer.2005.04.002
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546
   Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013
   Zhang L, 2017, BIOCHEM BIOPH RES CO, V486, P224, DOI 10.1016/j.bbrc.2017.02.101
   Zhou ZL, 2010, BIOCHEM BIOPH RES CO, V398, P565, DOI 10.1016/j.bbrc.2010.06.119
NR 57
TC 0
Z9 0
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR
PY 2019
VL 120
IS 4
BP 5377
EP 5385
DI 10.1002/jcb.27816
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA HL8RK
UT WOS:000459010100063
PM 30320908
DA 2020-12-01
ER

PT J
AU Faustino, AF
   Barbosa, GM
   Silva, M
   Castanho, MARB
   Da Poian, AT
   Cabrita, EJ
   Santos, NC
   Almeida, FCL
   Martins, IC
AF Faustino, Andre F.
   Barbosa, Glauce M.
   Silva, Micael
   Castanho, Miguel A. R. B.
   Da Poian, Andrea T.
   Cabrita, Eurico J.
   Santos, Nuno C.
   Almeida, Fabio C. L.
   Martins, Ivo C.
TI Fast NMR method to probe solvent accessibility and disordered regions in
   proteins
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IMMUNOGLOBULIN-BINDING DOMAIN; CAPSID PROTEIN; HYDROGEN-EXCHANGE; G B1;
   VISUALIZATION; STABILITY; DATABASE; SURFACE; SYSTEM; SHAPE
AB Understanding protein structure and dynamics, which govern key cellular processes, is crucial for basic and applied research. Intrinsically disordered protein (IDP) regions display multifunctionality via alternative transient conformations, being key players in disease mechanisms. IDP regions are abundant, namely in small viruses, allowing a large number of functions out of a small proteome. The relation between protein function and structure is thus now seen from a different perspective: as IDP regions enable transient structural arrangements, each conformer can play different roles within the cell. However, as IDP regions are hard and time-consuming to study via classical techniques (optimized for globular proteins with unique conformations), new methods are required. Here, employing the dengue virus (DENV) capsid (C) protein and the immunoglobulin-binding domain of streptococcal protein G, we describe a straightforward NMR method to differentiate the solvent accessibility of single amino acid N-H groups in structured and IDP regions. We also gain insights into DENV C flexible fold region biological activity. The method, based on minimal pH changes, uses the well-established H-1-N-15 HSQC pulse sequence and is easily implementable in current protein NMR routines. The data generated are simple to interpret, with this rapid approach being an useful first-choice IDPs characterization method.
C1 [Faustino, Andre F.; Castanho, Miguel A. R. B.; Santos, Nuno C.; Martins, Ivo C.] Univ Lisbon, Inst Med Mol, Fac Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
   [Barbosa, Glauce M.; Da Poian, Andrea T.; Almeida, Fabio C. L.] Univ Fed Rio De Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio De Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage CENABIO, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Silva, Micael; Cabrita, Eurico J.] Univ Nova Lisboa, Dept Quim, UCIBIO, Fac Ciencias & Tecnol, Quinta Torre, P-2829516 Monte De Caparica, Portugal.
   [Faustino, Andre F.] IBET, Apartado 12, P-2780901 Oeiras, Portugal.
RP Santos, NC; Martins, IC (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.; Almeida, FCL (corresponding author), Univ Fed Rio De Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio De Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941902 Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Natl Inst Struct Biol & Bioimage CENABIO, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM nsantos@fm.ul.pt; falmeida@bioqmed.ufrj.br;
   ivomartins@medicina.ulisboa.pt
RI Da Poian, Andrea T./V-1699-2019; Cabrita, Eurico/E-8053-2011; Silva,
   Micael/Q-5474-2019; Silva, Micael/J-2595-2014; Martins, Ivo/G-2534-2013;
   Santos, Nuno/N-7248-2013
OI Cabrita, Eurico/0000-0002-0720-2751; Silva, Micael/0000-0002-0103-4451;
   Silva, Micael/0000-0002-0103-4451; Castanho, Miguel/0000-0001-7891-7562;
   Martins, Ivo/0000-0002-9284-8599; Faustino, Andre
   F./0000-0002-7364-8524; Santos, Nuno/0000-0002-0580-0475
FU Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia,
   Tecnologia e Ensino Superior (FCT-MCTES, Portugal)Portuguese Foundation
   for Science and Technology [PTDC/QUI-BIQ/112929/2009,
   PTDC/SAU-ENB/117013/2010, PTDC/BBB-BQB/3494/2014]; Calouste Gulbenkian
   Foundation (FCG, Portugal) project Science Frontiers Research Prize
   2010; European Union Marie Sklodowska-Curie Research and Innovation
   Staff Exchange H2020-MSCA-RISE-2014 project INPACTEuropean Union (EU)
   [644167]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Brazil)National Council for Scientific and Technological
   Development (CNPq) [471239/2012-7, 306669/2013-7]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/110.636/2012, E-26/110.092/2013,
   E-26/201.167/2014]; FCT-MCTES fellowship [SFRH/BD/77609/2011,
   PD/BD/128202/2016, SFRH/BPD/74287/2010]; Program "Investigador FCT"
   [IF/00772/2013]; FEDER, through POR Lisboa 2020 -Programa Operacional
   Regional de Lisboa, PORTUGAL 2020; Fundacao para a Ciencia e a
   TecnologiaPortuguese Foundation for Science and Technology;
   FCT-MCTESPortuguese Foundation for Science and Technology
   [ROTEIRO/0031/2013 - PINFRA/22161/2016]; FEDER through COMPETE 2020; FCT
   through PIDDAC; POCI; PORL;  [LISBOA01-0145-FEDER-007391]
FX This work was supported by Fundacao para a Ciencia e a Tecnologia -
   Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES,
   Portugal) projects PTDC/QUI-BIQ/112929/2009, PTDC/SAU-ENB/117013/2010
   and PTDC/BBB-BQB/3494/2014, Calouste Gulbenkian Foundation (FCG,
   Portugal) project Science Frontiers Research Prize 2010, European Union
   Marie Sklodowska-Curie Research and Innovation Staff Exchange
   H2020-MSCA-RISE-2014 project INPACT (Grant 644167), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, grant numbers
   471239/2012-7 and 306669/2013-7) and Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil, grant
   numbers E-26/110.636/2012, E-26/110.092/2013 and E-26/201.167/2014). AFF
   acknowledges FCT-MCTES fellowship SFRH/BD/77609/2011. MS acknowledges
   FCT-MCTES fellowship PD/BD/128202/2016. ICM acknowledges consecutive
   funding from the FCT-MCTES fellowship SFRH/BPD/74287/2010 and the
   Program "Investigador FCT" (IF/00772/2013 Research Contract). This work
   was also supported by LISBOA01-0145-FEDER-007391 project, cofunded by
   FEDER, through POR Lisboa 2020 -Programa Operacional Regional de Lisboa,
   PORTUGAL 2020, and Fundacao para a Ciencia e a Tecnologia. The NMR
   spectrometers at FCT NOVA are part of Rede Nacional de RMN (PTNMR),
   supported by FCT-MCTES (ROTEIRO/0031/2013 - PINFRA/22161/2016) co-funded
   by FEDER through COMPETE 2020, POCI, and PORL and FCT through PIDDAC.
CR Andreas LB, 2016, P NATL ACAD SCI USA, V113, P9187, DOI 10.1073/pnas.1602248113
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1
   CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   De Paula VS, 2013, J MOL BIOL, V425, P4479, DOI 10.1016/j.jmb.2013.08.001
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517
   ENGLANDER SW, 1992, ANNU REV BIOPH BIOM, V21, P243, DOI 10.1146/annurev.bb.21.060192.001331
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   GALLAGHER T, 1994, BIOCHEMISTRY-US, V33, P4721, DOI 10.1021/bi00181a032
   GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600
   Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Jensen MR, 2014, CHEM REV, V114, P6632, DOI 10.1021/cr400688u
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021
   Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012
   KOIDE S, 1995, J BIOMOL NMR, V6, P306
   Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723
   Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005
   Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109
   Lindman S, 2006, BIOPHYS J, V90, P2911, DOI 10.1529/biophysj.105.071050
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martins AS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01951
   Martins I. C., 2012, International Patent Publication, Patent No. [WO/ 2012/ 159187, 2012159187]
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004
   Monteith WB, 2014, P NATL ACAD SCI USA, V111, P11335, DOI 10.1073/pnas.1406845111
   ORBAN J, 1995, BIOCHEMISTRY-US, V34, P15291, DOI 10.1021/bi00046a038
   Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649
   Rossi P, 2015, PROTEINS, V83, P309, DOI 10.1002/prot.24719
   Ryabov Y, 2011, J AM CHEM SOC, V133, P6154, DOI 10.1021/ja201020c
   Ryabov Y, 2009, J AM CHEM SOC, V131, P9522, DOI 10.1021/ja902336c
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Toseland CP, 2006, NUCLEIC ACIDS RES, V34, pD199, DOI 10.1093/nar/gkj035
   van der Schot G, 2015, J BIOMOL NMR, V62, P497, DOI 10.1007/s10858-015-9942-7
   van der Schot G, 2013, J BIOMOL NMR, V57, P27, DOI 10.1007/s10858-013-9762-6
   Varadi M, 2014, NUCLEIC ACIDS RES, V42, pD326, DOI 10.1093/nar/gkt960
   Vendruscolo M, 2003, J AM CHEM SOC, V125, P15686, DOI 10.1021/ja036523z
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Zeng JY, 2009, J BIOMOL NMR, V45, P265, DOI 10.1007/s10858-009-9366-3
NR 55
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 7
PY 2019
VL 9
AR 1647
DI 10.1038/s41598-018-37599-z
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK5PC
UT WOS:000458017800115
PM 30733478
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lixa, C
   Mujo, A
   de Magalhaes, MTQ
   Almeida, FCL
   Lima, LMTR
   Pinheiro, AS
AF Lixa, Carolina
   Mujo, Amanda
   de Magalhaes, Mariana T. Q.
   Almeida, Fabio C. L.
   Lima, Luis Mauricio T. R.
   Pinheiro, Anderson S.
TI Oligomeric transition and dynamics of RNA binding by the HuR RRM1 domain
   in solution
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE HuR; RRM; RNA; Structure; Dynamics; Ion-mobility; NMR
ID ANTIGEN-R HUR; RECOGNITION MOTIF DOMAIN; MESSENGER-RNA; BACKBONE
   DYNAMICS; NMR-SPECTROSCOPY; PROTEIN HUR; COMPLEX-FORMATION; STRUCTURAL
   BASIS; GENE-EXPRESSION; N-15
AB Human antigen R (HuR) functions as a major post-transcriptional regulator of gene expression through its RNA-binding activity. HuR is composed by three RNA recognition motifs, namely RRM1, RRM2, and RRM3. The two N-terminal RRM domains are disposed in tandem and contribute mostly to HuR interaction with adenine and uracil-rich elements (ARE) in mRNA. Here, we used a combination of NMR and electrospray ionization-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS) to characterize the structure, dynamics, RNA recognition, and dimerization of HuR RRM1. Our solution structure reveals a canonical RRM fold containing a 19-residue, intrinsically disordered N-terminal extension, which is not involved in RNA binding. NMR titration results confirm the primary RNA-binding site to the two central -strands, 1 and 3, for a cyclooxygenase 2 (Cox2) ARE I-derived, 7-nucleotide RNA ligand. We show by N-15 relaxation that, in addition to the N- and C-termini, the 2-3 loop undergoes fast backbone dynamics (ps-ns) both in the free and RNA-bound state, indicating that no structural ordering happens upon RNA interaction. ESI-IMS-MS reveals that HuR RRM1 dimerizes, however dimer population represents a minority. Dimerization occurs via the -helical surface, which is oppositely orientated to the RNA-binding -sheet. By using a DNA analog of the Cox2 ARE I, we show that DNA binding stabilizes HuR RRM1 monomer and shifts the monomer-dimer equilibrium toward the monomeric species. Altogether, our results deepen the current understanding of the mechanism of RNA recognition employed by HuR.
C1 [Lixa, Carolina; Mujo, Amanda; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, Brazil.
   [de Magalhaes, Mariana T. Q.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941902 Rio De Janeiro, Brazil.
   [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Fac Pharm, BR-21941590 Rio De Janeiro, Brazil.
RP Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, Brazil.
EM pinheiro@iq.ufrj.br
RI Pinheiro, Anderson S/B-6350-2014
OI Pinheiro, Anderson/0000-0001-5118-6931
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brazil Initiative Collaboration Grant from Brown
   University
FX We would like to thank the staff of the UEMP-IBqM-UFRJ (Proteomic/Mass
   Spectrometry Platform) and the CNRMN-UFRJ (NMR Platform) for providing
   access to their facilities and excellent technical support. This work
   was supported by grants from FundacAo Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional
   Cientifico e Tecnologico (CNPq), and by a Brazil Initiative
   Collaboration Grant from Brown University to ASP. CL is recipient of a
   FundacAo Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) "outstanding student" graduate fellowship.
CR Afroz T, 2015, METHOD ENZYMOL, V558, P235, DOI 10.1016/bs.mie.2015.01.015
   BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005
   Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012
   Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043
   Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272
   Blanco FF, 2016, ONCOTARGET, V7, P74043, DOI 10.18632/oncotarget.12189
   Blatter M, 2015, J MOL BIOL, V427, P3001, DOI 10.1016/j.jmb.2015.05.020
   Blaxall BC, 2000, MOL CARCINOGEN, V28, P76
   Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854
   Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002
   Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110
   Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001
   Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200
   de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862
   Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070
   Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987
   Diaz-Quintana A, 2015, FEBS LETT, V589, P1059, DOI 10.1016/j.febslet.2015.03.013
   Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007
   Domingues MN, 2015, J MOL BIOL, V427, P2491, DOI 10.1016/j.jmb.2015.05.017
   Duviganud JB, 2016, BIOCHEMISTRY-US, V10, P2553
   Eichhorn CD, 2016, NUCLEIC ACIDS RES, V44, P9977, DOI 10.1093/nar/gkw833
   Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Giaginis C, 2015, TUMOR BIOL, V36, P315, DOI 10.1007/s13277-014-2637-y
   Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004
   Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6
   Hom RA, 2010, J MOL BIOL, V400, P145, DOI 10.1016/j.jmb.2010.04.067
   Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200
   Joshi A, 2014, PEERJ, V2, DOI 10.7717/peerj.305
   Joshi A, 2011, STRUCTURE, V19, P1816, DOI 10.1016/j.str.2011.09.020
   Kasashima K, 2002, NUCLEIC ACIDS RES, V30, P4519, DOI 10.1093/nar/gkf567
   Katahira M, 2001, J MOL BIOL, V311, P973, DOI 10.1006/jmbi.2001.4862
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kim HS, 2013, RNA BIOL, V10, P579, DOI 10.4161/rna.24341
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kuwasako K, 2017, PROTEIN SCI, V26, P280, DOI 10.1002/pro.3080
   Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   Lopez de Silanes Isabel, 2005, RNA Biol, V2, P11
   Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14
   Meisner NC, 2009, J MOL BIOL, V386, P435, DOI 10.1016/j.jmb.2008.12.020
   Migone F, 2002, GENOME BIOL, V3
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Mujo A, 2015, BIOMOL NMR ASSIGN, V9, P281, DOI 10.1007/s12104-014-9592-9
   Murachelli AG, 2012, NAT STRUCT MOL BIOL, V19, P378, DOI 10.1038/nsmb.2242
   Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   Samatanga B, 2017, NUCLEIC ACIDS RES, V45, P6037, DOI 10.1093/nar/gkx136
   Scheiba RM, 2014, RNA BIOL, V11, P1250, DOI 10.1080/15476286.2014.996069
   Schelhorn C, 2014, NUCLEIC ACIDS RES, V42, P10185, DOI 10.1093/nar/gku700
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Singh M, 2013, RNA BIOL, V10, P353, DOI 10.4161/rna.23608
   Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018
   Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105
   Song ZW, 2012, BIOCHEMISTRY-US, V51, P6667, DOI 10.1021/bi300539t
   Soufari H, 2017, RNA, V23, P308, DOI 10.1261/rna.059733.116
   STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003
   Tsuda K, 2014, PROTEINS, V82, P2879, DOI 10.1002/prot.24651
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828
   Wang I, 2014, NUCLEIC ACIDS RES, V42, P5949, DOI 10.1093/nar/gku193
   Williams JP, 2009, RAPID COMMUN MASS SP, V23, P3563, DOI 10.1002/rcm.4285
   Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011
   Zhang J, 2017, NUCLEIC ACIDS RES, V45, P2829, DOI 10.1093/nar/gkw961
   Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200
   Zhu ZP, 2013, TUMOR BIOL, V34, P2299, DOI 10.1007/s13277-013-0774-3
NR 71
TC 3
Z9 3
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD DEC
PY 2018
VL 72
IS 3-4
BP 179
EP 192
DI 10.1007/s10858-018-0217-y
PG 14
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA HE3SZ
UT WOS:000453281600007
PM 30535889
DA 2020-12-01
ER

PT J
AU Machado, LESF
   De Paula, VS
   Pustovalova, Y
   Bezsonova, I
   Valente, AP
   Korzhnev, DM
   Almeida, FCL
AF Machado, Luciana E. S. F.
   De Paula, Viviane S.
   Pustovalova, Yulia
   Bezsonova, Irina
   Valente, Ana Paula
   Korzhnev, Dmitry M.
   Almeida, Fabio C. L.
TI Conformational Dynamics of a Cysteine-Stabilized Plant Defensin Reveals
   an Evolutionary Mechanism to Expose Hydrophobic Residues
SO BIOCHEMISTRY
LA English
DT Article
ID NMR RELAXATION DISPERSION; PISUM-SATIVUM DEFENSIN-1; FYN SH3 DOMAIN;
   ANTIMICROBIAL PEPTIDES; EXCHANGE DYNAMICS; CHEMICAL-SHIFTS; PROTEIN;
   INTERMEDIATE; STATE; N-15
AB Sugar cane defensin 5 (Sd5) is a small antifungal protein, whose structure is held together by four conserved disulfide bridges. Sd5 and other proteins sharing a cysteine-stabilized alpha-beta (CS alpha beta) fold lack a regular hydrophobic core. Instead, they are stabilized by tertiary contacts formed by surface-exposed hydrophilic and hydrophobic residues. Despite excessive cross-links, Sd5 exhibits complex millisecond conformational dynamics involving all secondary structure elements. We used Carr-Purcell-Meiboom-Gill (CPMG) NMR relaxation dispersion (RD) measurements performed at different temperatures and denaturant concentrations to probe brief excursions of Sd5 to a sparsely populated "excited" state. Temperature-dependent CPMG RD experiments reveal that the excited state is enthalpically unfavorable, suggesting a rearrangement of stabilizing contacts formed by surface-exposed side chains and/or secondary structure, while the experiments performed at different denaturant concentrations suggest a decrease in accessible surface area of Sd5 in the excited state. The measured backbone N-15 chemical shift changes point to a global conformational rearrangement such as a potential alpha- to beta-transition of the Sd5 alpha-helix or other major secondary structure reorganization and concomitant conformational changes in other parts of the protein. Overall, the emerging picture of Sd5 dynamics suggests this protein can populate two alternative well-ordered conformational states, with the excited conformer being more compact than the native state and having a distinct secondary structure and side-chain arrangements. The observation of an energetically unfavorable yet more compact excited state reveals a remarkable evolution of the CS alpha beta fold to expose and reorganize hydrophobic residues, which enables the creation of versatile binding sites.
C1 [Machado, Luciana E. S. F.; De Paula, Viviane S.; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.
   [Machado, Luciana E. S. F.; De Paula, Viviane S.; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, BR-21941902 Rio De Janeiro, Brazil.
   [Machado, Luciana E. S. F.; Pustovalova, Yulia; Bezsonova, Irina; Korzhnev, Dmitry M.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, BR-21941902 Rio De Janeiro, Brazil.; Korzhnev, DM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.
EM korzhniev@uchc.edu; falmeida@bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [215141, 210361, 204432]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [209306/2013-2, 457773/2014-6]; FINEPCiencia Tecnologia e Inovacao
   (FINEP) [0267/16]
FX The work presented here was funded by FAPERJ grants 215141, 210361, and
   204432 awarded to F.C.L.A., CNPq grants 209306/2013-2 and 457773/2014-6
   awarded to F.C.L.A., and FINEP grant 0267/16 awarded to F.C.L.A.
CR Aerts AM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00047
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   Boehm T, 2012, ANNU REV GENOM HUM G, V13, P127, DOI 10.1146/annurev-genom-090711-163747
   Choy WY, 2005, J AM CHEM SOC, V127, P5066, DOI 10.1021/ja042560u
   Cruzeiro-Silva C, 2014, BIOCHEMISTRY-US, V53, P2890, DOI 10.1021/bi401542v
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   De Paula VS, 2013, J MOL BIOL, V425, P4479, DOI 10.1016/j.jmb.2013.08.001
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y
   Fersht A., 1999, LAVOISIER
   Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001
   Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008
   Gachomo EW, 2012, MOL BIOL REP, V39, P4461, DOI 10.1007/s11033-011-1235-y
   Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615
   Hansen AL, 2012, J AM CHEM SOC, V134, P3178, DOI 10.1021/ja210711v
   Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x
   Korzhnev DM, 2005, J AM CHEM SOC, V127, P15602, DOI 10.1021/ja054550e
   Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855
   Korzhnev DM, 2006, J AM CHEM SOC, V128, P5262, DOI 10.1021/ja0601540
   Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655
   Korzhnev DM, 2007, J MOL BIOL, V372, P497, DOI 10.1016/j.jmb.2007.06.012
   Korzhnev DM, 2006, BIOCHEMISTRY-US, V45, P10175, DOI 10.1021/bi0611560
   Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lacerda AF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00116
   Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j
   MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152
   MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466
   Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004
   Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Neudecker P, 2006, J BIOMOL NMR, V34, P129, DOI 10.1007/s10858-006-0001-2
   Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521
   Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079
   Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x
   Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Thomma Bart P. H. J., 2003, Current Drug Targets - Infectious Disorders, V3, P1, DOI 10.2174/1568005033342000
   Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Valente AP, 2013, MOLECULES, V18, P11311, DOI 10.3390/molecules180911311
   Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101
NR 47
TC 4
Z9 4
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 9
PY 2018
VL 57
IS 40
BP 5797
EP 5806
DI 10.1021/acs.biochem.8b00753
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GW8OK
UT WOS:000447238100005
PM 30207151
DA 2020-12-01
ER

PT J
AU Pinheiro, GMS
   Amorim, GC
   Iqbal, A
   Ramos, CHI
   Almeida, FCL
AF Pinheiro, Glaucia M. S.
   Amorim, Gisele C.
   Iqbal, Anwar
   Ramos, C. H. I.
   Almeida, Fabio C. L.
TI H-1, N-15 and C-13 resonance assignments of the J-domain of co-chaperone
   Sis1 from Saccharomyces cerevisiae
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE HSP40 type II; Co-chaperone; J-domain; NMR
ID MOLECULAR CHAPERONES; HSP70 CHAPERONES; NMR-SPECTROSCOPY; LARGER
   PROTEINS; CHEMICAL-SHIFTS; DNAJ; BACKBONE; HSP40; TRANSLOCATION;
   SPECIFICITY
AB Protein folding in the cell is usually aided by molecular chaperones, from which the Hsp70 (Hsp=heat shock protein) family has many important roles, such as aiding nascent folding and participating in translocation. Hsp70 has ATPase activity which is stimulated by binding to the J-domain present in co-chaperones from the Hsp40 family. Hsp40s have many functions, as for instance the binding to partially folded proteins to be delivered to Hsp70. However, the presence of the J-domain characterizes Hsp40s or, by this reason, as J-proteins. The J-domain alone can stimulate Hsp70 ATPase activity. Apparently, it also maintains the same conformation as in the whole protein although structural information on full J-proteins is still missing. This work reports the H-1, N-15 and C-13 resonance assignments of the J-domain of a Hsp40 from Saccharomyces cerevisiae, named Sis1. Secondary structure and order parameter prediction from chemical shifts are also reported. Altogether, the data show that Sis1 J-domain is highly structured and predominantly formed by -helices, results that are in very good agreement with those previously reported for the crystallographic structure.
C1 [Pinheiro, Glaucia M. S.; Ramos, C. H. I.] Univ Estadual Campinas, UNICAMP, Inst Chem, Campinas, SP, Brazil.
   [Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil.
   [Amorim, Gisele C.; Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, RJ, Brazil.
   [Amorim, Gisele C.] Univ Fed Rio de Janeiro, Numpex Bio, Duque De Caxias, RJ, Brazil.
RP Ramos, CHI (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Chem, Campinas, SP, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance CNRMN, Natl Ctr Struct Biol & Bioimaging CENABIO, Rio De Janeiro, RJ, Brazil.
EM cramos@iqm.unicamp.br; falmeida@bioqmed.ufrj.br
RI Ramos, CH/C-1571-2012
OI Ramos, CH/0000-0002-7246-9081
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Biomagnetic Resonance Data Bank (BMRB) [27405]
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). The chemical shift
   assignments is available at Biomagnetic Resonance Data Bank (BMRB ID
   27405).
CR Borges JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050927
   CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X
   Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108
   GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003
   HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   JOHN BK, 1993, J MAGN RESON SER A, V101, P113, DOI 10.1006/jmra.1993.1019
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0
   Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452
   Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6
   Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019
   Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156
   Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042
   Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40
   Tiroli-Cepeda AO, 2011, PROTEIN PEPTIDE LETT, V18, P101
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172
   Wolfe KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095914
   Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315
   YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005
   YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099
   Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD OCT
PY 2018
VL 12
IS 2
BP 279
EP 281
DI 10.1007/s12104-018-9823-6
PG 3
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA GS6QY
UT WOS:000443824500012
PM 29713947
DA 2020-12-01
ER

PT J
AU Moraes, AH
   Asam, C
   Almeida, FCL
   Wallner, M
   Ferreira, F
   Valente, AP
AF Moraes, Adolfo H.
   Asam, Claudia
   Almeida, Fabio C. L.
   Wallner, Michael
   Ferreira, Fatima
   Valente, Ana Paula
TI Structural basis for cross-reactivity and conformation fluctuation of
   the major beech pollen allergen Fag s 1
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BET V 1; NMR-SPECTROSCOPY; RELAXATION DISPERSION; BACKBONE DYNAMICS;
   CHEMICAL-SHIFTS; PROTEIN; STATES; EXCHANGE; ANTIBODY; LIGANDS
AB Fag s 1 is a member of the Pathogen Related protein family 10 (PR-10) and can elicit cross-reaction with IgE antibodies produced against the birch pollen allergen Bet v1. The Nuclear Magnetic Resonance (NMR) structure of Fag s 1 is presented along with its dynamic properties. It shares 66% identity with Bet v 1 and exhibits the expected three a-helices and seven beta-sheets arranged as a semi-beta barrel and exposing the residues mapped as the Bet v 1 IgE epitope. The structural dynamics of Fag s 1 were monitored on the fast and intermediate timescales, using relaxation rates. The complex dynamics of Fag s 1 are closely related to the internal cavity, and they modulate IgE and ligand binding.
C1 [Moraes, Adolfo H.] Univ Fed Minas Gerais, Chem Dept, Belo Horizonte, MG, Brazil.
   [Asam, Claudia; Wallner, Michael; Ferreira, Fatima] Univ Salzburg, Dept Mol Biol, Salzburg, Austria.
   [Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Dept Struct Biol, Natl NMR Ctr, Rio De Janeiro, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Dept Struct Biol, Natl NMR Ctr, Rio De Janeiro, Brazil.
EM valente.anap@gmail.com
RI Valente, Ana Paula/J-3010-2017; Ferreira, Fatima/AAB-4321-2019; Moraes,
   Adolfo/G-3931-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Ferreira,
   Fatima/0000-0003-0989-2335; Moraes, Adolfo/0000-0002-3344-4084
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Austrian
   Science Fund FWFAustrian Science Fund (FWF) [P27589]
FX We thank Prof. Dmitry M. Korzhnev (UConn Health-USA) for useful
   comments. A.P.V. acknowledges receipt of a research grant from CNPq and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ);
   A.P.V. and F.C.L.A. are recipients of CNPq research fellowships; and
   A.P.V. and F.C.L.A. are recipients of FAPERJ research fellowships. F.F.,
   C.A. and M.W. acknowledge receipt of a research grant from the Austrian
   Science Fund FWF (P27589).
CR Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016
   Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200
   Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361
   Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887
   Borkar AN, 2016, P NATL ACAD SCI USA, V113, P7171, DOI 10.1073/pnas.1521349113
   Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349
   Brunger A., 1998, CRYSTALLOGR, P905
   Choy WY, 2005, J AM CHEM SOC, V127, P5066, DOI 10.1021/ja042560u
   De Simone A., 2015, ELIFE, V2015, P1
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114
   Ferrolino MC, 2013, BIOCHEMISTRY-US, V52, P8843, DOI 10.1021/bi4013462
   Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001
   Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670
   Grutsch S, 2014, BIOPHYS J, V107, P2963, DOI 10.1016/j.bpj.2014.10.062
   Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615
   Hauser M, 2011, CLIN EXP ALLERGY, V41, P1804, DOI 10.1111/j.1365-2222.2011.03866.x
   Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1
   Homans SW, 2007, TOP CURR CHEM, V272, P51, DOI 10.1007/128_2006_090
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kofler S, 2012, J MOL BIOL, V422, P109, DOI 10.1016/j.jmb.2012.05.016
   Korzhnev D. E, 2001, PRACTICAL ASPECTS NM
   Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y
   Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315
   Lisova O, 2014, J MOL RECOGNIT, V27, P205, DOI 10.1002/jmr.2352
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Mcconnell H. M, 1958, J CHEM PHYS, V430, P11
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200
   Moraes AH, 2016, BIOMOL NMR ASSIGN, V10, P45, DOI 10.1007/s12104-015-9634-y
   Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286
   Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39
   Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]
   Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419
   von Loetzen CS, 2012, BIOSCIENCE REP, V32, P567, DOI 10.1042/BSR20120058
   Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735
   Yanaka S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10246-9
NR 42
TC 4
Z9 4
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 12
PY 2018
VL 8
AR 10512
DI 10.1038/s41598-018-28358-1
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM7ET
UT WOS:000438343600022
PM 30002383
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Almeida, PA
   Fidalgo, TKS
   Freitas-Fernandes, LB
   Almeida, FCL
   Souza, IPR
   Valente, AP
AF Almeida, Priscila A.
   Fidalgo, Tatiana K. S.
   Freitas-Fernandes, Liana B.
   Almeida, Fabio C. L.
   Souza, Ivete P. R.
   Valente, Ana Paula
TI Salivary metabolic profile of children and adolescents after
   hemodialysis
SO METABOLOMICS
LA English
DT Article
DE Saliva; Metabolomics; Chronic kidney disease; Children; Adolescent
ID CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; CALCULUS; METABONOMICS;
   DIAGNOSTICS
AB Introduction The application of metabolomic analysis in the pediatric nephrology field may offer an innovative approach to profile analysis of renal diseases.
   Objective We aimed to analyze the salivary the major metabolites in the saliva of children and adolescents with chronic kidney disease (CKD) before and after hemodialysis.
   Method Thirty-six children diagnosed with CKD and forty healthy children were recruited for the study. H-1-NMR spectra were analyzed using multivariate and univariate approaches.
   Results The CKD and the healthy control groups presented with similar numbers of dental caries (p > 0.05) as determined by the number of decayed, missing, or filled deciduous teeth (0.87 +/- 2.2 and 0.67 +/- 2.1, respectively) or permanent teeth (0.79 +/- 1.30 and 0.90 +/- 1.7, respectively). The amount of dental calculus was significantly higher in the CKD group than in the healthy control group (p < 0.001). Multivariate analyses using PLS-DA and O-PLS-DA demonstrated differences in the salivary metabolome of CKD patients before and after hemodialysis, as well as between post-dialysis CKD patients and healthy controls, suggesting that HD was not able to recover oral homeostasis. PLSDA and OPLS-DA models showed satisfactory accuracy (ACC = 0.72) and prediction (0.64). On multivariate and univariate analyses, urea, acetate, ethanol, and fatty acid were significantly decreased in CKD saliva after hemodialysis. By contrast, saliva from the healthy controls had significantly higher levels of acetate and propionate and lower levels of ethanol, lactate, butyrate, phenylalanine, and creatinine than saliva from post-dialysis CKD patients.
   Conclusion Our results demonstrate that hemodialysis alters the expression of salivary metabolites; however, this alteration does not reestablish the healthy salivary metabolome, as the salivary metabolomic profile of healthy children is significantly different from that of children and adolescents with CKD, both before and after hemodialysis. The unique salivary characteristics of children with CKD may influence their oral health status.
C1 [Almeida, Priscila A.; Freitas-Fernandes, Liana B.; Souza, Ivete P. R.] Univ Fed Rio de Janeiro, Dept Pediat Dent & Orthodont, Sch Dent, Rio De Janeiro, RJ, Brazil.
   [Fidalgo, Tatiana K. S.] Univ Estado Rio De Janeiro, Sch Dent, Dept Prevent & Community Dent, Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance, Med Biochem Inst, Rio De Janeiro, RJ, Brazil.
RP Souza, IPR (corresponding author), Univ Fed Rio de Janeiro, Dept Pediat Dent & Orthodont, Sch Dent, Rio De Janeiro, RJ, Brazil.; Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance, Med Biochem Inst, Rio De Janeiro, RJ, Brazil.
EM pomarico@gmail.com; valente.anap@gmail.com
RI Valente, Ana Paula/J-3010-2017; da Silva Fidalgo, Tatiana
   Kelly/I-4969-2014
OI Valente, Ana Paula/0000-0001-7219-1123; da Silva Fidalgo, Tatiana
   Kelly/0000-0003-1340-9967; Souza, Ivete Pomarico/0000-0003-0449-6624
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [306214/2013, 303785/2014-4, 426265/2016-5]; Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [201.278/2014, 620.012/2015, 202.902/2015]; Centro
   Nacional de Ressonancia Magnetica Nuclear (CNRMN); Instituto Nacional de
   Ciencia and Tecnologia de Biologia Estrutural e Bioimagem (InBEB)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq (306214/2013; 303785/2014-4;
   426265/2016-5), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro - FAPERJ (201.278/2014; 620.012/2015;
   202.902/2015), Centro Nacional de Ressonancia Magnetica Nuclear (CNRMN),
   and Instituto Nacional de Ciencia and Tecnologia de Biologia Estrutural
   e Bioimagem (InBEB).
CR Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2
   Arregger AL, 2008, STEROIDS, V73, P77, DOI 10.1016/j.steroids.2007.09.001
   Benmoussa L, 2015, J ORAL MAXIL SURG, V73, P2142, DOI 10.1016/j.joms.2015.05.029
   Desai AA, 2009, HEMODIAL INT, V13, P347, DOI 10.1111/j.1542-4758.2009.00377.x
   DRIESSENS FCM, 1985, J PERIODONTAL RES, V20, P329, DOI 10.1111/j.1600-0765.1985.tb00442.x
   EPSTEIN SR, 1980, J PERIODONTOL, V51, P336, DOI 10.1902/jop.1980.51.6.336
   Fidalgo TKS, 2015, METABOLOMICS, V11, P583, DOI 10.1007/s11306-014-0717-z
   Fidalgo TKS, 2013, METABOLOMICS, V9, P657, DOI 10.1007/s11306-012-0484-7
   Fujiwara M, 2015, J PHARMACEUT BIOMED, V111, P159, DOI 10.1016/j.jpba.2015.03.035
   Fujiwara M, 2009, ANAL BIOANAL CHEM, V394, P1655, DOI 10.1007/s00216-009-2830-9
   Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2
   Gupta M, 2015, SAUDI DENT J, V27, P113, DOI 10.1016/j.sdentj.2014.11.014
   Hocher B, 2017, NAT REV NEPHROL, V13, P269, DOI 10.1038/nrneph.2017.30
   Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011
   Jankowski J, 2001, KIDNEY INT, V59, P1134, DOI 10.1046/j.1523-1755.2001.00599.x
   Kaysen GA, 2007, KIDNEY INT, V72, P779, DOI 10.1038/sj.ki.5002478
   Klassen Judith T, 2002, J Can Dent Assoc, V68, P34
   Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379
   Liu JY, 2012, ORAL ONCOL, V48, P569, DOI 10.1016/j.oraloncology.2012.01.021
   MANHOLD JH, 1965, J PERIODONTOL, V36, P299, DOI 10.1902/jop.1965.36.4.299
   Martins C, 2008, PEDIATR NEPHROL, V23, P619, DOI 10.1007/s00467-007-0718-5
   Martins C, 2012, PEDIATR NEPHROL, V27, P1961, DOI 10.1007/s00467-012-2194-9
   Moco S, 2013, PEDIATR RES, V73, P570, DOI 10.1038/pr.2013.1
   Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a
   PETERSON S, 1985, PEDIATR RES, V19, P796, DOI 10.1203/00006450-198508000-00003
   de Oliveira LRP, 2016, J PROTEOME RES, V15, P2491, DOI 10.1021/acs.jproteome.6b00007
   Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042
   Seethalakshmi C, 2014, J CLIN DIAGN RES, V8, pCC12, DOI 10.7860/JCDR/2014/10404.5306
   Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613
   Staples A, 2010, CURR OPIN PEDIATR, V22, P161, DOI 10.1097/MOP.0b013e328336ebb0
   Tomas I, 2008, ARCH ORAL BIOL, V53, P528, DOI 10.1016/j.archoralbio.2008.01.006
   van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j
   Walt DR, 2007, ANN NY ACAD SCI, V1098, P389, DOI 10.1196/annals.1384.031
   WHO, 1997, ORAL HLTH SURVEYS BA
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Wong CJ, 2012, AM J KIDNEY DIS, V60, P1002, DOI 10.1053/j.ajkd.2012.07.018
   Wong H, 2006, KIDNEY INT, V70, P585, DOI 10.1038/sj.ki.5001608
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027
NR 39
TC 4
Z9 4
U1 2
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD NOV
PY 2017
VL 13
IS 11
AR 141
DI 10.1007/s11306-017-1283-y
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FK6HJ
UT WOS:000413603800017
DA 2020-12-01
ER

PT J
AU Iqbal, A
   Almeida, FCL
AF Iqbal, Anwar
   Almeida, Fabio C. L.
TI H-1, C-13 and N-15 chemical shift assignments of Saccharomyces
   cerevisiae type 1 thioredoxin in the oxidized state by solution NMR
   spectroscopy
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Thioredoxin-1; NMR; Protein structure; Catalytic activity; Redox;
   Secondary structure prediction
ID PROTEIN SECONDARY STRUCTURE; REDUCED FORM; TORSION ANGLES; WATER CAVITY;
   REDUCTASE; SYSTEM; BACKBONE; EXCHANGE; INDEX
AB Thioredoxins (Trx) are ubiquitous proteins that regulate several biochemical processes inside the cell. Trx is an important player, displaying oxidoreductase activity and helping to keep and regulate the oxidative state of the cellular environment. Trx also participates in the regulation of many cellular functions, such as DNA synthesis, protection against oxidative stress, cell cycle and signal transduction. The oxidized Trx is the target for another set of proteins, such as thioredoxin reductase (TrR), which used the reductive potential of NADPH. The oxidized state of Trx also plays important role in regulation of redox state in the cells. In this regard, the oxidized form of Trx is a putative conformer that contributes to the cellular redox environment. Here we report the chemical shift assignments (H-1, C-13 and N-15) in solution at 15 degrees C. We also showed the secondary structure analysis of the oxidized form of yeast thioredoxin (yTrx1) as basis for future NMR studies of protein-target interactions and dynamics. The assignment was done at low concentration (200 mu M) because it is important to keep intact the water cavity.
C1 [Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, CCS CNRMN, Av Carlos Chagas Filho 373, BR-21941599 Rio De Janeiro, RJ, Brazil.
   [Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, CCS CNRMN, Av Carlos Chagas Filho 373, BR-21941599 Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.
EM falmeida@bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); CAPES (Brazil)CAPES; FAPERJ (Rio de Janeiro,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); program PAPD of FAPERJ
FX This work is supported by the following funding agencies: CNPq (Brazil),
   CAPES (Brazil) and FAPERJ (Rio de Janeiro, Brazil). AI is supported by
   the program PAPD of FAPERJ.
CR Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P716, DOI 10.1016/j.bbapap.2008.12.016
   Cruzeiro-Silva C, 2014, BIOCHEMISTRY-US, V53, P2890, DOI 10.1021/bi401542v
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Ebrahimian T, 2008, ANTIOXID REDOX SIGN, V10, P1127, DOI 10.1089/ars.2007.1985
   Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   Iqbal A, 2015, J BIOMOL NMR, V63, P417, DOI 10.1007/s10858-015-9996-6
   Iqbal A, 2015, BIOCHEMISTRY-US, V54, P2429, DOI 10.1021/acs.biochem.5b00082
   KALLIS GB, 1980, J BIOL CHEM, V255, P261
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695
   MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X
   Mukherjee A, 2008, BRIT J RADIOL, V81, pS57, DOI 10.1259/bjr/34180435
   Netto LES, 2016, FREE RADICAL RES, V50, P206, DOI 10.3109/10715762.2015.1120864
   Pinheiro AS, 2008, PROTEINS, V70, P584, DOI 10.1002/prot.21693
   Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
   World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6
NR 26
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD OCT
PY 2017
VL 11
IS 2
BP 221
EP 224
DI 10.1007/s12104-017-9752-9
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA FG6HO
UT WOS:000410473300020
PM 28808882
DA 2020-12-01
ER

PT J
AU Santos, GC
   Zeidler, JD
   Perez-Valencia, JA
   Sant'Anna-Silva, ACB
   Da Poian, AT
   El-Bacha, T
   Almeida, FCL
AF Santos, G. C.
   Zeidler, J. D.
   Perez-Valencia, J. A.
   Sant'Anna-Silva, A. C. B.
   Da Poian, A. T.
   El-Bacha, T.
   Almeida, F. C. L.
TI Metabolomic Analysis Reveals Vitamin D-induced Decrease in Polyol
   Pathway and Subtle Modulation of Glycolysis in HEK293T Cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID UP-REGULATED PROTEIN-1; 1,25-DIHYDROXYVITAMIN D-3; OXIDATIVE STRESS;
   THIOREDOXIN FUNCTION; MUSCLE-CELLS; SYSTEM; TXNIP; EXPRESSION; SORBITOL;
   CANCER
AB We combined H-1 NMR metabolomics with functional and molecular biochemical assays to describe the metabolic changes elicited by vitamin D in HEK293T, an embryonic proliferative cell line adapted to high-glucose concentrations. Activation of the polyol pathway, was the most important consequence of cell exposure to high glucose concentration, resembling cells exposed to hyperglycemia. Vitamin D induced alterations in HEK293T cells metabolism, including a decrease in sorbitol, glycine, glutamate, guanine. Vitamin D modulated glycolysis by increasing phosphoglycerate mutase and decreasing enolase activities, changing carbon fate without changing glucose consumption, lactate export and Krebs cycle. The decrease in sorbitol intracellular concentration seems to be related to vitamin D regulated redox homeostasis and protection against oxidative stress, and helped maintaining the high proliferative phenotype, supported by the decrease in glycine and guanine and orotate concentration and increase in choline and phosphocholine concentration. The decrease in orotate and guanine indicated an increased biosynthesis of purine and pyrimidines. Vitamin D elicited metabolic alteration without changing cellular proliferation and mitochondrial respiration, but reclaiming reductive power. Our study may contribute to the understanding of the metabolic mechanism of vitamin D upon exposure to hyperglycemia, suggesting a role of protection against oxidative stress.
C1 [Santos, G. C.; Zeidler, J. D.; Perez-Valencia, J. A.; Sant'Anna-Silva, A. C. B.; Da Poian, A. T.; Almeida, F. C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Leopoldo De Meis, Brazil.
   [Santos, G. C.; El-Bacha, T.; Almeida, F. C. L.] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.
   [El-Bacha, T.] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil.
RP Santos, GC; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Leopoldo De Meis, Brazil.; Santos, GC; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Natl Ctr Nucl Magnet Resonance CNRMN, Rio De Janeiro, Brazil.
EM gcjunior@bioqmed.ufrj.br; falmeida@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Perez-Valencia, Juan
   Alberto/AAX-7487-2020
OI Perez-Valencia, Juan Alberto/0000-0002-8282-1763; Zeidler, Julianna
   D./0000-0003-3168-1518
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); National Cancer
   Foundation
FX We thank CNPq, CAPES, FAPERJ, National Cancer Foundation for funding.
CR Bener A, 2016, DIABETES METAB SYND, V10, P198, DOI 10.1016/j.dsx.2016.06.007
   Bhatia M, 2016, REDOX BIOL, V8, P68, DOI 10.1016/j.redox.2015.12.004
   Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bortman P, 2002, BRAZ J MED BIOL RES, V35, P1, DOI 10.1590/S0100-879X2002000100001
   Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S
   CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9
   Ciampi R, 2008, MOL CELL ENDOCRINOL, V291, P57, DOI 10.1016/j.mce.2008.05.003
   Clarson LH, 1997, PLACENTA, V18, P333, DOI 10.1016/S0143-4004(97)80068-9
   DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149
   Devi TS, 2013, EXP CELL RES, V319, P1001, DOI 10.1016/j.yexcr.2013.01.012
   El-Bacha T, 2016, J VIROL, V90, P7429, DOI 10.1128/JVI.00187-16
   Fukumoto Seiji, 2014, Bonekey Rep, V3, P497, DOI 10.1038/bonekey.2013.231
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Glunde K., 2011, NAT REV CANCER, V23, P1
   GRUNEWALD RW, 1995, AM J PHYSIOL-RENAL, V269, pF696
   HANSEN CM, 1994, CLIN EXP METASTAS, V12, P195, DOI 10.1007/BF01753887
   Hao W, 2015, J BIOL CHEM, V290, P17106, DOI 10.1074/jbc.M114.631291
   Hill NT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.148
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Jung DW, 2013, ACS CHEM BIOL, V8, P1271, DOI 10.1021/cb300687k
   Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287
   Kotsa K, 2009, FERTIL STERIL, V92, P1053, DOI 10.1016/j.fertnstert.2008.07.1757
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   Li YC, 2002, J CLIN INVEST, V110, P229, DOI [10.1172/JCI200215219, 10.1172/JCI0215219]
   Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016
   Lokeshwar BL, 1999, CANCER EPIDEM BIOMAR, V8, P241
   Luque-Cordoba D, 2017, J PHARMACEUT BIOMED, V136, P22, DOI 10.1016/j.jpba.2016.12.023
   MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W
   Morrison JA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-62
   Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645
   NORMAN AW, 1982, ENDOCR REV, V3, P331, DOI 10.1210/edrv-3-4-331
   Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177
   Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158
   Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200
   Pereira DSA, 2009, BIOCHEM J, V417, P717, DOI DOI 10.1042/BJ20080805
   Reher M, 2007, FEMS MICROBIOL LETT, V273, P196, DOI 10.1111/j.1574-6968.2007.00787.x
   Rodrigues M. F., 2015, BIOCHEM J, DOI [10.1042/BJ20150645, DOI 10.1042/BJ20150645(2015]
   Ryan ZC, 2016, J BIOL CHEM, V291, P1514, DOI 10.1074/jbc.M115.684399
   SAKAKIBARA F, 1993, DIABETES, V42, P1594, DOI 10.2337/diabetes.42.11.1594
   Shao W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-197
   Sharavana G., 2016, EUR J NUTR, DOI [10.1007/s00394-016-1283-0, DOI 10.1007/S00394-016-1283-0(2016)]
   Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008
   Song YR, 2003, ENDOCRINOLOGY, V144, P3885, DOI 10.1210/en.2003-0314
   Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3
   Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k
   TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926
   WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2525, DOI 10.1073/pnas.88.6.2525
   Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6
   Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699
   Zheng W, 2013, J STEROID BIOCHEM, V138, P79, DOI 10.1016/j.jsbmb.2013.03.012
   Zhou JB, 2013, MITOCHONDRION, V13, P163, DOI 10.1016/j.mito.2012.06.004
   Zhou XZ, 2016, J STEROID BIOCHEM, V163, P147, DOI 10.1016/j.jsbmb.2016.04.022
NR 56
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 25
PY 2017
VL 7
AR 9510
DI 10.1038/s41598-017-10006-9
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE8IK
UT WOS:000408448600047
PM 28842639
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Verly, RM
   Resende, JM
   Junior, EFC
   de Magalhaes, MTQ
   Guimaraes, CFCR
   Munhoz, VHO
   Bemquerer, MP
   Almeida, FCL
   Santoro, MM
   Pilo-Veloso, D
   Bechinger, B
AF Verly, Rodrigo M.
   Resende, Jarbas M.
   Junior, Eduardo F. C.
   de Magalhaes, Mariana T. Q.
   Guimaraes, Carlos F. C. R.
   Munhoz, Victor H. O.
   Bemquerer, Marcelo Porto
   Almeida, Fabio C. L.
   Santoro, Marcelo M.
   Pilo-Veloso, Dorila
   Bechinger, Burkhard
TI Structure and membrane interactions of the homodimeric antibiotic
   peptide homotarsinin
SO SCIENTIFIC REPORTS
LA English
DT Article
ID STATE NMR-SPECTROSCOPY; ISOTHERMAL TITRATION CALORIMETRY; ANTIMICROBIAL
   PEPTIDES; PORE FORMATION; SECONDARY STRUCTURE; BIOLOGICAL-ACTIVITY;
   CIRCULAR-DICHROISM; INSECT IMMUNITY; CHEMICAL-SHIFTS; LIPID-MEMBRANES
AB Antimicrobial peptides (AMPs) from amphibian skin are valuable template structures to find new treatments against bacterial infections. This work describes for the first time the structure and membrane interactions of a homodimeric AMP. Homotarsinin, which was found in Phyllomedusa tarsius anurans, consists of two identical cystine-linked polypeptide chains each of 24 amino acid residues. The high-resolution structures of the monomeric and dimeric peptides were determined in aqueous buffers. The dimer exhibits a tightly packed coiled coil three-dimensional structure, keeping the hydrophobic residues screened from the aqueous environment. An overall cationic surface of the dimer assures enhanced interactions with negatively charged membranes. An extensive set of biophysical data allowed us to establish structure-function correlations with antimicrobial assays against Gram-positive and Gram-negative bacteria. Although both peptides present considerable antimicrobial activity, the dimer is significantly more effective in both antibacterial and membrane biophysical assays.
C1 [Verly, Rodrigo M.; Resende, Jarbas M.; Guimaraes, Carlos F. C. R.; Munhoz, Victor H. O.; Pilo-Veloso, Dorila] Univ Fed Minas Gerais, Dept Quim, POB 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Verly, Rodrigo M.; Junior, Eduardo F. C.; Guimaraes, Carlos F. C. R.; Munhoz, Victor H. O.] Univ Fed Vales Jequitinhonha & Mucuri, Dept Quim, BR-39100000 Diamantina, MG, Brazil.
   [de Magalhaes, Mariana T. Q.; Santoro, Marcelo M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, POB 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Bemquerer, Marcelo Porto] Empresa Brasileira Pesquisa Agr EMBRAPA Recursos, Lab Espectrometria Massa, Estacao Parque Biol, Final W5, BR-70770900 Brasilia, DF, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas CNRMN, Rio De Janeiro, Brazil.
   [Bechinger, Burkhard] Univ Strasbourg, Inst Chim, CNRS, UMR7177, Strasbourg, France.
RP Bechinger, B (corresponding author), Univ Strasbourg, Inst Chim, CNRS, UMR7177, Strasbourg, France.
EM bechinge@unistra.fr
RI Resende, Jarbas M/R-4519-2018; Bemquerer, Marcelo Porto/A-9688-2013;
   Verly, Rodrigo/E-7493-2015
OI Bemquerer, Marcelo Porto/0000-0002-9740-5818; Verly,
   Rodrigo/0000-0003-0356-6862; Resende, Jarbas/0000-0001-9827-7312
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIG (Project: CEX)Minas Gerais State Research Foundation
   (FAPEMIG) [RED-00010-14]; Centro Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES [63-2010]; PRPq-UFMG; Agence Nationale de la
   Recherche (projects TRANSPEP)French National Research Agency (ANR)
   [07-PCV-0018]; Agence Nationale de la Recherche (LabEx Chemistry of
   Complex Systems)French National Research Agency (ANR)
   [10-LABX-0026_CSC]; Agence Nationale de la Recherche (membrane
   DNP)French National Research Agency (ANR) [12-BSV5-0012]; Agence
   Nationale de la Recherche (MemPepSyn)French National Research Agency
   (ANR) [14-CE34-0001-01]; University of Strasbourg; CNRSCentre National
   de la Recherche Scientifique (CNRS); RTRA International Center of
   Frontier Research in Chemistry
FX RMV, VHOM, MPB, FCLA and DPV acknowledge grants from CNPq. This work is
   a collaboration research project of members of the Rede Mineira de
   Quimica (RQ-MG) supported by FAPEMIG (Project: CEX - RED-00010-14) and
   was supported by Centro Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES, project 63-2010) and PRPq-UFMG. The financial
   contributions to BB of the Agence Nationale de la Recherche (projects
   TRANSPEP 07-PCV-0018, membrane DNP 12-BSV5-0012, MemPepSyn
   14-CE34-0001-01 and the LabEx Chemistry of Complex Systems
   10-LABX-0026_CSC), the University of Strasbourg, the CNRS and the RTRA
   International Center of Frontier Research in Chemistry are gratefully
   acknowledged.
CR Abraham T, 2005, BIOCHEMISTRY-US, V44, P11279, DOI 10.1021/bi050898a
   Alvarez C, 2003, CHEM PHYS LIPIDS, V122, P97, DOI 10.1016/S0009-3084(02)00181-0
   Amiche M., 1998, EXS, V85, P57
   Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022
   Bax A., 2005, J MAGN RESON, V65, P355
   Bechinger B, 2005, BBA-BIOMEMBRANES, V1712, P101, DOI 10.1016/j.bbamem.2005.03.003
   Bechinger B, 2017, J DENT RES, V96, P254, DOI 10.1177/0022034516679973
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Berger S., 2004, 200 MORE NMR EXPT PR
   Bozelli JC, 2012, CHEM PHYS LIPIDS, V165, P365, DOI 10.1016/j.chemphyslip.2011.12.005
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Chan W.C., 2000, FMOC SOLID PHASE PEP
   Clarke DJ, 2006, BIOCHEM SOC T, V34, P251, DOI 10.1042/BST0340251
   Dalla Serra M, 2008, BIOCHEMISTRY-US, V47, P7888, DOI 10.1021/bi800616k
   de Magalhaes MTQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059255
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Fiddes J C, 2000, Curr Opin Drug Discov Devel, V3, P655
   Hara T, 2001, BIOPOLYMERS, V58, P437, DOI 10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.3.CO;2-9
   HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Karpiski T.M., 2013, ARCH BIOMED SCI, V1, P1
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kreil G., CIBA FDN S, P77
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lorenzon EN, 2012, ANTIMICROB AGENTS CH, V56, P3004, DOI 10.1128/AAC.06262-11
   MONERA OD, 1993, J BIOL CHEM, V268, P19218
   Perrone B, 2014, EUR BIOPHYS J BIOPHY, V43, P499, DOI 10.1007/s00249-014-0980-y
   Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n
   Raimondo D, 2005, P NATL ACAD SCI USA, V102, P6309, DOI 10.1073/pnas.0409004102
   Resende JM, 2008, PEPTIDES, V29, P1633, DOI 10.1016/j.peptides.2008.06.022
   Resende JM, 2014, BIOPHYS J, V107, P901, DOI 10.1016/j.bpj.2014.07.014
   Resende JM, 2009, P NATL ACAD SCI USA, V106, P16639, DOI 10.1073/pnas.0905069106
   Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001
   Shagaghi N, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1986-z
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.0.CO;2-8
   SPENCER JH, 1992, ADV ENZYME REGUL, V32, P117
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   Tencza SB, 1999, J ANTIMICROB CHEMOTH, V44, P33, DOI 10.1093/jac/44.1.33
   Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s
   Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063
   Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wenzel M, 2015, CHEMBIOCHEM, V16, P1101, DOI 10.1002/cbic.201500020
   Wieprecht T, 2002, CURR TOP MEMBR, V52, P31
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Xu XQ, 2015, CHEM REV, V115, P1760, DOI 10.1021/cr4006704
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 60
TC 11
Z9 12
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 19
PY 2017
VL 7
AR 40854
DI 10.1038/srep40854
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI2DZ
UT WOS:000392298200001
PM 28102305
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Santos, TL
   Moraes, A
   Nakaie, CR
   Almeida, FCL
   Schreier, S
   Valente, AP
AF Santos, Talita L.
   Moraes, Adolfo
   Nakaie, Clovis R.
   Almeida, Fabio C. L.
   Schreier, Shirley
   Valente, Ana Paula
TI Structural and Dynamic Insights of the Interaction between Tritrpticin
   and Micelles: An NMR Study
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID ANTIMICROBIAL PEPTIDE TRITRPTICIN; TRYPTOPHAN-RICH; CONFORMATIONAL
   SELECTION; MEMBRANE INTERACTIONS; LIPID INTERACTIONS; INDUCED FIT;
   SIDE-CHAINS; BINDING; PROTEINS; MODEL
AB A large number of antimicrobial peptides (AMPs) acts with high selectivity and specificity through interactions with membrane lipid components. These peptides undergo complex conformational changes in solution; upon binding to an interface, one major conformation is stabilized. Here we describe a study of the interaction between tritrpticin (TRP3), a cathelicidin AMP, and micelles of different chemical composition. The peptide's structure and dynamics were examined using one-dimensional and two-dimensional NMR. Our data showed that the interaction occurred by conformational selection and the peptide acquired similar structures in all systems studied, despite differences in detergent headgroup charge or dipole orientation. Fluorescence and paramagnetic relaxation enhancement experiments showed that the peptide is located in the interface region and is slightly more deeply inserted in 1-myristoyl-2-hydroxy-sn-glycero-3-phospho-10-rac-glycerol (LMPG, anionic) than in 1-lauroyl-2-hydroxy- sn-glycero-3-phosphocholine (LLPC, zwitterionic) micelles. Moreover, the tilt angle of an assumed helical portion of the peptide is similar in both systems. In previous work we proposed that TRP3 acts by a toroidal pore mechanism. In view of the high hydrophobic core exposure, hydration, and curvature presented by micelles, the conformation of TRP3 in these systems could be related to the peptide's conformation in the toroidal pore.
C1 [Santos, Talita L.; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Nucl Magnet Resonance Natl Ctr, Rio De Janeiro, Brazil.
   [Moraes, Adolfo] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil.
   [Nakaie, Clovis R.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.
   [Schreier, Shirley] Univ Sao Paulo, Dept Biochem, Sao Paulo, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Nucl Magnet Resonance Natl Ctr, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Cilli, Eduardo Maffud/B-9130-2012; Valente, Ana Paula/J-3010-2017;
   Schreier, Shirley/F-7001-2014; Moraes, Adolfo/G-3931-2018
OI Cilli, Eduardo Maffud/0000-0002-4767-0904; Valente, Ana
   Paula/0000-0001-7219-1123; Moraes, Adolfo/0000-0002-3344-4084
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX T.L.S. acknowledges receipt of a PhD fellowship from Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq); A.P.V. acknowledges
   receipt of a research grant from CNPq and Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ); A.P.V., S.S., F.C.L.A., and C.R.N.
   are recepients of CNPq research fellowships; and A.P.V. and F.C.L.A. are
   recipients of FAPERJ research fellowships.
CR Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660
   Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239
   Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022
   Anthis NJ, 2015, Q REV BIOPHYS, V48, P35, DOI 10.1017/S0033583514000122
   Arias M, 2016, BBA-BIOMEMBRANES, V1858, P1012, DOI 10.1016/j.bbamem.2015.12.023
   Arias M, 2015, BBA-BIOMEMBRANES, V1848, P277, DOI 10.1016/j.bbamem.2014.08.024
   Bahar AA, 2013, PHARMACEUTICALS, V6, P1543, DOI 10.3390/ph6121543
   Bandyopadhyay S, 2013, BIOCHEM BIOPH RES CO, V430, P1, DOI 10.1016/j.bbrc.2012.11.015
   Benfield AP, 2006, ANGEW CHEM INT EDIT, V45, P6830, DOI 10.1002/anie.200600844
   Blundell CD, 2013, BIOORGAN MED CHEM, V21, P4976, DOI 10.1016/j.bmc.2013.06.056
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071
   Bozelli JC, 2012, CHEM PHYS LIPIDS, V165, P365, DOI 10.1016/j.chemphyslip.2011.12.005
   Fenwick RB, 2011, EUR BIOPHYS J BIOPHY, V40, P1339, DOI 10.1007/s00249-011-0754-8
   Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006
   Chan W.C., 2000, FMOC SOLID PHASE PEP
   Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19
   CHEVALIER Y, 1991, LANGMUIR, V7, P848, DOI 10.1021/la00053a007
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dufourc EJ, 2012, CURR PROTEIN PEPT SC, V13, P620, DOI 10.2174/138920312804142138
   Feixas F, 2014, BIOPHYS CHEM, V186, P31, DOI 10.1016/j.bpc.2013.10.007
   Feng J, 2011, COLLOID SURFACE B, V83, P229, DOI 10.1016/j.colsurfb.2010.11.025
   Galdiero S, 2013, INT J MOL SCI, V14, P18758, DOI 10.3390/ijms140918758
   Gomes-Neto F, 2013, MOLECULES, V18, P10056, DOI 10.3390/molecules180810056
   Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014
   Haney EF, 2010, CHEM PHYS LIPIDS, V163, P82, DOI 10.1016/j.chemphyslip.2009.09.002
   He LZ, 2002, J PHYS CHEM B, V106, P7596, DOI 10.1021/jp020034o
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Hocking HG, 2013, CHEMPHYSCHEM, V14, P3082, DOI 10.1002/cphc.201300219
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Koller D, 2014, BBA-BIOMEMBRANES, V1838, P2250, DOI 10.1016/j.bbamem.2014.05.013
   KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98
   KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047
   Kushibiki T, 2014, BBA-PROTEINS PROTEOM, V1844, P527, DOI 10.1016/j.bbapap.2013.12.017
   Lakowicz J.R., 2006, PRINCIPLES FLUORESCE
   LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4
   le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1
   Liu L, 2013, BBA-BIOMEMBRANES, V1828, P2479, DOI 10.1016/j.bbamem.2013.06.017
   LORBER B, 1990, BIOCHIM BIOPHYS ACTA, V1023, P254, DOI 10.1016/0005-2736(90)90421-J
   Manzini MC, 2014, BBA-BIOMEMBRANES, V1838, P1985, DOI 10.1016/j.bbamem.2014.04.004
   McLachlan AA, 2006, J COLLOID INTERF SCI, V295, P243, DOI 10.1016/j.jcis.2005.08.008
   Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095
   MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Nagpal S, 1999, J BIOL CHEM, V274, P23296, DOI 10.1074/jbc.274.33.23296
   Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001
   Nguyen LT, 2011, BBA-BIOMEMBRANES, V1808, P2297, DOI 10.1016/j.bbamem.2011.05.015
   Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275
   Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002
   Oliver RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062488
   Palladino P, 2010, J FLUORESC, V20, P191, DOI 10.1007/s10895-009-0537-0
   Pambou E, 2015, LANGMUIR, V31, P9781, DOI 10.1021/acs.langmuir.5b02077
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f
   Salay LC, 2004, FEBS LETT, V565, P171, DOI 10.1016/j.febslet.2004.03.093
   Salay LC, 2012, COLLOID SURFACE B, V100, P95, DOI 10.1016/j.colsurfb.2012.05.002
   Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015
   Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837
   Schibli DJ, 2002, BIOCHEM CELL BIOL, V80, P667, DOI 10.1139/O02-147
   Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c
   STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031
   Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004
   Tinoco LW, 2007, J BIOMOL NMR, V39, P315, DOI 10.1007/s10858-007-9202-6
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Valente AP, 2013, MOLECULES, V18, P11311, DOI 10.3390/molecules180911311
   Vitiello G, 2009, J COLLOID INTERF SCI, V336, P827, DOI 10.1016/j.jcis.2009.04.008
   Wang Q, 2013, P NATL ACAD SCI USA, V110, P20545, DOI 10.1073/pnas.1312788110
   Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016
   Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004
   Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106
   WUTHRICH K, 1990, J BIOL CHEM, V265, P22059
   Yang ST, 2002, BIOCHEM BIOPH RES CO, V296, P1044, DOI 10.1016/S0006-291X(02)02048-X
   Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c
   Yu HY, 2013, BBA-BIOMEMBRANES, V1828, P2720, DOI 10.1016/j.bbamem.2013.07.020
NR 79
TC 7
Z9 7
U1 0
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD DEC 20
PY 2016
VL 111
IS 12
BP 2676
EP 2688
DI 10.1016/j.bpj.2016.10.034
PG 13
WC Biophysics
SC Biophysics
GA EF8LI
UT WOS:000390580000014
PM 28002744
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Fredriksson, J
   de Paula, VS
   Valente, AP
   Almeida, FCL
   Billeter, M
AF Fredriksson, Jonas
   de Paula, Viviane S.
   Valente, Ana Paula
   Almeida, Fabio C. L.
   Billeter, Martin
TI DIADECOMP: A new approach to analyze decompositions from projection
   spectroscopy
SO JOURNAL OF MAGNETIC RESONANCE
LA English
DT Article
DE Projection spectroscopy; Decompositions; Minimal NMR data; Protein
   characterization; DIADECOMP; Human defensin beta 6
ID BETA-DEFENSIN 6; MULTIWAY DECOMPOSITION; NMR-SPECTRA; IDENTIFICATION;
   ASSIGNMENT; CCR2
AB We demonstrate for the first time a complete small protein characterization with the projection decomposition approach, including full assignments as well as determination of the 3D fold. In TOCSYand NOESY-type 4D experiments, pairing of signals from hydrogens and from their respective heavy atoms in decompositions represents a new problem. An approach, referred to as "DIADECOMP" (diagonal decomposition), is introduced to solve this problem; it consists of two separate decompositions of the input projections, differing in a 45 rotation of the spectral axes. While DIADECOMP requires a somewhat complex formulation, in practice it results in observing signals in the rotated decompositions that correspond to sums or differences of frequencies. When applied to a small protein, human defensin (36, the analysis of a HCC(CO)NH-TOCSY with DIADECOMP results in largely unambiguous assignments of the aliphatic side chain groups. Furthermore, DIADECOMP applied to a N-15-HSQC-NOESY-N-15-HSQC provides all expected short distances between amide groups (defined as all H-N-H-N distances <3.5 angstrom in a reference structure). It is worth noting that short H-N-H-N distances unambiguously define a-helices, the alignment of beta-strands in sheets, as well as the presence of 0-bulges. This approach of using a minimal amount of NMR data, namely four projection experiments recorded in similar to 2.5 days, resulted for the human defensin (36 in complete assignments and a backbone fold with a RMSD of the non-flexible structure of 0.6 A. Uniqueness of decompositions specifically from TOCSY- and NOESY-type 4D experiments is discussed. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Fredriksson, Jonas; Billeter, Martin] Univ Gothenburg, Dept Chem & Mol Biol, Box 462, S-40530 Gothenburg, Sweden.
   [Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem, BR-21941 Rio De Janeiro, Brazil.
   [de Paula, Viviane S.; Valente, Ana Paula; Almeida, Fabio C. L.] Ctr Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil.
   [de Paula, Viviane S.] Univ Fed Rio de Janeiro, Campus Xerem, Duque De Caxias, Brazil.
RP Billeter, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, S-40530 Gothenburg, Sweden.; Almeida, FCL (corresponding author), Anexo CNRMN, CCS, BR-21941920 Rio De Janeiro, RJ, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br; martin.billeter@chem.gu.se
RI De Paula, Viviane/L-1947-2013; Valente, Ana Paula/J-3010-2017
OI De Paula, Viviane/0000-0003-3171-6477; Valente, Ana
   Paula/0000-0001-7219-1123
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); National Center of Nuclear Magnetic
   Resonance (CNRMN, UFRJ, Rio de Janeiro); Sven and Lilly Lawski
   foundation for scientific research
FX V.S.P., A.P.V. and F.C.L.A. thank CNPq, FAPERJ and the National Center
   of Nuclear Magnetic Resonance (CNRMN, UFRJ, Rio de Janeiro). J.F.
   gratefully acknowledges support from the Sven and Lilly Lawski
   foundation for scientific research.
CR Bro R, 1997, J CHEMOMETR, V11, P393, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<393::AID-CEM483>3.0.CO;2-L
   CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0
   De Paula VS, 2013, J MOL BIOL, V425, P4479, DOI 10.1016/j.jmb.2013.08.001
   De Paula VS, 2014, J BIOL CHEM, V289, P22969, DOI 10.1074/jbc.M114.572529
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Eghbalnia HR, 2005, J AM CHEM SOC, V127, P12528, DOI 10.1021/ja052120I
   Fredriksson J, 2012, J BIOMOL NMR, V54, P43, DOI 10.1007/s10858-012-9649-y
   Fredriksson J, 2012, J MAGN RESON, V217, P48, DOI 10.1016/j.jmr.2012.02.006
   Freeman R, 2012, TOP CURR CHEM, V316, P1, DOI 10.1007/128_2010_103
   Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Lacerda AF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00116
   Malmodin D, 2005, J AM CHEM SOC, V127, P13486, DOI 10.1021/ja0545822
   Malmodin D, 2006, MAGN RESON CHEM, V44, pS185, DOI 10.1002/mrc.1824
   Pazgier M, 2006, PROTEIN EXPRES PURIF, V49, P1, DOI 10.1016/j.pep.2006.05.004
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Staykova DK, 2008, J BIOMOL NMR, V42, P87, DOI 10.1007/s10858-008-9265-z
   Thomma Bart P. H. J., 2003, Current Drug Targets - Infectious Disorders, V3, P1, DOI 10.2174/1568005033342000
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Valente AP, 2013, MOLECULES, V18, P11311, DOI 10.3390/molecules180911311
   Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446
NR 22
TC 1
Z9 1
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1090-7807
EI 1096-0856
J9 J MAGN RESON
JI J. Magn. Reson.
PD DEC
PY 2016
VL 273
BP 1
EP 8
DI 10.1016/j.jmr.2016.10.002
PG 8
WC Biochemical Research Methods; Physics, Atomic, Molecular & Chemical;
   Spectroscopy
SC Biochemistry & Molecular Biology; Physics; Spectroscopy
GA EF1JZ
UT WOS:000390082400001
PM 27718459
DA 2020-12-01
ER

PT J
AU de Oliveira, LRP
   Martins, C
   Fidalgo, TKS
   Freitas-Fernandes, LB
   Torres, RD
   Soares, AL
   Almeida, FCL
   Valente, AP
   de Souza, IPR
AF Piedade de Oliveira, Livia Roberta
   Martins, Carla
   Silva Fidalgo, Tatiana Kelly
   Freitas-Fernandes, Liana Bastos
   Torres, Rafaela de Oliveira
   Soares, Aline Laignier
   Almeida, Fabio C. L.
   Valente, Ana Paula
   Ribeiro de Souza, Ivete Pomarico
TI Salivary Metabolite Fingerprint of Type 1 Diabetes in Young Children
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE type 1 diabetes mellitus; saliva; children; metabolomics; NMR
ID MELLITUS PATIENTS; METABOLOMICS; ADOLESCENTS; CARIES; URINE; ACID
AB Metabolomics is an important tool for the evaluation of the human condition, in both health or disease. This study analyzed the salivary components of type I diabetic children (DM1) under six years of age, to assess oral health related to diabetes control, as well as metabolite profiling using NMR. Partial least squared discriminant analysis (PLS-DA) was used to compare healthy (HG) and uncontrolled DM1 subjects that demonstrated a separation between the groups with classificatory performance of ACC = 0.80, R-2 = 0.92, Q(2): = 0.02 and for DM1 children with glycemia >200 mg/dL of ACC = 0.74, R-2 = 0.91, Q(2) = 0.06. The metabolites that mostly contributed to the distinction between the groups in the loading factor were acetate, n-acetyl-sugar, lactate, and sugar. The univariate analysis showed a decreased salivary concentration of succinic acid and increased levels of lactate, acetate, and sucrose in uncontrolled and DM1 children with glycemia >200 mg/dL. The present study demonstrates that the salivary profile of DM1 differs from that of HG children. It appears that diabetes status control has an important effect on the salivary composition.
C1 [Piedade de Oliveira, Livia Roberta; Martins, Carla; Silva Fidalgo, Tatiana Kelly; Freitas-Fernandes, Liana Bastos; Torres, Rafaela de Oliveira; Soares, Aline Laignier; Ribeiro de Souza, Ivete Pomarico] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, BR-21941971 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP de Souza, IPR (corresponding author), Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, BR-21941971 Rio De Janeiro, RJ, Brazil.; Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br; pomarico@gmail.com
RI Valente, Ana Paula/J-3010-2017; da Silva Fidalgo, Tatiana
   Kelly/I-4969-2014
OI Valente, Ana Paula/0000-0001-7219-1123; da Silva Fidalgo, Tatiana
   Kelly/0000-0003-1340-9967; Souza, Ivete Pomarico/0000-0003-0449-6624
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [(CNPq)-303785/2014-4, 306214/2013-0, 150151/2014-4]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [FAPERJ: E-26/202902/2015, E-26/110490/2014,
   2014/2-209396, E-26/201278/2014]; Centro Nacional de Ressonancia
   Magnetica Nuclear (CNRMN); Instituto Nacional de Ciencia e Tecnologia de
   Biologia Estrutural e Bioimagem (InBEB)
FX The authors acknowledge Karen Santos and Gileno Santos for technical
   support. We also thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-303785/2014-4, 306214/2013-0, and
   150151/2014-4), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ: E-26/202902/2015, E-26/110490/2014,
   2014/2-209396, and E-26/201278/2014), Centro Nacional de Ressonancia
   Magnetica Nuclear (CNRMN), Instituto Nacional de Ciencia e Tecnologia de
   Biologia Estrutural e Bioimagem (InBEB) for financial support.
CR Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2
   Al-Zahrani MS, 2011, OPEN DENT J, V5, P154, DOI 10.2174/1874210601105010154
   ALDER P, 1973, J DENT RES, V52, P535
   Arrieta-Blanco Juan Jose, 2003, Med Oral, V8, P97
   Barnes VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105181
   Ben-Aryeh Hanna, 1993, Journal of Diabetes and its Complications, V7, P57, DOI 10.1016/1056-8727(93)90025-T
   Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598
   Blaikie TPJ, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/4/046010
   Brouwers MCGJ, 2015, DIABETES CARE, V38, pE11, DOI 10.2337/dc14-2205
   Culeddu N, 2012, METABOLOMICS, V8, P1162, DOI 10.1007/s11306-012-0420-x
   Darpolor MM, 2014, NMR BIOMED, V27, P381, DOI 10.1002/nbm.3072
   DARWAZEH AMG, 1991, J ORAL PATHOL MED, V20, P280, DOI 10.1111/j.1600-0714.1991.tb00928.x
   de Lima DC, 2008, J PROSTHET DENT, V99, P60, DOI 10.1016/S0022-3913(08)60010-4
   Deja S, 2013, J PHARMACEUT BIOMED, V83, P43, DOI 10.1016/j.jpba.2013.04.017
   Amaral Fábio M. Franco do, 2006, Arq Bras Endocrinol Metab, V50, P515, DOI 10.1590/S0004-27302006000300015
   Ertel NH, 2003, DIABETES CARE, V26, P549, DOI 10.2337/diacare.26.2.549
   FAHIEN LA, 1988, J BIOL CHEM, V263, P13610
   Fidalgo TKS, 2015, METABOLOMICS, V11, P583, DOI 10.1007/s11306-014-0717-z
   Fidalgo TKS, 2013, METABOLOMICS, V9, P657, DOI 10.1007/s11306-012-0484-7
   FOX PC, 1987, J AM DENT ASSOC, V115, P581, DOI 10.1016/S0002-8177(87)54012-0
   Fujii S, 2014, CLIN CHIM ACTA, V430, P140, DOI 10.1016/j.cca.2014.01.006
   GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296
   Grootveld M, 2005, BIOCHEM BIOPH RES CO, V329, P1, DOI 10.1016/j.bbrc.2005.01.112
   Jurysta C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/430426
   Karjalainen KM, 1997, CARIES RES, V31, P13, DOI 10.1159/000262367
   Lal S, 2008, PEDIATRICS, V121, pE1139, DOI 10.1542/peds.2007-1486
   Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538
   Lasisi T J, 2012, Ann Ib Postgrad Med, V10, P25
   Malicka B, 2015, ARCH ORAL BIOL, V60, P425, DOI 10.1016/j.archoralbio.2014.07.010
   Martins C, 2013, CARIES RES, V47, P56, DOI 10.1159/000343574
   Mata AD, 2004, MOL CELL BIOCHEM, V261, P137, DOI 10.1023/B:MCBI.0000028748.40917.6f
   Miralles Lucia, 2006, Med Oral Patol Oral Cir Bucal, V11, pE256
   Novotna M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/379626
   Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042
   Salvi G E, 1998, Ann Periodontol, V3, P40, DOI 10.1902/annals.1998.3.1.40
   Schmidt AM, 1996, J PERIODONTAL RES, V31, P508, DOI 10.1111/j.1600-0765.1996.tb01417.x
   Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953
   Tsutsui H, 2012, ANAL BIOANAL CHEM, V404, P1925, DOI 10.1007/s00216-012-6320-0
   van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j
   Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140
   Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573
   Zuppi C, 2002, CLIN CHEM, V48, P660
NR 46
TC 10
Z9 10
U1 1
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD AUG
PY 2016
VL 15
IS 8
BP 2491
EP 2499
DI 10.1021/acs.jproteome.6b00007
PG 9
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA DT1IW
UT WOS:000381235900013
PM 27306956
DA 2020-12-01
ER

PT J
AU El-Bacha, T
   Struchiner, CJ
   Cordeiro, MT
   Almeida, FCL
   Marques, ET
   Da Poian, AT
AF El-Bacha, Tatiana
   Struchiner, Claudio J.
   Cordeiro, Marli Tenorio
   Almeida, Fabio C. L.
   Marques, Ernesto Torres, Jr.
   Da Poian, Andrea T.
TI H-1 Nuclear Magnetic Resonance Metabolomics of Plasma Unveils Liver
   Dysfunction in Dengue Patients
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID NMR-SPECTROSCOPY; HUMAN-BLOOD; AMINO-ACID; SERUM; INFECTION; GLUTAMINE;
   URINE
AB Dengue, due to its global burden, is the most important arthropod-borne flavivirus disease, and early detection lowers fatality rates to below 1%. Since the metabolic resources crucial for viral replication are provided by host cells, detection of changes in the metabolic profile associated with disease pathogenesis could help with the identification of markers of prognostic and diagnostic importance. We applied H-1 nuclear magnetic resonance exploratory metabolomics to study longitudinal changes in plasma metabolites in a cohort in Recife, Brazil. To gain statistical power, we used innovative paired multivariate analyses to discriminate individuals with primary and secondary infection presenting as dengue fever (DF; mild) and dengue hemorrhagic fever (DHF; severe) and subjects with a nonspecific nondengue (ND) illness (ND subjects). Our results showed that a decrease in plasma low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) discriminated dengue virus (DENV)-infected subjects from ND subjects, and also, subjects with severe infection even presented a decrease in lipoprotein concentrations compared to the concentrations in subjects with mild infection. These results add to the ongoing discussion that the manipulation of lipid metabolism is crucial for DENV replication and infection. In addition, a decrease in plasma glutamine content was characteristic of DENV infection and disease severity, and an increase in plasma acetate levels discriminated subjects with DF and DHF from ND subjects. Several other metabolites shown to be altered in DENV infection and the implications of these alterations are discussed. We hypothesize that these changes in the plasma metabolome are suggestive of liver dysfunction, could provide insights into the underlying molecular mechanisms of dengue virus pathogenesis, and could help to discriminate individuals at risk of the development of severe infection and predict disease outcome.
   IMPORTANCE
   Dengue, due to its global burden, is the most important mosquito-borne viral disease. There is no specific treatment for dengue disease, and early detection lowers fatality rates to below 1%. In this study, we observed the effects of dengue virus infection on the profile of small molecules in the blood of patients with mild and severe infection. Variations in the profiles of these small molecules reflected the replication of dengue virus in different tissues and the extent of tissue damage during infection. The results of this study showed that the molecules that changed the most were VLDL, LDL, and amino acids. We propose that these changes reflect liver dysfunction and also that they can be used to discriminate subjects with mild dengue from those with severe dengue.
C1 [El-Bacha, Tatiana; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Dept Doencas Endem Samuel Pessoa, Rio De Janeiro, RJ, Brazil.
   [Cordeiro, Marli Tenorio; Marques, Ernesto Torres, Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, RJ, Brazil.
   [Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [El-Bacha, Tatiana] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, RJ, Brazil.
RP El-Bacha, T; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
EM tatiana@nutricao.ufrj.br; dapoian@bioqmed.ufrj.br
RI Marques, Ernesto T. A/L-4967-2013; Da Poian, Andrea T./V-1699-2019;
   Struchiner, Claudio J/M-9360-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Struchiner, Claudio
   J/0000-0003-2114-847X; El-Bacha, Tatiana/0000-0003-0809-0218; Da Poian,
   Andrea/0000-0002-3969-704X
FU MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [306669/2013-7, 483229/2010-5]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/201.571/2014, E-26/201.167/2014, E-26/110.092/2013];
   Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS)
   [AMS-NAF2-ElBacha] Funding Source: researchfish
FX This work, including the efforts of Andrea T. Da Poian, was funded by
   MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (306669/2013-7). This work, including the efforts of
   Tatiana El-Bacha, was funded by MCTI vertical bar Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (483229/2010-5). This
   work, including the efforts of Claudio J. Struchiner, was funded by MCTI
   vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq). This work, including the efforts of Tatiana
   El-Bacha, was funded by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). This work, including the efforts of Tatiana
   El-Bacha, was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (E-26/201.571/2014). This
   work, including the efforts of Andrea T. Da Poian, was funded by
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (E-26/201.167/2014 and E-26/110.092/2013). This work,
   including the efforts of Claudio J. Struchiner, was funded by Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ).
CR Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m
   Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904
   Brasier AR, 2015, J CLIN VIROL, V64, P97, DOI 10.1016/j.jcv.2015.01.011
   Brazil Ministry of Health, 2015, B EPIDEMIOLOGICO, V48
   Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203
   Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c
   Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039
   DUNHAM CM, 1991, CIRC SHOCK, V35, P78
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Fontaine KA, 2014, J VIROL, V88, P4366, DOI 10.1128/JVI.03134-13
   Gonzalez I., 2011, MIXOMICS OMICS DATA
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015
   Ishida H, 2013, BIOCHEM BIOPH RES CO, V437, P127, DOI 10.1016/j.bbrc.2013.06.051
   Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515
   Lu CJ, 2012, TALANTA, V100, P51, DOI 10.1016/j.talanta.2012.07.076
   Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366
   Munshi SU, 2011, J VIRAL HEPATITIS, V18, pE591, DOI 10.1111/j.1365-2893.2011.01488.x
   Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892
   Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401
   Newsholme F, 1999, J NUTR BIOCHEM, V10, P316
   Nie CY, 2014, J VIRAL HEPATITIS, V21, P53, DOI 10.1111/jvh.12122
   Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029
   Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234
   Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982
   R Core Team, 2015, R LANG ENV STAT COMP
   Saito T, 2013, METABOLISM, V62, P1577, DOI 10.1016/j.metabol.2013.07.002
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Shahfiza N, 2015, ASIAN PAC J TROP MED, V8, P452, DOI [10.1016/S1995-7645(14)60359-X, 10.1016/j.apjtm.2015.05.012]
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251
   TOLLINGER CD, 1979, CLIN CHEM, V25, P1787
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Voge NV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004449
   Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z
   WHO, 2011, COMPR GUID PREV CONT
   Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 50
TC 15
Z9 15
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2016
VL 90
IS 16
BP 7429
EP 7443
DI 10.1128/JVI.00187-16
PG 15
WC Virology
SC Virology
GA DU6EJ
UT WOS:000382306500032
PM 27279613
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Moraes, AH
   Asam, C
   Batista, A
   Almeida, FCL
   Wallner, M
   Ferreira, F
   Valente, AP
AF Moraes, A. H.
   Asam, C.
   Batista, A.
   Almeida, F. C. L.
   Wallner, M.
   Ferreira, F.
   Valente, A. P.
TI H-1, C-13 and N-15 resonance assignments and second structure
   information of Fag s 1: Fagales allergen from Fagus sylvatica
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Fag s 1; Fagales; Beech pollen allergen; NMR assignments; Secondary
   structure
ID POLLEN ALLERGY; IMMUNOTHERAPY; MECHANISMS
AB Fagales allergens belonging to the Bet v 1 family account responsible for the majority of spring pollinosis in the temperate climate zones in the Northern hemisphere. Among them, Fag s 1 from beech pollen is an important trigger of Fagales pollen associated allergic reactions. The protein shares high similarity with birch pollen Bet v 1, the best-characterized member of this allergen family. Of note, recent work on Bet v 1 and its homologues found in Fagales pollen demonstrated that not all allergenic members of this family have the capacity to induce allergic sensitization. Fag s 1 was shown to bind pre-existing IgE antibodies most likely primarily directed against other members of this multi-allergen family. Therefore, it is especially interesting to compare the structures of Bet v 1-like pollen allergens, which have the potential to induce allergic sensitization with allergens that are mainly cross-reactive. This in the end will help to identify allergy eliciting molecular pattern on Bet v 1-like allergens. In this work, we report the H-1, N-15 and C-13 NMR assignment of beech pollen Fag s 1 as well as the secondary structure information based on backbone chemical shifts.
C1 [Moraes, A. H.; Batista, A.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet, Rio De Janeiro, Brazil.
   [Asam, C.; Wallner, M.; Ferreira, F.] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Wallner, Michael/L-5437-2015; Valente, Ana Paula/J-3010-2017; Ferreira,
   Fatima/AAB-4321-2019; Moraes, Adolfo/G-3931-2018; Asam,
   Claudia/L-5433-2015; Almeida, Fabio/O-4989-2018; Ferreira,
   Fatima/E-4889-2011
OI Wallner, Michael/0000-0001-6568-7892; Valente, Ana
   Paula/0000-0001-7219-1123; Ferreira, Fatima/0000-0003-0989-2335; Moraes,
   Adolfo/0000-0002-3344-4084; Asam, Claudia/0000-0003-3238-438X; Almeida,
   Fabio/0000-0001-6046-7006; Ferreira, Fatima/0000-0003-0989-2335
FU Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P 23417] Funding
   Source: researchfish; Austrian Science Fund FWFAustrian Science Fund
   (FWF) [P 23417, P 27589] Funding Source: Medline
CR Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016
   Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361
   Crameri R, 2006, IMMUNOL ALLERGY CLIN, V26, P179, DOI 10.1016/j.iac.2006.02.003
   D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   Hauser M, 2011, CLIN EXP ALLERGY, V41, P1804, DOI 10.1111/j.1365-2222.2011.03866.x
   Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934
   Pichler U, 2014, CLIN EXP ALLERGY, V44, P438, DOI 10.1111/cea.12250
   Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Thomas WR, 2013, CLIN EXP ALLERGY, V43, P152, DOI 10.1111/j.1365-2222.2012.04059.x
NR 11
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD APR
PY 2016
VL 10
IS 1
BP 45
EP 48
DI 10.1007/s12104-015-9634-y
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA DG6WX
UT WOS:000372227900008
PM 26289775
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Moraes, AH
   Simonelli, L
   Pedotti, M
   Almeida, FCL
   Varani, L
   Valente, AP
AF Moraes, Adolfo H.
   Simonelli, Luca
   Pedotti, Mattia
   Almeida, Fabio C. L.
   Varani, Luca
   Valente, Ana P.
TI Antibody Binding Modulates Conformational Exchange in Domain III of
   Dengue Virus E Protein
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID DISPERSION NMR-SPECTROSCOPY; ENVELOPE PROTEIN; ROTATIONAL DIFFUSION;
   BACKBONE DYNAMICS; MEMBRANE-FUSION; MODEL-FREE; NEUTRALIZING ANTIBODY;
   CRYSTAL-STRUCTURE; RELAXATION DATA; E-GLYCOPROTEIN
AB Domain III of dengue virus E protein (DIII) participates in the recognition of cell receptors and in structural rearrangements required for membrane fusion and ultimately viral infection; furthermore, it contains epitopes for neutralizing antibodies and has been considered a potential vaccination agent. In this work, we addressed various structural aspects of DIII and their relevance for both the dengue virus infection mechanism and antibody recognition. We provided a dynamic description of DIII at physiological and endosomal pHs and in complex with the neutralizing human antibody DV32.6. We observed conformational exchange in the isolated DIII, in regions important for the packing of E protein dimers on the virus surface. This conformational diversity is likely to facilitate the partial detachment of DIII from the other E protein domains, which is required to achieve fusion to the host cellular membranes and to expose the epitopes of many anti-DIII antibodies. A comparison of DIII of two dengue virus serotypes revealed many common features but also some possibly unexpected differences. Antibody binding to DIII of dengue virus serotype 4 attenuated the conformational exchange in the epitope region but, surprisingly, generated exchange in other parts of DIII through allosteric effects.
C1 [Moraes, Adolfo H.; Almeida, Fabio C. L.; Valente, Ana P.] Univ Fed Rio de Janeiro, Natl NMR Ctr CNRMN, Rio De Janeiro, Brazil.
   [Simonelli, Luca; Pedotti, Mattia; Varani, Luca] USI, Inst Res Biomed, Bellinzona, Switzerland.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Natl NMR Ctr CNRMN, Rio De Janeiro, Brazil.; Varani, L (corresponding author), USI, Inst Res Biomed, Bellinzona, Switzerland.
EM luca.varani@irb.usi.ch; valente@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Moraes,
   Adolfo/G-3931-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Moraes, Adolfo/0000-0002-3344-4084;
   Simonelli, Luca/0000-0001-6331-7716; varani, luca/0000-0002-0963-0987
FU Brazilian Swiss Joint Research Programme (BSJRP) [0112-04]; Instituto
   Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem;
   MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [590124/2011-0, 303785/2014-4, 301407/2010-0]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [CNE-E-26/102.747/2012, E-26/110.090/2013];
   Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen
   Forschung (SNF) [138518]
FX Brazilian Swiss Joint Research Programme (BSJRP) provided funding to
   Luca Varani under grant number 0112-04. Instituto Nacional de Ciencia e
   Tecnologia em Biologia Estrutural e Bioimagem provided funding to Ana
   Paula Valente. MCTI vertical bar Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) provided funding to Ana Paula Valente
   under grant number 590124/2011-0. MCTI vertical bar Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) provided funding to Ana
   Paula Valente under grant numbers 303785/2014-4 and 301407/2010-0.
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) provided funding to Ana Paula Valente under grant
   numbers CNE-E-26/102.747/2012 and E-26/110.090/2013. Schweizerischer
   Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF)
   provided funding to Luca Varani under grant number 138518.
CR Adhikary R, 2012, J BIOL CHEM, V287, P27139, DOI 10.1074/jbc.M112.372698
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06
   BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005
   Bardelli M, 2015, J MOL RECOGNIT, V28, P393, DOI 10.1002/jmr.2454
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   Elahi M, 2013, PROTEINS, V81, P1090, DOI 10.1002/prot.24237
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Gandham SHA, 2014, BIOCHEM BIOPH RES CO, V453, P309, DOI 10.1016/j.bbrc.2014.09.053
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100
   James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y
   Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   Lisova O, 2014, J MOL RECOGNIT, V27, P205, DOI 10.1002/jmr.2352
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Marks RM, 2001, J MED CHEM, V44, P2178, DOI 10.1021/jm000412i
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287
   Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h
   Prakash MK, 2010, BIOPHYS J, V99, P588, DOI 10.1016/j.bpj.2010.04.024
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Simonelli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055561
   Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   WHO, 2009, DENGUE GUIDELINES FO
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 61
TC 8
Z9 9
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2016
VL 90
IS 4
BP 1802
EP 1811
DI 10.1128/JVI.02314-15
PG 10
WC Virology
SC Virology
GA DC3XL
UT WOS:000369152700009
PM 26637461
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Iqbal, A
   Moraes, AH
   Valente, AP
   Almeida, FCL
AF Iqbal, Anwar
   Moraes, Adolfo Henrique
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Structures of the reduced and oxidized state of the mutant D24A of yeast
   thioredoxin 1: insights into the mechanism for the closing of the water
   cavity
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
ID ESCHERICHIA-COLI THIOREDOXIN; SEQUENTIAL ASSIGNMENT; CRYSTAL-STRUCTURE;
   PROTEIN BACKBONE; NMR-SPECTROSCOPY; TORSION ANGLES; REACTIVITY; PROGRAM;
   RESIDUE; PROTON
C1 [Iqbal, Anwar; Moraes, Adolfo Henrique; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem, BR-21941920 Rio De Janeiro, Brazil.
   [Iqbal, Anwar; Moraes, Adolfo Henrique; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, BR-21941920 Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem, Av Carlos Chagas Filho,373 CCS Anexo CNRMN, BR-21941920 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Moraes,
   Adolfo/G-3931-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Moraes, Adolfo/0000-0002-3344-4084
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); INBEB
FX We are thankful to the financial support from CNPq, FAPERJ and INBEB for
   supporting this work (Brazilian funding agencies). We are also thankful
   to the National Center of Nuclear Magnetic Resonance (CNRMN) for the NMR
   time.
CR Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P716, DOI 10.1016/j.bbapap.2008.12.016
   BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Campos-Acevedo AA, 2013, ACTA CRYSTALLOGR F, V69, P488, DOI 10.1107/S1744309113010622
   Cruzeiro-Silva C, 2014, BIOCHEMISTRY-US, V53, P2890, DOI 10.1021/bi401542v
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   HOLMGREN A, 1979, J BIOL CHEM, V254, P9113
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   Iqbal A, 2015, BIOCHEMISTRY-US, V54, P2429, DOI 10.1021/acs.biochem.5b00082
   Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447
   KALLIS GB, 1980, J BIOL CHEM, V255, P261
   KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065
   Pinheiro AS, 2008, PROTEINS, V70, P584, DOI 10.1002/prot.21693
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Weichsel A, 2010, PROTEIN SCI, V19, P1801, DOI 10.1002/pro.455
   WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033
NR 31
TC 2
Z9 2
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD DEC
PY 2015
VL 63
IS 4
BP 417
EP 423
DI 10.1007/s10858-015-9996-6
PG 7
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA CX6CT
UT WOS:000365789500009
PM 26482062
DA 2020-12-01
ER

PT J
AU Bublin, M
   Kostadinova, M
   Fuchs, JE
   Ackerbauer, D
   Moraes, AH
   Almeida, FCL
   Lengger, N
   Hafner, C
   Ebner, C
   Radauer, C
   Liedl, KR
   Valente, AP
   Breiteneder, H
AF Bublin, Merima
   Kostadinova, Maria
   Fuchs, Julian E.
   Ackerbauer, Daniela
   Moraes, Adolfo H.
   Almeida, Fabio C. L.
   Lengger, Nina
   Hafner, Christine
   Ebner, Christof
   Radauer, Christian
   Liedl, Klaus R.
   Valente, Ana Paula
   Breiteneder, Heimo
TI A Cross-Reactive Human Single-Chain Antibody for Detection of Major Fish
   Allergens, Parvalbumins, and Identification of a Major IgE-Binding
   Epitope
SO PLOS ONE
LA English
DT Article
ID REPORTED FOOD ALLERGY; CARP PARVALBUMIN; COD; PREVALENCE; IMMUNOTHERAPY;
   DESIGN; EUROPE
AB Fish allergy is associated with moderate to severe IgE-mediated reactions to the calcium binding parvalbumins present in fish muscle. Allergy to multiple fish species is caused by parvalbumin-specific cross-reactive IgE recognizing conserved epitopes. In this study, we aimed to produce cross-reactive single chain variable fragment (scFv) antibodies for the detection of parvalbumins in fish extracts and the identification of IgE epitopes. Parvalbumin- specific phage clones were isolated from the human ETH-2 phage display library by three rounds of biopanning either against cod parvalbumin or by sequential biopanning against cod (Gad m 1), carp (Cyp c 1) and rainbow trout (Onc m 1) parvalbumins. While biopanning against Gad m 1 resulted in the selection of clones specific exclusively for Gad m 1, the second approach resulted in the selection of clones cross-reacting with all three parvalbumins. Two clones, scFv-gco9 recognizing all three parvalbumins, and scFv-goo8 recognizing only Gad m 1 were expressed in the E. coli non-suppressor strain HB2151 and purified from the periplasm. scFv-gco9 showed highly selective binding to parvalbumins in processed fish products such as breaded cod sticks, fried carp and smoked trout in Western blots. In addition, the scFv-gco9-AP produced as alkaline phosphatase fusion protein, allowed a single-step detection of the parvalbumins. In competitive ELISA, scFv-gco9 was able to inhibit binding of IgE from fish allergic patients' sera to all three mu-parvalbumins by up to 80%, whereas inhibition by scFv-goo8 was up to 20%. H-1/N-15 HSQC NMR analysis of the rGad m 1:scFv-gco9 complex showed participation of amino acid residues conserved among these three parvalbumins explaining their cross-reactivity on a molecular level. In this study, we have demonstrated an approach for the selection of cross-reactive parvalbumin-specific antibodies that can be used for allergen detection and for mapping of conserved epitopes.
C1 [Bublin, Merima; Kostadinova, Maria; Ackerbauer, Daniela; Lengger, Nina; Radauer, Christian; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.
   [Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria.
   [Moraes, Adolfo H.; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet, Rio De Janeiro, Brazil.
   [Hafner, Christine] Karl Landsteiner Inst Dermatol Res, St Polten, Austria.
   [Hafner, Christine] Karl Landsteiner Univ Med Sci, Dept Dermatol, St Polten, Austria.
   [Ebner, Christof] Allergy Clin Reumannpl, Vienna, Austria.
RP Bublin, M (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.
EM merima.bublin@meduniwien.ac.at
RI Valente, Ana Paula/J-3010-2017; Moraes, Adolfo/G-3931-2018; Almeida,
   Fabio/O-4989-2018; Liedl, Klaus/F-3099-2015
OI Valente, Ana Paula/0000-0001-7219-1123; Moraes,
   Adolfo/0000-0002-3344-4084; Almeida, Fabio/0000-0001-6046-7006; Radauer,
   Christian/0000-0001-9920-4449; Bublin, Merima/0000-0002-7191-9431;
   Breiteneder, Heimo/0000-0003-2022-8689; Liedl, Klaus/0000-0002-0985-2299
FU Austrian Science Fund (FWF)Austrian Science Fund (FWF) [SFB-F4608]
FX This study was supported by the Austrian Science Fund (FWF;
   http://www.fwf.ac.at/) grant: SFB-F4608 to HB. The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bugajska-Schretter A, 1998, J ALLERGY CLIN IMMUN, V101, P67, DOI 10.1016/S0091-6749(98)70195-2
   Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477
   Chen LY, 2006, J AGR FOOD CHEM, V54, P5577, DOI 10.1021/jf060291g
   DEMARTINO M, 1990, J ALLERGY CLIN IMMUN, V86, P909, DOI 10.1016/S0091-6749(05)80154-X
   ELSAYED S, 1983, ALLERGY, V38, P449, DOI 10.1111/j.1398-9995.1983.tb02353.x
   Faeste CK, 2008, J IMMUNOL METHODS, V329, P45, DOI 10.1016/j.jim.2007.09.007
   Failler P., 2007, FAO FISHERIES CIRCUL
   Gajewski KG, 2009, J FOOD PROTECT, V72, P818, DOI 10.4315/0362-028X-72.4.818
   Griesmeier U, 2010, ALLERGY, V65, P191, DOI 10.1111/j.1398-9995.2009.02162.x
   Gruber P, 2009, BIOL CHEM, V390, P445, DOI 10.1515/BC.2009.063
   Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019
   Kerschbaumer RJ, 1997, ANAL BIOCHEM, V249, P219, DOI 10.1006/abio.1997.2171
   KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313
   KUMAR VD, 1990, BIOCHEMISTRY-US, V29, P1404, DOI 10.1021/bi00458a010
   Lapteva YS, 2013, BBA-PROTEINS PROTEOM, V1834, P1607, DOI 10.1016/j.bbapap.2013.04.025
   Lee PW, 2011, J AGR FOOD CHEM, V59, P12309, DOI 10.1021/jf203277z
   Lopata AL, 2005, INT ARCH ALLERGY IMM, V138, P21, DOI 10.1159/000087354
   Ma Y, 2008, MOL NUTR FOOD RES, V52, pS196, DOI 10.1002/mnfr.200700284
   McGowan EC, 2013, J ALLERGY CLIN IMMUN, V132, P1216, DOI 10.1016/j.jaci.2013.07.018
   Moraes AH, 2014, PROTEINS, V82, P3032, DOI 10.1002/prot.24664
   Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423
   Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305
   PASCUAL C, 1992, J PEDIATR-US, V121, pS29, DOI 10.1016/S0022-3476(05)81403-9
   Perez-Gordo M, 2013, MOL NUTR FOOD RES, V57, P1283, DOI 10.1002/mnfr.201200332
   Perez-Gordo M, 2012, INT ARCH ALLERGY IMM, V157, P31, DOI 10.1159/000324677
   Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769
   Sharp MF, 2015, MOL IMMUNOL, V63, P437, DOI 10.1016/j.molimm.2014.09.019
   Sharp MF, 2014, CLIN REV ALLERG IMMU, V46, P258, DOI 10.1007/s12016-013-8363-1
   Soller L, 2012, J ALLERGY CLIN IMMUN, V130, P986, DOI 10.1016/j.jaci.2012.06.029
   Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576
   Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290
   Swoboda I, 2013, J ALLERGY CLIN IMMUN, V132, P979, DOI 10.1016/j.jaci.2013.04.027
   Untersmayr E, 2006, MOL IMMUNOL, V43, P1454, DOI 10.1016/j.molimm.2005.07.038
   Van Do T, 2005, J ALLERGY CLIN IMMUN, V116, P1314, DOI 10.1016/j.jaci.2005.07.033
   Viti F, 2000, METHOD ENZYMOL, V326, P480
   Yoshida S, 2008, FOOD CHEM, V111, P857, DOI 10.1016/j.foodchem.2008.04.062
NR 36
TC 7
Z9 7
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2015
VL 10
IS 11
AR e0142625
DI 10.1371/journal.pone.0142625
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CW7CD
UT WOS:000365154600052
PM 26579717
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mujo, A
   Lixa, C
   Carneiro, LAM
   Anobom, CD
   Almeida, FC
   Pinheiro, AS
AF Mujo, Amanda
   Lixa, Carolina
   Carneiro, Leticia A. M.
   Anobom, Cristiane D.
   Almeida, Fabio C.
   Pinheiro, Anderson S.
TI H-1, N-15 and C-13 resonance assignments of the RRM1 domain of the key
   post-transcriptional regulator HuR
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Human antigen R; RNA-binding Protein; AU-rich elements; Assignment;
   Chemical shift
ID PROTEIN HUR
AB Human antigen R (HuR) is a ubiquitous protein that recognizes adenylate and uridylate-rich elements in mRNA, thereby interfering with the fate of protein translation. This protein plays a central role in the outcome of the inflammatory response as it may stabilize or silence mRNAs of key components of the immune system. HuR is able to interact with other RNA-binding proteins, reflecting a complex network that dictates mRNAs post-transcriptional control. HuR is composed of three functional domains, known as RNA-recognition motifs (RRM1, RRM2 and RRM3). It is known that RRM1 is the most important domain for mRNA-binding affinity. In this study, we completed the NMR chemical shift assignment of the RRM1 domain of HuR, as a first step to further establishing the structure, dynamics and function relationship for this protein.
C1 [Mujo, Amanda; Lixa, Carolina; Anobom, Cristiane D.; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Carneiro, Leticia A. M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Immunol, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM pinheiro@iq.ufrj.br
RI Carneiro, Leticia/T-8978-2019; Bom, Cristiane Dinis Ano/X-9461-2019;
   Pinheiro, Anderson S/B-6350-2014; Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006; Pinheiro,
   Anderson/0000-0001-5118-6931
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Brazil Initiative Collaboration
   grant from Brown University; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES
FX This work was supported by grants from Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and by a Brazil
   Initiative Collaboration grant from Brown University to A. S. P. A. M.
   and C. L. are recipients of a Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) graduate fellowship.
CR Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584
   Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043
   Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987
   Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002
   Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009
   Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832
   Meisner NC, 2010, ADV EXP MED BIOL, V700, P106, DOI 10.1007/978-1-4419-7823-3_10
   Meisner NC, 2009, J MOL BIOL, V386, P435, DOI 10.1016/j.jmb.2008.12.020
   Roretz VC, 2011, BIOCHIM BIOPHYS ACTA, V1813, P1663
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828
NR 11
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD OCT
PY 2015
VL 9
IS 2
BP 281
EP 284
DI 10.1007/s12104-014-9592-9
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA CR6FN
UT WOS:000361440100013
PM 25487676
DA 2020-12-01
ER

PT J
AU Cabral, KMS
   Raymundo, DP
   Silva, VS
   Sampaio, LAG
   Johanson, L
   Hill, LF
   Almeida, FCL
   Cordeiro, Y
   Almeida, MS
AF Cabral, Katia M. S.
   Raymundo, Diana P.
   Silva, Viviane S.
   Sampaio, Laura A. G.
   Johanson, Laizes
   Hill, Luis Fernando
   Almeida, Fabio C. L.
   Cordeiro, Yraima
   Almeida, Marcius S.
TI Biophysical Studies on BEX3, the p75(NTR)-Associated Cell Death
   Executor, Reveal a High-Order Oligomer with Partially Folded Regions
SO PLOS ONE
LA English
DT Article
ID MAGNETIC-RESONANCE RELAXATION; P75 NEUROTROPHIN RECEPTOR; MODEL-FREE
   APPROACH; SECONDARY STRUCTURE; BACKBONE DYNAMICS; ALPHA-SYNUCLEIN;
   PROTEIN; NMR; NADE; N-15
AB BEX3 (Brain Expressed X-linked protein 3) is a member of a mammal-specific placental protein family. Several studies have found the BEX proteins to be associated with neurodegeneration, the cell cycle and cancer. BEX3 has been predicted to be intrinsically disordered and also to represent an intracellular hub for cell signaling. The pro-apoptotic activity of BEX3 in association with a number of additional proteins has been widely supported; however, to the best of our knowledge, very limited data are available on the conformation of any of the members of the BEX family. In this study, we structurally characterized BEX3 using biophysical experimental data. Small angle X-ray scattering and atomic force microscopy revealed that BEX3 forms a specific higher-order oligomer that is consistent with a globular molecule. Solution nuclear magnetic resonance, partial proteinase K digestion, circular dichroism spectroscopy, and fluorescence techniques that were performed on the recombinant protein indicated that the structure of BEX3 is composed of approximately 31% a-helix and 20% beta-strand, contains partially folded regions near the N- and C-termini, and a core which is proteolysis-resistant around residues 55-120. The self-oligomerization of BEX3 has been previously reported in cell culture and is consistent with our in vitro data.
C1 [Cabral, Katia M. S.; Raymundo, Diana P.; Silva, Viviane S.; Sampaio, Laura A. G.; Johanson, Laizes; Almeida, Fabio C. L.; Almeida, Marcius S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Hill, Luis Fernando] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.; Almeida, Marcius S.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, Rio De Janeiro, Brazil.
RP Almeida, MS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM msalmeida@bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Cordeiro, Yraima/J-7619-2012
OI Almeida, Fabio/0000-0001-6046-7006; Cordeiro,
   Yraima/0000-0003-4278-212X; almeida, marcius/0000-0003-4921-8185
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [Universal
   CNPq 470349/2012-3]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [APQ1/E-26/111.771/2012]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal
   CNPq 470349/2012-3, http://www.cnpq.br); Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (APQ1/E-26/111.771/2012,
   www.faperj.br). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abragam A, 1961, PRINCIPLES NUCL MAGN
   Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001
   BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U
   BOYD J, 1990, CHEM PHYS LETT, V175, P477, DOI 10.1016/0009-2614(90)85567-V
   Canaves JM, 1998, J BIOL CHEM, V273, P34214, DOI 10.1074/jbc.273.51.34214
   Chen Y, 2009, J INT MED RES, V37, P281, DOI 10.1177/147323000903700201
   Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059
   CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111
   COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703
   Erickson HP, 2000, BIOL PROCEDURES ONLI, V11, P32
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Fernandez EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117206
   Gaczynska M, 2008, CURR OPIN COLLOID IN, V13, P351, DOI 10.1016/j.cocis.2008.01.004
   Glatter O., 1982, SMALL ANGLE XRAY SCA
   Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   Guinier A., 1955, SMALL ANGLE SCATTERI, P268
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4
   Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031
   Kimura MT, 2001, J BIOL CHEM, V276, P17291, DOI 10.1074/jbc.M005453200
   Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188
   Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   MCDONALD CC, 1967, J AM CHEM SOC, V89, P6332, DOI 10.1021/ja01000a061
   Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012
   Muka J, 2003, VITAM HORM, V66, P385, DOI 10.1016/S0083-6729(03)01011-2
   Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200
   Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102
   Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687
   Park JA, 2000, J NEUROSCI, V20, P9096
   Parkhurst CN, 2010, J BIOL CHEM, V285, P5361, DOI 10.1074/jbc.M109.045054
   Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220
   Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z
   Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3
   SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015
   Snyder DA, 2005, J AM CHEM SOC, V127, P16505, DOI 10.1021/ja053564h
   Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044
   Themistou E, 2009, BIOPHYS J, V97, P2567, DOI 10.1016/j.bpj.2009.08.023
   Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012
   Tong XJ, 2003, INT J ONCOL, V22, P1357
   Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010
   Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8
   Wall J, 1999, METHOD ENZYMOL, V309, P204
   WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335
   Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q
   Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yasui S, 2007, MOL CELL NEUROSCI, V35, P100, DOI 10.1016/j.mcn.2007.02.007
   Yi JS, 2003, NEUROSCI LETT, V347, P126, DOI 10.1016/S0304-3940(03)00656-6
   Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043
   Yu Y, 2006, BRAIN RES, V1100, P13, DOI 10.1016/j.brainres.2006.05.010
   Zhang MJ, 1998, BIOCHEM BIOPH RES CO, V243, P113, DOI 10.1006/bbrc.1997.8070
   ZHANG YZ, 1995, THESIS U PENNSYLVANI
   Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022
NR 69
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2015
VL 10
IS 9
AR e0137916
DI 10.1371/journal.pone.0137916
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS0ZE
UT WOS:000361790200044
PM 26383250
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, VLA
   Alves, NS
   Casalinho, ALF
   Mendes, YS
   Albernaz, FP
   Bianconi, ML
   Peabody, DS
   Silva, JL
   AnoBom, CD
   Valente, AP
   Almeida, FCL
   Souza, TLF
   Gomes, AMO
   Oliveira, AC
AF Braga, V. L. A.
   Alves, N. S.
   Casalinho, A. L. F.
   Mendes, Y. S.
   Albernaz, F. P.
   Bianconi, M. L.
   Peabody, D. S.
   Silva, J. L.
   AnoBom, C. D.
   Valente, A. P.
   Almeida, F. C. L.
   Souza, T. L. F.
   Gomes, A. M. O.
   Oliveira, A. C.
TI Structural and physicochemical studies of the fusion mechanisms and
   assembly of Hepatitis C Virus
SO JOURNAL OF VIRAL HEPATITIS
LA English
DT Meeting Abstract
CT 15th International Symposium on Viral Hepatitis and Liver Diseases
   (ISVHLD)
CY JUN 26-28, 2015
CL Berlin, GERMANY
DE HCV; fusion mechanisms and assembly process
C1 [Braga, V. L. A.; Alves, N. S.; Casalinho, A. L. F.; Mendes, Y. S.; Albernaz, F. P.; Bianconi, M. L.; Silva, J. L.; Valente, A. P.; Almeida, F. C. L.; Gomes, A. M. O.; Oliveira, A. C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
   [Peabody, D. S.] UNMSM USA, Dept Mol Genet & Microbiol, Florida, Brazil.
   [Peabody, D. S.] UNMSM USA, Canc Res & Treatment Center, Florida, Brazil.
   [AnoBom, C. D.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, Brazil.
   [Souza, T. L. F.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
RI Bom, Cristiane Dinis Ano/X-9461-2019; Silva, Jerson/J-8984-2014
OI Silva, Jerson/0000-0001-9523-9441
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1352-0504
EI 1365-2893
J9 J VIRAL HEPATITIS
JI J. Viral Hepatitis
PD JUN
PY 2015
VL 22
SU 2
SI SI
MA P106
BP 74
EP 74
DI 10.1111/jvh.100_12425
PG 1
WC Gastroenterology & Hepatology; Infectious Diseases; Virology
SC Gastroenterology & Hepatology; Infectious Diseases; Virology
GA CL3XB
UT WOS:000356884200132
OA Bronze
DA 2020-12-01
ER

PT J
AU Fidalgo, TKS
   Freitas-Fernandes, LB
   Almeida, FCL
   Valente, AP
   Souza, IPR
AF Fidalgo, Tatiana K. S.
   Freitas-Fernandes, Liana B.
   Almeida, Fabio C. L.
   Valente, Ana P.
   Souza, Ivete P. R.
TI Longitudinal evaluation of salivary profile from children with dental
   caries before and after treatment
SO METABOLOMICS
LA English
DT Article
DE Saliva; Metabolomic profile; Children; NMR; Dental caries; Oral
   microorganisms
ID EARLY-CHILDHOOD CARIES; MUTANS-STREPTOCOCCI; H-1-NMR ANALYSIS;
   COLONIZATION; METABOLOMICS; STANDARDS; BIOFILM; INFANTS; SERUM; FLUID
AB Saliva is a biofluid largely used in metabolomics for the assessment of local and systemic diseases. Our group has previously demonstrated the salivary metabolomic signature of children with dental caries (Fidalgo et al. Metabolomics 9(3):657-666, 2013). The aim of the current study was investigation, using NMR spectroscopy, of the changes observed for metabolite markers for caries lesions before and after dental treatment. Saliva from children with and without dental caries before and after treatment was analyzed by NMR. Partial least squared discriminant analysis (PLS-DA) conducted on the spectroscopic data sets showed a clear separation of saliva metabolic profile of children with and without caries, and multilevel PLS-DA demonstrated difference before and after dental treatment. Our results demonstrate that organic acids are associated with disease activity because their reductions were observed after dental treatment. There was a demonstrated reduction here in the levels of acetate, propionate, fatty acid, butyrate and saccharides. We also observed a drop in the level of microorganisms upon dental treatment. The dental treatment therefore modified the properties of the oral cavity, leading to changes in the salivary profiles after treatment.
C1 [Fidalgo, Tatiana K. S.; Freitas-Fernandes, Liana B.; Souza, Ivete P. R.] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, BR-21941971 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.; Valente, Ana P.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, BR-21941971 Rio De Janeiro, RJ, Brazil.
RP Souza, IPR (corresponding author), Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Cidade Univ CCS,Caixa Postal 68066, BR-21941971 Rio De Janeiro, RJ, Brazil.
EM pomarico@gmail.com
RI da Silva Fidalgo, Tatiana Kelly/I-4969-2014; Almeida, Fabio/O-4989-2018;
   Valente, Ana Paula/J-3010-2017
OI da Silva Fidalgo, Tatiana Kelly/0000-0003-1340-9967; Almeida,
   Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123;
   Souza, Ivete Pomarico/0000-0003-0449-6624
FU National Institute of Science and Technology of Structural Biology and
   Bioimaging (INCT-INBEB); CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ);
   FINEPCiencia Tecnologia e Inovacao (FINEP); CAPESCAPES
FX The authors acknowledge the financial support from the following
   agencies: National Institute of Science and Technology of Structural
   Biology and Bioimaging (INCT-INBEB), CNPq, FAPERJ, FINEP, and CAPES.
   Also, the authors thank Dr. Ewa Szymanska for helping us with the
   M-PLS-DA Matlab routines.
CR Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2
   American Academy of Pedodontics & American Academy of Pediatrics, 2011, PEDIAT DENT S, V30, P40
   Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762
   Bergandi L, 2007, EUR J ORAL SCI, V115, P93, DOI 10.1111/j.1600-0722.2007.00437.x
   Bertini I, 2014, METABOLOMICS, V10, P302, DOI 10.1007/s11306-013-0572-3
   Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598
   Bretz Walter A, 2003, J Evid Based Dent Pract, V3, P185, DOI 10.1016/j.jebdp.2003.11.002
   CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501
   Cuevas-Cordoba B, 2014, OMICS, V18, P87, DOI 10.1089/omi.2013.0064
   Fidalgo TKD, 2014, J DENT, V42, P1372, DOI 10.1016/j.jdent.2014.07.011
   DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721
   Deja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084637
   Fidalgo TKS, 2013, METABOLOMICS, V9, P657, DOI 10.1007/s11306-012-0484-7
   Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6
   Garcia-Godoy F, 2008, J AM DENT ASSOC, V139, p25S, DOI 10.14219/jada.archive.2008.0352
   Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3
   Grootveld M, 2005, BIOCHEM BIOPH RES CO, V329, P1, DOI 10.1016/j.bbrc.2005.01.112
   Jolliffe I.T., 2002, PRINCIPAL COMPONENT
   Law V, 2007, AUST DENT J, V52, P26, DOI 10.1111/j.1834-7819.2007.tb00462.x
   Li LP, 2013, ASAIO J, V59, P286, DOI 10.1097/MAT.0b013e31828e2d9f
   LI YH, 1994, ARCH ORAL BIOL, V39, P1057, DOI 10.1016/0003-9969(94)90058-2
   Martins PA, 2013, CARIES RES, V47, P211, DOI 10.1159/000345534
   Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401
   Morou-Bermudez E, 2011, ARCH ORAL BIOL, V56, P1282, DOI 10.1016/j.archoralbio.2011.04.015
   Neyraud E, 2013, METABOLOMICS, V9, P213, DOI 10.1007/s11306-012-0440-6
   Ng DJY, 2011, METABOLOMICS, V7, P155, DOI 10.1007/s11306-010-0250-7
   Olszowski T, 2012, ORAL DIS, V18, P389, DOI 10.1111/j.1601-0825.2011.01887.x
   Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543
   Puchades-Carrasco L, 2013, CLIN CANCER RES, V19, P4770, DOI 10.1158/1078-0432.CCR-12-2917
   Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042
   Rigante D, 2008, RHEUMATOL INT, V28, P801, DOI 10.1007/s00296-008-0524-9
   Seow WK, 2000, J DENT RES, V79, P63, DOI 10.1177/00220345000790011101
   Silwood CJL, 1999, NMR BIOMED, V12, P345, DOI 10.1002/(SICI)1099-1492(199910)12:6<345::AID-NBM580>3.0.CO;2-C
   Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613
   SLOMIANY BL, 1989, ARCH ORAL BIOL, V34, P229, DOI 10.1016/0003-9969(89)90063-0
   SREEBNY LM, 1985, ARCH ORAL BIOL, V30, P269, DOI 10.1016/0003-9969(85)90044-5
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Szymanska E, 2012, METABOLOMICS, V8, P894, DOI 10.1007/s11306-011-0384-2
   Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369
   Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201
   Tayab T, 2012, EUR J PAEDIATR DENT, V13, P107
   Tenuta LMA, 2006, J DENT RES, V85, P834, DOI 10.1177/154405910608500911
   Titania K, 2012, OPEN ACCESS SCI REPO, V1, P1
   van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j
   VANHOUTE J, 1989, J DENT RES, V68, P451, DOI 10.1177/00220345890680030301
   Wan AKL, 2003, J DENT RES, V82, P504, DOI 10.1177/154405910308200703
   World Health Organization, 1997, OR HLTH SURV BAS MET
NR 47
TC 15
Z9 16
U1 0
U2 37
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD JUN
PY 2015
VL 11
IS 3
BP 583
EP 593
DI 10.1007/s11306-014-0717-z
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CH6HL
UT WOS:000354137100007
DA 2020-12-01
ER

PT J
AU Iqbal, A
   Gomes-Neto, F
   Myiamoto, CA
   Valente, AP
   Almeida, FCL
AF Iqbal, Anwar
   Gomes-Neto, Francisco
   Myiamoto, Catarina Akiko
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Dissection of the Water Cavity of Yeast Thioredoxin 1: The Effect of a
   Hydrophobic Residue in the Cavity
SO BIOCHEMISTRY
LA English
DT Article
ID ESCHERICHIA-COLI THIOREDOXIN; MAGNETIC-RESONANCE RELAXATION; NMR
   SOLUTION STRUCTURE; MODEL-FREE APPROACH; ASPARTIC-ACID 26;
   CRYSTAL-STRUCTURE; REDUCED FORM; ACTIVE-SITE; PROTEIN; DYNAMICS
AB The water cavity of yeast thioredoxin 1 (yTrx1) is an ancestral, conserved structural element that is poorly understood. We recently demonstrated that the water cavity is involved in the complex protein dynamics that are responsible for the catalytically relevant event of coupling hydration, proton exchange, and motion at the interacting loops. Its main feature is the presence of the conserved polar residue, Asp24, which is buried in a hydrophobic cavity. Here, we evaluated the role of the solvation of Asp24 as the main element that is responsible for the formation of the water cavity in thioredoxins. We showed that the substitution of Asp24 with a hydrophobic residue (D24A) was not sufficient to completely close the cavity. The dynamics of the D24A mutant of yTrx1 at multiple time scales revealed that the D24A mutant presents motions at different time scales near the active site, interaction loops, and water cavity, revealing the existence of a smaller dissected cavity. Molecular dynamics simulation, along with experimental molecular dynamics, allowed a detailed description of the water cavity in wild-type yTrx1 and D24A. The cavity connects the interacting loops, the central beta-sheet, and a-helices 2 and 4. It is formed by three contiguous lobes, which we call lobes AC. Lobe A is hydrophilic and the most superficial. It is formed primarily by the conserved Lys54. Lobe B is the central lobe formed by the catalytically important residues Cys33 and Asp24, which are strategically positioned. Lobe C is the most hydrophobic and is formed by the conserved cis-Pro73. The central lobe B is closed upon introduction of the D24A mutation, revealing that independent forces other than solvation of Asp24 maintain lobes A and C in the open configuration. These data allow us to better understand the properties of this enzyme.
C1 [Iqbal, Anwar; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Valente, Ana Paula] Univ Fed Rio de Janeiro, Ctr Struct Biol & Bioimaging CENABIO, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes-Neto, Francisco] Fiocruz MS, Inst Oswaldo Cruz, Toxicol Lab, BR-21045900 Rio De Janeiro, Brazil.
   [Myiamoto, Catarina Akiko] Fac Integradas Tres Lagoas AEMS, Tres Lagoas, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Annex CNRMN, CCS, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; program Science Without
   Borders-CNPq
FX We thank the following funding agencies for funding: FAPERJ, CNPq,
   CAPES, and the program Science Without Borders-CNPq.
CR Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P716, DOI 10.1016/j.bbapap.2008.12.016
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006
   Campos-Acevedo AA, 2013, ACTA CRYSTALLOGR F, V69, P488, DOI 10.1107/S1744309113010622
   Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x
   Cruzeiro-Silva C, 2014, BIOCHEMISTRY-US, V53, P2890, DOI 10.1021/bi401542v
   Dixit SB, 1997, J CHEM SOC FARADAY T, V93, P1105, DOI 10.1039/a603913h
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Ferreiro D.U., 2014, Q REV BIOPHYS, P1
   Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111
   Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020
   Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n
   Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447
   Ji CG, 2008, BIOPHYS J, V95, P1080, DOI 10.1529/biophysj.108.131110
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032
   Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168
   LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998
   LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Luzar A, 2000, J CHEM PHYS, V113, P10663, DOI 10.1063/1.1320826
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Modig K, 2004, J AM CHEM SOC, V126, P102, DOI 10.1021/ja038325d
   Oliveira MA, 2010, BIOCHEMISTRY-US, V49, P3317, DOI 10.1021/bi901962p
   OTTING G, 1991, Journal of Biomolecular NMR, V1, P209, DOI 10.1007/BF01877232
   OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083
   Pinheiro AS, 2006, J BIOMOL NMR, V36, P35, DOI 10.1007/s10858-006-0025-7
   Pinheiro AS, 2008, PROTEINS, V70, P584, DOI 10.1002/prot.21693
   Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200
   Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300
   Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088
   Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vazquez DS, 2015, BBA-PROTEINS PROTEOM, V1854, P127, DOI 10.1016/j.bbapap.2014.11.004
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Weichsel A, 2010, PROTEIN SCI, V19, P1801, DOI 10.1002/pro.455
   Whittaker SBM, 2011, J MOL BIOL, V414, P511, DOI 10.1016/j.jmb.2011.09.038
   WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001
   Zhang Y, 2008, ACTA CRYSTALLOGR F, V64, P323, DOI 10.1107/S1744309108004612
NR 53
TC 6
Z9 6
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 21
PY 2015
VL 54
IS 15
BP 2429
EP 2442
DI 10.1021/acs.biochem.5b00082
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CG6RJ
UT WOS:000353429600003
PM 25830254
DA 2020-12-01
ER

PT J
AU Faustino, AF
   Guerra, GM
   Huber, RG
   Hollmann, A
   Domingues, MM
   Barbosa, GM
   Enguita, FJ
   Bond, PJ
   Castanho, MARB
   Da Poian, AT
   Almeida, FCL
   Santos, NC
   Martins, IC
AF Faustino, Andre F.
   Guerra, Gabriela M.
   Huber, Roland G.
   Hollmann, Axel
   Domingues, Marco M.
   Barbosa, Glauce M.
   Enguita, Francisco J.
   Bond, Peter J.
   Castanho, Miguel A. R. B.
   Da Poian, Andrea T.
   Almeida, Fabio C. L.
   Santos, Nuno C.
   Martins, Ivo C.
TI Understanding Dengue Virus Capsid Protein Disordered N-Terminus and
   pep14-23-Based Inhibition
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID MAMMALIAN IMPORTIN-ALPHA; HEPATITIS-C VIRUS; BIOPHYSICAL
   CHARACTERIZATION; MODEL MEMBRANES; BINDING; REGION; SPECTROSCOPY;
   PEPTIDES; DYNAMICS; REVEALS
AB Dengue virus (DENV) infection affects millions of people and is becoming a major global disease for which there is no specific available treatment. pep14-23 is a recently designed peptide, based on a conserved segment of DENV capsid (C) protein. It inhibits the interaction of DENV C with host intracellular lipid droplets (LDs), which is crucial for viral replication. Combining bioinformatics and biophysics, here, we analyzed pep14-23 structure and ability to bind different phospholipids, relating that information with the full-length DENV C. We show that pep14-23 acquires a-helical conformation upon binding to negatively charged phospholipid membranes, displaying an asymmetric charge distribution structural arrangement. Structure prediction for the N-terminal segment reveals four viable homodimer orientations that alternatively shield or expose the DENV C hydrophobic pocket. Taken together, these findings suggest a new biological role for the disordered N-terminal region, which may function as an autoinhibitory domain mediating DENV C interaction with its biological targets. The results fit with our current understanding of DENV C and pep14-23 structure and function, paving the way for similar approaches to understanding disordered proteins and improved peptidomimetics drug development strategies against DENV and similar Flavivirus infections.
C1 [Faustino, Andre F.; Guerra, Gabriela M.; Hollmann, Axel; Domingues, Marco M.; Enguita, Francisco J.; Castanho, Miguel A. R. B.; Santos, Nuno C.; Martins, Ivo C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
   [Huber, Roland G.; Bond, Peter J.] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore.
   [Barbosa, Glauce M.; Da Poian, Andrea T.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal.
EM nsantos@fm.ul.pt; ivomartins@fm.ul.pt
RI Huber, Roland/AAG-6353-2019; Da Poian, Andrea T./V-1699-2019; Martins,
   Ivo C/G-2534-2013; GUERRA, GRAZIA MARIA/ABE-7457-2020; Enguita,
   Francisco J./A-2347-2009; Almeida, Fabio/O-4989-2018; Guerra, Grazia
   Maria/AAQ-4433-2020; Santos, Nuno/N-7248-2013
OI Huber, Roland/0000-0001-5093-5988; Martins, Ivo C/0000-0002-9284-8599;
   Enguita, Francisco J./0000-0002-8072-8557; Almeida,
   Fabio/0000-0001-6046-7006; Da Poian, Andrea/0000-0002-3969-704X; Bond,
   Peter/0000-0003-2900-098X; Hollmann, Axel/0000-0002-8060-2997; Santos,
   Nuno/0000-0002-0580-0475; FCCN, Bogus/0000-0003-1034-3552; Guerra,
   Grazia Maria/0000-0003-4131-7904; Domingues, Marco/0000-0003-1502-1421;
   Faustino, Andre F./0000-0002-7364-8524; FCCN, Bogus/0000-0001-6282-8004;
   Castanho, Miguel/0000-0001-7891-7562
FU Fundacao para a Ciencia e Tecnologia-Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009,
   PTDC/SAU-ENB/117013/2010]; Calouste Gulbenkian Foundation (FCG,
   Portugal); European Union project FP7-IRSES MEMPEPACROSS; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq) [471239/2012-7, 306669/2013-7]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/102.919/2011, E-26/110.636/2012]; FCT-MEC
   [SFRH/BD/77609/2011, SFRH/BPD/72037/2010, SFRH/BPD/74287/2010]; Program
   "Investigador FCT" [IF/00772/2013]
FX The authors thank T. Freitas (IMM, FMUL) for technical assistance. This
   work was supported by Fundacao para a Ciencia e Tecnologia-Ministerio da
   Educacao e Ciencia (FCT-MEC, Portugal) projects PTDC/QUI-BIQ/112929/2009
   and PTDC/SAU-ENB/117013/2010, Calouste Gulbenkian Foundation (FCG,
   Portugal) project Science Frontiers Research Prize 2010, European Union
   project FP7-IRSES MEMPEPACROSS, Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil, grant numbers 471239/2012-7 and
   306669/2013-7) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ, Brazil, grant numbers
   E-26/102.919/2011 and E-26/110.636/2012). A.F.F. and A.H. also
   acknowledge FCT-MEC fellowships SFRH/BD/77609/2011 and
   SFRH/BPD/72037/2010, respectively. I.C.M. acknowledges consecutive
   funding from the FCT-MEC fellowship SFRH/BPD/74287/2010 and the Program
   "Investigador FCT" (IF/00772/2013 Research Contract).
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Case D.A., 2014, AMBER14
   Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200
   Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008
   Darlix JL, 2014, VIRUS RES, V193, P2, DOI 10.1016/j.virusres.2014.05.011
   Domingues MM, 2012, BIOPOLYMERS, V98, P338, DOI 10.1002/bip.22095
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Enserink M, 2010, SCIENCE, V329, P736, DOI 10.1126/science.329.5993.736
   Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Fermani S, 2012, J BIOL CHEM, V287, P21372, DOI 10.1074/jbc.M112.350355
   Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3
   Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021
   Sanchez-Martin MJ, 2012, INT J PHARMACEUT, V436, P593, DOI 10.1016/j.ijpharm.2012.07.051
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Knowlton K., 2009, MOSQUITO BORNE DENGU, P116
   Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200
   LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martins I. C., 2012, INT PATENT PUBLICATI, Patent No. W0/2012/159187
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Moritsugu K, 2012, J AM CHEM SOC, V134, P7094, DOI 10.1021/ja3008402
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Peng ZL, 2015, CELL MOL LIFE SCI, V72, P137, DOI 10.1007/s00018-014-1661-9
   Popovic M, 2007, FEBS J, V274, P5325, DOI 10.1111/j.1742-4658.2007.06053.x
   Redondo-Morata L, 2012, BIOPHYS J, V102, P66, DOI 10.1016/j.bpj.2011.10.051
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1
   Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819
   Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9
   White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Yang HY, 2010, J PHYS CHEM B, V114, P16978, DOI 10.1021/jp1091569
NR 53
TC 22
Z9 22
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD FEB
PY 2015
VL 10
IS 2
BP 517
EP 526
DI 10.1021/cb500640t
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CB9HN
UT WOS:000349942700021
PM 25412346
DA 2020-12-01
ER

PT J
AU Moraes, AH
   Ackerbauer, D
   Kostadinova, M
   Bublin, M
   de Oliveira, GA
   Ferreira, F
   Almeida, FCL
   Breiteneder, H
   Valente, AP
AF Moraes, Adolfo H.
   Ackerbauer, Daniela
   Kostadinova, Maria
   Bublin, Merima
   de Oliveira, Guilherme Augusto
   Ferreira, Fatima
   Almeida, Fabio C. L.
   Breiteneder, Heimo
   Valente, Ana Paula
TI Solution and high-pressure NMR studies of the structure, dynamics, and
   stability of the cross-reactive allergenic cod parvalbumin Gad m 1
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE protein structure; -parvalbumin; allergenicity; high-pressure NMR;
   cross-reactivity
ID MAGNETIC-RESONANCE RELAXATION; CALCIUM-BINDING PROTEIN; MODEL-FREE
   APPROACH; POLLEN ALLERGENS; BETA-PARVALBUMIN; CHEMICAL-SHIFTS; IGE
   REACTIVITY; TORSION ANGLES; FOOD ALLERGY; FISH ALLERGY
AB Beta-parvalbumins from different fish species have been identified as the main elicitors of IgE-mediated reactions in fish-allergic individuals. Here, we report for the first time the NMR determination of the structure and dynamics of the major Atlantic cod (Gadus morhua) allergen Gad m 1 and compare them with other known parvalbumins. Although the Gad m 1 structure and accessibility of putative IgE epitopes are similar to parvalbumins in mackerel and carp, the charge distribution at the putative epitopes is different. The determination of the Gad m 1 structure contributes to a better understanding of cross-reactivity among fish parvalbumins. In addition, the high-pressure NMR and temperature variation experiments revealed the important contribution of the AB motif and other regions to the protein folding. This structural information could assist the future identification of hot spots for targeted mutations to develop hypoallergenic Ca2+-free forms for potential use in immunotherapy. Proteins 2014; 82:3032-3042. (c) 2014 Wiley Periodicals, Inc.
C1 [Moraes, Adolfo H.; de Oliveira, Guilherme Augusto; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance, Inst Med Biochem, Dept Biol Struct, Rio De Janeiro, Brazil.
   [Ackerbauer, Daniela; Kostadinova, Maria; Bublin, Merima; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.
   [Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Ferreira, Fatima/E-4889-2011; Almeida, Fabio/O-4989-2018; Ferreira,
   Fatima/AAB-4321-2019; Moraes, Adolfo/G-3931-2018; Valente, Ana
   Paula/J-3010-2017; de Oliveira, Guilherme A. P./O-1192-2013
OI Ferreira, Fatima/0000-0003-0989-2335; Almeida,
   Fabio/0000-0001-6046-7006; Ferreira, Fatima/0000-0003-0989-2335; Moraes,
   Adolfo/0000-0002-3344-4084; Valente, Ana Paula/0000-0001-7219-1123; de
   Oliveira, Guilherme A. P./0000-0002-0063-5888; Bublin,
   Merima/0000-0002-7191-9431; Breiteneder, Heimo/0000-0003-2022-8689
FU Austrian Science FundAustrian Science Fund (FWF) [SFB F4608];
   CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); INBEB
FX Grant sponsor: Austrian Science Fund; Grant number: SFB F4608; Grant
   sponsors: Brazilian agencies CNPq; FAPERJ; INBEB.
CR Akasaka K, 2001, BIOCHEMISTRY-US, V40, P8665, DOI 10.1021/bi010312u
   Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BERNHISELBROADBENT J, 1992, J ALLERGY CLIN IMMUN, V90, P622, DOI 10.1016/0091-6749(92)90135-O
   Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cho MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037270
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Focke-Tejkl M, 2012, CURR OPIN ALLERGY CL, V12, P555, DOI 10.1097/ACI.0b013e328357ca53
   Garmatiuk T, 2013, IMMUNOBIOLOGY, V218, P1155, DOI 10.1016/j.imbio.2013.04.006
   Griesmeier U, 2010, ALLERGY, V65, P191, DOI 10.1111/j.1398-9995.2009.02162.x
   Henzl MT, 2004, BIOCHEMISTRY-US, V43, P10906, DOI 10.1021/bi049254d
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7
   Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019
   Ledesma A, 2002, CLIN EXP ALLERGY, V32, P1476, DOI 10.1046/j.1365-2745.2002.01493.x
   Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Ma Y, 2008, MOL NUTR FOOD RES, V52, pS196, DOI 10.1002/mnfr.200700284
   Moraes AH, 2013, BIOMOL NMR ASSIGN, V7, P133, DOI 10.1007/s12104-012-9393-y
   Morii A, 2013, EUR FOOD RES TECHNOL, V236, P165, DOI 10.1007/s00217-012-1867-8
   Perez-Gordo M, 2013, MOL NUTR FOOD RES, V57, P1283, DOI 10.1002/mnfr.201200332
   Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012
   Roche J, 2013, CHEMBIOCHEM, V14, P1754, DOI 10.1002/cbic.201300244
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020
   Somkuti J, 2012, BIOCHEMISTRY-US, V51, P5903, DOI 10.1021/bi300403h
   Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290
   Swoboda I, 2013, J ALLERGY CLIN IMMUN, V132, P979, DOI 10.1016/j.jaci.2013.04.027
   Tomura S, 2008, FISHERIES SCI, V74, P411, DOI 10.1111/j.1444-2906.2008.01538.x
   Untersmayr E, 2006, MOL IMMUNOL, V43, P1454, DOI 10.1016/j.molimm.2005.07.038
   Van Do T, 2005, J ALLERGY CLIN IMMUN, V116, P1314, DOI 10.1016/j.jaci.2005.07.033
   Venter C, 2011, PEDIATR CLIN N AM, V58, P327, DOI 10.1016/j.pcl.2011.02.011
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Wallner M, 2007, J ALLERGY CLIN IMMUN, V120, P374, DOI 10.1016/j.jaci.2007.05.021
   Wild C, 2007, ALLERGY, V62, P33, DOI 10.1111/j.1398-9995.2006.01245.x
   Zuidmeer-Jongejan L, 2012, CLIN TRANSL ALLERGY, V2, P1
NR 43
TC 11
Z9 11
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD NOV
PY 2014
VL 82
IS 11
BP 3032
EP 3042
DI 10.1002/prot.24664
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AS6MT
UT WOS:000344378300015
PM 25116395
DA 2020-12-01
ER

PT J
AU Asam, C
   Batista, AL
   Moraes, AH
   de Paula, VS
   Almeida, FCL
   Aglas, L
   Kitzmuller, C
   Bohle, B
   Ebner, C
   Ferreira, F
   Wallner, M
   Valente, AP
AF Asam, C.
   Batista, A. L.
   Moraes, A. H.
   de Paula, V. S.
   Almeida, F. C. L.
   Aglas, L.
   Kitzmueller, C.
   Bohle, B.
   Ebner, C.
   Ferreira, F.
   Wallner, M.
   Valente, A. P.
TI Bet v 1-a Trojan horse for small ligands boosting allergic
   sensitization?
SO CLINICAL AND EXPERIMENTAL ALLERGY
LA English
DT Article
DE allergenicity; allergic sensitization; allergic sensitization; Bet v 1;
   epitope mapping; human IgE epitope; IgE reactivity; NMR
ID BIRCH POLLEN ALLERGEN; CONFORMATIONAL STABILITY; MAJOR ALLERGEN;
   BINDING; REACTIVITY; EPITOPES
AB Background Birch pollen allergy represents the main cause of winter and spring pollinosis in the temperate climate zone of the northern hemisphere and sensitization towards Bet v 1, the major birch pollen allergen, affects over 100 million allergic patients. The major birch pollen allergen Bet v 1 has been described as promiscuous acceptor for a wide variety of hydrophobic ligands.
   Objective In search of intrinsic properties of Bet v 1, which account responsible for the high allergenic potential of the protein, we thought to investigate the effects of ligand-binding on immunogenic as well as allergenic properties.
   Methods As surrogate ligand of Bet v 1 sodium deoxycholate (DOC) was selected. Recombinant and natural Bet v 1 were characterised physico-chemically as well as immunologically in the presence or absence of DOC, and an animal model of allergic sensitization was established. Moreover, human IgE binding to Bet v 1 was analysed by nuclear magnetic resonance (NMR) spectroscopy.
   Results Ligand-binding had an overall stabilizing effect on Bet v 1. This translated in a Th2 skewing of the immune response in a mouse model. Analyses of human IgE binding on Bet v 1 in mediator release assays revealed that ligand-bound allergen-induced degranulation at lower concentrations; however, in basophil activation tests with human basophils ligand-binding did not show this effect. For the first time, human IgE epitopes on Bet v 1 were determined using antibodies isolated from patients' sera. The IgE epitope mapping of Bet v 1 demonstrated the presence of multiple binding regions.
   Conclusions and clinical relevance Deoxycholate binding stabilizes conformational IgE epitopes on Bet v 1; however, the epitopes themselves remain unaltered. Therefore, we speculate that humans are exposed to both ligand-bound and free Bet v 1 during sensitization, disclosing the ligand-binding cavity of the allergen as key structural element.
C1 [Asam, C.; Aglas, L.; Ferreira, F.; Wallner, M.] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
   [Batista, A. L.; Moraes, A. H.; de Paula, V. S.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Programa Biol Estrutural, BR-21941902 Rio De Janeiro, Brazil.
   [Kitzmueller, C.; Bohle, B.] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Immunomodulat, Vienna, Austria.
   [Ebner, C.] Allergieambulatorium Reumannpl, Vienna, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Natl NMR Ctr, Responsible NMR Expt, CNRMN, Av Carlos Chagas Filho 373,Bloco K, BR-21941902 Rio De Janeiro, Brazil.
EM michael.wallner@sbg.ac.at; valente@cnrmn.bioqmed.ufrj.br
RI Ferreira, Fatima/AAB-4321-2019; Valente, Ana Paula/J-3010-2017; Aglas,
   Lorenz/L-3996-2015; De Paula, Viviane/L-1947-2013; Wallner,
   Michael/L-5437-2015; Ferreira, Fatima/E-4889-2011; Moraes,
   Adolfo/G-3931-2018; Almeida, Fabio/O-4989-2018
OI Ferreira, Fatima/0000-0003-0989-2335; Valente, Ana
   Paula/0000-0001-7219-1123; Aglas, Lorenz/0000-0002-1236-5934; De Paula,
   Viviane/0000-0003-3171-6477; Wallner, Michael/0000-0001-6568-7892;
   Ferreira, Fatima/0000-0003-0989-2335; Moraes,
   Adolfo/0000-0002-3344-4084; Almeida, Fabio/0000-0001-6046-7006; Bohle,
   Barbara/0000-0002-5105-7985; Kitzmuller, Claudia/0000-0002-3829-8020
FU Christian Doppler Research Association, Austria; Biomay AG, Vienna,
   Austria; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P
   23417-B13]; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CAPESCAPES; INBEB,
   Brazil; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P 23417]
   Funding Source: researchfish
FX Christian Doppler Research Association, Austria; Biomay AG, Vienna,
   Austria; Austrian Science Fund (FWF) Project P 23417-B13 and CNPq,
   FAPERJ, CAPES and INBEB, Brazil.
CR Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278
   Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624
   Ferreira F, 1998, FASEB J, V12, P231
   Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804
   Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082
   Hauser M, 2011, CLIN EXP ALLERGY, V41, P1804, DOI 10.1111/j.1365-2222.2011.03866.x
   Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002
   Kofler S, 2012, J MOL BIOL, V422, P109, DOI 10.1016/j.jmb.2012.05.016
   Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007
   Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Ohkuri T, 2010, J IMMUNOL, V185, P4199, DOI 10.4049/jimmunol.0902249
   Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012
   Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x
   Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413
   So T, 2001, IMMUNOLOGY, V104, P259, DOI 10.1046/j.1365-2567.2001.01314.x
   Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084
   Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1
   Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065
   Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548
   Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x
   Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064
   Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138
NR 23
TC 26
Z9 26
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-7894
EI 1365-2222
J9 CLIN EXP ALLERGY
JI Clin. Exp. Allergy
PD AUG
PY 2014
VL 44
IS 8
BP 1083
EP 1093
DI 10.1111/cea.12361
PG 11
WC Allergy; Immunology
SC Allergy; Immunology
GA AM0WN
UT WOS:000339568500012
PM 24979350
DA 2020-12-01
ER

PT J
AU Manzini, MC
   Perez, KR
   Riske, KA
   Bozelli, JC
   Santos, TL
   da Silva, MA
   Saraiva, GKV
   Politi, MJ
   Valente, AP
   Almeida, FCL
   Chaimovich, H
   Rodrigues, MA
   Bemquerer, MP
   Schreier, S
   Cuccovia, IM
AF Manzini, Mariana C.
   Perez, Katia R.
   Riske, Karin A.
   Bozelli, Jose C., Jr.
   Santos, Talita L.
   da Silva, Marcia A.
   Saraiva, Greice K. V.
   Politi, Mario J.
   Valente, Ana P.
   Almeida, Fabio C. L.
   Chaimovich, Hernan
   Rodrigues, Magali A.
   Bemquerer, Marcelo P.
   Schreier, Shirley
   Cuccovia, Iolanda M.
TI Peptide:lipid ratio and membrane surface charge determine the mechanism
   of action of the antimicrobial peptide BP100. Conformational and
   functional studies
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE BP100; Antimicrobial peptide; CD; NMR; Zeta potential; Model membrane
   leakage
ID ELECTRON-SPIN-RESONANCE; CIRCULAR-DICHROISM; PHOSPHOLIPID-MEMBRANES;
   BIOLOGICAL-ACTIVITY; BILAYER-MEMBRANES; MELITTIN HYBRIDS; LIPID
   VESICLES; ACIDIC LIPIDS; ION-EXCHANGE; PLANT-CELLS
AB The cecropin-melittin hybrid antimicrobial peptide BP100 (H-KKLFKKILKYL-NH2) is selective for Gram-negative bacteria, negatively charged membranes, and weakly hemolytic. We studied BP100 conformational and functional properties upon interaction with large unilamellar vesicles, LUVs, and giant unilamellar vesicles, GUVs, containing variable proportions of phosphatidylcholine (PC) and negatively charged phosphatidylglycerol (PG). CD and NMR spectra showed that upon binding to PG-containing LUVs BP100 acquires a-helical conformation, the helix spanning residues 3-11. Theoretical analyses indicated that the helix is amphipathic and surface-seeking. CD and dynamic light scattering data evinced peptide and/or vesicle aggregation, modulated by peptide: lipid ratio and PG content. BP100 decreased the absolute value of the zeta potential () of LUVs with low PG contents; for higher PG, binding was analyzed as an ion-exchange process. At high salt, BP100-induced LUVS leakage requires higher peptide concentration, indicating that both electrostatic and hydrophobic interactions contribute to peptide binding. While a gradual release took place at low peptide:lipid ratios, instantaneous loss occurred at high ratios, suggesting vesicle disruption. Optical microscopy of GUVs confirmed BP100-promoted disruption of negatively charged membranes. The mechanism of action of BP100 is determined by both peptide:lipid ratio and negatively charged lipid content While gradual release results from membrane perturbation by a small number of peptide molecules giving rise to changes in acyl chain packing, lipid clustering (leading to membrane defects), and/or membrane thinning, membrane disruption results from a sequence of events large-scale peptide and lipid clustering, giving rise to peptide-lipid patches that eventually would leave the membrane in a carpet-like mechanism. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Manzini, Mariana C.; Bozelli, Jose C., Jr.; da Silva, Marcia A.; Saraiva, Greice K. V.; Politi, Mario J.; Chaimovich, Hernan; Schreier, Shirley; Cuccovia, Iolanda M.] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05513970 Sao Paulo, Brazil.
   [Perez, Katia R.; Riske, Karin A.] Univ Fed Sao Paulo, Dept Biophys, BR-04044020 Sao Paulo, Brazil.
   [Santos, Talita L.; Valente, Ana P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Nucl Magnet Resonance Natl Ctr, Rio De Janeiro, Brazil.
   [Rodrigues, Magali A.; Bemquerer, Marcelo P.] Embrapa Recursos Genet & Biotecnol, BR-70770917 Brasilia, DF, Brazil.
RP Schreier, S (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, CP 26077, BR-05513970 Sao Paulo, Brazil.
EM schreier@iq.usp.br; imcuccov@iq.usp.br
RI Bemquerer, Marcelo Porto/A-9688-2013; Politi, Mario J/F-2605-2016;
   Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017; Chaimovich,
   Hernan/B-5006-2011; Perez, Katia/J-2312-2016; Chaimovich,
   Hernan/B-8393-2009; Schreier, Shirley/F-7001-2014; Cuccovia, Iolanda
   M/G-1183-2012; Riske, Karin A/F-2314-2014
OI Bemquerer, Marcelo Porto/0000-0002-9740-5818; Almeida,
   Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123;
   Chaimovich, Hernan/0000-0001-9380-2157; Chaimovich,
   Hernan/0000-0001-9380-2157; Cuccovia, Iolanda M/0000-0001-8285-7419;
   Rodrigues, Magali/0000-0003-1333-7051
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2007/50970-5, 2013/08166-5]; CNPqNational Council for Scientific and
   Technological Development (CNPq); Institut Nacional de Ciencia e
   Tecnologia de fluidos complexos (INCTFCx); Nude de Apoio Pesquisa de
   Fluidos Complexos (NAPFCx); CAPESCAPES; CAPES post-doctoral;
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPq research fellowshipsNational Council for Scientific and
   Technological Development (CNPq)
FX The following funding agencies are acknowledged: FAPESP (2007/50970-5
   and 2013/08166-5); CNPq, Institut Nacional de Ciencia e Tecnologia de
   fluidos complexos (INCTFCx), Nude de Apoio Pesquisa de Fluidos Complexos
   (NAPFCx). We thank Drs. P. Di Mascio and F.M. Prado, from the Institute
   of Chemistry, USP, for use of the mass spectrometry facility, and Drs.
   A. Miranda and T.M. Domingues, from UNIFESP, for use of the circular
   dichroism facility. We also thank Dr. Filipe da Silva Lima for help in
   the preparation of Scheme 2 and Graphical Abstract. Authors are
   recipients of the following fellowships: M.C. Manzini, CNPq M.Sc.; T.L.
   Santos, CAPES Ph.D.; M.A. Rodrigues, CAPES post-doctoral; G.K.V.
   Saraiva, CNPq Ph.D., J.C. Bozzelli Jr., FAPESP Ph.D.; S. Schreier, I.M.
   Cuccovia, A.P.C. Valente, F.L.C. Almeida, M.P. Bemquerer, and H.
   Chaimovich, CNPq research fellowships.
CR Albericio F, 2004, CURR OPIN CHEM BIOL, V8, P211, DOI 10.1016/j.cbpa.2004.03.002
   Almeida PF, 2012, BBA-BIOMEMBRANES, V1818, P178, DOI 10.1016/j.bbamem.2011.07.019
   Alves CS, 2012, BIOPOLYMERS, V98, P294, DOI 10.1002/bip.22075
   Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955
   ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S
   ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303
   Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022
   Bachar M, 2000, BIOPHYS J, V78, P1359, DOI 10.1016/S0006-3495(00)76690-2
   Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Benrraou M, 2003, J PHYS CHEM B, V107, P13432, DOI 10.1021/jp021714u
   BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9
   BOMAN HG, 1989, FEBS LETT, V259, P103, DOI 10.1016/0014-5793(89)81505-4
   Brogden K.A., 2005, NATURE, V238, P350
   Chan W.C., 2000, FMOC SOLID PHASE PEP
   Chen FY, 2002, BIOPHYS J, V82, P908, DOI 10.1016/S0006-3495(02)75452-0
   CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Cruzeiro Silva C., 2007, BIOCHIM BIOPHYS ACTA, V1768, P182
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a
   Cabrera MPD, 2011, LANGMUIR, V27, P10805, DOI 10.1021/la202608r
   DUFOURC EJ, 1986, BIOCHEMISTRY-US, V25, P6448, DOI 10.1021/bi00369a016
   DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P33, DOI 10.1016/0005-2736(86)90315-9
   Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m
   Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327
   Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319
   FAN P, 1993, BIOCHEMISTRY-US, V32, P1573, DOI 10.1021/bi00057a023
   Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]
   Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591
   Freire JM, 2011, EUR BIOPHYS J BIOPHY, V40, P481, DOI 10.1007/s00249-010-0661-4
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
   GORDON DJ, 1971, ARCH BIOCHEM BIOPHYS, V142, P481, DOI 10.1016/0003-9861(71)90511-X
   HARTMANN W, 1978, BIOCHIM BIOPHYS ACTA, V509, P474, DOI 10.1016/0005-2736(78)90241-9
   HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0
   Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6
   Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001
   JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020
   Jean-Francois F, 2008, BIOPHYS J, V95, P5748, DOI 10.1529/biophysj.108.136655
   Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Klasczyk B, 2010, LANGMUIR, V26, P18951, DOI 10.1021/la103631y
   Kleinschmidt JH, 1997, BIOPHYS J, V73, P2546, DOI 10.1016/S0006-3495(97)78283-3
   Kleinschmidt JH, 1997, BIOPHYS J, V72, P767, DOI 10.1016/S0006-3495(97)78711-3
   Knecht V, 2013, BIOPHYS J, V104, P818, DOI 10.1016/j.bpj.2012.12.056
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g
   LAROCHE G, 1990, BIOCHEMISTRY-US, V29, P6460, DOI 10.1021/bi00479a018
   Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q
   Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105
   MANNING MC, 1988, BIOPHYS CHEM, V31, P77, DOI 10.1016/0301-4622(88)80011-5
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   Matyus E, 2007, CURR MED CHEM, V14, P2789, DOI 10.2174/092986707782360105
   Maximiano FA, 2008, QUIM NOVA, V31, P910, DOI 10.1590/S0100-40422008000400032
   Maximiano FA, 2006, LANGMUIR, V22, P8050, DOI 10.1021/la061042p
   Mazzuca C, 2010, BIOPHYS J, V99, P1791, DOI 10.1016/j.bpj.2010.07.010
   Mecke A, 2005, BIOPHYS J, V89, P4043, DOI 10.1529/biophysj.105.062596
   Melo M.N., 2010, THESIS LISBOA U PORT
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0
   Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001
   Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Pincet F, 1999, EUR PHYS J B, V11, P127, DOI 10.1007/s100510050923
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   QUINA FH, 1979, J PHYS CHEM-US, V83, P1844, DOI 10.1021/j100477a010
   RALSTON E, 1981, BIOCHIM BIOPHYS ACTA, V649, P133, DOI 10.1016/0005-2736(81)90019-5
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021
   Scarpa MV, 2002, LANGMUIR, V18, P8817, DOI 10.1021/la025652a
   Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x
   SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2
   Schreier S, 2004, BIOPOLYMERS, V74, P389, DOI 10.1002/bip.20092
   Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7
   STIGTER D, 1964, J PHYS CHEM-US, V68, P3603, DOI 10.1021/j100794a028
   Subiros-Funosas R, 2009, TETRAHEDRON LETT, V50, P6200, DOI 10.1016/j.tetlet.2009.08.117
   Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0
   Tanford C., 1980, HYDROPHOBIC EFFECT F, P60
   TATULIAN SA, 1987, EUR J BIOCHEM, V170, P413, DOI 10.1111/j.1432-1033.1987.tb13715.x
   Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002
   TREINER C, 1990, COLLOID POLYM SCI, V268, P88, DOI 10.1007/BF01410429
   URRY DW, 1972, BIOCHIM BIOPHYS ACTA, V265, P115, DOI 10.1016/0304-4157(72)90021-4
   Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004
   Wadhwani P, 2014, BBA-BIOMEMBRANES, V1838, P940, DOI 10.1016/j.bbamem.2013.11.001
   WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8
   WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007
   WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   WU YL, 1995, BIOPHYS J, V68, P2361, DOI 10.1016/S0006-3495(95)80418-2
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 100
TC 59
Z9 62
U1 0
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD JUL
PY 2014
VL 1838
IS 7
BP 1985
EP 1999
DI 10.1016/j.bbamem.2014.04.004
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI2NO
UT WOS:000336695300034
PM 24743023
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Cruzeiro-Silva, C
   Gomes-Neto, F
   Machado, LESF
   Miyamoto, CA
   Pinheiro, AS
   Correa-Pereira, N
   de Magalhaes, MTQ
   Valente, AP
   Almeida, FCL
AF Cruzeiro-Silva, Carolina
   Gomes-Neto, Francisco
   Machado, Luciana E. S. F.
   Miyamoto, Catarina A.
   Pinheiro, Anderson S.
   Correa-Pereira, Natalia
   de Magalhaes, Mariana T. Q.
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Hydration and Conformational Equilibrium in Yeast Thioredoxin 1:
   Implication for H+ Exchange
SO BIOCHEMISTRY
LA English
DT Article
ID ESCHERICHIA-COLI THIOREDOXIN; MAGNETIC-RESONANCE RELAXATION; NMR
   SOLUTION STRUCTURE; ACTIVE-SITE CYSTEINES; MODEL-FREE APPROACH;
   ASPARTIC-ACID 26; CRYSTAL-STRUCTURE; REDUCED FORM; BACKBONE DYNAMICS;
   PROTEIN
AB One of the ancestral features of thioredoxins is the presence of a water cavity. Here, we report that a largely hydrated, conserved, buried aspartic acid in the water cavity modulates the dynamics of the interacting loops of yeast thioredoxin 1 (yTrx1). It is well-established that the aspartic acid, Asp24 for yTrx1, works as a proton acceptor in the reduction of the target protein. We propose a complementary role for Asp24 of coupling hydration and conformational motion of the water cavity and interacting loops. The intimate contact between the water cavity and the interacting loops means that motion at the water cavity will affect the interacting loops and vice versa. The D24N mutation alters the conformational equilibrium for both the oxidized and reduced states, quenching the conformational motion in the water cavity. By measuring the hydration and molecular dynamics simulation of wild-type yTrx1 and the D24N mutant, we showed that Asn24 is more exposed to water than Asp24 and the water cavity is smaller in the mutant, closing the inner part of the water cavity. We discuss how the conformational equilibrium contributes to the mechanism of catalysis and H+ exchange.
C1 [Cruzeiro-Silva, Carolina; Machado, Luciana E. S. F.; Correa-Pereira, Natalia; de Magalhaes, Mariana T. Q.; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Struct Biol & Bioimaging, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes-Neto, Francisco] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, BR-21045900 Rio De Janeiro, Brazil.
   [Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Miyamoto, Catarina A.] AEMS, Fac Integradas Tres Lagoas, Tres Lagoas, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, CCS, Annex CNRMN, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Pinheiro, Anderson S/B-6350-2014;
   Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Pinheiro, Anderson/0000-0001-5118-6931
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES
FX We thank FAPERJ, CNPq, and CAPES for funding.
CR Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001
   Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P716, DOI 10.1016/j.bbapap.2008.12.016
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006
   Campos-Acevedo AA, 2013, ACTA CRYSTALLOGR F, V69, P488, DOI 10.1107/S1744309113010622
   Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665
   Carvalho ATP, 2006, J COMPUT CHEM, V27, P966, DOI 10.1002/jcc.20404
   Carvalho ATP, 2006, J PHYS CHEM B, V110, P5758, DOI 10.1021/jp053275f
   Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x
   Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j
   Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l
   Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114
   Dangi B, 2002, BIOCHEMISTRY-US, V41, P9376, DOI 10.1021/bi0258501
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dixit SB, 1997, J CHEM SOC FARADAY T, V93, P1105, DOI 10.1039/a603913h
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOLMGREN A, 1979, J BIOL CHEM, V254, P9113
   Holmgren A., 1995, CCD ASTRONOMY, V2, P1
   Holmgren A, 2010, FREE RADICAL BIO MED, V49, P1617, DOI 10.1016/j.freeradbiomed.2010.09.005
   Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020
   Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n
   JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001
   Ji CG, 2008, BIOPHYS J, V95, P1080, DOI 10.1529/biophysj.108.131110
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   KALLIS GB, 1980, J BIOL CHEM, V255, P261
   Kelley JJ, 1997, BIOCHEMISTRY-US, V36, P5029, DOI 10.1021/bi962181g
   Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093
   Lancelin JM, 2000, PROTEINS, V41, P334, DOI 10.1002/1097-0134(20001115)41:3<334::AID-PROT60>3.0.CO;2-M
   LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032
   Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168
   LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r
   LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998
   Leone M, 2004, BIOCHEMISTRY-US, V43, P6043, DOI 10.1021/bi036261d
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Modig K, 2004, J AM CHEM SOC, V126, P102, DOI 10.1021/ja038325d
   Oliveira MA, 2010, BIOCHEMISTRY-US, V49, P3317, DOI 10.1021/bi901962p
   OTTING G, 1991, Journal of Biomolecular NMR, V1, P209, DOI 10.1007/BF01877232
   OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083
   Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627
   Peterson FC, 2005, PROTEIN SCI, V14, P2195, DOI 10.1110/ps.051477905
   Pinheiro AS, 2006, J BIOMOL NMR, V36, P35, DOI 10.1007/s10858-006-0025-7
   Pinheiro AS, 2008, PROTEINS, V70, P584, DOI 10.1002/prot.21693
   Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200
   Roos G, 2010, PROTEIN SCI, V19, P190, DOI 10.1002/pro.269
   Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461
   Rubini M, 2013, CHEMBIOCHEM, V14, P1053, DOI 10.1002/cbic.201300178
   Sanz-Barrio R, 2012, J EXP BOT, V63, P365, DOI 10.1093/jxb/err282
   Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300
   Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088
   STONE MJ, 1993, BIOCHEMISTRY-US, V32, P426, DOI 10.1021/bi00053a007
   Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b
   WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.bb.20.060191.001411
   Weichsel A, 2010, PROTEIN SCI, V19, P1801, DOI 10.1002/pro.455
   Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231
   WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001
   Zhang Y, 2008, ACTA CRYSTALLOGR F, V64, P323, DOI 10.1107/S1744309108004612
NR 70
TC 6
Z9 6
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 13
PY 2014
VL 53
IS 18
BP 2890
EP 2902
DI 10.1021/bi401542v
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AH3JR
UT WOS:000336020000004
PM 24738963
OA Green Published
DA 2020-12-01
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Faustino, Andre F.
   Carvalho, Filomena A.
   Martins, Ivo C.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density
   Lipoproteins
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Faustino, Andre F.; Carvalho, Filomena A.; Martins, Ivo C.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Mohana-Borges, Ronaldo; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013
CR [Anonymous], 2012, Patent, Patent No. [WO/2012/15918, 201215918]
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Carvalho FA, 2012, IUBMB LIFE, V64, P465, DOI 10.1002/iub.1037
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Faustino, 2013, NANOMEDICIN IN PRESS
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
NR 7
TC 0
Z9 0
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 388A
EP 388A
DI 10.1016/j.bpj.2013.11.2194
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000402195
OA Bronze
DA 2020-12-01
ER

PT J
AU Schreier, S
   Manzini, MC
   Perez, KR
   Riske, KA
   Bozelli, JC
   Politi, MJ
   Valente, AP
   Almeida, FC
   Chaimovich, H
   Rodrigues, MA
   Bemquerer, MP
   Cuccovia, IM
AF Schreier, Shirley
   Manzini, Mariana C.
   Perez, Katia R.
   Riske, Karin A.
   Bozelli, Jose C., Jr.
   Politi, Mario J.
   Valente, Ana P.
   Almeida, Fabio C.
   Chaimovich, Hernan
   Rodrigues, Magali A.
   Bemquerer, Marcelo P.
   Cuccovia, Iolanda M.
TI Peptide:Lipid Ratio and Membrane Surface Charge Modulate the Mechanism
   of Action of the Antimicrobial Peptide BP100
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Schreier, Shirley; Manzini, Mariana C.; Bozelli, Jose C., Jr.; Politi, Mario J.; Chaimovich, Hernan; Cuccovia, Iolanda M.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil.
   [Perez, Katia R.; Riske, Karin A.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Valente, Ana P.; Almeida, Fabio C.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Rodrigues, Magali A.; Bemquerer, Marcelo P.] Embrapa Genet & Biotechnol Resources, Brasilia, DF, Brazil.
RI Chaimovich, Hernan/B-5006-2011; Cuccovia, Iolanda M/G-1183-2012;
   Schreier, Shirley/F-7001-2014; Chaimovich, Hernan/B-8393-2009; Politi,
   Mario J/F-2605-2016; Bemquerer, Marcelo Porto/A-9688-2013
OI Chaimovich, Hernan/0000-0001-9380-2157; Cuccovia, Iolanda
   M/0000-0001-8285-7419; Chaimovich, Hernan/0000-0001-9380-2157;
   Bemquerer, Marcelo Porto/0000-0002-9740-5818
NR 0
TC 1
Z9 1
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 441A
EP 441A
DI 10.1016/j.bpj.2013.11.2485
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000402466
OA Bronze
DA 2020-12-01
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Faustino, Andre F.
   Carvalho, Filomena A.
   Martins, Ivo C.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue virus capsid protein interacts specifically with very low-density
   lipoproteins
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Dengue virus capsid protein; Lipoproteins; Single-molecule studies;
   AFM-based force spectroscopy; Dynamic light scattering
ID HEPATITIS-C VIRUS; GLOBAL DISTRIBUTION; INTEGRAL-EQUATIONS; LIPID
   PROFILE; INFECTION; FEVER; VISUALIZATION; SPECTROSCOPY; FLAVIVIRIDAE;
   PREDICTOR
AB Dengue affects millions of people worldwide. No specific treatment is currently available, in part due to an incomplete understanding of the viral components' interactions with host cellular structures. We tested dengue virus (DENV) capsid protein (C) interaction with low-and very low-density lipoproteins (LDL and VLDL, respectively) using atomic force microscopy-based force spectroscopy, dynamic light scattering, NMR and computational analysis. Data reveal a specific DENV C interaction with VLDL, but not LDL. This binding is potassium-dependent and involves the DENV C N-terminal region, as previously observed for the DENV C-lipid droplets (LDs) interaction. A successful inhibition of DENV C-VLDL binding was achieved with a peptide drug lead. The similarities between LDs and VLDL, and between perilipin 3 (DENV C target on LDs) and ApoE, indicate ApoE as the molecular target on VLDL. We hypothesize that DENV may form lipoviroparticles, which would constitute a novel step on DENV life cycle.
   From the Clinical Editor: Using atomic force microscopy-based force spectroscopy, dynamic light scattering, NMR, and computational analysis, these authors demonstrate that dengue viral capsid proteins (DENV C) bind to very low density lipoprotein surfaces, but not to LDLs, in a potassium-dependent manner. This observation suggests the formation of lipo-viroparticles, which may be a novel step in its life cycle, and may offer potential therapeutic interventions directed to this step. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Faustino, Andre F.; Carvalho, Filomena A.; Martins, Ivo C.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage, Rio De Janeiro, Brazil.
RP Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
EM nsantos@fm.ul.pt
RI Da Poian, Andrea T./V-1699-2019; Almeida, Fabio/O-4989-2018; Borges,
   Ronaldo S Mohana/C-5575-2013; Martins, Ivo C/G-2534-2013; Carvalho,
   Filomena/M-9202-2013; Santos, Nuno/N-7248-2013
OI Almeida, Fabio/0000-0001-6046-7006; Martins, Ivo C/0000-0002-9284-8599;
   Carvalho, Filomena/0000-0001-6088-3894; Faustino, Andre
   F./0000-0002-7364-8524; Santos, Nuno/0000-0002-0580-0475; Castanho,
   Miguel/0000-0001-7891-7562; Da Poian, Andrea/0000-0002-3969-704X; FCCN,
   Bogus/0000-0003-1034-3552
FU Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009,
   PTDC/SAU-ENB/117013/2010]; Calouste Gulenkian Foundation (Portugal);
   European UnionEuropean Union (EU); FCT-CAPESCAPESPortuguese Foundation
   for Science and Technology; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ);
   FINEPCiencia Tecnologia e Inovacao (FINEP); CAPESCAPES [PVE171/2012];
   INCT-Dengue; FCT-MEC [SFRH/BD/77609/2011, SFRH/BPD/74287/2010]
FX This work was supported by Fundacao para a Ciencia e Tecnologia -
   Ministerio da Educacao e Ciencia (FCT-MEC, Portugal, projects
   PTDC/QUI-BIQ/112929/2009 and PTDC/SAU-ENB/117013/2010), Calouste
   Gulenkian Foundation (Portugal), European Union FP7-IRSES project
   MEMPEPACROSS, FCT-CAPES Portugal-Brazil joint cooperation projects, and
   by the Brazilian Funding Agencies CNPq, FAPERJ, FINEP, CAPES
   (PVE171/2012) and INCT-Dengue. AFF and ICM acknowledge FCT-MEC for
   fellowships SFRH/BD/77609/2011 and SFRH/BPD/74287/2010, respectively.
CR Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Alves MJ, 2013, EUROSURVEILLANCE, V18, P20398
   Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Berne B. J., 1990, DYNAMIC LIGHT SCATTE
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carvalho FA, 2012, IUBMB LIFE, V64, P465, DOI 10.1002/iub.1037
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Clark Kristina Bargeron, 2012, Yale Journal of Biology and Medicine, V85, P3
   Cushley RJ, 2002, ANNU REV BIOPH BIOM, V31, P177, DOI 10.1146/annurev.biophys.31.101101.140910
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Enserink M, 2010, SCIENCE, V329, P736, DOI 10.1126/science.329.5993.736
   Fujie H, 1999, J MED VIROL, V59, P141, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;141::AID-JMV3&gt;3.0.CO;2-5
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KAHLON TS, 1992, LIPIDS, V27, P1055, DOI 10.1007/BF02535588
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Malvern Instruments Ltd, 2004, ZET NAN SER
   Martins I. C., 2012, International Patent Publication, Patent No. [WO/ 2012/ 159187, 2012159187]
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nelson DL, 2005, LEHNINGER PRINCIPLES
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Santos NC, 1996, BIOPHYS J, V71, P1641, DOI 10.1016/S0006-3495(96)79369-4
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Wood RJ, 2006, J NUTR, V136, P384
NR 43
TC 34
Z9 34
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JAN
PY 2014
VL 10
IS 1
BP 247
EP 255
DI 10.1016/j.nano.2013.06.004
PG 9
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 281LR
UT WOS:000329103500026
PM 23792329
DA 2020-12-01
ER

PT J
AU De Paula, VS
   Gomes, NSF
   Lima, LG
   Miyamoto, CA
   Monteiro, RQ
   Almeida, FCL
   Valente, AP
AF De Paula, V. S.
   Gomes, N. S. F.
   Lima, L. G.
   Miyamoto, C. A.
   Monteiro, R. Q.
   Almeida, F. C. L.
   Valente, A. P.
TI Structural Basis for the Interaction of Human beta-Defensin 6 and Its
   Putative Chemokine Receptor CCR2 and Breast Cancer Microvesicles
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE innate immune system; CCR2; beta-defensin; NMR; backbone dynamics
ID TYROSINE SULFATION; HUMAN BETA-DEFENSIN-1; NMR-SPECTROSCOPY; PROTEIN;
   CELLS; TUMOR; RELAXATION; SYSTEM; TRANSFORMATION; RECOGNITION
AB Human beta-defensins (hBDs) are believed to function as alarm molecules that stimulate the adaptive immune system when a threat is present. In addition to its antimicrobial activity, defensins present other activities such as chemoattraction of a range of different cell types to the sites of inflammation. We have solved the structure of the hBD6 by NMR spectroscopy that contains a conserved beta-defensin domain followed by an extended C-terminus. We use NMR to monitor the interaction of hBD6 with microvesicles shed by breast cancer cell lines and with peptides derived from the extracellular domain of CC chemokine receptor 2 (Nt-CCR2) possessing or not possessing sulfation on Tyr26 and Tyr28. The NMR-derived model of the hBD6/CCR2 complex reveals a contiguous binding surface on hBD6, which comprises amino acid residues of the alpha-helix and beta 2-beta 3 loop. The microvesicle binding surface partially overlaps with the chemokine receptor interface. NMR spin relaxation suggests that free hBD6 and the hBD6/CCR2 complex exhibit microsecond-to-millisecond conformational dynamics encompassing the CCR2 binding site, which might facilitate selection of the molecular configuration optimal for binding. These data offer new insights into the structure-function relation of the hBD6-CCR2 interaction, which is a promising target for the design of novel anticancer agents. (C) 2013 Published by Elsevier Ltd.
C1 [De Paula, V. S.; Gomes, N. S. F.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, Brazil.
   [Lima, L. G.; Monteiro, R. Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.
   [Miyamoto, C. A.] Fac Integradas Tres Lagoas, BR-79600000 Tres Lagoas, MS, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; De Paula, Viviane/L-1947-2013; DE QUEIROZ
   MONTEIRO, ROBSON/B-8007-2014; Valente, Ana Paula/J-3010-2017
OI Almeida, Fabio/0000-0001-6046-7006; De Paula,
   Viviane/0000-0003-3171-6477; Valente, Ana Paula/0000-0001-7219-1123;
   Monteiro, Robson/0000-0002-5260-2332
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES;
   National Institute of Structural Biology and Bioimaging
FX This research was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro Carlos Chagas Filho, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, and the National Institute
   of Structural Biology and Bioimaging. We thank Fabricio Cruz and Karen
   Santos for technical assistance.
CR Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108
   Bevers EM, 1996, LUPUS, V5, P480, DOI 10.1177/096120339600500531
   Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044
   Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y
   de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W., 2002, PYMOL USERS MANUAL
   Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108
   Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040
   Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999
   Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2
   Frey B, 2011, SEMIN IMMUNOPATHOL, V33, P497, DOI 10.1007/s00281-010-0228-6
   Gao Guanghua, 2004, Methods Mol Biol, V261, P79
   Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200
   Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200
   Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846
   Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993
   Keller R, 2004, COMPUTER AIDED RESON
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143
   Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041
   Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC
   Liu YA, 2012, J IMMUNOTHER, V35, P299, DOI 10.1097/CJI.0b013e3182518e83
   Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2
   Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200
   Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n
   Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004
   Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984
   Santini MT, 2001, BBA-MOL CELL BIOL L, V1531, P111, DOI 10.1016/S1388-1981(01)00093-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200
   Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359
   Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004
   Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v
   Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q
NR 60
TC 18
Z9 19
U1 0
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD NOV 15
PY 2013
VL 425
IS 22
BP 4479
EP 4495
DI 10.1016/j.jmb.2013.08.001
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 267LY
UT WOS:000328100500036
PM 23938203
DA 2020-12-01
ER

PT J
AU Favero-Retto, MP
   Palmieri, LC
   Souza, TACB
   Almeida, FCL
   Lima, LMTR
AF Favero-Retto, Maely P.
   Palmieri, Leonardo C.
   Souza, Tatiana A. C. B.
   Almeida, Fabio C. L.
   Lima, Luis Mauricio T. R.
TI Structural meta-analysis of regular human insulin in pharmaceutical
   formulations
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Human insulin; Crystallography; Nuclear magnetic resonance; Mass
   spectra; Small-angle X-ray scattering; Biosimilar; Meta-analysis
ID SIMILAR BIOTHERAPEUTIC PRODUCTS; X-RAY; RECEPTOR-BINDING;
   CRYSTALLOGRAPHY BEAMLINE; ASSOCIATION PROPERTIES; POWDER DIFFRACTION;
   CONTROLLED-RELEASE; MONOMERIC INSULIN; CRYSTAL-STRUCTURE; NMR
AB We have studied regular acting, wild-type human insulin at potency of 100 U/mL from four different pharmaceutical products directly from their final finished formulation by the combined use of mass spectrometry (MS), dynamic light scattering (DLS), small-angle X-ray scattering (SA)(S), nuclear magnetic resonance (NMR), and single-crystal protein 'crystallography (PX). All products showed similar oligomeric assembly in solution as judged by DLS and SAXS measurements. The NMR spectra were compatible with well folded proteins, showing close conformational identity for the human insulin in the four products. Crystallographic assays conducted with the final formulated products resulted in all insulin crystals belonging to the R3 space group with two a dimer in the asymmetric unit, both with the B-chain in the T configuration. Meta-analysis of the 24 crystal structures solved from the four distinct insulin products revealed close similarity between them regardless of variables such as biological origin, product batch, country origin of the product, and analytical approach, revealing a low conformational variability for the converging insulin structural ensemble. We propose the use of MS, SAXS, NMR fingerprint, and PX as a precise chemical and structural proof of folding identity of regular insulin in the final, formulated product. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Favero-Retto, Maely P.; Palmieri, Leonardo C.; Lima, Luis Mauricio T. R.] Fed Univ Rio Janeiro UFRJ, Sch Pharm, BR-21941590 Rio De Janeiro, Brazil.
   [Favero-Retto, Maely P.] Brazilian Natl Canc Inst INCA, Rio De Janeiro, Brazil.
   [Favero-Retto, Maely P.] Brazilian Natl Inst Traumatol & Orthoped INTO, Rio De Janeiro, Brazil.
   [Souza, Tatiana A. C. B.] Brazilian Synchrotron Light Lab LNLS CNPEM, Campinas, Brazil.
   [Almeida, Fabio C. L.] Fed Univ Rio Janeiro UFRJ, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance CNRMN, BR-21941590 Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.; Lima, Luis Mauricio T. R.] Fed Univ Rio Janeiro UFRJ, Natl Inst Sci & Technol Struct Biol & Bioimaging, BR-21941590 Rio De Janeiro, Brazil.
   [Lima, Luis Mauricio T. R.] Brazilian Natl Inst Metrol Qual & Technol INMETRO, Struct Biol Lab DIMAV, Rio De Janeiro, Brazil.
RP Lima, LMTR (corresponding author), Fed Univ Rio Janeiro UFRJ, Sch Pharm, CCS, Bss34, BR-21941590 Rio De Janeiro, Brazil.
EM LML@UFRJ.BR
RI Palmieri, Leonardo C/A-9341-2013; Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU Instituto Nacional de Traumato-Ortopedia (INTO-MS-Brasil); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   INCT-CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos
   Chagas Filho (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ); Brazillian Synchrotron Light
   Laboratory (LNLS); Instituto Nacional de Metrologia, Normalizacao e
   Qualidade Industrial (INMETRO)
FX We would like to thank Dr. Patricia R. Guimaraes and Dr. Russolina B.
   Zingali (Proteomic Facility at IBqM-UFRJ), Dr. Fernando de Mattos and
   Dr. Walan Grizolli (LNLS) for excellent support at the respective
   facilities. This research was supported by Instituto Nacional de
   Traumato-Ortopedia (INTO-MS-Brasil), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), INCT-CNPq; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ),
   Brazillian Synchrotron Light Laboratory (LNLS) and Instituto Nacional de
   Metrologia, Normalizacao e Qualidade Industrial (INMETRO). Funding
   agencies had no role in study design, data collection, and analysis.
CR Abel JJ, 1926, P NATL ACAD SCI USA, V12, P132, DOI 10.1073/pnas.12.2.132
   ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0
   Agilent Technologies, 2011, CRYSALISPRO SOFTWARE
   Aldridge S, 2012, NAT BIOTECHNOL, V30, P124, DOI 10.1038/nbt0212-124c
   Annibali N., 2003, Patent No. [09/955259[US7091032], 7091032]
   [Anonymous], 2010, NAT REV DRUG DISCOV, V9, P422
   [Anonymous], 1999, INT C HARM SPEC TEST, VQ6B, P1
   Aubin Y, 2008, ANAL CHEM, V80, P2623, DOI 10.1021/ac7026222
   Bagarolli RA, 2010, J DIABETES COMPLICAT, V24, P192, DOI 10.1016/j.jdiacomp.2009.03.003
   Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215
   Best CH, 1923, J BIOL CHEM, V57, P709
   BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0
   Brunger AT, 1997, NAT STRUCT BIOL, V4, P862
   BRYANT C, 1993, BIOCHEMISTRY-US, V32, P8075, DOI 10.1021/bi00083a004
   BRZOVIC PS, 1994, BIOCHEMISTRY-US, V33, P13057, DOI 10.1021/bi00248a015
   Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180
   Carey K, 2011, NAT BIOTECHNOL, V29, P177, DOI 10.1038/nbt0311-177
   Castanheira LG, 2011, BIOLOGICALS, V39, P282, DOI 10.1016/j.biologicals.2011.06.017
   Castanheira LG, 2011, BIOLOGICALS, V39, P308, DOI 10.1016/j.biologicals.2011.06.021
   CHANCE RE, 1981, DIABETES CARE, V4, P147, DOI 10.2337/diacare.4.2.147
   Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069
   Chantelau E, 2000, LANCET, V355, P2166, DOI 10.1016/S0140-6736(05)72795-1
   CHAWDHURY SA, 1983, DIABETOLOGIA, V25, P460
   CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2
   Coan T.D., 2001, ABN AMRO BANK NV GEN, P1
   Crowfoot D, 1935, NATURE, V135, P591, DOI 10.1038/135591a0
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   DeFelippis MR, 2006, BIOLOGICALS, V34, P49, DOI 10.1016/j.biologicals.2005.08.014
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DEREWENDA U, 1989, BRIT MED BULL, V45, P4, DOI 10.1093/oxfordjournals.bmb.a072320
   DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0
   DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X
   Diederichs K, 2010, ACTA CRYSTALLOGR D, V66, P733, DOI 10.1107/S0907444910014836
   Eisenstein M, 2011, NAT BIOTECHNOL, V29, P782, DOI 10.1038/nbt.1967
   Eliaschewitz FG, 2004, TRANSPL P, V36, P1117, DOI 10.1016/j.transproceed.2004.04.065
   EMEA, 2006, EMEACVMPERA418282200, P1
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   European Medicines Agency - EMEA - Committee for Medicinal Products for Human Use (CHMP), 2005, CHMP43704 EMEA, P1
   Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22
   Filho S.A., 2000, Patent No. [08/886967 [6068993], 08886967]
   FINEBERG SE, 1983, DIABETOLOGIA, V25, P465
   Finotelli PV, 2010, COLLOID SURFACE B, V81, P206, DOI 10.1016/j.colsurfb.2010.07.008
   Furnham N, 2006, NAT STRUCT MOL BIOL, V13, P184, DOI 10.1038/nsmb0306-184
   GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106
   GROS P, 1990, SCIENCE, V249, P1149, DOI 10.1126/science.2396108
   Guerreiro LH, 2012, COLLOID SURFACE B, V94, P101, DOI 10.1016/j.colsurfb.2012.01.021
   Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870
   Guinier A., 1955, SMALL ANGLE SCATTERI
   Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510
   Hallas M., 1952, SCIENCE, V116, P394
   HARDING MM, 1966, J MOL BIOL, V16, P212, DOI 10.1016/S0022-2836(66)80274-7
   Higgins K A, 1988, Drug Des Deliv, V3, P159
   HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025
   HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0
   Hughes DA, 2010, CLIN PHARMACOL THER, V87, P257, DOI 10.1038/clpt.2009.112
   iyi-Jones R.O., 1983, DIABETES CARE S1, V6, P9
   JOHNSON IS, 1982, DIABETES CARE, V5, P4, DOI 10.2337/diacare.5.2.S4
   JOSHI SR, 2009, J ASSOC PHYSICIAN  S, V57, P38
   KADIMA W, 1992, J BIOL CHEM, V267, P8963
   Kang HN, 2011, BIOLOGICALS, V39, P304, DOI 10.1016/j.biologicals.2011.08.007
   KEEFER LM, 1981, P NATL ACAD SCI-BIOL, V78, P1391, DOI 10.1073/pnas.78.3.1391
   Keller R.L.J., 2004, OPTIMIZING PROCESS N
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003
   Kling J, 2008, NAT BIOTECHNOL, V26, P479, DOI 10.1038/nbt0508-479
   KNEGTEL RMA, 1991, EUR J BIOCHEM, V202, P447, DOI 10.1111/j.1432-1033.1991.tb16394.x
   KOWARSKI CR, 1988, PHARMACEUT RES, V5, P245
   KRISTENSEN SM, 1991, J MOL BIOL, V218, P221, DOI 10.1016/0022-2836(91)90886-B
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Ledford H, 2010, NATURE, V468, P18, DOI 10.1038/468018a
   Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426
   Leslie A.G., 1992, PROTEIN CRYSTALLOGR
   Lima LMTR, 2009, BBA-PROTEINS PROTEOM, V1794, P873, DOI 10.1016/j.bbapap.2009.03.011
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   Markussen J, 1990, Patent No. [US4916212, 4916212, 739123[US 4916212]]
   Markussen J., 1982, Patent No. [233051 [US4343898], 4343898]
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MORIHARA K, 1979, NATURE, V280, P412, DOI 10.1038/280412a0
   Mullard A, 2010, NAT REV DRUG DISCOV, V9, P905, DOI 10.1038/nrd3325
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nicholls R.A., 2011, CONFORMATION INDEPEN
   Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983
   Norrman M, 2006, J APPL CRYSTALLOGR, V39, P391, DOI 10.1107/S0021889806011058
   Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+
   Palmieri LC, 2013, BIOPHYS CHEM, V173, P1, DOI 10.1016/j.bpc.2013.01.003
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0
   Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P698, DOI 10.1016/j.tibtech.2009.09.004
   Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26
   RENSCHEIDT H, 1984, EUR J BIOCHEM, V142, P7, DOI 10.1111/j.1432-1033.1984.tb08243.x
   Richards JP, 1998, PHARMACEUT RES, V15, P1434, DOI 10.1023/A:1011961923870
   Richards JP, 1999, J PHARM SCI, V88, P861, DOI 10.1021/js990107o
   Riggs A.D., 1979, Patent No. [90980[US4366246], 4366246]
   Salbo R, 2012, RAPID COMMUN MASS SP, V26, P1181, DOI 10.1002/rcm.6211
   Scott DA, 1935, BIOCHEM J, V29, P1048, DOI 10.1042/bj0291048
   Silva VD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024735
   Skrlin A, 2010, BIOLOGICALS, V38, P557, DOI 10.1016/j.biologicals.2010.05.002
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P597, DOI 10.1107/S0907444907009791
   Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894
   US Department of Health and Human Services Food and Drug Administration, 2012, GUID IND QUAL CONS D
   US Department of Health and Human Services Food and Drug Administration, 2012, GUID IND SCI CONS DE
   Uversky VN, 2003, J PHARM SCI, V92, P847, DOI 10.1002/jps.10355
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Von Dreele RB, 2000, ACTA CRYSTALLOGR D, V56, P1549, DOI 10.1107/S0907444900013901
   WAGNER G, 1992, ANNU REV BIOPH BIOM, V21, P167, DOI 10.1146/annurev.biophys.21.1.167
   Waldron-Lynch F, 2011, NAT REV DRUG DISCOV, V10, P439, DOI 10.1038/nrd3402
   Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917
   Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s
   WOOD SP, 1975, EUR J BIOCHEM, V55, P531, DOI 10.1111/j.1432-1033.1975.tb02190.x
   Wu CL, 2006, CLINICAL TRIALS OF DRUGS AND BIOPHARMACEUTICALS, P363
   Wuthrich K, 2010, ACTA CRYSTALLOGR F, V66, P1365, DOI 10.1107/S1744309110030320
   Young A, 2005, AMYLIN PHYSL PHARM
   Zuperl S, 2007, J CHEM INF MODEL, V47, P737, DOI 10.1021/ci6005273
NR 116
TC 21
Z9 21
U1 0
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0939-6411
EI 1873-3441
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD NOV
PY 2013
VL 85
IS 3
BP 1112
EP 1121
DI 10.1016/j.ejpb.2013.05.005
PN B
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 296QP
UT WOS:000330200800033
PM 23692694
OA Green Published
DA 2020-12-01
ER

PT J
AU Moraes, AH
   Ackerbauer, D
   Kostadinova, M
   Bublin, M
   Ferreira, F
   Almeida, FCL
   Breiteneder, H
   Valente, AP
AF Moraes, A. H.
   Ackerbauer, D.
   Kostadinova, M.
   Bublin, M.
   Ferreira, F.
   Almeida, F. C. L.
   Breiteneder, H.
   Valente, A. P.
TI H-1, C-13 and N-15 resonance assignments and second structure
   information of Gad m 1: a beta-parvalbumin allergen from Atlantic cod
   (Gadus morhua)
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Gad m 1; beta-parvalbumin; Allergen; NMR assignments; Secondary
   structure
AB Gad m 1 is the major allergen from Atlantic cod. It belongs to beta-parvalbumin protein family and is characterized by the presence of two calcium-binding sites so called EF-hand motifs. beta-Parvalbumins such as Gad m 1 are the most important fish allergens and their high cross-reactivity is the cause of the observed polysensitization to various fish species in allergic patients. Despite extensive efforts, the complete elucidation of beta-parvalbumin-IgE complexes has not been achieved yet. Allergen structural studies are essential for the development of novel immunotherapy strategies, including vaccination with hypoallergenic derivatives and chimeric molecules. Here, we report for the first time the NMR study of a beta-parvalbumin: Gad m 1. This report includes: H-1, C-13 and N-15 resonance assignments of Gad m 1 as well as the second structure information based on the C-13 chemical shifts.
C1 [Moraes, A. H.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Ackerbauer, D.; Kostadinova, M.; Bublin, M.; Breiteneder, H.] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.
   [Ferreira, F.] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet, Inst Bioquim Med, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Ferreira, Fatima/AAB-4321-2019; Moraes, Adolfo/G-3931-2018; Almeida,
   Fabio/O-4989-2018; Ferreira, Fatima/E-4889-2011; Valente, Ana
   Paula/J-3010-2017
OI Ferreira, Fatima/0000-0003-0989-2335; Moraes,
   Adolfo/0000-0002-3344-4084; Almeida, Fabio/0000-0001-6046-7006;
   Ferreira, Fatima/0000-0003-0989-2335; Valente, Ana
   Paula/0000-0001-7219-1123; Bublin, Merima/0000-0002-7191-9431
CR Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016
   Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022
   Griesmeier U, 2010, ALLERGY, V65, P191, DOI 10.1111/j.1398-9995.2009.02162.x
   Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019
   Keller R, 2004, COMPUTER AIDED RESON
   Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1
   Ma Y, 2008, MOL NUTR FOOD RES, V52, pS196, DOI 10.1002/mnfr.200700284
   Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Wallner M, 2007, J ALLERGY CLIN IMMUN, V120, P374, DOI 10.1016/j.jaci.2007.05.021
   Wild C, 2007, ALLERGY, V62, P33, DOI 10.1111/j.1398-9995.2006.01245.x
NR 11
TC 3
Z9 3
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD OCT
PY 2013
VL 7
IS 2
BP 133
EP 136
DI 10.1007/s12104-012-9393-y
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA 209FO
UT WOS:000323740300004
PM 22585088
DA 2020-12-01
ER

PT J
AU Valente, AP
   de Paula, VS
   Almeida, FCL
AF Valente, Ana Paula
   de Paula, Viviane Silva
   Almeida, Fabio C. L.
TI Revealing the Properties of Plant Defensins through Dynamics
SO MOLECULES
LA English
DT Review
DE defensins; dynamics; NMR; membrane recognition
ID DISPERSION NMR-SPECTROSCOPY; MAGNETIC-RESONANCE RELAXATION;
   PISUM-SATIVUM DEFENSIN-1; EXCITED PROTEIN STATES; TIME-SCALE DYNAMICS;
   MODEL-FREE APPROACH; CHEMICAL-EXCHANGE; ANTIMICROBIAL PEPTIDES;
   CONFORMATIONAL SELECTION; BINDING CASCADES
AB Defensins are potent, ancient natural antibiotics that are present in organisms ranging from lower organisms to humans. Although the structures of several defensins have been well characterized, the dynamics of only a few have been studied. This review discusses the diverse dynamics of two plant defensins for which the structure and dynamics have been characterized, both in the free state and in the presence of target membranes. Multiple motions are observed in loops and in secondary structure elements and may be related to twisting or breathing of the alpha-helix and beta-sheet. This complex behavior is altered in the presence of an interface and is responsive to the presence of the putative target. The stages of membrane recognition and disruption can be mapped over a large time scale range, demonstrating that defensins in solution exist as an ensemble of different conformations, a subset of which is selected upon membrane binding. Therefore, studies on the dynamics have revealed that defensins interact with membranes through a mechanism of conformational selection.
C1 [Valente, Ana Paula; de Paula, Viviane Silva; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br; vpaula@cnrmn.bioqmed.ufrj.br;
   falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; De Paula, Viviane/L-1947-2013; Almeida,
   Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; De Paula,
   Viviane/0000-0003-3171-6477; Almeida, Fabio/0000-0001-6046-7006
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); INBEB
FX We thank CNPq, FAPERJ and INBEB for financial support.
CR Aerts AM, 2009, FEBS LETT, V583, P2513, DOI 10.1016/j.febslet.2009.07.004
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   Arnett E, 2011, CURR PHARM DESIGN, V17, P4254, DOI 10.2174/138161211798999348
   Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Bosco DA, 2010, J MOL BIOL, V403, P723, DOI 10.1016/j.jmb.2010.08.001
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104
   Cavanagh J, 2000, NAT STRUCT BIOL, V7, P11, DOI 10.1038/71202
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006
   Conibear AC, 2013, J BIOL CHEM, V288, P10830, DOI 10.1074/jbc.M113.451047
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009
   De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002
   FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280
   Fisher E., 1894, BER DTSCH CHEM GES, V27, P2984
   Gao Guanghua, 2004, Methods Mol Biol, V261, P79
   Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014
   Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o
   Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407
   Ishima R, 1999, J BIOMOL NMR, V14, P369, DOI 10.1023/A:1008324025406
   Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718
   Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012
   Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y
   Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723
   KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98
   KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047
   Kumar S, 2000, PROTEIN SCI, V9, P10
   Leitner DM, 2008, ANNU REV PHYS CHEM, V59, P233, DOI 10.1146/annurev.physchem.59.032607.093606
   Li Y, 2010, J AM CHEM SOC, V132, P8856, DOI 10.1021/ja103251h
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j
   Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073
   Lundstrom P, 2008, J BIOMOL NMR, V42, P35, DOI 10.1007/s10858-008-9260-4
   Lundstrom P, 2009, NAT PROTOC, V4, P1641, DOI 10.1038/nprot.2009.118
   Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932
   Orekhov VY, 2004, J AM CHEM SOC, V126, P1886, DOI 10.1021/ja038620y
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Peng JW, 2012, J PHYS CHEM LETT, V3, P1039, DOI 10.1021/jz3002103
   Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014
   Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001
   Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x
   Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550
   Salmon L, 2011, BIOCHEMISTRY-US, V50, P2735, DOI 10.1021/bi200177v
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z
   Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181
   Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104
   Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004
   Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106
   Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821
   Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100
   Wu ZH, 2009, J PHYS CHEM B, V113, P12375, DOI 10.1021/jp903548d
   Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101
   Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185
NR 73
TC 14
Z9 16
U1 0
U2 9
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2013
VL 18
IS 9
BP 11311
EP 11326
DI 10.3390/molecules180911311
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 298EJ
UT WOS:000330306600078
PM 24064452
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Machado, LEF
   Pustovalova, Y
   Kile, AC
   Pozhidaeva, A
   Cimprich, KA
   Almeida, FCL
   Bezsonova, I
   Korzhnev, DM
AF Machado, Luciana E. F.
   Pustovalova, Yulia
   Kile, Andrew C.
   Pozhidaeva, Alexandra
   Cimprich, Karlene A.
   Almeida, Fabio C. L.
   Bezsonova, Irina
   Korzhnev, Dmitry M.
TI PHD domain from human SHPRH
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
ID CELL NUCLEAR ANTIGEN; DNA-DAMAGE TOLERANCE; GENOMIC INSTABILITY;
   UBIQUITIN LIGASE; PROTEIN; FINGER; POLYUBIQUITINATION; SYSTEM; GENE
C1 [Machado, Luciana E. F.; Pustovalova, Yulia; Pozhidaeva, Alexandra; Bezsonova, Irina; Korzhnev, Dmitry M.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA.
   [Machado, Luciana E. F.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Kile, Andrew C.; Cimprich, Karlene A.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.
RP Bezsonova, I (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA.
EM bezsonova@uchc.edu; korzhniev@uchc.edu
RI Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006; Pozhidaeva,
   Alexandra/0000-0001-8602-1790
FU UCHC; Agilent Technologies Foundation [2730]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   INCT-INBEB; Science without Boarders (Ciencias sem Fronteiras) CNPq;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [ES016486, T32CA09151]; CAPESCAPES;
   American Cancer SocietyAmerican Cancer Society [PF-12-156-01-DMC];
   NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151, T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151, T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151, T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151, T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151, T32CA009151, T32CA009151, T32CA009151, T32CA009151,
   T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [R01ES016486, R01ES016486,
   R01ES016486, R01ES016486, R01ES016486, R01ES016486, R01ES016486,
   R01ES016486, R01ES016486, R01ES016486, R01ES016486, R01ES016486] Funding
   Source: NIH RePORTER
FX This work was supported by UCHC startup funds and Agilent Technologies
   Foundation Grant #2730 to D.M.K., grants from FAPERJ, INCT-INBEB and
   Science without Boarders (Ciencias sem Fronteiras) CNPq program to
   F.C.L.A., NIH Grant ES016486 to K.A.C., and CAPES sandwich Ph.D.
   fellowship to L.E.F.M. A.C.K. was funded by NIH training Grant
   T32CA09151 and American Cancer Society fellowship PF-12-156-01-DMC.
CR Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805
   Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200
   Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295
   Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933
   Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9
   Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012
   Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026
   Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003
   Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105
   Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145
   Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308
   Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sood R, 2003, GENOMICS, V82, P153, DOI 10.1016/S0888-7543(03)00121-6
   Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919
   Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103
   Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013
   Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08
NR 23
TC 4
Z9 4
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD AUG
PY 2013
VL 56
IS 4
BP 393
EP 399
DI 10.1007/s10858-013-9758-2
PG 7
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 208FE
UT WOS:000323661800011
PM 23907177
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Gomes-Neto, F
   Valente, AP
   Almeida, FCL
AF Gomes-Neto, Francisco
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Modeling the Interaction of Dodecylphosphocholine Micelles with the
   Anticoccidial Peptide PW2 Guided by NMR Data
SO MOLECULES
LA English
DT Article
DE molecular dynamics simulation; NMR; structure; antimicrobial; membrane;
   micelles; peptide structure
ID MOLECULAR-DYNAMICS SIMULATIONS; PHAGE DISPLAY LIBRARIES; ANTIMICROBIAL
   PEPTIDES; CHEMICAL-SHIFTS; PROTEIN INTERACTIONS; MEMBRANE-PROTEIN;
   QUANTUM NMR; SPECTROSCOPY; RELAXATION; SYSTEM
AB Antimicrobial peptides are highly dynamic entities that acquire structure upon binding to a membrane interface. To better understand the structure and the mechanism for the molecular recognition of dodecylphosphocholine (DPC) micelles by the anticoccidial peptide PW2, we performed molecular dynamics (MD) simulations guided by NMR experimental data, focusing on strategies to explore the transient nature of micelles, which rearrange on a millisecond to second timescale. We simulated the association of PW2 with a pre-built DPC micelle and with free-DPC molecules that spontaneously forms micelles in the presence of the peptide along the simulation. The simulation with spontaneous micelle formation provided the adequate environment which replicated the experimental data. The unrestrained MD simulations reproduced the NMR structure for the entire 100 ns MD simulation time. Hidden discrete conformational states could be described. Coulomb interactions are important for initial approximation and hydrogen bonds for anchoring the aromatic region at the interface, being essential for the stabilization of the interaction. Arg9 is strongly attached with phosphate. We observed a helix elongation process stabilized by the intermolecular peptide-micelle association. Full association that mimics the experimental data only happens after complete micelle re-association. Fast micelle dynamics without dissociation of surfactants leads to only superficial binding.
C1 [Gomes-Neto, Francisco] Fiocruz MS, Lab Toxinol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Gomes-Neto, Francisco; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Struct Biol & Bioimaging, BR-21941920 Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Struct Biol & Bioimaging, BR-21941920 Rio De Janeiro, Brazil.
EM francisco.neto@ioc.fiocruz.br; falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq); INBEB
FX We thank the funding agencies FAPERJ, CAPES and CNPq for financial
   support. We also thank INBEB for funding.
CR BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3
   Bond PJ, 2004, J AM CHEM SOC, V126, P15948, DOI 10.1021/ja044819e
   Bonvin AMJJ, 1996, J BIOMOL NMR, V7, P72
   BONVIN AMJJ, 1994, J BIOMOL NMR, V4, P143, DOI 10.1007/BF00178343
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P1448, DOI 10.1016/j.bbamem.2010.08.010
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   da Silva A, 2002, MOL BIOCHEM PARASIT, V120, P53, DOI 10.1016/S0166-6851(01)00439-X
   Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Galloux M, 2010, J BIOL CHEM, V285, P19409, DOI 10.1074/jbc.M109.076083
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   Lohner K, 1999, BIOCHEMISTRY-US, V38, P16514, DOI 10.1021/bi9913101
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   Marrink SJ, 2000, J PHYS CHEM B, V104, P12165, DOI 10.1021/jp001898h
   MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466
   MIERKE DF, 1994, J AM CHEM SOC, V116, P1042, DOI 10.1021/ja00082a027
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425
   PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x
   Patist A, 2002, J COLLOID INTERF SCI, V245, P1, DOI 10.1006/jcis.2001.7955
   Pelta MD, 2002, MAGN RESON CHEM, V40, pS147, DOI 10.1002/mrc.1107
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f
   Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521
   Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300
   Thomma Bart P. H. J., 2003, Current Drug Targets - Infectious Disorders, V3, P1, DOI 10.2174/1568005033342000
   Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07
   Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f
   Tinoco LW, 2007, J BIOMOL NMR, V39, P315, DOI 10.1007/s10858-007-9202-6
   Tinoco LW, 2002, J BIOL CHEM, V277, P36351, DOI 10.1074/jbc.M204225200
   TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007
   WENNERSTROM H, 1979, J AM CHEM SOC, V101, P6860, DOI 10.1021/ja00517a012
   Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299
   Wuthrich K., 1986, NMR PROTEINS NUCL AC, V1
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 53
TC 6
Z9 6
U1 0
U2 4
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2013
VL 18
IS 8
BP 10056
EP 10080
DI 10.3390/molecules180810056
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 298DL
UT WOS:000330304100085
PM 23966088
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Faustino, AF
   Guerra, GM
   Hollmann, A
   Castanho, MARB
   Almeida, FCL
   da Poian, AT
   Santos, NC
   Martins, IC
AF Faustino, A. F.
   Guerra, G. M.
   Hollmann, A.
   Castanho, M. A. R. B.
   Almeida, F. C. L.
   da Poian, A. T.
   Santos, N. C.
   Martins, I. C.
TI pep14-23, a peptide drug lead against dengue virus, binds anionic lipids
   becoming alpha-helical
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Faustino, A. F.; Guerra, G. M.; Hollmann, A.; Castanho, M. A. R. B.; Santos, N. C.; Martins, I. C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.
   [Almeida, F. C. L.; da Poian, A. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Martins, Ivo C/G-2534-2013
OI Martins, Ivo C/0000-0002-9284-8599
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
NR 2
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S64
EP S64
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300112
DA 2020-12-01
ER

PT J
AU Fidalgo, TKS
   Freitas-Fernandes, LB
   Angeli, R
   Muniz, AMS
   Gonsalves, E
   Santos, R
   Nadal, J
   Almeida, FCL
   Valente, AP
   Souza, IPR
AF Fidalgo, Tatiana K. S.
   Freitas-Fernandes, Liana B.
   Angeli, Renata
   Muniz, Adriane M. S.
   Gonsalves, Elicardo
   Santos, Raquel
   Nadal, Jurandir
   Almeida, Fabio C. L.
   Valente, Ana P.
   Souza, Ivete P. R.
TI Salivary metabolite signatures of children with and without dental
   caries lesions
SO METABOLOMICS
LA English
DT Article
DE Children; Saliva; Dental caries; Metabolomic profile; NMR
ID MASS-SPECTROMETRY; MAGNETIC-RESONANCE; H-1-NMR ANALYSIS; METABOLOMICS;
   DIAGNOSIS; HUMANS; PLASMA; LIPIDS; H-1
AB A metabolomic approach was used to analyze endogenous metabolites and to correlate with a specific biological state. The analysis of salivary metabolites is a growing area of investigation with potential for basic and clinical applications. Analyses of children's saliva in different dentitions and with or without caries could potentially reveal a specific profile related to oral disease risk. Nuclear Magnetic Resonance (NMR) is well suited for mixture analysis followed by Principal Component Analysis combined with Linear Regression (PCA-LR) statistics and was used to identify differences in the salivary metabolites. The classificatory analysis was performed using PCA-LR based on 1,000 cross-validation bootstrap runs from both classifiers in order to increase the data information from a small sample size. The PCA-LR presented a statistically good classificatory performance for children with and without caries with an accuracy of 90.11 % (P < 0.001), 89.61 % sensitivity (P < 0.001), and 90.82 % specificity (P < 0.001). Children with caries lesions presented higher levels of several metabolites, including lactate, fatty acid, acetate and n-butyrate. Saliva from subjects with different dentition stages was also analyzed. Although the salivary samples were poorly classified, permanent dentition presented increased levels of acetate, saccharides and propionate. The NMR data and PCA-LR were able to classify saliva from children with or without caries, with performance indexes comparable to the partial least-squares regression discriminant analysis (PLS-DA) results also performed. Our data also showed similar salivary metabolite profiles for healthy subjects despite the differences in their oral hygiene habits, socioeconomic status and food intake.
C1 [Fidalgo, Tatiana K. S.; Freitas-Fernandes, Liana B.; Santos, Raquel; Souza, Ivete P. R.] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Angeli, Renata; Almeida, Fabio C. L.; Valente, Ana P.] Univ Fed Rio de Janeiro, Natl Ctr Nucl Magnet Resonance Jiri Jonas, Inst Med Biochem, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Muniz, Adriane M. S.] Phys Educ Coll Brazilian Army, EsEFEx, Rio De Janeiro, Brazil.
   [Muniz, Adriane M. S.; Nadal, Jurandir] Univ Fed Rio de Janeiro, Biomed Engn Program, COPPE, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Gonsalves, Elicardo] Univ Fed Rio de Janeiro, Sch Phys, BR-21941913 Rio De Janeiro, RJ, Brazil.
RP Souza, IPR (corresponding author), Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM pomarico@gmail.com
RI Valente, Ana Paula/J-3010-2017; Muniz, Adriane M. S./N-9027-2013; da
   Silva Fidalgo, Tatiana Kelly/I-4969-2014; Nadal, Jurandir/I-4135-2012;
   Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; da Silva Fidalgo, Tatiana
   Kelly/0000-0003-1340-9967; Nadal, Jurandir/0000-0003-3921-7787; Almeida,
   Fabio/0000-0001-6046-7006; Souza, Ivete Pomarico/0000-0003-0449-6624
FU National Institute of Science and Technology of Structural Biology and
   Bioimaging (INCT-INBEB); CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ);
   FINEPCiencia Tecnologia e Inovacao (FINEP); CAPESCAPES
FX The authors acknowledge the financial support from the following
   agencies: National Institute of Science and Technology of Structural
   Biology and Bioimaging (INCT-INBEB), CNPq, FAPERJ, FINEP, and CAPES. We
   also acknowledge the Bruker (Bruker Biospin, Rheinstetten, Germany) for
   providing a demo license of AMIX program during the analysis of the
   data.
CR Al-Tarawneh SK, 2011, OMICS, V15, P353, DOI 10.1089/omi.2010.0134
   Bereton R. G., 2006, TRAC TRENDS ANAL CHE, V25, P1103
   Bergandi L, 2007, EUR J ORAL SCI, V115, P93, DOI 10.1111/j.1600-0722.2007.00437.x
   Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598
   Bollard ME, 2005, NMR BIOMED, V18, P143, DOI 10.1002/nbm.935
   Di Luigi L, 2006, INT J SPORTS MED, V27, P709, DOI 10.1055/s-2005-872931
   Favretto D, 2012, ANAL BIOANAL CHEM, V402, P1109, DOI 10.1007/s00216-011-5540-z
   Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007
   Grootveld M, 2005, BIOCHEM BIOPH RES CO, V329, P1, DOI 10.1016/j.bbrc.2005.01.112
   Hardt M, 2005, BIOCHEMISTRY-US, V44, P2885, DOI 10.1021/bi048176r
   Jolliffe I.T., 2002, PRINCIPAL COMPONENT
   Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033
   KURODA H, 1982, J NEUROL NEUROSUR PS, V45, P257, DOI 10.1136/jnnp.45.3.257
   Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4
   Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015
   Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042
   Martin FPJ, 2009, J PROTEOME RES, V8, P5568, DOI 10.1021/pr900607v
   Neyraud E, 2013, METABOLOMICS, V9, P213, DOI 10.1007/s11306-012-0440-6
   Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042
   Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035
   Sahiner B, 2008, MED PHYS, V35, P1559, DOI 10.1118/1.2868757
   Schumacher M, 1996, COMPUT STAT DATA AN, V21, P661, DOI 10.1016/0167-9473(95)00032-1
   Silwood CJL, 1999, NMR BIOMED, V12, P345, DOI 10.1002/(SICI)1099-1492(199910)12:6<345::AID-NBM580>3.0.CO;2-C
   Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613
   SLOMIANY BL, 1989, ARCH ORAL BIOL, V34, P229, DOI 10.1016/0003-9969(89)90063-0
   Streckfus CF, 2006, J ORAL PATHOL MED, V35, P292, DOI 10.1111/j.1600-0714.2006.00427.x
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Takahashi N, 2010, J DENT RES, V89, P1383, DOI 10.1177/0022034510377792
   Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369
   Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396
   Tomita Y, 2008, J OLEO SCI, V57, P115, DOI 10.5650/jos.57.115
   VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301
   Walsh MC, 2006, AM J CLIN NUTR, V84, P531
   Wei JE, 2011, INT J CANCER, V129, P2207, DOI 10.1002/ijc.25881
   Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027
NR 39
TC 27
Z9 29
U1 0
U2 45
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD JUN
PY 2013
VL 9
IS 3
BP 657
EP 666
DI 10.1007/s11306-012-0484-7
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 143YL
UT WOS:000318905100013
DA 2020-12-01
ER

PT J
AU Carvalho, FA
   Martins, IC
   Carneiro, FA
   Assuncao-Miranda, I
   Faustino, AF
   Castanho, M
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Carvalho, Filomena A.
   Martins, Ivo C.
   Carneiro, Fabiana A.
   Assuncao-Miranda, Iranaia
   Faustino, Andre F.
   Castanho, Miguel
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Binding to Lipid Droplets and its
   Inhibition. towards a New Drug Target
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the Biophysical-Society
CY FEB 02-06, 2013
CL Philadelphia, PA
SP Biophys Soc
C1 [Carvalho, Filomena A.; Martins, Ivo C.; Faustino, Andre F.; Castanho, Miguel; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Carneiro, Fabiana A.; Assuncao-Miranda, Iranaia; Mohana-Borges, Ronaldo; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI CARNEIRO, FABIANA A/S-4525-2018; Martins, Ivo C/G-2534-2013; Borges,
   Ronaldo S Mohana/C-5575-2013; Carvalho, Filomena A./M-9202-2013; Santos,
   Nuno/N-7248-2013
OI Martins, Ivo C/0000-0002-9284-8599; Carvalho, Filomena
   A./0000-0001-6088-3894; Santos, Nuno/0000-0002-0580-0475
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
NR 2
TC 0
Z9 0
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 29
PY 2013
VL 104
IS 2
SU 1
BP 415A
EP 415A
DI 10.1016/j.bpj.2012.11.2313
PG 1
WC Biophysics
SC Biophysics
GA 105MI
UT WOS:000316074304114
OA Bronze
DA 2020-12-01
ER

PT J
AU Borges, JC
   Seraphim, TV
   Mokry, DZ
   Almeida, FCL
   Cyr, DM
   Ramos, CHI
AF Borges, Julio C.
   Seraphim, Thiago V.
   Mokry, David Z.
   Almeida, Fabio C. L.
   Cyr, Douglas M.
   Ramos, Carlos H. I.
TI Identification of Regions Involved in Substrate Binding and Dimer
   Stabilization within the Central Domains of Yeast Hsp40 Sis1
SO PLOS ONE
LA English
DT Article
ID MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DNAK CHAPERONE; HSP70; PROTEIN;
   YDJ1; ULTRACENTRIFUGATION; SPECTROSCOPY; AGGREGATION; SPECIFICITY
AB Protein folding, refolding and degradation are essential for cellular life and are regulated by protein homeostatic processes such those that involve the molecular chaperone DnaK/Hsp70 and its co-chaperone DnaJ. Hsp70 action is initiated when proteins from the DnaJ family bind an unfolded protein for delivery purposes. In eukaryotes, the DnaJ family can be divided into two main groups, Type I and Type II, represented by yeast cytosolic Ydj1 and Sis1, respectively. Although sharing some unique features both members of the DnaJ family, Ydj1 and Sis1 are structurally and functionally distinct as deemed by previous studies, including the observation that their central domains carry the structural and functional information even in switched chimeras. In this study, we combined several biophysical tools for evaluating the stability of Sis1 and mutants that had the central domains (named Gly/Met rich domain and C-terminal Domain I) deleted or switched to those of Ydj1 to gain insight into the role of these regions in the structure and function of Sis1. The mutants retained some functions similar to full length wild-type Sis1, however they were defective in others. We found that: 1) Sis1 unfolds in at least two steps as follows: folded dimer to partially folded monomer and then to an unfolded monomer. 2) The Gly/Met rich domain had intrinsically disordered characteristics and its deletion had no effect on the conformational stability of the protein. 3) The deletion of the C-terminal Domain I perturbed the stability of the dimer. 4) Exchanging the central domains perturbed the conformational stability of the protein. Altogether, our results suggest the existence of two similar subdomains in the C-terminal domain of DnaJ that could be important for stabilizing each other in order to maintain a folded substrate-binding site as well as the dimeric state of the protein.
C1 [Seraphim, Thiago V.; Mokry, David Z.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.
   [Borges, Julio C.; Seraphim, Thiago V.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil.
   [Seraphim, Thiago V.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil.
   [Almeida, Fabio C. L.] Natl Ctr Nucl Magnet Resonance Macromol UFRJ, Inst Med Biochem, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA.
RP Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.
EM cramos@iqm.unicamp.br
RI Ramos, CH/C-1571-2012; Seraphim, Thiago V/J-9949-2013; Borges, Julio
   C/C-6160-2008; Almeida, Fabio/O-4989-2018
OI Ramos, CH/0000-0002-7246-9081; Borges, Julio C/0000-0003-4856-748X;
   Almeida, Fabio/0000-0001-6046-7006; Vargas Seraphim,
   Thiago/0000-0002-8682-8962
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministerio da Ciencia
   e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento
   (MCT/CNPq)National Council for Scientific and Technological Development
   (CNPq); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM056981, R01GM067785, R01GM056981, R01GM056981, R01GM056981,
   R01GM056981, R01GM067785, R01GM056981, R01GM056981, R01GM056981,
   R01GM056981, R01GM067785, R01GM056981, R01GM067785, R01GM056981,
   R01GM056981, R01GM056981, R01GM056981, R01GM056981, R01GM067785,
   R01GM067785, R01GM056981, R01GM067785, R01GM056981, R01GM067785,
   R01GM067785, R01GM056981, R01GM056981, R01GM056981, R01GM056981,
   R01GM056981] Funding Source: NIH RePORTER
FX We are grateful to the agencies that funded this work through grants,
   namely, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP
   - www.fapesp.br) and Ministerio da Ciencia e Tecnologia/Conselho
   Nacional de Pesquisa e Desenvolvimento (MCT/CNPq - www.cnpq.br). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Borges JC, 2011, CURR MED CHEM, V18, P1276
   Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200
   Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2
   CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4
   CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X
   da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132
   Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146
   Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2
   Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0
   Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452
   Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200
   Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159
   Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012
   Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824
   Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1
   Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690
   Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643
   Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019
   Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156
   Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627
   Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2
   Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40
   Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009
   SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343
   Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101
   Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/O09-175, 10.1139/o09-175]
NR 31
TC 19
Z9 21
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2012
VL 7
IS 12
AR e50927
DI 10.1371/journal.pone.0050927
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 057TZ
UT WOS:000312588200082
PM 23227221
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Oliveira, GAP
   Pereira, EG
   Dias, CV
   Souza, TLF
   Ferretti, GDS
   Cordeiro, Y
   Camillo, LR
   Cascardo, J
   Almeida, FC
   Valente, AP
   Silva, JL
AF de Oliveira, Guilherme A. P.
   Pereira, Elen G.
   Dias, Cristiano V.
   Souza, Theo L. F.
   Ferretti, Giulia D. S.
   Cordeiro, Yraima
   Camillo, Luciana R.
   Cascardo, Julio
   Almeida, Fabio C.
   Valente, Ana Paula
   Silva, Jerson L.
TI Moniliophthora perniciosa Necrosis- and Ethylene-Inducing Protein 2
   (MpNep2) as a Metastable Dimer in Solution: Structural and Functional
   Implications
SO PLOS ONE
LA English
DT Article
ID FUSARIUM-OXYSPORUM; WITCHES-BROOM; NEP1-LIKE PROTEINS; CAUSAL AGENT;
   CRINIPELLIS-PERNICIOSA; IDENTIFICATION; EXPRESSION; CAROTOVORA; DEFENSE;
   DISEASE
AB Understanding how Nep-like proteins (NLPs) behave during the cell cycle and disease progression of plant pathogenic oomycetes, fungi and bacteria is crucial in light of compelling evidence that these proteins play a role in Witches Broom Disease (WBD) of Theobroma cacao, one of the most important phytopathological problems to afflict the Southern Hemisphere. The crystal structure of MpNep2, a member of the NLP family and the causal agent of WBD, revealed the key elements for its activity. This protein has the ability to refold after heating and was believed to act as a monomer in solution, in contrast to the related homologs MpNep1 and NPP from the oomyceteous fungus Phytophthora parasitica. Here, we identify and characterize a metastable MpNep2 dimer upon over-expression in Escherichia coli using different biochemical and structural approaches. We found using ultra-fast liquid chromatography that the MpNep2 dimer can be dissociated by heating but not by dilution, oxidation or high ionic strength. Small-angle X-ray scattering revealed a possible tail-to-tail interaction between monomers, and nuclear magnetic resonance measurements identified perturbed residues involved in the putative interface of interaction. We also explored the ability of the MpNep2 monomer to refold after heating or chemical denaturation. We observed that MpNep2 has a low stability and cooperative fold that could be an explanation for its structure and activity recovery after stress. These results can provide new insights into the mechanism for MpNep2's action in dicot plants during the progression of WBD and may open new avenues for the involvement of NLP-oligomeric species in phytopathological disorders.
C1 [de Oliveira, Guilherme A. P.; Pereira, Elen G.; Ferretti, Giulia D. S.; Almeida, Fabio C.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Dias, Cristiano V.; Camillo, Luciana R.; Cascardo, Julio] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Lab Proteom, Ilheus, BA, Brazil.
   [Dias, Cristiano V.] Mars Ctr Cocoa Sci, Itajuipe, BA, Brazil.
   [Souza, Theo L. F.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil.
EM jerson@bioqmed.ufrj.br
RI Silva, Jerson/J-8984-2014; Cordeiro, Yraima/J-7619-2012; Pereira,
   Elen/H-9585-2013; Almeida, Fabio/O-4989-2018; de Souza, Theo
   LF/E-1705-2017; de Oliveira, Guilherme A. P./O-1192-2013; Valente, Ana
   Paula/J-3010-2017
OI Silva, Jerson/0000-0001-9523-9441; Cordeiro, Yraima/0000-0003-4278-212X;
   Pereira, Elen/0000-0001-8073-7931; Almeida, Fabio/0000-0001-6046-7006;
   de Souza, Theo LF/0000-0002-0109-0357; de Oliveira, Guilherme A.
   P./0000-0002-0063-5888; Valente, Ana Paula/0000-0001-7219-1123
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia
   Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Brazilian Synchrotron Light Laboratory (LNLS) [SAXS1-10895,
   SAXS1-11698]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico Brazil)National Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de
   Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT
   Program) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ) to J.L.S. This research was also supported by
   the Brazilian Synchrotron Light Laboratory (LNLS) under proposals
   SAXS1-10895 and SAXS1-11698. G.A.P.O. is the recipient of a graduate
   fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico Brazil). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012
   Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743
   Bae H, 2006, PLANT PHYSIOL, V141, P1056, DOI 10.1104/pp.106.076869
   Bae HH, 2005, MYCOL RES, V109, P1373, DOI 10.1017/S0953756205003941
   BAILEY BA, 1995, PHYTOPATHOLOGY, V85, P1250, DOI 10.1094/Phyto-85-1250
   Bailey BA, 1997, CAN J MICROBIOL, V43, P45, DOI 10.1139/m97-007
   Cechin AL, 2008, PLANT SIGNAL BEHAV, V3, P906, DOI 10.4161/psb.3.10.6643
   EVANS HC, 1980, T BRIT MYCOL SOC, V74, P515, DOI 10.1016/S0007-1536(80)80051-9
   Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x
   FRIAS GA, 1991, PLANT DIS, V75, P552, DOI 10.1094/PD-75-0552
   Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017
   Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008
   Jennings JC, 2000, WEED SCI, V48, P7, DOI 10.1614/0043-1745(2000)048[0007:IOEBAN]2.0.CO;2
   Keates SE, 2003, PLANT PHYSIOL, V132, P1610, DOI 10.1104/pp.102.019836
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Kufner I, 2009, PLANT SIGNAL BEHAV, V4, P977, DOI 10.4161/psb.4.10.9669
   Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017
   Mattinen L, 2004, MOL PLANT MICROBE IN, V17, P1366, DOI 10.1094/MPMI.2004.17.12.1366
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343
   Pemberton CL, 2004, MOL PLANT PATHOL, V5, P353, DOI 10.1111/j.1364-3703.2004.00235.x
   Penman D, 2000, MYCOL RES, V104, P671, DOI 10.1017/S0953756299001689
   Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573
   Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x
   Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974
   Schouten A, 2008, NEW PHYTOL, V177, P493, DOI 10.1111/j.1469-8137.2007.02274.x
   Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796
   Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Weber G, 1992, PROTEIN INTERACTIONS
   Zaparoli G, 2011, BIOCHEMISTRY-US, V50, P9901, DOI 10.1021/bi201253b
NR 36
TC 10
Z9 10
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 24
PY 2012
VL 7
IS 9
AR e45620
DI 10.1371/journal.pone.0045620
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016YB
UT WOS:000309554700053
PM 23029140
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Asam, C
   Batista, AL
   Moraes, A
   De-Paula, VS
   Almeida, FCL
   Briza, P
   Bohle, B
   Ferreira, F
   Valente, AP
   Wallner, M
AF Asam, C.
   Batista, A. L.
   Moraes, A.
   De-Paula, V. S.
   Almeida, F. C. L.
   Briza, P.
   Bohle, B.
   Ferreira, F.
   Valente, A. P.
   Wallner, M.
TI The effect of ligand-binding on structure, stability and biological
   activity of Bet v 1
SO IMMUNOLOGY
LA English
DT Meeting Abstract
CT European Congress of Immunology
CY SEP 05-08, 2012
CL Glasgow, SCOTLAND
C1 [Asam, C.; Ferreira, F.; Wallner, M.] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy Mol, A-5020 Salzburg, Austria.
   [Batista, A. L.; Moraes, A.; De-Paula, V. S.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, Rio De Janeiro, Brazil.
   [Briza, P.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.
   [Bohle, B.] Med Univ Vienna, Dept Pathophysiol, Christian Doppler Lab Immunomodulat, Vienna, Austria.
RI Moraes, Adolfo/G-3931-2018; Briza, Peter/D-7309-2012
OI Moraes, Adolfo/0000-0002-3344-4084; Briza, Peter/0000-0002-4941-6782
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD SEP
PY 2012
VL 137
SU 1
SI SI
BP 461
EP 461
PG 1
WC Immunology
SC Immunology
GA 011TW
UT WOS:000309189103243
DA 2020-12-01
ER

PT J
AU Abrantes, JL
   Alves, CM
   Costa, J
   Almeida, FCL
   Sola-Penna, M
   Fontes, CFL
   Souza, TML
AF Abrantes, Juliana L.
   Alves, Cristiane M.
   Costa, Jessica
   Almeida, Fabio C. L.
   Sola-Penna, Mauro
   Fontes, Carlos Frederico L.
   Souza, Thiago Moreno L.
TI Herpes simplex type 1 activates glycolysis through engagement of the
   enzyme 6-phosphofructo-1-kinase (PFK-1)
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE HSV-1; PFK-1; Glycolysis
ID SKELETAL-MUSCLE 6-PHOSPHOFRUCTO-1-KINASE; IMMUNODEFICIENCY-VIRUS TYPE-1;
   BREAST-CANCER CELLS; GLUCOSE-METABOLISM; DIFFERENTIAL EXPRESSION;
   PROTEIN-SYNTHESIS; VERO CELLS; PHOSPHOFRUCTOKINASE; INFECTION;
   PHOSPHORYLATION
AB Viruses such as HIV, HCV, Mayaro and HCMV affect cellular metabolic pathways, including glycolysis. Although some studies have suggested that the inhibition of glycolysis affects HSV-1 replication and that HSV-1-infected eyes have increased lactate production, the mechanisms by which HSV-1 induces glycolysis have never been investigated in detail. In this study, we observed an increase in glucose uptake, lactate efflux and ATP content in HSV-1-infected cells. HSV-1 triggered a MOI-dependent increase in the activity of phosphofructokinase-1 (PFK-1), a key rate-limiting enzyme of the glycolytic pathway. After HSV-1 infection, we observed increased PFK-1 expression, which increased PFK-1 total activity, and the phosphorylation of this enzyme at serine residues. HSV-1-induced glycolysis was associated with increased ATP content, and these events were critical for viral replication. In summary, our results suggest that HSV-1 triggers glycolysis through a different mechanism than other herpesviruses, such as HCMV. Thus, this study contributes to a better understanding of HSV-1 pathogenesis and provides insights into novel targets for antiviral therapy. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Abrantes, Juliana L.; Alves, Cristiane M.; Costa, Jessica; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Influenza & Viroses Exantematicas, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Abrantes, Juliana L.; Fontes, Carlos Frederico L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Estrutura & Regulacao Prot & ATPase, Programa Posgrad Quim Biol, Rio De Janeiro, RJ, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Rio De Janeiro, RJ, Brazil.
   [Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Dept Farmacos, Fac Farm, Lab Enzimol & Controle Metab, Rio De Janeiro, RJ, Brazil.
RP Abrantes, JL (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Influenza & Viroses Exantematicas, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
EM abrantes@bioqmed.ufrj.br; tmoreno@ioc.fiocruz.br
RI Almeida, Fabio/O-4989-2018; Souza, Thiago Moreno L./G-2900-2012; Fontes,
   C.F.L. or Fontes/G-2343-2014; Sola-Penna, Mauro/E-8221-2011
OI Almeida, Fabio/0000-0001-6046-7006; Souza, Thiago Moreno
   L./0000-0003-2212-3899; Fontes, C.F.L. or Fontes/0000-0002-9384-0898;
   Sola-Penna, Mauro/0000-0001-9796-6829
CR Abdel-Haq Nahed, 2006, Indian Journal of Pediatrics, V73, P313, DOI 10.1007/BF02825826
   Alves GG, 2003, MOL GENET METAB, V78, P302, DOI 10.1016/S1096-7192(03)00037-4
   Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577
   BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8
   BLOUGH HA, 1979, JAMA-J AM MED ASSOC, V241, P2798, DOI 10.1001/jama.241.26.2798
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Burlandy FM, 2001, INTERVIROLOGY, V44, P344, DOI 10.1159/000050069
   Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6
   Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010
   COREY L, 1986, NEW ENGL J MED, V314, P686, DOI 10.1056/NEJM198603133141105
   COURTNEY RJ, 1973, VIROLOGY, V52, P447, DOI 10.1016/0042-6822(73)90340-1
   Da Silva D, 2010, ARCH BIOCHEM BIOPHYS, V496, P53, DOI 10.1016/j.abb.2010.01.013
   De Logu A, 2000, ANTIVIR RES, V48, P177, DOI 10.1016/S0166-3542(00)00127-3
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00
   ELMAGHRABI MR, 1983, METHOD ENZYMOL, V99, P212
   Esquenazi D, 2002, RES MICROBIOL, V153, P647, DOI 10.1016/S0923-2508(02)01377-3
   Gong YH, 2002, ANTIVIR RES, V55, P319, DOI 10.1016/S0166-3542(02)00054-2
   Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z
   HUSSEY CR, 1977, EUR J BIOCHEM, V80, P497, DOI 10.1111/j.1432-1033.1977.tb11905.x
   Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002
   Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012
   Kamakura M, 2008, MICROBES INFECT, V10, P405, DOI 10.1016/j.micinf.2007.12.019
   Kellenberger LD, 2010, J ONCOL, V2010, DOI 10.1155/2010/514310
   KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191
   Kuo YC, 2001, ANTIVIR RES, V51, P95, DOI 10.1016/S0166-3542(01)00141-3
   LUTHER MA, 1986, BIOCHEMISTRY-US, V25, P7931, DOI 10.1021/bi00372a022
   MAHRENHOLZ AM, 1991, BIOCHEM BIOPH RES CO, V174, P1255, DOI 10.1016/0006-291X(91)91556-R
   McArdle J, 2011, J VIROL, V85, P705, DOI 10.1128/JVI.01557-10
   Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132
   Olefsky JM, 1999, J BIOL CHEM, V274, P1863, DOI 10.1074/jbc.274.4.1863
   Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597
   da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805
   Petiot E, 2010, BIOTECHNOL BIOENG, V107, P143, DOI 10.1002/bit.22783
   Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008
   Qin R, 2006, BIOCHEMISTRY-US, V45, P793, DOI 10.1021/bi051558s
   RADSAK KD, 1981, J GEN VIROL, V57, P33, DOI 10.1099/0022-1317-57-1-33
   Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023
   Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07
   Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09
   Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091
   Roizman B, 1996, P NATL ACAD SCI USA, V93, P11307, DOI 10.1073/pnas.93.21.11307
   Roizman B., 1996, FIELDS VIROLOGY, P2231
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731
   SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1
   Seo E, 2010, KOREAN J PHYSIOL PHA, V14, P99, DOI 10.4196/kjpp.2010.14.2.99
   Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406
   Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4
   Sola-Penna M, 2008, IUBMB LIFE, V60, P605, DOI 10.1002/iub.97
   Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996
   Souza TML, 2007, PLANTA MED, V73, P200, DOI 10.1055/s-2007-967109
   Terekhina N A, 1998, Zh Mikrobiol Epidemiol Immunobiol, P92
   Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124
   Vignoli AL, 2000, MOL CELL BIOCHEM, V215, P73, DOI 10.1023/A:1026590916661
   VORA S, 1985, CANCER RES, V45, P2993
   Waggoner-Fountain LA, 2004, PEDIATR REV, V25, P86, DOI 10.1542/pir.25-3-86
   Whitley R, 2006, Herpes, V13, P53
   WIDNELL CC, 1990, FASEB J, V4, P1634
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698
   Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x
   Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002
   Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10
   Zancan P, 2008, IUBMB LIFE, V60, P526, DOI 10.1002/iub.58
   Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006
   Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409
NR 69
TC 36
Z9 37
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD AUG
PY 2012
VL 1822
IS 8
BP 1198
EP 1206
DI 10.1016/j.bbadis.2012.04.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 969CH
UT WOS:000306032800003
PM 22542512
OA Bronze
DA 2020-12-01
ER

PT J
AU Martins, IC
   Gomes-Neto, F
   Faustino, AF
   Carvalho, FA
   Carneiro, FA
   Bozza, PT
   Mohana-Borges, R
   Castanho, MARB
   Almeida, FCL
   Santos, NC
   Da Poian, AT
AF Martins, Ivo C.
   Gomes-Neto, Francisco
   Faustino, Andre F.
   Carvalho, Filomena A.
   Carneiro, Fabiana A.
   Bozza, Patricia T.
   Mohana-Borges, Ronaldo
   Castanho, Miguel A. R. B.
   Almeida, Fabio C. L.
   Santos, Nuno C.
   Da Poian, Andrea T.
TI The disordered N-terminal region of dengue virus capsid protein contains
   a lipid-droplet-binding motif
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE atomic force microscopy (AFM); capsid protein; conformational selection;
   dengue virus (DENV); intrinsically disordered protein; lipid droplet;
   NMR
ID HEPATITIS-C VIRUS; CORE PROTEIN; CONFORMATIONAL DIVERSITY; INTRINSIC
   DISORDER; VISUALIZATION; SPECTROSCOPY; FLEXIBILITY; INHIBITOR;
   ALIGNMENT; SYSTEM
AB Dengue is the major arthropod-borne human viral disease, for which no vaccine or specific treatment is available. We used NMR, zeta potential measurements and atomic force microscopy to study the structural features of the interaction between dengue virus C (capsid) protein and LDs (lipid droplets), organelles crucial for infectious particle formation. C protein-binding sites to LD were mapped, revealing a new function for a conserved segment in the N-terminal disordered region and indicating that conformational selection is involved in recognition. The results suggest that the positively charged N-terminal region of C protein prompts the interaction with negatively charged LDs, after which a conformational rearrangement enables the access of the central hydrophobic patch to the LD surface. Taken together, the results allowed the design of a peptide with inhibitory activity of C protein LD binding, paving the way for new drug development approaches against dengue.
C1 [Martins, Ivo C.; Gomes-Neto, Francisco; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Martins, Ivo C.; Faustino, Andre F.; Carvalho, Filomena A.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
   [Gomes-Neto, Francisco; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes-Neto, Francisco; Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Carneiro, Fabiana A.] Univ Fed Rio de Janeiro, BR-25245390 Duque De Caxias, RJ, Brazil.
   [Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM dapoian@bioqmed.ufrj.br
RI Martins, Ivo C/G-2534-2013; Da Poian, Andrea T./V-1699-2019; Almeida,
   Fabio/O-4989-2018; Borges, Ronaldo S Mohana/C-5575-2013; Carvalho,
   Filomena A./M-9202-2013; Santos, Nuno/N-7248-2013; CARNEIRO, FABIANA
   A/S-4525-2018
OI Martins, Ivo C/0000-0002-9284-8599; Almeida, Fabio/0000-0001-6046-7006;
   Carvalho, Filomena A./0000-0001-6088-3894; Santos,
   Nuno/0000-0002-0580-0475; Mohana Borges, Ronaldo/0000-0002-1796-475X;
   Faustino, Andre F./0000-0002-7364-8524; FCCN, Bogus/0000-0001-6282-8004;
   Castanho, Miguel/0000-0001-7891-7562; Da Poian,
   Andrea/0000-0002-3969-704X; Carneiro, Fabiana/0000-0002-6584-4875; FCCN,
   Bogus/0000-0003-1034-3552; Bozza, Patricia/0000-0001-8349-9529
FU European UnionEuropean Union (EU); National Institute of Science and
   Technology in Dengue (INCTD, Brazil); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq); Fundagao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao para a Ciencia e a Tecnologia
   (FCT)-Ministerio da Educacao e Ciencia (MEC) (Portugal)
   [PTDC/QUI-BIQ/112929/20091]; Fundacao Calouste Gulbenkian (Portugal);
   FCT-Fundacao Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior
   (CAPES) Portugal-Brazil joint co-operation project; Marie Curie
   International Outgoing FellowshipEuropean Union (EU) [MC-10F237373]; FCT
   postdoctoral fellowship [SFRH/BPD/46324/2008, SFRH/BPD/74287/2010]
FX This work was supported by the European Union 7th Framework Programme
   PEOPLE IRSES (International Research Staff Exchange Scheme) project
   MEMPEPACROSS, the National Institute of Science and Technology in Dengue
   (INCTD, Brazil), the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq, Brazil), the Fundagao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil), the Fundacao para
   a Ciencia e a Tecnologia (FCT)-Ministerio da Educacao e Ciencia (MEC)
   (Portugal) [grant number PTDC/QUI-BIQ/112929/20091, the Fundacao
   Calouste Gulbenkian (Portugal), and FCT-Fundacao Coordenacao de
   Aperfeicoamento do Pessoal de Nivel Superior (CAPES) Portugal-Brazil
   joint co-operation projects. I.C.M. is the recipient of consecutive
   postdoctoral funding from a Marie Curie International Outgoing
   Fellowship [grant number MC-10F237373) and FCT postdoctoral fellowships
   [grant numbers SFRH/BPD/46324/2008 and SFRH/BPD/74287/2010].
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001
   Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1
   Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494
   Puttikhunt C, 2009, ARCH VIROL, V154, P1211, DOI 10.1007/s00705-009-0426-5
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08
   Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225
   Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090
   Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009
   Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   WAGNER G, 1986, EUR J BIOCHEM, V157, P275, DOI 10.1111/j.1432-1033.1986.tb09666.x
   Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wu E, 2004, TRENDS MICROBIOL, V12, P162, DOI 10.1016/j.tim.2004.02.005
   Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984
NR 50
TC 57
Z9 57
U1 0
U2 25
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN 15
PY 2012
VL 444
BP 405
EP 415
DI 10.1042/BJ20112219
PN 3
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 962KZ
UT WOS:000305545300005
PM 22428600
DA 2020-12-01
ER

PT J
AU Moure, VR
   Razzera, G
   Araujo, LM
   Oliveira, MAS
   Gerhardt, ECM
   Muller-Santos, M
   Almeida, F
   Pedrosa, FO
   Valente, AP
   Souza, EM
   Huergo, LF
AF Moure, Vivian R.
   Razzera, Guilherme
   Araujo, Luiza M.
   Oliveira, Marco A. S.
   Gerhardt, Edileusa C. M.
   Mueller-Santos, Marcelo
   Almeida, Fabio
   Pedrosa, Fabio O.
   Valente, Ana P.
   Souza, Emanuel M.
   Huergo, Luciano F.
TI Heat stability of Proteobacterial P-II protein facilitate purification
   using a single chromatography step
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE P-II proteins; Heat treatment; Melting temperature; Protein NMR
ID SIGNAL-TRANSDUCTION PROTEIN; IN-VITRO URIDYLYLATION;
   AZOSPIRILLUM-BRASILENSE; HERBASPIRILLUM-SEROPEDICAE; PII PROTEIN; GLNZ;
   2-OXOGLUTARATE; AMTB; COMPLEX; NMR
AB The P-II proteins comprise a family of widely distributed signal transduction proteins that integrate the signals of cellular nitrogen, carbon and energy status, and then regulate, by protein-protein interaction, the activity of a variety of target proteins including enzymes, transcriptional regulators and membrane transporters. We have previously shown that the P-II proteins from Azospirillum brasilense, GInB and GInZ, do not alter their migration behavior under native gel electrophoresis following incubated for a few minutes at 95 degrees C. This data suggested that P-II proteins were either resistant to high temperatures and/or that they could return to their native state after having been unfolded by heat. Here we used H-1 NMR to show that the A. brasilense GInB is stable up to 70 degrees C. The melting temperature (Tm) of GInB was determined to be 84 degrees C using the fluorescent dye Sypro-Orange. P-II proteins from other Proteobacteria also showed a high Tm. We exploited the thermo stability of P-II by introducing a thermal treatment step in the P-II purification protocol, this step significantly improved the homogeneity of A. brasilense GInB and GInZ, Herbaspirillum seropedicae GInB and GInK, and of Escherichia coli GInK. Only a single chromatography step was necessary to obtain homogeneities higher than 95%. NMR1 and in vitro uridylylation analysis showed that A. brasilense GInB purified using the thermal treatment maintained its folding and activity. The purification protocol described here can facilitate the study of P-II protein family members. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Moure, Vivian R.; Araujo, Luiza M.; Oliveira, Marco A. S.; Gerhardt, Edileusa C. M.; Mueller-Santos, Marcelo; Pedrosa, Fabio O.; Souza, Emanuel M.; Huergo, Luciano F.] Univ Fed Parana, Dept Bioquim & Biol Mol, Inst Nacl Ciencia & Tecnol Fixacao Biol Nitrogeni, BR-81531990 Curitiba, Parana, Brazil.
   [Razzera, Guilherme; Almeida, Fabio; Valente, Ana P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
RP Huergo, LF (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, Inst Nacl Ciencia & Tecnol Fixacao Biol Nitrogeni, CP19046, BR-81531990 Curitiba, Parana, Brazil.
EM huergo@ufpr.br
RI Muller-Santos, Marcelo/D-7272-2013; Valente, Ana Paula/J-3010-2017; de
   Souza, Emanuel Maltempi/C-1920-2013; Pedrosa, Fabio 0/C-1938-2013;
   Moure, Vivian/H-2257-2013; Almeida, Fabio/O-4989-2018; Oliveira, Marco
   A.S./F-4664-2017; Razzera, Guilherme/M-5372-2014
OI Muller-Santos, Marcelo/0000-0001-9615-6007; Valente, Ana
   Paula/0000-0001-7219-1123; de Souza, Emanuel
   Maltempi/0000-0003-1546-9218; Almeida, Fabio/0000-0001-6046-7006;
   Oliveira, Marco A.S./0000-0002-1993-7771; Muller-Santos,
   Marcelo/0000-0001-9524-9084; Huergo, Luciano/0000-0002-7587-9510;
   Razzera, Guilherme/0000-0002-1448-3037
FU CNPq/INCTNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; CNPq-BrazilNational Council for Scientific and
   Technological Development (CNPq)
FX We are grateful to Roseli Prado and Valter A. Baura for technical
   assistance. Mike Merrick is thanked for providing plasmids used in this
   work and for critical reading of the manuscript. This work was supported
   by CNPq/INCT and CAPES. V.R.M is supported by a Ph.D. fellowship from
   CNPq-Brazil.
CR Araujo LM, 2008, BRAZ J MED BIOL RES, V41, P289, DOI 10.1590/S0100-879X2008000400006
   Araujo MS, 2004, PROTEIN EXPRES PURIF, V33, P19, DOI 10.1016/j.pep.2003.08.024
   Benelli EM, 2001, CAN J MICROBIOL, V47, P309, DOI 10.1139/cjm-47-4-309
   Bonatto AC, 2007, PROTEIN EXPRES PURIF, V55, P293, DOI 10.1016/j.pep.2007.04.012
   Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107
   Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004
   Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x
   Huergo LF, 2005, FEMS MICROBIOL LETT, V253, P47, DOI 10.1016/j.femsle.2005.09.026
   Huergo LF, 2009, J BIOL CHEM, V284, P6674, DOI 10.1074/jbc.M807378200
   Inaba J, 2009, EUR J SOIL BIOL, V45, P94, DOI 10.1016/j.ejsobi.2008.08.006
   Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t
   Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z
   Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321
   Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1
   Portugal M.E.G., BRAZ J MED RES UNPUB
   Radchenko MV, 2010, J BIOL CHEM, V285, P31037, DOI 10.1074/jbc.M110.153908
   Razzera G, 2009, BIOMOL NMR ASSIGN, V3, P103, DOI 10.1007/s12104-009-9151-y
   Rodrigues TE, 2011, BBA-PROTEINS PROTEOM, V1814, P1203, DOI 10.1016/j.bbapap.2011.05.012
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SHIH P, 1995, PROTEIN SCI, V4, P2050, DOI 10.1002/pro.5560041010
   SON HS, 1987, J BIOL CHEM, V262, P8690
   Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036
   Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101
   VASUDEVAN SG, 1994, FEBS LETT, V337, P255, DOI 10.1016/0014-5793(94)80203-3
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   Xu YB, 2003, ACTA CRYSTALLOGR D, V59, P2183, DOI 10.1107/S0907444903019589
   Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x
NR 27
TC 18
Z9 18
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD JAN
PY 2012
VL 81
IS 1
BP 83
EP 88
DI 10.1016/j.pep.2011.09.008
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 853PS
UT WOS:000297438800014
PM 21963770
OA Bronze
DA 2020-12-01
ER

PT J
AU D'Andrea, MG
   Domingues, CC
   Malheiros, SVP
   Neto, FG
   Barbosa, LRS
   Itri, R
   Almeida, FCL
   de Paula, E
   Bianconi, ML
AF D'Andrea, Mariana G.
   Domingues, Cleyton C.
   Malheiros, Sonia V. P.
   Gomes Neto, Francisco
   Barbosa, Leandro R. S.
   Itri, Rosangela
   Almeida, Fabio C. L.
   de Paula, Eneida
   Bianconi, M. Lucia
TI Thermodynamic and Structural Characterization of Zwitterionic Micelles
   of the Membrane Protein Solubilizing Amidosulfobetaine Surfactants
   ASB-14 and ASB-16
SO LANGMUIR
LA English
DT Article
ID NONIONIC SURFACTANT; AQUEOUS-SOLUTIONS; TEMPERATURE; MICELLIZATION;
   ENTHALPY; BINDING; WATER; SPECTROSCOPY; DETERGENTS; ANION
AB Surface tension and isothermal titration calorimetry (ITC) were used to determine the critical micelle concentration (cmc) of the zwitterionic amidosulfobetaine surfactants ASB-14 and ASB-16 (linear-allcylamidopropyldi-methylammoniopropanosulfonates) at 25 degrees C. The cmc and the heat of micellizabon were determined from 15 to 75 degrees C by ITC for both surfactants. The increase in temperature caused significant changes in the enthalpy and in the entropy of micellization, with small changes in the standard Gibbs energy (Delta G(mic)), which is consistent to an enthalpy-entropy compensation with a compensatory temperature of 311 K (ASB-14) and 314 K (ASB-16). In the studied temperature range, the heat capacity of micellization (Delta C-p(mic)) was essentially constant. The experimental Delta C-p(mic) was lower than that expected if only hydrophobic interactions were considered, suggesting that polar interactions at the head groups are of significant importance in the thermodynamics of micelle formation by these surfactants. Indeed, a NMR NOESY spectrum showed NOES that are improbable to occur within the same monomer, resulting from interactions at the polar head groups involving more than one monomer. The ITC and NMR results indicate a tilt in the polar headgroup favoring the polar interactions. We have also observed COSY correlations typical of dipolar interactions that could be recovered with the partial alignment of the molecule in solution, which results in an anisotropic tumbling. The anisotropy suggested an ellipsoidal shape of the micelles, which results in a positive magnetic susceptibility, and ultimately in orientation induced by the magnetic field. Such an ellipsoidal shape was confirmed from results obtained by SAXS experiments that revealed aggregation numbers of 108 and 168 for ASB-14 and ASB-16 micelles, respectively. This study characterizes an interesting micelle system that can be used in the study of membrane proteins by solution NMR. spectroscopy.
C1 [D'Andrea, Mariana G.; Bianconi, M. Lucia] Univ Fed Rio de Janeiro, IBQM, Lab Biocalorimet, BR-21941290 Rio de Janeiro, Brazil.
   [Domingues, Cleyton C.; de Paula, Eneida] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Bioquim, Campinas, SP, Brazil.
   [Malheiros, Sonia V. P.] Fac Med Jundiai, Dept Biol & Fisiol, Jundiai, SP, Brazil.
   [Gomes Neto, Francisco; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941290 Rio De Janeiro, Brazil.
   [Barbosa, Leandro R. S.; Itri, Rosangela] IFUSP, Inst Fis USP, Sao Paulo, Brazil.
RP Bianconi, ML (corresponding author), Univ Fed Rio de Janeiro, IBQM, Lab Biocalorimet, Predio CCS Bloco & Sala 27b, BR-21941290 Rio de Janeiro, Brazil.
EM bianconi@bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Itri, Rosangela/B-4312-2014; Barbosa, L. R.
   S./AAN-7787-2020; Barbosa, Leandro/E-6577-2012; de Paula,
   Eneida/C-3031-2013
OI Almeida, Fabio/0000-0001-6046-7006; Barbosa, L. R.
   S./0000-0001-5997-2160; Barbosa, Leandro/0000-0001-5997-2160; de Paula,
   Eneida/0000-0003-4504-5723; Itri, Rosangela/0000-0001-9311-0804
FU Financiadora de Estudos e Projetos (FINEP/CT-Infra)Ciencia Tecnologia e
   Inovacao (FINEP); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento
   de Pessoal de Ensino Superior (CAPES)CAPES
FX This work was supported by research grants from Financiadora de Estudos
   e Projetos (FINEP/CT-Infra), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro FAPERJ, and Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP). M.G.D and C.C.D. acknowledge
   the fellowships from CNPq and Coordenacao de Aperfeicoamento de Pessoal
   de Ensino Superior (CAPES). We thank Dr. Watson Loh for facilities.
CR Bain AD, 1996, CONCEPT MAGNETIC RES, V8, P191, DOI 10.1002/(SICI)1099-0534(1996)8:3<191::AID-CMR3>3.0.CO;2-U
   BAPTISTA MD, 1992, J PHYS CHEM-US, V96, P6442, DOI 10.1021/j100194a063
   Barbosa LRS, 2006, J PHYS CHEM B, V110, P13086, DOI 10.1021/jp056486t
   Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bhattacharya S, 2005, LANGMUIR, V21, P5747, DOI 10.1021/la047072e
   BIJMA K, 1994, LANGMUIR, V10, P2578, DOI 10.1021/la00020a015
   Blandamer MJ, 2000, PHYS CHEM CHEM PHYS, V2, P4369, DOI 10.1039/b004501m
   BLANDAMER MJ, 1995, ADV COLLOID INTERFAC, V58, P171, DOI 10.1016/0001-8686(95)00252-L
   Blandamer MJ, 1996, PURE APPL CHEM, V68, P1577, DOI 10.1351/pac199668081577
   Caetano W, 2003, J COLLOID INTERF SCI, V260, P414, DOI 10.1016/S0021-9797(02)00248-5
   Chevallet M, 1998, ELECTROPHORESIS, V19, P1901, DOI 10.1002/elps.1150191108
   CORREIA VR, 1992, J AM CHEM SOC, V114, P2144, DOI 10.1021/ja00032a031
   Cuccovia IM, 1999, J COLLOID INTERF SCI, V220, P96, DOI 10.1006/jcis.1999.6511
   Dar AA, 2007, J PHYS CHEM B, V111, P3122, DOI 10.1021/jp066926w
   Di Profio P, 1998, LANGMUIR, V14, P2662, DOI 10.1021/la971106j
   Dias RS, 2005, ELECTROPHORESIS, V26, P2908, DOI 10.1002/elps.200400182
   Domingues CC, 2008, BRAZ J MED BIOL RES, V41, P758, DOI 10.1590/S0100-879X2008000900003
   Farrukh MA, 2008, LANGMUIR, V24, P12995, DOI 10.1021/la802179m
   GARCIA MED, 1986, TALANTA, V33, P255, DOI 10.1016/0039-9140(86)80060-1
   Garidel P, 2000, LANGMUIR, V16, P5267, DOI 10.1021/la9912390
   GILL SJ, 1976, P NATL ACAD SCI USA, V73, P2955, DOI 10.1073/pnas.73.9.2955
   Glatter O., 1982, SMALL ANGLE XRAY SCA
   Graciani MD, 2005, LANGMUIR, V21, P7161, DOI 10.1021/la050862j
   Guinier A., 1955, SMALL ANGLE SCATTERI
   Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2
   Henningsen R, 2002, PROTEOMICS, V2, P1479, DOI 10.1002/1615-9861(200211)2:11<1479::AID-PROT1479>3.0.CO;2-A
   Hildebrand A, 2004, LANGMUIR, V20, P320, DOI 10.1021/la035526m
   KEN A, 1988, BIOCHEMISTRY-US, V27, P3446
   Kresheck GC, 2006, J COLLOID INTERF SCI, V298, P432, DOI 10.1016/j.jcis.2005.12.003
   Kresheck GC, 1998, J PHYS CHEM B, V102, P6596, DOI 10.1021/jp9820469
   Kresheck GC, 2009, J PHYS CHEM B, V113, P6732, DOI 10.1021/jp811048d
   KUNIEDA H, 1976, J PHYS CHEM-US, V80, P2468, DOI 10.1021/j100563a007
   Lah J, 2006, J PHYS CHEM B, V110, P23279, DOI 10.1021/jp062796f
   LAUGHLIN RG, 1991, LANGMUIR, V7, P842, DOI 10.1021/la00053a006
   Luche S, 2003, PROTEOMICS, V3, P249, DOI 10.1002/pmic.200390037
   LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002
   Majhi PR, 2001, LANGMUIR, V17, P3844, DOI 10.1021/la001660k
   MARIGNAN J, 1986, J PHYS CHEM-US, V90, P645, DOI 10.1021/j100276a033
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   Matsuno R, 2010, LANGMUIR, V26, P13028, DOI 10.1021/la1015466
   MEHRIAN T, 1993, COLLOID SURFACE A, V71, P255, DOI 10.1016/0927-7757(93)80040-L
   MILLS CO, 1986, BIOCHIM BIOPHYS ACTA, V876, P677, DOI 10.1016/0005-2760(86)90057-3
   NUSSELDER JJH, 1992, J COLLOID INTERF SCI, V148, P353, DOI 10.1016/0021-9797(92)90174-K
   OLOFSSON G, 1985, J PHYS CHEM-US, V89, P1473, DOI 10.1021/j100254a034
   Patist A, 2000, J SURFACTANTS DETERG, V3, P53, DOI 10.1007/s11743-000-0113-4
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   PRESS WH, 1994, NUMERICAL RECIPES AR
   Priebe JP, 2008, J PHYS CHEM B, V112, P14373, DOI 10.1021/jp801337n
   Priebe JP, 2010, LANGMUIR, V26, P1008, DOI 10.1021/la902469d
   SACHS JN, 2004, BIOPHYS J, V86, P187
   SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475
   SCHERER PG, 1987, EMBO J, V6, P2915, DOI 10.1002/j.1460-2075.1987.tb02595.x
   Sinibaldi R, 2008, EUR BIOPHYS J BIOPHY, V37, P673, DOI 10.1007/s00249-008-0306-z
   Sinibaldi R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2735620
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Barbosa LRS, 2010, J PHYS CHEM B, V114, P11371, DOI 10.1021/jp1013829
   Sugihara G, 1999, J COLLOID INTERF SCI, V219, P31, DOI 10.1006/jcis.1999.6378
   TANFORD C, 1972, J PHYS CHEM-US, V76, P3020, DOI 10.1021/j100665a018
   Taylor G. W., 1987, STRUCTURE ANAL SMALL
   TEIXEIRA CV, 2001, BIOCHIM BIOPHYS ACTA, V93, P1510
   Tondo DW, 2007, J PHYS CHEM B, V111, P11867, DOI 10.1021/jp075208m
   WEERS JG, 1991, LANGMUIR, V7, P854, DOI 10.1021/la00053a008
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   ZIELINSKI R, 1989, J COLLOID INTERF SCI, V129, P175, DOI 10.1016/0021-9797(89)90428-1
NR 66
TC 15
Z9 15
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 5
PY 2011
VL 27
IS 13
BP 8248
EP 8256
DI 10.1021/la1037525
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 783ZS
UT WOS:000292124000036
PM 21657261
DA 2020-12-01
ER

PT J
AU de Paula, VS
   Razzera, G
   Barreto-Bergter, E
   Almeida, FCL
   Valente, AP
AF de Paula, Viviane Silva
   Razzera, Guilherme
   Barreto-Bergter, Eliana
   Almeida, Fabio C. L.
   Valente, Ana Paula
TI Portrayal of Complex Dynamic Properties of Sugarcane Defensin 5 by NMR:
   Multiple Motions Associated with Membrane Interaction
SO STRUCTURE
LA English
DT Article
ID TORSION ANGLE DYNAMICS; CONFORMATIONAL DIVERSITY; COMBINATORIAL DESIGN;
   RESIDUAL DIPOLAR; PROTEIN; ASSIGNMENT; BINDING; PEPTIDES; ENTROPY;
   STATES
AB Defensins are essentially ancient natural antibiotics with potent activity extending from lower organisms to humans. Sd5 is a recently described antifungal defensin that appears to be the result of a recent gain of function. We reported here the solution NMR structure of Sd5 and characterized the backbone dynamics in the free state and in the presence of membrane models. N-15 relaxation dispersion measurements indicate intrinsic conformational exchange processes, showing two clear distinct k(ex), 490 and 1800 s(-1). These multiple motions may be related to transient twisting or breathing of the alpha helix and beta sheet. The stages of membrane recognition and disruption by Sd5 over a large timescale range were mapped and demonstrated that Sd5 in solution sampled an ensemble of different conformations, of which a subset is selected upon membrane binding. Defensins share similar structures, but we demonstrated here that their dynamics can be extremely diverse.
C1 [de Paula, Viviane Silva; Razzera, Guilherme; Almeida, Fabio C. L.; Valente, Ana Paula] Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil.
RP Valente, AP (corresponding author), Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Bergter, Eliana Barreto/E-2664-2013;
   Valente, Ana Paula/J-3010-2017; De Paula, Viviane/L-1947-2013; Razzera,
   Guilherme/M-5372-2014
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123; De Paula, Viviane/0000-0003-3171-6477;
   Razzera, Guilherme/0000-0002-1448-3037
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); ICGEB-Trieste; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro Carlos Chagas Filho (FAPERJ-Pensa Rio); Coordenacao de
   Aperfeigoamento de Pessoal de Nivel Superior (CAPES)CAPES; National
   Institute of Structural Biology and Bioimaging (INBEB)
FX This research was supported by Grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), ICGEB-Trieste, Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho
   (FAPERJ-Pensa Rio), Coordenacao de Aperfeigoamento de Pessoal de Nivel
   Superior (CAPES) and National Institute of Structural Biology and
   Bioimaging (INBEB). We also thank Fabricio Cruz for technical
   assistance.
CR Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0
   Boehr DD, 2009, CELL, V139, P1049, DOI 10.1016/j.cell.2009.11.031
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Cavanagh J, 2000, NAT STRUCT BIOL, V7, P11, DOI 10.1038/71202
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009
   de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013
   De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y
   DeLano W., 2002, PYMOL USERS MANUAL
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m
   Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x
   Forman-Kay JD, 1999, NAT STRUCT BIOL, V6, P1086, DOI 10.1038/70008
   FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451
   Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959
   Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118
   Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393
   Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Keller R, 2004, COMPUTER AIDED RESON
   Ladokhin AS, 1997, METHOD ENZYMOL, V278, P474
   Law AB, 2009, J AM CHEM SOC, V131, P6322, DOI 10.1021/ja809915a
   Lee AL, 2000, NAT STRUCT BIOL, V7, P72
   Leng J, 2003, BIOPHYS J, V85, P1624, DOI 10.1016/S0006-3495(03)74593-7
   Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n
   Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z
   Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004
   Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863
   Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247
   Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377
   Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375
   Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z
   Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vallurupalli P, 2006, P NATL ACAD SCI USA, V103, P11910, DOI 10.1073/pnas.0602310103
   Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821
   Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100
NR 47
TC 32
Z9 32
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD JAN 12
PY 2011
VL 19
IS 1
BP 26
EP 36
DI 10.1016/j.str.2010.11.011
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 708FP
UT WOS:000286348000006
PM 21220113
DA 2020-12-01
ER

PT J
AU Palmieri, LD
   Lima, LMTR
   Freire, JBB
   Bleicher, L
   Polikarpov, I
   Almeida, FCL
   Foguel, D
AF Palmieri, Leonardo de C.
   Lima, Luis Mauricio T. R.
   Freire, Juliana B. B.
   Bleicher, Lucas
   Polikarpov, Igor
   Almeida, Fabio C. L.
   Foguel, Debora
TI Novel Zn2+-binding Sites in Human Transthyretin IMPLICATIONS FOR
   AMYLOIDOGENESIS AND RETINOL-BINDING PROTEIN RECOGNITION
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FAMILIAL AMYLOID POLYNEUROPATHY; INDUCED CONFORMATIONAL-CHANGES;
   CRYSTAL-STRUCTURE; ZINC-BINDING; AGGREGATION; FIBRILS; PRESSURE;
   IDENTIFICATION; RESOLUTION; INSIGHTS
AB Human transthyretin (TTR) is a homotetrameric protein involved in several amyloidoses. Zn2+ enhances TTR aggregation in vitro, and is a component of ex vivo TTR amyloid fibrils. We report the first crystal structure of human TTR in complex with Zn2+ at pH 4.6-7.5. All four structures reveal three tetra-coordinated Zn2+-binding sites (ZBS 1-3) per monomer, plus a fourth site (ZBS 4) involving amino acid residues from a symmetry-related tetramer that is not visible in solution by NMR.Zn2+ binding perturbs loop E-alpha-helix-loop F, the region involved in holo-retinol-binding protein (holo-RBP) recognition, mainly at acidic pH; TTR affinity for holo-RBP decreases similar to 5-fold in the presence of Zn2+. Interestingly, this same region is disrupted in the crystal structure of the amyloidogenic intermediate of TTR formed at acidic pH in the absence of Zn2+. HNCO and HNCA experiments performed in solution at pH 7.5 revealed that upon Zn2+ binding, although the alpha-helix persists, there are perturbations in the resonances of the residues that flank this region, suggesting an increase in structural flexibility. While stability of the monomer of TTR decreases in the presence of Zn2+, which is consistent with the tertiary structural perturbation provoked by Zn2+ binding, tetramer stability is only marginally affected by Zn2+. These data highlight structural and functional roles of Zn2+ in TTR-related amyloidoses, as well as in holo-RBP recognition and vitamin A homeostasis.
C1 [Palmieri, Leonardo de C.; Freire, Juliana B. B.; Almeida, Fabio C. L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Fac Farm, Dept Med, BR-21941590 Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol Jiri Jo, Dept Med, BR-21941590 Rio De Janeiro, Brazil.
   [Bleicher, Lucas; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil.
RP Lima, LMTR (corresponding author), Fac Farm UFRJ, Av Carlos Chagas Filho 373,CCS,Bss34, BR-21941902 Rio De Janeiro, Brazil.
EM mauricio@pharma.ufrj.br; foguel@bioqmed.ufrj.br
RI Bleicher, Lucas/R-5153-2019; Polikarpov, Igor/D-2575-2012; Palmieri,
   Leonardo C/A-9341-2013; Bleicher, Lucas/B-7967-2013; Almeida,
   Fabio/O-4989-2018
OI Bleicher, Lucas/0000-0001-7121-4952; Almeida, Fabio/0000-0001-6046-7006;
   Polikarpov, Igor/0000-0001-9496-4174; Foguel, Debora/0000-0001-7312-7115
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CNPq (INCT-Bioimagem e Biologia Estrutural),
   CAPES Nanobiotec-Brasil 04-2008, and FAPERJ (to D. F. and L. M. T. R.
   L.).; Supported by a fellowship from CNPq, CAPES PNPD-2009, and FAPERJ.
CR Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1
   Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817
   Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821
   BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5
   BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015
   COUTSELINIS A, 1977, CLIN CHEM, V23, P915
   Davis DP, 2001, J MOL BIOL, V313, P1021, DOI 10.1006/jmbi.2001.5092
   Deng NJ, 2006, BIOPHYS J, V90, P3865, DOI 10.1529/biophysj.105.064444
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9
   Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200
   Ghosh M, 2004, BIOCHEM J, V378, P317, DOI 10.1042/BJ20031706
   Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818
   Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870
   HERBERT J, 1993, NEUROLOGY, V43, pA175
   Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078
   Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052
   Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d
   Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088
   Keller R. L. J., 2004, THESIS ETH ZURICH ZU
   Kingsbury JS, 2007, ANAL CHEM, V79, P1990, DOI 10.1021/ac061546s
   Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956
   LAI Z, 1996, J W BIOCH, V35, P6470
   Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c
   Leslie A.G.W., 1992, JOINT CCP4 ESF EAMCB, V26
   Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x
   Liu K, 2000, NAT STRUCT BIOL, V7, P754
   Liu K, 2000, J MOL BIOL, V303, P555, DOI 10.1006/jmbi.2000.4164
   Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295
   MARTONE RL, 1993, AMYLOID AMYLOIDOSIS, P517
   Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0
   OKUNEWICK JP, 1963, NATURE, V198, P966, DOI 10.1038/198966a0
   Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029
   Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223
   Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076
   Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626
   RICCIO P, 1995, NEUROCHEM RES, V20, P1107, DOI 10.1007/BF00995566
   Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g
   Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   SCOTT BJ, 1983, CLIN CHEM, V29, P629
   Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715
   Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002
   Susuki S, 2008, AMYLOID, V15, P108, DOI 10.1080/13506120802006013
   Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   White JT, 2001, P NATL ACAD SCI USA, V98, P13019, DOI 10.1073/pnas.241406698
   Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   Yang MF, 2005, BIOPHYS J, V89, P433, DOI 10.1529/biophysj.105.059642
   Zanotti G, 2008, FEBS J, V275, P5841, DOI 10.1111/j.1742-4658.2008.06705.x
   ZHANG Q, 2003, J W BIOCH, V42, P8756
NR 58
TC 30
Z9 30
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 8
PY 2010
VL 285
IS 41
BP 31731
EP 31741
DI 10.1074/jbc.M110.157206
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 661WX
UT WOS:000282764600065
PM 20659897
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Razzera, G
   Gadermaier, G
   de Paula, V
   Almeida, MS
   Egger, M
   Jahn-Schmid, B
   Almeida, FCL
   Ferreira, F
   Valente, AP
AF Razzera, Guilherme
   Gadermaier, Gabriele
   de Paula, Viviane
   Almeida, Marcius S.
   Egger, Matthias
   Jahn-Schmid, Beatrice
   Almeida, Fabio C. L.
   Ferreira, Fatima
   Valente, Ana Paula
TI Mapping the Interactions between a Major Pollen Allergen and Human IgE
   Antibodies
SO STRUCTURE
LA English
DT Article
ID MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION;
   SITE-DIRECTED MUTAGENESIS; TORSION ANGLE DYNAMICS; X-RAY
   CRYSTALLOGRAPHY; MODEL-FREE APPROACH; CROSS-REACTIVITY; BIRCH POLLEN;
   CRYSTAL-STRUCTURE; AMINO-ACID
AB The interaction of specific IgE antibodies with allergens is a key event in the induction of allergic symptoms, thus representing an important target for therapeutic interventions in Type I allergies. We report here the solution NMR structure of Art v 1, the major mugwort pollen allergen. Art v 1 is the first protein structure with an allergenic defensin fold linked to a polyproline domain, which has not been identified in any reported allergen structure in the PDB. Moreover, the direct interaction of polyclonal IgE antibodies from an allergic patient has been mapped on the surface of an allergen for the first time. The data presented herein provide the basis for the design of tools for safe and effective vaccination against mugwort pollen allergy.
C1 [Razzera, Guilherme; de Paula, Viviane; Almeida, Marcius S.; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
   [Gadermaier, Gabriele; Egger, Matthias; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
   [Jahn-Schmid, Beatrice] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Ferreira, Fatima/E-4889-2011; Valente, Ana
   Paula/J-3010-2017; Ferreira, Fatima/AAB-4321-2019; Gadermaier,
   Gabriele/L-5997-2015; Razzera, Guilherme/M-5372-2014; De Paula,
   Viviane/L-1947-2013
OI Almeida, Fabio/0000-0001-6046-7006; Ferreira,
   Fatima/0000-0003-0989-2335; Valente, Ana Paula/0000-0001-7219-1123;
   Ferreira, Fatima/0000-0003-0989-2335; Gadermaier,
   Gabriele/0000-0002-4886-417X; almeida, marcius/0000-0003-4921-8185;
   Razzera, Guilherme/0000-0002-1448-3037; Egger,
   Matthias/0000-0001-7462-5132; De Paula, Viviane/0000-0003-3171-6477
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); ICGEB-Trieste; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro Carlos Chagas Filho (FAPERJ-Pensa Rio); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; National
   Institute of Structural Biology and Bioimaging (INBEB)
FX This work was supported by the Christian Doppler Research Association
   and Biomay, Vienna, Austria, Grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), ICGEB-Trieste, Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho
   (FAPERJ-Pensa Rio), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and National Institute of Structural Biology and
   Bioimaging (INBEB).
CR Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x
   Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114
   Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x
   Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852
   Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Egger Matthias, 2009, Front Biosci (Elite Ed), V1, P77
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Ferreira F, 1998, FASEB J, V12, P231
   Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P544, DOI 10.1016/j.jaci.2007.05.025
   Gadermaier G, 2010, MOL IMMUNOL, V47, P1292, DOI 10.1016/j.molimm.2009.11.029
   Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706
   Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273
   Gruber P, 2009, BIOL CHEM, V390, P445, DOI 10.1515/BC.2009.063
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432
   Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731
   Keller R, 2004, COMPUTER AIDED RESON
   Kettner J, 2007, ALLERGY, V62, P33
   Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200
   Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118
   Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200
   Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Moreau V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-71
   Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022
   Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012
   Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026
   Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036
   Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018
   Parronchi P, 2000, INT ARCH ALLERGY IMM, V121, P2, DOI 10.1159/000024291
   Razzera G, 2009, BIOMOL NMR ASSIGN, V3, P103, DOI 10.1007/s12104-009-9151-y
   SATTLER M, 1995, PROG NUCL MAGN RESON, V34, P93
   Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007
   Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149
   Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x
   Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084
   Stadler MB, 2003, FASEB J, V17, P1141, DOI 10.1096/fj.02-1052fje
   Thomas K, 2009, FOOD CHEM TOXICOL, V47, P1041, DOI 10.1016/j.fct.2009.02.001
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Wallner M, 2007, J ALLERGY CLIN IMMUN, V120, P374, DOI 10.1016/j.jaci.2007.05.021
NR 49
TC 37
Z9 38
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD AUG 11
PY 2010
VL 18
IS 8
BP 1011
EP 1021
DI 10.1016/j.str.2010.05.012
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 639DG
UT WOS:000280950400015
PM 20696401
DA 2020-12-01
ER

PT J
AU Giordano, RJ
   Cardo-Vila, M
   Salameh, A
   Anobom, CD
   Zeitlin, BD
   Hawked, DH
   Valente, AP
   Almeida, FCL
   Nor, JE
   Sidman, RL
   Pasqualini, R
   Arap, W
AF Giordano, Ricardo J.
   Cardo-Vila, Marina
   Salameh, Ahmad
   Anobom, Cristiane D.
   Zeitlin, Benjamin D.
   Hawked, David H.
   Valente, Ana P.
   Almeida, Fabio C. L.
   Noer, Jacques E.
   Sidman, Richard L.
   Pasqualini, Renata
   Arap, Wadih
TI From combinatorial peptide selection to drug prototype (I): Targeting
   the vascular endothelial growth factor receptor pathway
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE peptide; cancer; VEGFR; angiogenesis; retinopathy of prematurity
ID TUMOR ANGIOGENESIS; MACULAR DEGENERATION; ANTI-VEGF; THERAPY; MICE;
   NEUROPILIN-1; PLGF; SUPPRESSION; DISCOVERY; MEDICINE
AB Inhibition of blood vessel formation is a viable therapeutic approach in angiogenesis-dependent diseases. We previously used a combinatorial screening on vascular endothelial growth factor (VEGF)activated endothelial cells to select the sequence CPQPRPLC and showed that the motif Arg-Pro-Leu targets VEGF receptor-1 and neuropilin-1. Here, we evaluated and validated (D)(LPR), a derivative molecule with strong antiangiogenesis attributes. This prototype drug markedly inhibits neovascularization in three mouse models: Matrigel-based assay, functional human/murine blood vessel formation, and retinopathy of prematurity. In addition to its systemic activity, (D)(LPR) also inhibits retinal angiogenesis when administered in an eye-drop formulation. Finally, in preliminary studies, we have showed targeted drug activity in an experimental tumor-bearing mouse model. These results show that drugs targeting extracellular domains of VEGF receptors are active, affect signal transduction, and have potential for clinical application. On a larger context, this study illustrates the power of ligand-directed selection plus retro-inversion for rapid drug discovery and development.
C1 [Sidman, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Sidman, Richard L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   [Giordano, Ricardo J.; Cardo-Vila, Marina; Salameh, Ahmad; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA.
   [Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Natl Nucl Magnet Resonance Ctr, BR-21941 Rio De Janeiro, Brazil.
   [Zeitlin, Benjamin D.; Noer, Jacques E.] Univ Michigan, Sch Dent, Angiogenesis Res Lab, Ann Arbor, MI 48109 USA.
   [Hawked, David H.] Univ Texas MD Anderson Canc Ctr, Ctr Targeted Therapy, Houston, TX 77030 USA.
RP Sidman, RL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.
EM richard_sidman@hms.harvard.edu; rpasqual@mdanderson.org;
   warap@mdanderson.org
RI Valente, Ana Paula/J-3010-2017; Zeitlin, Benjamin/B-9628-2008; Almeida,
   Fabio/O-4989-2018; Giordano, Ricardo/A-2074-2010; Bom, Cristiane Dinis
   Ano/X-9461-2019
OI Valente, Ana Paula/0000-0001-7219-1123; Zeitlin,
   Benjamin/0000-0003-0110-0188; Almeida, Fabio/0000-0001-6046-7006;
   Giordano, Ricardo/0000-0001-8116-6771; 
FU Department of Defense (DOD)United States Department of Defense; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Gillson-Longenbaugh
   Foundation; Marcus Foundation; AngelWorks; Susan G. Komen Breast Cancer
   FoundationSusan G. Komen Breast Cancer Foundation
FX We thank Bih-Fang Pan for technical assistance and E. Helene Sage for
   critical reading of the manuscript. This work was supported by grants
   from the Department of Defense (DOD) and National Institutes of Health
   (J.E.N., R.L.S., R.P., and W.A.) and by awards from the
   Gillson-Longenbaugh Foundation, the Marcus Foundation, and AngelWorks
   (W.A. and R.P.); M. C.-V. received a postdoctoral fellowship award from
   the Susan G. Komen Breast Cancer Foundation.
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Arden GB, 2005, BRIT J OPHTHALMOL, V89, P764, DOI 10.1136/bjo.2004.062547
   Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219
   Chorev M, 2005, BIOPOLYMERS, V80, P67, DOI 10.1002/bip.20219
   Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8
   Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531
   Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104
   Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287
   Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403
   Falciani C, 2005, CHEM BIOL, V12, P417, DOI 10.1016/j.chembiol.2005.02.009
   Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038
   Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524
   Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115
   Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104
   Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008
   Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249
   Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760
   Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042
   Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314
   Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691
   Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186
   Lahdenranta J, 2001, P NATL ACAD SCI USA, V98, P10368, DOI 10.1073/pnas.181329198
   Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545
   Loges S, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2008.03203.x
   Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731
   Luttun A, 2004, BBA-REV CANCER, V1654, P79, DOI 10.1016/j.bbcan.2003.09.002
   MEISTER A, 1965, BIOCH AMINO ACIDS, V1, P1
   Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253
   Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018
   PASSANITI A, 1992, LAB INVEST, V67, P519
   PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]
   Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101
   Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005
   Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106
   von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200
   Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831
   Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106
NR 46
TC 46
Z9 49
U1 0
U2 17
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 16
PY 2010
VL 107
IS 11
BP 5112
EP 5117
DI 10.1073/pnas.0915141107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 570YI
UT WOS:000275714300057
PM 20190181
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU de Medeiros, LN
   Angeli, R
   Sarzedas, CG
   Barreto-Bergter, E
   Valente, AP
   Kurtenbach, E
   Almeida, FCL
AF de Medeiros, Luciano Neves
   Angeli, Renata
   Sarzedas, Carolina G.
   Barreto-Bergter, Eliana
   Valente, Ana Paula
   Kurtenbach, Eleonora
   Almeida, Fabio C. L.
TI Backbone dynamics of the antifungal Psd1 pea defensin and its
   correlation with membrane interaction by NMR spectroscopy
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Plant defensin; Membrane; Membrane protein; NMR; Dynamic; Lipari-Szabo;
   Antimicrobial; Fungus; Protein recognition; Membrane recognition;
   Transient interaction; Psd1; Antifungal
ID NUCLEAR-MAGNETIC-RESONANCE; PISUM-SATIVUM DEFENSIN-1; CONFORMATIONAL
   DIVERSITY; ANTIMICROBIAL PEPTIDES; PICHIA-PASTORIS; PLANT DEFENSIN;
   RELAXATION; PROTEINS; BINDING; DESIGN
AB Plant defensins are cysteine-rich cationic peptides, components of the innate immune system. The antifungal sensitivity of certain exemplars was correlated to the level of complex glycosphingolipids in the membrane of fungi strains. Psd1 is a 46 amino acid residue defensin isolated from pea seeds which exhibit antifungal activity. Its structure is characterized by the so-called cysteine-stabilized alpha/beta motif linked by three loops as determined by two-dimensional NMR. In the present work we explored the measurement of heteronuclear Nuclear Overhauser Effects, R1 and R2 N-15 relaxation ratios, and chemical shift to probe the backbone dynamics of Psd1 and its interaction with membrane mimetic systems with phosphatidylcholine (PC) or cloclecylphosphocholine (DPC) with glucosylceramide (CMH) isolated from Fusarium solani. The calculated R2 values predicted a slow motion around the highly conserved among Gly12 residue and also in the region of the Turn3 His36-Trp38. The results showed that Psd1 interacts with vesicles of PC or PC:CMH in slightly different forms. The interaction was monitored by chemical shift perturbation and relaxation properties. Using this approach we could map the loops as the binding site of Psd1 with the membrane. The major binding epitope showed conformation exchange properties in the mu s-ms timescale supporting the conformation selection as the binding mechanism. Moreover, the peptide corresponding to part of Loop1 (pepLoop1: Gly12 to Ser19) is also able to interact with DPC micelles acquiring a stable structure and in the presence of DPC:CMH the peptide changes to an extended conformation, exhibiting NOE mainly with the carbohydrate and ceramide parts of CMH. (c) 2009 Elsevier B.V. All rights reserved.
C1 [de Medeiros, Luciano Neves; Angeli, Renata; Sarzedas, Carolina G.; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil.
   [de Medeiros, Luciano Neves; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Programa Biol Mol & Estrutural, Ist Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol, Ctr Ciencias Saude, BR-21941900 Rio De Janeiro, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br; falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Medeiros,
   Luciano/E-5572-2012; Kurtenbach, Eleonora/L-4148-2016; Bergter, Eliana
   Barreto/E-2664-2013
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Medeiros, Luciano/0000-0001-7423-5177;
   Kurtenbach, Eleonora/0000-0002-2141-518X; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); ICGEB-Triestes; Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro Carlos Chagas Filho (FAPERJPensa Rio); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; National
   Institute of Structural Biology and Bioimaging (INBEB)
FX Thanks are due to Dr. Pedro L. Oliveira (UFRJ, Brazil) for the use of
   their laboratory facilities and for useful discussions. We also thank R.
   M. Domingues and Fabricio Cruz for technical assistance. This work was
   supported by grants from Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), ICGEB-Triestes, Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJPensa Rio),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   National Institute of Structural Biology and Bioimaging (INBEB).
CR Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0
   Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8
   BUYONG M, 2003, P NATL ACAD SCI USA, V13, P5772
   Cabral KMS, 2003, PROTEIN EXPRES PURIF, V31, P115, DOI 10.1016/S1046-5928(03)00136-0
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   da Silva A, 2002, MOL BIOCHEM PARASIT, V120, P53, DOI 10.1016/S0166-6851(01)00439-X
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   De-Paula VS, 2008, PLANT MOL BIOL, V68, P321, DOI 10.1007/s11103-008-9372-y
   Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007
   Duarte RS, 1998, BBA-LIPID LIPID MET, V1390, P186, DOI 10.1016/S0005-2760(97)00179-3
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Janisiewicz WJ, 2008, POSTHARVEST BIOL TEC, V47, P218, DOI 10.1016/j.postharvbio.2007.06.010
   Jelinek R, 2005, CURR PROTEIN PEPT SC, V6, P103, DOI 10.2174/1389203053027511
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j
   Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1
   Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129
   Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Powers JPS, 2005, BIOCHEMISTRY-US, V44, P15504, DOI 10.1021/bi051302m
   Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423
   Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x
   Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011
   Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43
   Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573
   Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Tinoco LW, 2007, J BIOMOL NMR, V39, P315, DOI 10.1007/s10858-007-9202-6
   Tinoco LW, 2002, J BIOL CHEM, V277, P36351, DOI 10.1074/jbc.M204225200
   Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vila-Perello M, 2006, J MED CHEM, V49, P448, DOI 10.1021/jm050882i
   Vila-Perello M, 2005, J BIOL CHEM, V280, P1661, DOI 10.1074/jbc.M410577200
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100
NR 47
TC 64
Z9 64
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 1879-2642
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD FEB
PY 2010
VL 1798
IS 2
SI SI
BP 105
EP 113
DI 10.1016/j.bbamem.2009.07.013
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 559WP
UT WOS:000274859300007
PM 19632194
DA 2020-12-01
ER

PT J
AU Melo, MN
   Sousa, FJR
   Carneiro, FA
   Castanho, MARB
   Valente, AP
   Almeida, FCL
   Da Poian, AT
   Mohana-Borges, R
AF Melo, Manuel Nuno
   Sousa, Francisco J. R.
   Carneiro, Fabiana A.
   Castanho, Miguel A. R. B.
   Valente, Ana Paula
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Mohana-Borges, Ronaldo
TI Interaction of the Dengue Virus Fusion Peptide with Membranes Assessed
   by NMR: The Essential Role of the Envelope Protein Trp101 for Membrane
   Fusion
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE dengue virus; fusion peptide; membrane fusion; NMR; transfer NOE
ID IMMUNODEFICIENCY-VIRUS; RICH REGION; WEST-NILE; GLYCOPROTEIN;
   TRYPTOPHAN; BINDING; ENTRY; IMMUNOPATHOGENESIS; FLAVIVIRUSES;
   ENCEPHALITIS
AB Dengue virus (DV) infection depends on a step of membrane fusion, which occurs in the acidic environment of the endosome. This process is mediated by virus surface envelope glycoprotein, in which the loop between residues D98-G112 is considered to be crucial, acting as a fusion peptide. Here, we have characterized functionally and structurally the interaction between the DV fusion peptide and different model membranes by fluorescence and NMR. Its interaction was strongest in dodecylphosphocholine (DPC) micelles. and anionic phosphatidylcholine/phosphatidylglycerol vesicles, the only vesicle that was fused by DV fusion peptide. The three-dimensional structure of DV fusion peptide bound to DPC micelles was solved by solution homonuclear NMR with an r.m.s.d. of 0.98 angstrom. The most striking result obtained from the solution structure was the hydrophobic triad formed by residues W101, L107, and F108, pointing toward the same direction, keeping the segment between G102 and G106 in a loop conformation. The interaction of DV fusion peptide with phosphatidylcholine/phosphatidylglycerol vesicles was also mapped by transfer-nuclear Overhauser enhancement (NOE) experiments, in which the majority of the NOE cross-peaks were from the hydrophobic triad, corroborating the DPC-bound structure. Substitution of the residue W101 by an alanine residue completely abolished membrane binding and, thus, fusion by the peptide and its NOE cross-peaks. In conclusion, the 15-residue DV fusion peptide has intrinsic ability to promote membrane fusion, most likely due to the hydrophobic interaction among the residues W101, L107, and F108, which maintains its loop in the correct spatial conformation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Melo, Manuel Nuno; Sousa, Francisco J. R.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Lab Genom Estrut, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
   [Melo, Manuel Nuno; Carneiro, Fabiana A.; Valente, Ana Paula; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [Melo, Manuel Nuno; Castanho, Miguel A. R. B.] Univ Lisbon, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal.
   [Valente, Ana Paula; Almeida, Fabio C. L.; Mohana-Borges, Ronaldo] Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Lab Genom Estrut, Inst Biofis Carlos Chagas Filho, Edificio Ctr Ciencias Saude,Bloco C Sala 36 Sub S, BR-21941902 Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; CARNEIRO, FABIANA A/S-4525-2018;
   Borges, Ronaldo S Mohana/C-5575-2013; Almeida, Fabio/O-4989-2018;
   Valente, Ana Paula/J-3010-2017
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123; FCCN, Bogus/0000-0001-6282-8004; Castanho,
   Miguel/0000-0001-7891-7562; Melo, Manuel Nuno/0000-0001-6567-0513; Da
   Poian, Andrea/0000-0002-3969-704X; Carneiro,
   Fabiana/0000-0002-6584-4875; FCCN, Bogus/0000-0003-1034-3552; Mohana
   Borges, Ronaldo/0000-0002-1796-475X
FU WHO/TDRWorld Health Organization; CNPqNational Council for Scientific
   and Technological Development (CNPq); FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); IMBEBB;
   PRONEX-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FINEP (GENOPROT Dengue)Ciencia
   Tecnologia e Inovacao (FINEP); National Institutes of Science and
   Technology in Dengue (INCTD-engue) and in Structural Biology and
   Bioimaging (INCT-INBEB); FCT (Portugal)Portuguese Foundation for Science
   and Technology; CAPES/GRICES (Brazil, Portugal)CAPES; FCTPortuguese
   Foundation for Science and Technology [PTDC/QUI/69937/2006]; CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX We thank Drs. Ana Carolina Zeri and Mauricio Sfor a of the National
   Laboratory of Synchrotron Light (LNLS) for help with the acquisitions on
   the Varian spectrometer. We also thank Dr. Jerson Lima Silva of the
   Medical Biochemistry Institute (Universidade Federal do Rio de Janeiro)
   and Dr. Roberto De Guzman of the University of Kansas for helpful
   insights in this project, and Dr. Martha Sorenson (Medical Biochemistry
   Institute, Universidade Federal do Rio de Janeiro) for proofreading the
   manuscript. This work was supported by the following funding agencies:
   WHO/TDR, CNPq, FAPERJ, TWAS, IMBEBB, PRONEX-FAPERJ, and FINEP (GENOPROT
   Dengue), the National Institutes of Science and Technology in Dengue
   (INCTD-engue) and in Structural Biology and Bioimaging (INCT-INBEB). The
   authors acknowledge a grant from FCT (Portugal) to M.N.M. and funding
   from CAPES/GRICES (Brazil, Portugal) and FCT project
   PTDC/QUI/69937/2006. F.J.R.S. holds a Ph.D. fellowship from CNPq
   (Brazil).
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   DAPOIAN AT, 2009, STRUCTURE FUNCTION M, pCH19
   de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Giannecchini S, 2004, VIROLOGY, V320, P156, DOI 10.1016/j.virol.2003.12.001
   Guillen J, 2008, BIOCHEMISTRY-US, V47, P8214, DOI 10.1021/bi800814q
   Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293
   Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414
   Lu YN, 2008, BIOCHEM BIOPH RES CO, V371, P356, DOI 10.1016/j.bbrc.2008.04.044
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Michael NL, 1999, NAT MED, V5, P740, DOI 10.1038/10462
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nemec KN, 2006, BIOCHEMISTRY-US, V45, P12448, DOI 10.1021/bi061440r
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Santos NC, 2003, BBA-BIOMEMBRANES, V1612, P123, DOI 10.1016/S0005-2736(03)00112-3
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091
   STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023
   Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
NR 45
TC 34
Z9 34
U1 0
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 25
PY 2009
VL 392
IS 3
BP 736
EP 746
DI 10.1016/j.jmb.2009.07.035
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 500QE
UT WOS:000270317700015
PM 19619560
OA Green Published
DA 2020-12-01
ER

PT J
AU Razzera, G
   Gadermaier, G
   Almeida, MS
   Ferreira, F
   Almeida, FCL
   Valente, AP
AF Razzera, Guilherme
   Gadermaier, Gabriele
   Almeida, Marcius S.
   Ferreira, Fatima
   Almeida, Fabio C. L.
   Valente, Ana Paula
TI Sequence-specific H-1, N-15 and C-13 resonance assignments of Art v 1: a
   proline-rich allergen of Artemisia vulgaris pollen
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE Art v 1; NMR assignments; Proline-rich allergen; Defensin-like
ID MUGWORT POLLEN
AB Art v 1 is the major allergen of Artemisia vulgaris. The IgE raised against Art v 1 not only can cross-react with other proteins from the Asteraceae family members but also with components of various forms of food. Art v 1 is an important target for immunotherapy strategies, including vaccination with hypoallergenic derivatives or chimeras. We report the H-1, C-13, and N-15 resonance assignments of the recombinant Art v 1 and identification of secondary structures based on C-13 chemical shifts.
C1 [Razzera, Guilherme; Almeida, Marcius S.; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, Inst Bioquim Med, Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Ferreira, Fatima/E-4889-2011; Ferreira,
   Fatima/AAB-4321-2019; Almeida, Fabio/O-4989-2018; Gadermaier,
   Gabriele/L-5997-2015; Razzera, Guilherme/M-5372-2014
OI Valente, Ana Paula/0000-0001-7219-1123; Ferreira,
   Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335;
   Almeida, Fabio/0000-0001-6046-7006; Gadermaier,
   Gabriele/0000-0002-4886-417X; Razzera, Guilherme/0000-0002-1448-3037;
   almeida, marcius/0000-0003-4921-8185
CR Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016
   Bauer L, 1996, CLIN EXP ALLERGY, V26, P1161, DOI 10.1111/j.1365-2222.1996.tb00503.x
   Dedic A, 2009, MOL IMMUNOL, V46, P416, DOI 10.1016/j.molimm.2008.10.012
   Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje
   Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528
   Keller R, 2004, COMPUTER AIDED RESON
   Schmid-Grendelmeier P, 2003, J ALLERGY CLIN IMMUN, V111, P1328, DOI 10.1067/mai.2003.1495
   Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003
   Wallner M, 2007, J ALLERGY CLIN IMMUN, V120, P374, DOI 10.1016/j.jaci.2007.05.021
   Wild C, 2007, ALLERGY, V62, P33, DOI 10.1111/j.1398-9995.2006.01245.x
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
NR 12
TC 5
Z9 5
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
EI 1874-270X
J9 BIOMOL NMR ASSIGN
JI Biomol. NMR Assign.
PD JUN
PY 2009
VL 3
IS 1
BP 103
EP 106
DI 10.1007/s12104-009-9151-y
PG 4
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA 444UW
UT WOS:000266006900025
PM 19636957
DA 2020-12-01
ER

PT J
AU Verly, RM
   de Moraes, CM
   Resende, JM
   Aisenbrey, C
   Bernquerer, MP
   Pilo-Veloso, D
   Valente, AP
   Almeida, FCL
   Bechinger, B
AF Verly, Rodrigo M.
   de Moraes, Cleria Mendonca
   Resende, Jarbas M.
   Aisenbrey, Christopher
   Bernquerer, Marcelo Porto
   Pilo-Veloso, Dorila
   Valente, Ana Paula
   Almeida, Fabio C. L.
   Bechinger, Burkhard
TI Structure and Membrane Interactions of the Antibiotic Peptide
   Dermadistinctin K by Multidimensional Solution and Oriented N-15 and
   P-31 Solid-State NMR Spectroscopy
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID NUCLEAR-MAGNETIC-RESONANCE; CIRCULAR-DICHROISM SPECTRA; ANTIMICROBIAL
   PEPTIDES; LIPID-BILAYERS; PHYLLOMEDUSA-DISTINCTA; PHOSPHOLIPID-BILAYERS;
   BIOLOGICAL-ACTIVITY; DEFENSE PEPTIDES; LYTIC PEPTIDES; MAGAININ 2
AB DD K, a peptide first isolated from the skin secretion of the Phyllomedusa distincta frog, has been prepared by solid-phase chemical peptide synthesis and its conformation was studied in trifluoroethanol/water as well as in the presence of sodium dodecyl sulfate and dodecylphosphocholine micelles or small unilamellar vesicles. Multidimensional solution NMR spectroscopy indicates an alpha-helical conformation in membrane environments starting at residue 7 and extending to the C-terminal carboxyamide. Furthermore, DD K has been labeled with N-15 at a single alanine position that is located within the helical core region of the sequence. When reconstituted into oriented phosphatidylcholine membranes the resulting N-15 solid-state NMR spectrum shows a well-defined helix alignment parallel to the membrane surface in excellent agreement with the amphipathic character of DD K. Proton-decoupled P-31 solid-state NMR spectroscopy indicates that the peptide creates a high level of disorder at the level of the phospholipid headgroup suggesting that DD K partitions into the bilayer where it severely disrupts membrane packing.
C1 [de Moraes, Cleria Mendonca; Resende, Jarbas M.; Aisenbrey, Christopher; Bechinger, Burkhard] Univ Strasbourg, CNRS, Inst Chim, UMR7177, Strasbourg, France.
   [Verly, Rodrigo M.; de Moraes, Cleria Mendonca; Resende, Jarbas M.; Pilo-Veloso, Dorila] Univ Fed Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil.
   [Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, CNRMN, Inst Bioquim Med, Programa Biol Estrutural, Rio De Janeiro, Brazil.
   [Bernquerer, Marcelo Porto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
RP Bechinger, B (corresponding author), Univ Strasbourg, CNRS, Inst Chim, UMR7177, Strasbourg, France.
EM bechinger@chimie.u-strasbg.fr
RI Valente, Ana Paula/J-3010-2017; Bemquerer, Marcelo Porto/A-9688-2013;
   Verly, Rodrigo/E-7493-2015; Almeida, Fabio/O-4989-2018; Resende, Jarbas
   M/R-4519-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Bemquerer, Marcelo
   Porto/0000-0002-9740-5818; Verly, Rodrigo/0000-0003-0356-6862; Almeida,
   Fabio/0000-0001-6046-7006; Resende, Jarbas/0000-0001-9827-7312
FU Fundacao da Amparo a Pesquisa do Estado de Minas GeraisFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Vaincre la
   Mucovicidose [TG0501]
FX This work was supported by Fundacao da Amparo a Pesquisa do Estado de
   Minas Gerais and by Vaincre la Mucovicidose (TG0501).
CR Aisenbrey C, 2006, J BIOL CHEM, V281, P7708, DOI 10.1074/jbc.M513151200
   Aisenbrey C, 2004, BIOCHEMISTRY-US, V43, P10502, DOI 10.1021/bi049409h
   Aisenbrey C, 2007, EUR BIOPHYS J BIOPHY, V36, P451, DOI 10.1007/s00249-006-0122-2
   Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2
   Apponyi MA, 2004, PEPTIDES, V25, P1035, DOI 10.1016/j.peptides.2004.03.006
   Balla MS, 2004, EUR BIOPHYS J BIOPHY, V33, P109, DOI 10.1007/s00249-003-0342-7
   BATENBURG AM, 1988, BIOCHEMISTRY-US, V27, P5678, DOI 10.1021/bi00415a043
   Batista CVF, 1999, PEPTIDES, V20, P679, DOI 10.1016/S0196-9781(99)00050-9
   Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614
   Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9
   Bechinger B, 2005, BBA-BIOMEMBRANES, V1712, P101, DOI 10.1016/j.bbamem.2005.03.003
   Bechinger B, 2004, BBA-BIOMEMBRANES, V1666, P190, DOI 10.1016/j.bbamem.2004.08.008
   Bechinger B, 2004, CRIT REV PLANT SCI, V23, P271, DOI 10.1080/07352680490452825
   BECHINGER B, 1991, J MAGN RESON, V95, P585, DOI 10.1016/0022-2364(91)90173-Q
   BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208
   Bechinger B, 2001, BIOCHEMISTRY-US, V40, P9428, DOI 10.1021/bi010162n
   Bechinger B, 2003, CONCEPT MAGN RESON A, V18A, P130
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x
   Brand GD, 2002, J BIOL CHEM, V277, P49332, DOI 10.1074/jbc.M209289200
   Brand GD, 2006, BIOCHEM BIOPH RES CO, V347, P739, DOI 10.1016/j.bbrc.2006.06.168
   Braun S., 1998, 150 MORE BASIC NMR E
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206
   Cady SD, 2007, J AM CHEM SOC, V129, P5719, DOI 10.1021/ja070305e
   CLARIGDE TDW, 1999, TETRAHEDRON ORGANIC
   Cross TA, 1997, METHOD ENZYMOL, V289, P672
   CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1
   Davis JH, 1999, PROG NUCL MAG RES SP, V35, P1, DOI 10.1016/S0079-6565(99)00009-6
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DEMPSEY CE, 1991, BIOCHIM BIOPHYS ACTA, V1061, P175, DOI 10.1016/0005-2736(91)90283-E
   DUCLOHIER H, 1989, BIOPHYS J, V56, P1017, DOI 10.1016/S0006-3495(89)82746-8
   DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P22
   Epand RF, 2006, PROTEIN PEPTIDE LETT, V13, P1, DOI 10.2174/092986606774502063
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K
   Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760
   Griffin RG, 1998, NAT STRUCT BIOL, V5, P508, DOI 10.1038/749
   Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9
   Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0
   Hallock KJ, 2002, BIOPHYS J, V82, P2499, DOI 10.1016/S0006-3495(02)75592-6
   Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856
   Harzer U, 2000, BIOCHEMISTRY-US, V39, P13106, DOI 10.1021/bi000770n
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   INOUE K, 1977, J BIOCHEM-TOKYO, V81, P1097, DOI 10.1093/oxfordjournals.jbchem.a131534
   JONES AJS, 1978, BIOCHEMISTRY-US, V17, P2301, DOI 10.1021/bi00605a007
   Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3
   KILLIAN JA, 1990, EMBO J, V9, P815, DOI 10.1002/j.1460-2075.1990.tb08178.x
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976
   Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026
   Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621
   Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y
   Mei H, 2006, ACCOUNTS CHEM RES, V39, P176, DOI 10.1021/ar040037e
   MOLL F, 1990, BIOPHYS J, V57, P351, DOI 10.1016/S0006-3495(90)82536-4
   MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x
   Ouellet M, 2007, BIOCHEMISTRY-US, V46, P6597, DOI 10.1021/bi0620151
   PINES A, 1973, J CHEM PHYS, V59, P569, DOI 10.1063/1.1680061
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Prongidi-Fix L, 2007, J AM CHEM SOC, V129, P8430, DOI 10.1021/ja072668k
   Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890
   RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7
   Resende JM, 2008, PEPTIDES, V29, P1633, DOI 10.1016/j.peptides.2008.06.022
   REYNAUD JA, 1993, BIOCHEMISTRY-US, V32, P4997, DOI 10.1021/bi00070a005
   ROUX M, 1994, BIOCHEMISTRY-US, V33, P307, DOI 10.1021/bi00167a040
   SANDERS CR, 1990, BIOPHYS J, V58, P447, DOI 10.1016/S0006-3495(90)82390-0
   SCHERER PG, 1989, BIOCHEMISTRY-US, V28, P7720, DOI 10.1021/bi00445a030
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Silva LP, 2008, COMP BIOCHEM PHYS A, V151, P329, DOI 10.1016/j.cbpa.2007.02.031
   SMITH R, 1994, J MOL BIOL, V241, P456, DOI 10.1006/jmbi.1994.1520
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404
   Verly RM, 2008, PEPTIDES, V29, P15, DOI 10.1016/j.peptides.2007.10.028
   Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115
   Watts A, 1999, NAT PROD REP, V16, P419, DOI 10.1039/a801189c
   Wi S, 2008, J PHYS CHEM B, V112, P11402, DOI 10.1021/jp801825k
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 86
TC 40
Z9 41
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAR 18
PY 2009
VL 96
IS 6
BP 2194
EP 2203
DI 10.1016/j.bpj.2008.11.063
PG 10
WC Biophysics
SC Biophysics
GA 450BT
UT WOS:000266376700016
PM 19289046
OA Green Published
DA 2020-12-01
ER

PT J
AU da Silva, APP
   El-Bacha, T
   Kyaw, N
   dos Santos, RS
   Da-Silva, WS
   Almeida, FCL
   Da Poian, AT
   Galina, A
AF Pereira da Silva, Ana Paula
   El-Bacha, Tatiana
   Kyaw, Nattascha
   dos Santos, Reinaldo Sousa
   da-Silva, Wagner Seixas
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Galina, Antonio
TI Inhibition of energy-producing pathways of HepG2 cells by
   3-bromopyruvate
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE 3-bromopyruvate; glycolysis; hepatocellular carcinoma; HepG2 cell;
   mitochondrion; oxygen consumption; tumour cell
ID LIVER MALIC ENZYME; HEXOKINASE-II; PERMEABILITY TRANSITION;
   CANCER-CELLS; MITOCHONDRIAL; BROMOPYRUVATE; DEHYDROGENASE; GLUCOKINASE;
   MECHANISM; APOPTOSIS
AB 3-BrPA (3-bromopyruvate) is an alkylating agent with anti-tumoral activity on hepatocellular carcinoma. This compound inhibits cellular ATP production owing to its action on glycolysis and oxidative phosphorylation; however, the specific metabolic steps and mechanisms of 3-BrPA action in human hepatocellular carcinomas, particularly its effects on mitochondrial energetics, are poorly understood. In the present study it was found that incubation of HepG2 cells with a low concentration of 3-BrPA for a short period (150 mu M for 30 min) significantly affected both glycolysis and mitochondrial respiratory functions. The activity of mitochondrial hexokinase was not inhibited by 150 mu M 3-BrPA, but this concentration caused more than 70% inhibition of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and 3-phosphoglycerate kinase activities. Additionally, 3-BrPA treatment significantly impaired lactate production by HepG2 cells, even when glucose was withdrawn from the incubation medium. Oxygen consumption of HepG2 cells supported by either pyruvate/malate or succinate was inhibited when cells were pre- incubated with 3-BrPA in glucose-free medium. Oil the other hand, when cells were pre-incubated in glucose-supplemented medium, oxygen consumption was affected only when succinate was used as the oxidizable substrate. Ail increase in oligomycin-independent respiration was observed in HepG2 cells treated with 3-BrPA only when incubated in glucose-supplemented medium, indicating that 3-BrPA induces mitochondrial proton leakage as well as blocking the electron transport system. The activity of succinate dehydrogenase was inhibited by 70% by 3-BrPA treatment. These results suggest that the combined action of 3-BrPA oil succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death.
C1 [Pereira da Silva, Ana Paula; Kyaw, Nattascha; dos Santos, Reinaldo Sousa; da-Silva, Wagner Seixas; Galina, Antonio] Univ Fed Rio de Janeiro, Lab Bioenerget & Fisiol Mitocondrial, Programa Bioquim & Biofis Celular, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.
   [Pereira da Silva, Ana Paula; El-Bacha, Tatiana; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Virus, BR-21941902 Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.
RP Galina, A (corresponding author), Univ Fed Rio de Janeiro, Lab Bioenerget & Fisiol Mitocondrial, Programa Bioquim & Biofis Celular, Inst Bioquim Med, Av Carlos Chagas Filho 373-CCS,Bl D,Ss13, BR-21941902 Rio De Janeiro, Brazil.
EM galina@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Santos, Reinaldo dos/C-1043-2013;
   Galina, Antonio/A-9292-2008; da Silva, Wagner/A-7835-2008
OI Santos, Reinaldo dos/0000-0002-3219-4730; da Silva,
   Wagner/0000-0002-0001-0386; Da Poian, Andrea/0000-0002-3969-704X;
   El-Bacha, Tatiana/0000-0003-0809-0218
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [480378/2004-5]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/111.911/2008]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [grant number 480378/2004-5] and the Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   [grant number E-26/111.911/2008].
CR Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556
   BAKER JP, 1969, EUR J BIOCHEM, V11, P154, DOI 10.1111/j.1432-1033.1969.tb00753.x
   CHANG GG, 1977, BIOCHEMISTRY-US, V16, P311, DOI 10.1021/bi00621a024
   Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852
   Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299
   Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042
   da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   FARRAR G, 1995, INT J BIOCHEM CELL B, V27, P1145, DOI 10.1016/1357-2725(95)00090-C
   Geschwind JFH, 2002, CANCER RES, V62, P3909
   Gracy R W, 1975, Methods Enzymol, V41, P392
   Graham JM, 1997, SUBCELLULAR FRACTION
   Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020
   HAMILTON SD, 1984, CLIN CHEM, V30, P226
   JONES AR, 1995, CONTRACEPTION, V52, P317, DOI 10.1016/0010-7824(95)00217-X
   Kim W, 2007, MOL CANCER THER, V6, P2554, DOI 10.1158/1535-7163.MCT-07-0115
   Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047
   Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X
   Korotchkina LG, 1999, ARCH BIOCHEM BIOPHYS, V369, P277, DOI 10.1006/abbi.1999.1364
   LENZEN S, 1990, PHARMACOL TOXICOL, V66, P157, DOI 10.1111/j.1600-0773.1990.tb00725.x
   LENZEN S, 1988, BRIT J PHARMACOL, V95, P851, DOI 10.1111/j.1476-5381.1988.tb11714.x
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maciel EN, 2004, J NEUROCHEM, V90, P1025, DOI 10.1111/j.1471-4159.2004.02565.x
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Merlo-Pich M, 2004, EXP GERONTOL, V39, P277, DOI 10.1016/j.exger.2003.11.014
   Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285
   Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x
   Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200
   Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5
   Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Sakurai K, 1998, MOL PHARMACOL, V54, P1024
   SANBORN BM, 1971, BIOCHIM BIOPHYS ACTA, V227, P219, DOI 10.1016/0005-2744(71)90055-6
   SAPICO V, 1970, J BIOL CHEM, V245, P3252
   SATTERLEE J, 1991, BIOCHIM BIOPHYS ACTA, V1079, P247, DOI 10.1016/0167-4838(91)90065-8
   Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4
   Tiedge M, 2000, ARCH BIOCHEM BIOPHYS, V375, P251, DOI 10.1006/abbi.1999.1666
   TIPPETT PS, 1983, ARCH BIOCHEM BIOPHYS, V222, P285, DOI 10.1016/0003-9861(83)90526-X
   Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7
   TUNNICLIFF G, 1978, INT J BIOCHEM, V9, P249, DOI 10.1016/0020-711X(78)90006-X
   VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5
   VEDIA LM, 1992, J BIOL CHEM, V267, P24929
   WARBURG O, 1956, SCIENCE, V124, P269
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Xu RH, 2005, CANCER RES, V65, P613
NR 47
TC 84
Z9 87
U1 2
U2 27
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD FEB 1
PY 2009
VL 417
BP 717
EP 726
DI 10.1042/BJ20080805
PN 3
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 405XO
UT WOS:000263257700009
PM 18945211
DA 2020-12-01
ER

PT J
AU Amoedo, ND
   Rodrigues, MF
   Costa, L
   Pezzuto, P
   Giannini, ALM
   da Costa, RFM
   Benchimol, M
   Porto, TEB
   Almeida, FCL
   Galina, A
   Rumjanek, FD
AF Amoedo, Nivea D.
   Rodrigues, Mariana F.
   Costa, Leandro
   Pezzuto, Paula
   Giannini, Ana L. M.
   da Costa, Rodrigo F. M.
   Benchimol, Marlene
   Porto, Tatiana El-Bacha
   Almeida, Fabio C. L.
   Galina Filho, Antonio
   Rumjanek, Franklin D.
TI Metabolic profile of lung cancer cell lines treated with histone
   deacetylase inhibitor sodium butyrate
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Meeting Abstract
C1 [Amoedo, Nivea D.; Rodrigues, Mariana F.; Costa, Leandro; Pezzuto, Paula; Giannini, Ana L. M.; da Costa, Rodrigo F. M.; Benchimol, Marlene; Porto, Tatiana El-Bacha; Almeida, Fabio C. L.; Galina Filho, Antonio; Rumjanek, Franklin D.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM franklin@bioqmed.ufrj.br
RI Galina, Antonio/A-9292-2008
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
J9 INT J MOL MED
JI Int. J. Mol. Med.
PY 2009
VL 24
MA 128
BP S11
EP S11
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 502YQ
UT WOS:000270497500029
DA 2020-12-01
ER

PT J
AU Angeli, R
   da Paz, NVN
   Maciel, JC
   Araujo, FFB
   Paiva, PMG
   Calazans, GMT
   Valente, AP
   Almeida, FCL
   Coelho, LCBB
   Carvalho, LB
   Silva, MDC
   Correia, MTD
AF Angeli, Renata
   da Paz, Nathalia V. N.
   Maciel, Jackeline C.
   Araujo, Flavia F. B.
   Paiva, Patricia M. G.
   Calazans, Glicia M. T.
   Valente, Ana Paula
   Almeida, Fabio C. L.
   Coelho, Luana C. B. B.
   Carvalho, Luiz B., Jr.
   Silva, Maria da Paz C.
   dos Santos Correia, Maria Tereza
TI Ferromagnetic Levan Composite: An Affinity Matrix to Purify Lectin
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
ID CRATYLIA-MOLLIS LECTIN; SOLID-PHASE; CHEMILUMINESCENT ASSAYS;
   PURIFICATION; DACRON; SEEDS; POLYSACCHARIDE; IMMOBILIZATION
AB A simple and inexpensive procedure used magnetite and levan to synthesize a composite recovered by a magnetic field. Lectins from Canavalia ensiformis (Con A) and Cratylia mollis (Cramoll 1 and Cramoll 1,4) did bind specifically to composite. The magnetic property of derivative favored washing out contaminating proteins and recovery of pure lectins with glucose elution. Cramoll 1 was purified by this affinity binding procedure in two steps instead of a previous three-step protocol with ammonium sulfate fractionation, affinity chromatography on Sephadex G-75, and ion exchange chromatography through a CM-cellulose column. Copyright (C) 2009 Renata Angeli et al.
C1 [Angeli, Renata; da Paz, Nathalia V. N.; Maciel, Jackeline C.; Araujo, Flavia F. B.; Paiva, Patricia M. G.; Coelho, Luana C. B. B.; Carvalho, Luiz B., Jr.; Silva, Maria da Paz C.; dos Santos Correia, Maria Tereza] Univ Fed Pernambuco, Dept Bioquim, Lab Glicoprot, BR-50670901 Recife, PE, Brazil.
   [Angeli, Renata; Valente, Ana Paula; Almeida, Fabio C. L.; Carvalho, Luiz B., Jr.; Silva, Maria da Paz C.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
   [Maciel, Jackeline C.] Univ Fed Pernambuco, LIKA, BR-50670901 Recife, PE, Brazil.
   [Calazans, Glicia M. T.] Univ Fed Pernambuco, Dept Antibiot, BR-50670901 Recife, PE, Brazil.
RP Correia, MTD (corresponding author), Univ Fed Pernambuco, Dept Bioquim, Lab Glicoprot, BR-50670901 Recife, PE, Brazil.
EM mtscorreia@gmail.com
RI Almeida, Fabio/O-4989-2018; Carvalho, Luiz/AAX-8990-2020; Calazans,
   Glicia Maria M.T. Torres/E-4155-2015; Paiva, Patricia Maria
   Guedes/S-4038-2019; Valente, Ana Paula/J-3010-2017
OI Almeida, Fabio/0000-0001-6046-7006; Paiva, Patricia Maria
   Guedes/0000-0003-3467-708X; Valente, Ana Paula/0000-0001-7219-1123;
   Varejao, Nathalia/0000-0002-6952-8896
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This paper was financially supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). The authors are deeply
   grateful to the technical assistance of Mrs. Maria Barbosa Reis da Silva
   and Mr. Joao Virginio da Silva.
CR Amaral IPG, 2006, PROCESS BIOCHEM, V41, P1213, DOI 10.1016/j.procbio.2005.11.023
   Andrade CAS, 2004, INT J PHARMACEUT, V278, P435, DOI 10.1016/j.ijpharm.2004.03.028
   Banerjee S, 2004, ARCH BIOCHEM BIOPHYS, V421, P125, DOI 10.1016/j.abb.2003.09.040
   Baszkin A, 2000, COLLOID SURFACE B, V17, P191, DOI 10.1016/S0927-7765(99)00104-6
   Beltrao EIC, 1998, APPL BIOCHEM BIOTECH, V74, P125, DOI 10.1007/BF02825961
   BLAKE JD, 1982, J BACTERIOL, V151, P1595, DOI 10.1128/JB.151.3.1595-1597.1982
   Coelho RAL, 2002, BIOTECHNOL LETT, V24, P1705, DOI 10.1023/A:1020675815637
   Correia MTS, 1995, APPL BIOCHEM BIOTECH, V55, P261, DOI 10.1007/BF02786865
   De-Simone SG, 2006, J CHROMATOGR B, V838, P135, DOI 10.1016/j.jchromb.2006.02.036
   Gemeiner P, 2009, BIOTECHNOL ADV, V27, P1, DOI 10.1016/j.biotechadv.2008.07.003
   Heeboll-Nielsen A, 2004, BIOTECHNOL BIOENG, V87, P311, DOI 10.1002/bit.20116
   Larsen K, 2006, CARBOHYD RES, V341, P1209, DOI 10.1016/j.carres.2006.04.045
   LEAO AMAC, 1991, APPL BIOCHEM BIOTECH, V31, P53
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maciel EVM, 2004, BIOLOGICALS, V32, P57, DOI 10.1016/j.biologicals.2003.12.001
   Mo HQ, 2001, EUR J BIOCHEM, V268, P2609, DOI 10.1046/j.1432-1327.2001.02148.x
   Nascimento CO, 2002, BIOTECHNOL LETT, V24, P905, DOI 10.1023/A:1015557802326
   PAIVA PMG, 1992, APPL BIOCHEM BIOTECH, V36, P113, DOI 10.1007/BF02929691
   Pinheiro SMB, 1999, BIOTECHNOL TECH, V13, P919, DOI 10.1023/A:1008963202258
   REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0
   Roy I, 2005, BIOCHEM ENG J, V23, P193, DOI 10.1016/j.bej.2005.01.015
   Safarik I., 2004, BIOMAGN RES TECHNOL, V2, P1, DOI DOI 10.1186/1477-044X-2-7
   Safarikova M, 2000, BIOTECHNOL LETT, V22, P941, DOI 10.1023/A:1005698616574
   Santos ACO, 2004, MICRON, V35, P613, DOI 10.1016/j.micron.2004.01.004
   Shih IL, 2005, J AGR FOOD CHEM, V53, P8211, DOI 10.1021/jf058084o
   Souza SR, 2003, BIORESOURCE TECHNOL, V88, P255, DOI 10.1016/S0960-8524(03)00011-7
   Souza SR, 2001, CARBOHYD POLYM, V46, P191, DOI 10.1016/S0144-8617(00)00299-X
   Tajima K, 1997, CARBOHYD RES, V305, P117, DOI 10.1016/S0008-6215(97)00264-4
   Vina I, 2001, J MOL CATAL B-ENZYM, V11, P551, DOI 10.1016/S1381-1177(00)00043-6
   Yamamoto K, 2005, ANAL BIOCHEM, V336, P28, DOI 10.1016/j.ab.2004.09.030
NR 30
TC 10
Z9 11
U1 0
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1110-7243
EI 1110-7251
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2009
AR 179106
DI 10.1155/2009/179106
PG 6
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 464ZP
UT WOS:000267550000001
PM 19547713
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU De-Paula, VS
   Razzera, G
   Medeiros, L
   Miyamoto, CA
   Almeida, MS
   Kurtenbach, E
   Almeida, FCL
   Valente, AP
AF De-Paula, V. S.
   Razzera, G.
   Medeiros, L.
   Miyamoto, C. A.
   Almeida, M. S.
   Kurtenbach, E.
   Almeida, F. C. L.
   Valente, A. P.
TI Evolutionary relationship between defensins in the Poaceae family
   strengthened by the characterization of new sugarcane defensins
SO PLANT MOLECULAR BIOLOGY
LA English
DT Article
DE Defensins; Sugarcane; Poaceae; Andropogoneae tribe; NMR; Phylogenetic
   studies
ID PISUM-SATIVUM DEFENSIN-1; ANTIMICROBIAL PEPTIDES; PLANT DEFENSINS;
   FUNCTIONAL ANNOTATION; RAPHANUS-SATIVUS; SORGHUM-BICOLOR;
   GAMMA-THIONINS; SEQUENCE; GENOME; MAIZE
AB Plant defensins are small (45-54 amino acids), highly basic, cysteine-rich peptides structurally related to defensins of other organisms, including insects and mammals. Small putative proteins (MW < 10 kDa) containing eight cysteines were screened based on the sugarcane expressed sequence tag (EST) database. We selected ORFs that exhibited 25-100% similarity in primary sequence with other defensins in the NCBI database and that contained eight cysteines. This similarity is sufficient for folding prediction, but not enough for biological activity inference. Six putative defensins (Sd1-6) were selected, and activity assays showed that recombinant Sd1, Sd3 and Sd5 are active against fungi, but not against bacteria. Structural characterization, based on circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy showed that the structures of these Sds were compatible with alpha/beta proteins, a feature expected for plant defensins. Phylogenetic analysis revealed that sugarcane defensins could clearly be grouped within defensins from Poaceae family and Andropogoneae tribe. Our work demonstrates that defensins show strong conservation in the Poaceae family and may indicate that the same conservation occurs in other families. We suggest that evolutionary relationships within plant families can be used as a procedure to predict and annotate new defensins in genomes and group them in evolutionary classes to help in the investigation of their biological function.
C1 [De-Paula, V. S.; Razzera, G.; Miyamoto, C. A.; Almeida, M. S.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, RJ, Brazil.
   [Medeiros, L.; Kurtenbach, E.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Biol Mol & Estrutural, BR-21941 Rio De Janeiro, RJ, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Av Brigadeiro Trompowski S-N,CCS Bloco E Sala 10, Rio De Janeiro, RJ, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Medeiros, Luciano/E-5572-2012; De Paula, Viviane/L-1947-2013;
   Kurtenbach, Eleonora/L-4148-2016; Almeida, Fabio/O-4989-2018; Valente,
   Ana Paula/J-3010-2017; Razzera, Guilherme/M-5372-2014
OI Medeiros, Luciano/0000-0001-7423-5177; De Paula,
   Viviane/0000-0003-3171-6477; Kurtenbach, Eleonora/0000-0002-2141-518X;
   Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123; almeida, marcius/0000-0003-4921-8185;
   Razzera, Guilherme/0000-0002-1448-3037
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); MCT; FINEPCiencia Tecnologia e Inovacao (FINEP); FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Instituto Milenio de Biologia Estrutural em Biomedicia
   e Biotecnologia
FX The authors want to thank Mariana Soares Puppin and Leticia Lery for
   assistance. This work was supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), MCT, FINEP, FAPERJ and
   Instituto Milenio de Biologia Estrutural em Biomedicia e Biotecnologia.
CR Aerts AM, 2006, FEBS LETT, V580, P1903, DOI 10.1016/j.febslet.2006.02.061
   Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753
   Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Almeida MS, 2001, ARCH BIOCHEM BIOPHYS, V395, P199, DOI 10.1006/abbi.2001.2564
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Balandin M, 2005, PLANT MOL BIOL, V58, P269, DOI 10.1007/s11103-005-3479-1
   BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z
   Bruce TJ, 2007, CURR OPIN PLANT BIOL, V10, P387, DOI 10.1016/j.pbi.2007.05.002
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Cabral KMS, 2003, PROTEIN EXPRES PURIF, V31, P115, DOI 10.1016/S1046-5928(03)00136-0
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dillon SL, 2001, PLANT SYST EVOL, V230, P97, DOI 10.1007/s006060170007
   DYGERT S, 1965, ANAL BIOCHEM, V13, P367, DOI 10.1016/0003-2697(65)90327-1
   Egorov TA, 2005, PEPTIDES, V26, P2064, DOI 10.1016/j.peptides.2005.03.007
   Gale M, 2001, NOVART FDN SYMP, V236, P46
   GALE M, 2001, NOVART FDN SYMP, V236, P53
   Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538
   Grabowski M, 2007, CURR OPIN STRUC BIOL, V17, P347, DOI 10.1016/j.sbi.2007.06.003
   Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x
   Jelinek R, 2005, CURR PROTEIN PEPT SC, V6, P103, DOI 10.2174/1389203053027511
   Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x
   Kushmerick C, 1998, FEBS LETT, V440, P302, DOI 10.1016/S0014-5793(98)01480-X
   Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8
   LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7
   Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j
   Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791
   NITTI G, 1995, EUR J BIOCHEM, V228, P250, DOI 10.1111/j.1432-1033.1995.tb20257.x
   Pan YB, 2000, GENETICA, V108, P285, DOI 10.1023/A:1004191625603
   Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011
   Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8
   Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Rondeau P, 2005, ANN BOT-LONDON, V96, P1307, DOI 10.1093/aob/mci282
   Schimoler-O'Rourke R, 2001, APPL ENVIRON MICROB, V67, P2365, DOI 10.1128/AEM.67.5.2365-2366.2001
   Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533
   Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x
   Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543
   Takahashi S, 2005, THEOR APPL GENET, V110, P1523, DOI 10.1007/s00122-005-1990-z
   TERRAS FRG, 1992, J BIOL CHEM, V267, P15301
   Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797
   Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691
   Veldkamp CT, 2007, PROTEIN EXPRES PURIF, V52, P202, DOI 10.1016/j.pep.2006.09.009
   Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103
   Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101
   Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038
NR 52
TC 18
Z9 20
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-4412
J9 PLANT MOL BIOL
JI Plant Mol.Biol.
PD NOV
PY 2008
VL 68
IS 4-5
BP 321
EP 335
DI 10.1007/s11103-008-9372-y
PG 15
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA 363DN
UT WOS:000260246200001
PM 18618271
DA 2020-12-01
ER

PT J
AU Cardo-Vila, M
   Zurita, AJ
   Giordano, RJ
   Sun, J
   Rangel, R
   Guzman-Rojas, L
   Anobom, CD
   Valente, AP
   Almeida, FCL
   Lahdenranta, J
   Kolonin, MG
   Arap, W
   Pasqualini, R
AF Cardo-Vila, Marina
   Zurita, Amado J.
   Giordano, Ricardo J.
   Sun, Jessica
   Rangel, Roberto
   Guzman-Rojas, Liliana
   Anobom, Cristiane D.
   Valente, Ana P.
   Almeida, Fabio C. L.
   Lahdenranta, Johanna
   Kolonin, Mikhail G.
   Arap, Wadih
   Pasqualini, Renata
TI A Ligand Peptide Motif Selected from a Cancer Patient Is a
   Receptor-Interacting Site within Human Interleukin-11
SO PLOS ONE
LA English
DT Article
AB Interleukin-11 (IL-11) is a pleiotropic cytokine approved by the FDA against chemotherapy-induced thrombocytopenia. From a combinatorial selection in a cancer patient, we isolated an IL-11-like peptide mapping to domain I of the IL-11 (sequence CGRRAGGSC). Although this motif has ligand attributes, it is not within the previously characterized interacting sites. Here we design and validate in-tandem binding assays, site-directed mutagenesis and NMR spectroscopy to show (i) the peptide mimics a receptor-binding site within IL-11, (ii) the binding of CGRRAGGSC to the IL-11R alpha is functionally relevant, (iii) Arg(4) and Ser(8) are the key residues mediating the interaction, and (iv) the IL-11-like motif induces cell proliferation through STAT3 activation. These structural and functional results uncover an as yet unrecognized receptor-binding site in human IL-11. Given that IL-11R alpha has been proposed as a target in human cancer, our results provide clues for the rational design of targeted drugs.
C1 [Cardo-Vila, Marina; Zurita, Amado J.; Giordano, Ricardo J.; Sun, Jessica; Rangel, Roberto; Guzman-Rojas, Liliana; Lahdenranta, Johanna; Kolonin, Mikhail G.; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
   [Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.] Fed Univ, Natl NMR Ctr, BR-21941 Rio De Janeiro, Brazil.
RP Cardo-Vila, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
EM warap@mdanderson.org; rpasqual@mdanderson.org
RI Bom, Cristiane Dinis Ano/X-9461-2019; Valente, Ana Paula/J-3010-2017;
   Giordano, Ricardo/A-2074-2010; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Giordano,
   Ricardo/0000-0001-8116-6771; Almeida, Fabio/0000-0001-6046-7006;
   Kolonin, Mikhail/0000-0002-3743-7869; Rangel,
   Roberto/0000-0002-9088-7957
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI); U.S. Department of DefenseUnited States Department of
   Defense; Prostate Cancer Foundation; Marcus Foundation;
   Gillson-Longenbaugh Foundation; Susan G. Komen Breast Cancer
   FoundationSusan G. Komen Breast Cancer Foundation; Instituto de Salud
   Carlos III (Spain)Instituto de Salud Carlos III; Odyssey Program of The
   University of Texas M. D. Anderson Cancer Center; National Research
   Council (Brazil)National Council for Scientific and Technological
   Development (CNPq); Rio de Janeiro State Research Support Foundation;
   NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388, P50CA140388, P50CA140388, P50CA140388, P50CA140388,
   P50CA140388] Funding Source: NIH RePORTER
FX This work was supported by grants from the Specialized Program in
   Research Excellence (SPORE) of the National Cancer Institute (to WA and
   RP), from the U.S. Department of Defense (to MGK, WA, and RP), and by
   awards from the Prostate Cancer Foundation, the Marcus Foundation and
   the Gillson-Longenbaugh Foundation (to WA and RP). MCV received a
   postdoctoral fellowship from the Susan G. Komen Breast Cancer
   Foundation. AJZ received a postdoctoral fellowship from the Instituto de
   Salud Carlos III (Spain); RR is a Scholar from the Odyssey Program of
   The University of Texas M. D. Anderson Cancer Center. CDA received a
   predoctoral fellowship from the National Research Council (Brazil). FCLA
   and APV received support from the Rio de Janeiro State Research Support
   Foundation and the National Research Council (Brazil). The funding
   agencies had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121
   Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070
   Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901
   Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399
   Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5
   Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308
   Ciapponi L, 1995, J BIOL CHEM, V270, P31249, DOI 10.1074/jbc.270.52.31249
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696
   Czupryn M, 1995, ANN NY ACAD SCI, V762, P152
   CZUPRYN MJ, 1995, J BIOL CHEM, V270, P978, DOI 10.1074/jbc.270.2.978
   Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695
   Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897
   Ellerby HM, 1999, NAT MED, V5, P1032
   FOURCIN M, 1994, EUR J IMMUNOL, V24, P277, DOI 10.1002/eji.1830240143
   Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008
   Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249
   Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200
   Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100
   Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042
   Harmegnies D, 2003, BIOCHEM J, V375, P23, DOI 10.1042/BJ20030459
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410
   Hermanns HM, 2005, NAT STRUCT MOL BIOL, V12, P476, DOI 10.1038/nsmb0605-476
   Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971
   Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859
   Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6
   Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703
   Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048
   Kurth I, 1999, J IMMUNOL, V162, P1480
   Lebeau B, 1997, FEBS LETT, V407, P141, DOI 10.1016/S0014-5793(97)00326-8
   Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464
   Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965
   Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X
   MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x
   Muller-Newen G, 2000, J BIOL CHEM, V275, P4579, DOI 10.1074/jbc.275.7.4579
   Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40
   PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007
   Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145
   Pentz RD, 2003, HASTINGS CENT REP, V33, P20, DOI 10.2307/3527910
   Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199
   Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387
   Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105
   Schuster B, 2003, FEBS LETT, V538, P113, DOI 10.1016/S0014-5793(03)00154-6
   Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7
   Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501
   Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   SMITH GP, 1993, METHOD ENZYMOL, V217, P228
   Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989
   Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399
   Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458
   Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675
NR 62
TC 26
Z9 28
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2008
VL 3
IS 10
AR e3452
DI 10.1371/journal.pone.0003452
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 432IB
UT WOS:000265125600011
PM 18941632
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Resende, JM
   Moraes, CM
   Prates, MV
   Cesar, A
   Almeida, FCL
   Mundim, NCCR
   Valente, AP
   Bemquerer, MP
   Pilo-Veloso, D
   Bechinger, B
AF Resende, Jarbas M.
   Moraes, Cleria Mendonca
   Prates, Maura V.
   Cesar, Amary
   Almeida, Fabio C. L.
   Mundim, Nathalia C. C. R.
   Valente, Ana Paula
   Bemquerer, Marcelo P.
   Pilo-Veloso, Dorila
   Bechinger, Burkhard
TI Solution NMR structures of the antimicrobial peptides phylloseptin-1,-2,
   and-3 and biological activity: The role of charges and hydrogen bonding
   interactions in stabilizing helix conformations
SO PEPTIDES
LA English
DT Article
DE Amphipathic alpha-helix; Antibiotic; Antifungal; Helix capping; Hydrogen
   bonds; Membrane interactions; Helix dipole
ID NUCLEAR-MAGNETIC-RESONANCE; HOST-DEFENSE PEPTIDES; PROTEIN SECONDARY
   STRUCTURE; MEMBRANE-LYTIC PEPTIDES; SOLID-STATE NMR; ALPHA-HELIX;
   LIPID-BILAYERS; ANTIBACTERIAL PEPTIDES; AROMATIC INTERACTIONS;
   CIRCULAR-DICHROISM
AB Phylloseptins are antimicrobial peptides of 19-20 residues which are found in the skin secretions of the Phyllomedusa frogs that inhabit the tropical forests of South and Central Americas. The peptide sequences of PS-1, -2, and -3 carry an amidated C-terminus and they exhibit 74% sequence homology with major variations of only four residues close to the C-terminus. Here we investigated and compared the structures of the three phylloseptins in detail by CD- and two-dimensional NMR spectroscopies in the presence of phospholipid vesicles or in membrane-mimetic environments. Both CD and NMR spectroscopies reveal a high degree of helicity in the order PS-2 >= PS-1 > PS-3, where the differences accumulate at the C-terminus. The conformational. variations can be explained by taking into consideration electrostatic interactions of the negative ends of the helix dipoles with potentially cationic residues at positions 17 and 18. Whereas two are present in the sequence of PS-1 and -2 only one is present in PS-3. In conclusion, the antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions. (C) Elsevier Inc. All rights reserved.
C1 [Resende, Jarbas M.; Moraes, Cleria Mendonca; Cesar, Amary; Pilo-Veloso, Dorila] Univ Fed Minas Gerais, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil.
   [Resende, Jarbas M.; Moraes, Cleria Mendonca; Bechinger, Burkhard] Univ Strasbourg, CNRS, UMR7177, Inst Chim, F-67000 Strasbourg, France.
   [Prates, Maura V.; Mundim, Nathalia C. C. R.; Bemquerer, Marcelo P.] EMBRAPA, Recursos Genet & Biotecnol, PqEB, BR-70770900 Brasilia, DF, Brazil.
   [Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, CNRMN, Dept Bioquim Med, CCS, BR-21941590 Rio De Janeiro, Brazil.
   [Mundim, Nathalia C. C. R.] Univ Brasilia, Inst Biol, BR-70910900 Brasilia, DF, Brazil.
RP Bechinger, B (corresponding author), Univ Strasbourg, Inst Le Bel, Fac Chim, 4 Rue Blaise Pascal, F-67070 Strasbourg, France.
EM bechinger@chimie.u-strasbg.fr
RI Valente, Ana Paula/J-3010-2017; Resende, Jarbas M/R-4519-2018; Almeida,
   Fabio/O-4989-2018; Bemquerer, Marcelo Porto/A-9688-2013; Prates,
   Maura/S-8399-2019
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Bemquerer, Marcelo Porto/0000-0002-9740-5818;
   Prates, Maura/0000-0002-0206-5890; Resende, Jarbas/0000-0001-9827-7312
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq -
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES - Brazil)CAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG) [EDT 24000]; Brazilian-French program CAPES-COFECUBCAPES
   [487/05]
FX JMR thanks Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq - Brazil) for his PhD grant and CMM thanks Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil) for her
   postdoctoral grant. We also thank FAPEMIG (EDT 24000) and Vaincre la
   Mucoviscidose for financial support. We acknowledge the support by the
   Brazilian-French program CAPES-COFECUB (487/05) who promoted this
   collaboration by financing several transatlantic visits.
CR Aisenbrey C, 2006, J BIOL CHEM, V281, P7708, DOI 10.1074/jbc.M513151200
   Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2
   Apponyi MA, 2004, PEPTIDES, V25, P1035, DOI 10.1016/j.peptides.2004.03.006
   ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337
   Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9
   Bechinger B, 2004, CRIT REV PLANT SCI, V23, P271, DOI 10.1080/07352680490452825
   BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Bhattacharyya R, 2002, PROTEIN ENG, V15, P91, DOI 10.1093/protein/15.2.91
   Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x
   Brand GD, 2006, BIOCHEM BIOPH RES CO, V347, P739, DOI 10.1016/j.bbrc.2006.06.168
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   BULET P, 1991, J BIOL CHEM, V266, P24520
   Butterfield SM, 2002, J AM CHEM SOC, V124, P9751, DOI 10.1021/ja026668q
   CAFFREY MS, 1991, BIOCHEMISTRY-US, V30, P9238, DOI 10.1021/bi00102a015
   CARVER JA, 1990, EUR J BIOCHEM, V187, P645, DOI 10.1111/j.1432-1033.1990.tb15348.x
   Cavanagh J., 1996, PROTEIN NMR SPECTROS
   Chan W.C., 2000, FMOC SOLID PHASE PEP
   Chelli R, 2002, J AM CHEM SOC, V124, P6133, DOI 10.1021/ja0121639
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q
   DUCLOHIER H, 1989, BIOPHYS J, V56, P1017, DOI 10.1016/S0006-3495(89)82746-8
   GIOVANNINI MG, 1987, BIOCHEM J, V243, P113, DOI 10.1042/bj2430113
   Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hara T, 2001, BIOCHEMISTRY-US, V40, P12395, DOI 10.1021/bi011413v
   HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008
   Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l
   Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Leite JRSA, 2005, PEPTIDES, V26, P565, DOI 10.1016/j.peptides.2004.11.002
   MARION D, 1988, FEBS LETT, V227, P21, DOI 10.1016/0014-5793(88)81405-4
   MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004
   Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje
   Mason AJ, 2006, ANTIMICROB AGENTS CH, V50, P3305, DOI 10.1128/AAC.00490-06
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   MATSUZAKI K, 1989, BIOCHIM BIOPHYS ACTA, V981, P130, DOI 10.1016/0005-2736(89)90090-4
   Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p
   McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458
   Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202
   Park CB, 1996, BIOCHEM BIOPH RES CO, V218, P408, DOI 10.1006/bbrc.1996.0071
   PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Prieto J, 1997, J MOL BIOL, V274, P276, DOI 10.1006/jmbi.1997.1322
   Prongidi-Fix L, 2007, BIOCHEMISTRY-US, V46, P11253, DOI 10.1021/bi700766j
   Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n
   SADLER PJ, 1993, EUR J BIOCHEM, V212, P811, DOI 10.1111/j.1432-1033.1993.tb17722.x
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Shi ZS, 2001, BIOPOLYMERS, V60, P366, DOI 10.1002/1097-0282(2001)60:5<366::AID-BIP10177>3.0.CO;2-5
   Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.0.CO;2-8
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0
   Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o
   Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115
   Wayne PA, 1999, M100S9 NCCLS
   WESTERHOFF HV, 1995, EUR J BIOCHEM, V228, P257
   White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319
   Wieprecht T, 1997, FEBS LETT, V417, P135, DOI 10.1016/S0014-5793(97)01266-0
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 76
TC 47
Z9 50
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-9781
EI 1873-5169
J9 PEPTIDES
JI Peptides
PD OCT
PY 2008
VL 29
IS 10
BP 1633
EP 1644
DI 10.1016/j.peptides.2008.06.022
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 363RJ
UT WOS:000260284100001
PM 18656510
DA 2020-12-01
ER

PT J
AU Razzera, G
   Vernal, J
   Baruh, D
   Serpa, VI
   Tavares, C
   Lara, FA
   Souza, EM
   Pedrosa, FO
   Almeida, FCL
   Terenzi, H
   Valente, AP
AF Razzera, Guilherme
   Vernal, Javier
   Baruh, Debora
   Serpa, Viviane I.
   Tavares, Carolina
   Lara, Flavio Alves
   Souza, Emanuel M.
   Pedrosa, Fabio O.
   Almeida, Fabio C. L.
   Terenzi, Hernan
   Valente, Ana Paula
TI Spectroscopic characterization of a truncated hemoglobin from the
   nitrogen-fixing bacterium Herbaspirillum seropedicae
SO JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
LA English
DT Article
DE nuclear magnetic resonance; truncated globin; Herbaspirillum seropedicae
ID C-13 NMR-SPECTROSCOPY; BACILLUS-SUBTILIS; OXYGEN-BINDING; FERRIC HEME;
   PLANT; PROTEIN; GLOBIN; ASSIGNMENT; PATHOGEN; H-1-NMR
AB The Herbaspirillum seropedicae genome sequence encodes a truncated hemoglobin typical of group II (Hs-trHb1) members of this family. We show that His-tagged recombinant Hs-trHb1 is monomeric in solution, and its optical spectrum resembles those of previously reported globins. NMR analysis allowed us to assign heme substituents. All data suggest that Hs-trHb1 undergoes a transition from an aquomet form in the ferric state to a hexacoordinate low-spin form in the ferrous state. The close positions of Ser-E7, Lys-E10, Tyr-B10, and His-CD1 in the distal pocket place them as candidates for heme coordination and ligand regulation. Peroxide degradation kinetics suggests an easy access to the heme pocket, as the protein offered no protection against peroxide degradation when compared with free heme. The high solvent exposure of the heme may be due to the presence of a flexible loop in the access pocket, as suggested by a structural model obtained by using homologous globins as templates. The truncated hemoglobin described here has unique features among truncated hemoglobins and may function in the facilitation of O-2 transfer and scavenging, playing an important role in the nitrogen-fixation mechanism.
C1 [Razzera, Guilherme; Baruh, Debora; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, ICB CCS, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio de Janeiro, Brazil.
   [Lara, Flavio Alves] Univ Fed Rio de Janeiro, ICB CCS, Dept Bioquim Med, Lab Bioquim Artropodos Hematofagas, Rio de Janeiro, Brazil.
   [Vernal, Javier; Serpa, Viviane I.; Tavares, Carolina; Terenzi, Hernan] Univ Fed Santa Catarina, Dept Bioquim, Lab Expressao Gen, BR-88040900 Florianopolis, SC, Brazil.
   [Souza, Emanuel M.; Pedrosa, Fabio O.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, ICB CCS, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio de Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Pedrosa, Fabio 0/C-1938-2013; de Souza,
   Emanuel Maltempi/C-1920-2013; Almeida, Fabio/O-4989-2018; Lara, Flavio
   Alves/L-1861-2013; Razzera, Guilherme/M-5372-2014
OI Valente, Ana Paula/0000-0001-7219-1123; de Souza, Emanuel
   Maltempi/0000-0003-1546-9218; Almeida, Fabio/0000-0001-6046-7006;
   Razzera, Guilherme/0000-0002-1448-3037
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [550732/2002-0]; MCT; FINEPCiencia Tecnologia e Inovacao (FINEP);
   FAPESC; FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Instituto Milenio de Biologia
   Estrutural em Biomedicia e Biotecnologia
FX We thank Marcus Oliveira and Alejandro Vila for helpful discussions.
   This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grant no. 550732/2002-0, MCT, FINEP,
   FAPESC, FAPERJ, and Instituto Milenio de Biologia Estrutural em
   Biomedicia e Biotecnologia.
CR Baldani JI, 1996, INT J SYST BACTERIOL, V46, P802, DOI 10.1099/00207713-46-3-802
   Bertolucci C, 1996, CHEM BIOL, V3, P561, DOI 10.1016/S1074-5521(96)90147-7
   Bonamore A, 2005, FEBS J, V272, P4189, DOI 10.1111/j.1742-4658.2005.04831.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Caillet-Saguy C, 2006, J AM CHEM SOC, V128, P150, DOI 10.1021/ja054902h
   COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1
   Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223
   Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e
   Fabozzi G, 2006, MICROB PATHOGENESIS, V40, P211, DOI 10.1016/j.micpath.2006.01.004
   Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f
   Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024
   Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101
   Garrocho-Villegas V, 2007, GENE, V398, P78, DOI 10.1016/j.gene.2007.01.035
   Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200
   Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9
   Hardison R, 1999, AM SCI, V87, P126, DOI 10.1511/1999.2.126
   Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675
   Hill DR, 1996, J BACTERIOL, V178, P6587, DOI 10.1128/jb.178.22.6587-6598.1996
   Hoy JA, 2008, PLANT PHYSIOL BIOCH, V46, P371, DOI 10.1016/j.plaphy.2007.12.016
   Ilari A, 2007, ARCH BIOCHEM BIOPHYS, V457, P85, DOI 10.1016/j.abb.2006.09.033
   James EK, 2002, MOL PLANT MICROBE IN, V15, P894, DOI 10.1094/MPMI.2002.15.9.894
   Koshikawa K, 1998, BBA-PROTEIN STRUCT M, V1385, P89, DOI 10.1016/S0167-4838(98)00051-X
   Kundu S, 2003, TRENDS PLANT SCI, V8, P387, DOI 10.1016/S1360-1385(03)00163-8
   Kvist M, 2007, J BIOL INORG CHEM, V12, P324, DOI 10.1007/s00775-006-0190-x
   Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037
   Lecomte JTJ, 2005, CURR OPIN STRUC BIOL, V15, P290, DOI 10.1016/j.sbi.2005.05.008
   Lecomte JTJ, 2001, BIOCHEMISTRY-US, V40, P6541, DOI 10.1021/bi010226u
   Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200
   Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100
   Milani M, 2001, BIOCHEM MOL BIOL EDU, V29, P123, DOI 10.1016/S1470-8175(01)00024-8
   Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337
   Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200
   Perutz MF, 1999, CHEM BIOL, V6, pR291, DOI 10.1016/S1074-5521(99)80121-5
   Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424
   POTTS M, 1992, SCIENCE, V256, P1690, DOI 10.1126/science.256.5064.1690
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Scott NL, 2000, PROTEIN SCI, V9, P587
   Shokhireva TK, 2007, INORG CHEM, V46, P2041, DOI 10.1021/ic061408l
   Shokhireva TK, 2003, BIOCHEMISTRY-US, V42, P679, DOI 10.1021/bi026765w
   Thorsteinsson MV, 1996, BBA-PROTEIN STRUCT M, V1292, P133, DOI 10.1016/0167-4838(95)00178-6
   Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168
   Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31
   Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4
   Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k
   Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198
   Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018
   Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200
   Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7
   Yeh DC, 2000, BIOCHEMISTRY-US, V39, P1389, DOI 10.1021/bi992081l
NR 51
TC 8
Z9 8
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0949-8257
EI 1432-1327
J9 J BIOL INORG CHEM
JI J. Biol. Inorg. Chem.
PD SEP
PY 2008
VL 13
IS 7
BP 1085
EP 1096
DI 10.1007/s00775-008-0394-3
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 348ZP
UT WOS:000259248900005
PM 18548291
DA 2020-12-01
ER

PT J
AU Sarzedas, CG
   Lima, CS
   Juliano, MA
   Juliano, L
   Valente, AP
   Da Poian, AT
   Almeida, FCL
AF Sarzedas, Carolina G.
   Lima, Carla S.
   Juliano, Maria A.
   Juliano, Luiz
   Valente, Ana Paula
   Da Poian, Andrea T.
   Almeida, Fabio C. L.
TI A minor beta-structured conformation is the active state of a fusion
   peptide of vesicular stomatitis virus glycoprotein
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Workshop on Biophysics of Membrane-Active Peptides
CY 2007
CL Lisbon, PORTUGAL
DE membrane fusion; vesicular stomatitis virus; NMR; structure
ID MEMBRANE-FUSION; EMPIRICAL PARAMETERS; FOLDING PROBLEM; VIRAL FUSION;
   BINDING; PROTEIN; PHOSPHATIDYLSERINE; FORM; PH; RHABDOVIRUSES
AB Entry of enveloped animal viruses into their host cells always depends on a step of membrane fusion triggered by conformational changes in viral envelope glycoproteins. Vesicular stomatitis virus (VSV) infection is mediated by virus spike glycoprotein G, which induces membrane fusion at the acidic environment of the endosomal compartment. In a previous work, we identified a specific sequence in the VSV G protein, comprising the residues 145-164, directly involved in membrane interaction and fusion. In the present work we studied the interaction of pep[145-164] with membranes using NMR to solve the structure of the peptide in two membrane-mimetic systems: SDS micelles and liposomes composed of phosphatidylcholme and phosphatidylserine (PC: PS vesicles). The presence of medium-range NOEs showed that the peptide has a tendency to form N- and C-terminal helical segments in the presence of SDS micelles. Analysis of the chemical shift index indicated helix-coil equilibrium for the C-terminal helix under all conditions studied. At pH 7.0, the N-terminal helix also displayed a helix-coil equilibrium when pep[145-164] was free in solution or in the presence of PC: PS. Remarkably, at the fusogenic pH, the region of the N-terminal helix in the presence of SDS or PC: PS presented a third conformational species that was in equilibrium with the helix and random coil. The N-terminal helix content decreases pH and the minor P-structured conformation becomes more prevalent at the fusogenic pH. These data point to a P-conformation as the fusogenic active structure-which is in agreement with the X-ray structure, which shows a P-hairpin for the region corresponding to pep[145-164]. Copyright (c) 2007 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Sarzedas, Carolina G.; Lima, Carla S.; Valente, Ana Paula; Da Poian, Andrea T.; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   [Sarzedas, Carolina G.; Valente, Ana Paula; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941590 Rio De Janeiro, Brazil.
   [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04044020 Sao Paulo, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
EM dapoian@bioqmed.ufil.br
RI Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012; Valente,
   Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Da Poian, Andrea
   T./V-1699-2019
OI Juliano, Luiz/0000-0002-5589-2822; Valente, Ana
   Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006; Da Poian,
   Andrea/0000-0002-3969-704X
CR Carneiro FA, 2006, EUR BIOPHYS J BIOPHY, V35, P145, DOI 10.1007/s00249-005-0012-z
   Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200
   Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002
   Carneiro FA, 2006, MOL MEMBR BIOL, V23, P396, DOI 10.1080/09687860600780892
   Coll JM, 1997, ARCH VIROL, V142, P2089, DOI 10.1007/s007050050227
   Da Poian AT, 2005, BRAZ J MED BIOL RES, V38, P813, DOI 10.1590/S0100-879X2005000600002
   Da Poian AT, 1998, J VIROL METHODS, V70, P45, DOI 10.1016/S0166-0934(97)00166-3
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777
   Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X
   Estepa A, 1996, VIROLOGY, V216, P60, DOI 10.1006/viro.1996.0034
   GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991
   Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   MASTROMARINO P, 1987, J GEN VIROL, V68, P2359, DOI 10.1099/0022-1317-68-9-2359
   MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024
   MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399
   MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023
   Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710
   Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683
   SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X
   SCHLEGEL R, 1982, J VIROL, V43, P871, DOI 10.1128/JVI.43.3.871-875.1982
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   Stauffer F, 2007, ANTIVIR RES, V73, P31, DOI 10.1016/j.antiviral.2006.07.007
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 29
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD APR
PY 2008
VL 14
IS 4
BP 429
EP 435
DI 10.1002/psc.934
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 287FC
UT WOS:000254901300011
PM 17985397
DA 2020-12-01
ER

PT J
AU Pinheiro, AS
   Amorim, GC
   Netto, LES
   Almeida, FCL
   Valente, AP
AF Pinheiro, Anderson Sa
   Amorim, Gisele Cardoso
   Netto, Luis Eduardo Soares
   Almeida, Fabio C. L.
   Valente, Ana Paula
TI NMR solution structure of the reduced form of thioredoxin 1 from
   Sacharomyces cerevisiae
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE protein; structure; Trx1; yeast; Sacharomyces cerevisiae
ID ESCHERICHIA-COLI THIOREDOXIN; SACCHAROMYCES-CEREVISIAE; RESOLUTION;
   SYSTEM
C1 [Pinheiro, Anderson Sa; Amorim, Gisele Cardoso; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Rio De Janeiro, Brazil.
   [Netto, Luis Eduardo Soares] Univ Sao Paulo, Inst Biol, Sao Paulo, Brazil.
   [Valente, Ana Paula] CCS, BR-21941590 Rio De Janeiro, Brazil.
RP Valente, AP (corresponding author), CCS, Avenida Brigadeiro Trompowski,S-N,Bloco E,Sala 10, BR-21941590 Rio De Janeiro, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Amorim, Gisele/D-7876-2013; Amorim, Gisele/O-9231-2019; Pinheiro,
   Anderson S/B-6350-2014; Almeida, Fabio/O-4989-2018; Netto,
   Luis/A-3783-2008; Valente, Ana Paula/J-3010-2017
OI Amorim, Gisele/0000-0003-4348-9515; Amorim, Gisele/0000-0003-4348-9515;
   Almeida, Fabio/0000-0001-6046-7006; Netto, Luis/0000-0002-4250-9177;
   Valente, Ana Paula/0000-0001-7219-1123; Pinheiro,
   Anderson/0000-0001-5118-6931
CR Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017
   GAN ZR, 1991, J BIOL CHEM, V266, P1692
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B
   Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190
   Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851
   Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366
   Pinheiro AS, 2006, J BIOMOL NMR, V36, P35, DOI 10.1007/s10858-006-0025-7
   Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102
NR 14
TC 14
Z9 15
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PD FEB 1
PY 2008
VL 70
IS 2
BP 584
EP 587
DI 10.1002/prot.21693
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 249EB
UT WOS:000252208900029
PM 17932921
DA 2020-12-01
ER

PT J
AU Cruzeiro-Silva, C
   Gomes-Neto, F
   Tinoco, LW
   Cilh, EM
   Barros, PVR
   Lapido-Loureiro, PA
   Bisch, PM
   Almeida, FCL
   Valente, AP
AF Cruzeiro-Silva, C.
   Gomes-Neto, F.
   Tinoco, L. W.
   Cilh, E. M.
   Barros, P. V. R.
   Lapido-Loureiro, P. A.
   Bisch, P. M.
   Almeida, F. C. L.
   Valente, A. P.
TI Structural biology of membrane-acting peptides: Conformational
   plasticity of anticoccidial peptide PW2 probed by solution NMR
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
ID ANTIMICROBIAL PEPTIDES; PROTEIN INTERACTIONS; BINDING-SITES; RELAXATION;
   DYNAMICS; STATE; SPECTROSCOPY; DISPLAY; ASSOCIATION; MECHANISMS
AB The bottleneck for the complete understanding of the structure-function relationship of flexible membrane-acting peptides is its dynamics. At the same time, not only the structure but also the dynamics are the key points for their mechanism of action. Our model is PW2, a TRP-rich, cationic peptide selected from phage display libraries that shows anticoccidial activity against Eimeria acervulina. In this manuscript we used a combination of several NMR techniques to tackle these difficulties. The structural features of the membrane-acting peptide PW2 was studied in several membrane mimetic environments: we compared the structural features of PW2 in SDS and DPC micelles, that were reported earlier, with the structure properties in different lipid vesicles and the peptide free in water. We were able to unify the structural information obtained in each of these systems. The structural constraints of the peptide free in water were fundamental for the understanding of plasticity necessary for the membrane interaction. Our data suggested that the WWR sequence is the region responsible for anchoring the peptide to the interfaces, and that this same region displays some degree of conformational order in solution. For PW2, we found that affinity is related to the aromatic region, by anchoring the peptide to the membrane, and specificity is related to the N- and C-termini, which are able to accommodate in the membrane due to its plasticity. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Cruzeiro-Silva, C.; Gomes-Neto, F.; Almeida, F. C. L.; Valente, A. P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magent Nucl Jiri Jonas, Programa Biol Estruct, Rio De Janeiro, Brazil.
   [Tinoco, L. W.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Cilh, E. M.] Univ Estadual Paulista, UNESP, Sao Paulo, Brazil.
   [Barros, P. V. R.; Lapido-Loureiro, P. A.; Bisch, P. M.] Univ Estadual Paulista, Inst Biofis Carlos Chagas Filho, Sao Paulo, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magent Nucl Jiri Jonas, Programa Biol Estruct, Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br; valente@cnnnn.bioqmed.uftj.br
RI Valente, Ana Paula/J-3010-2017; Cilli, Eduardo Maffud/B-9130-2012;
   Tinoco, Luzineide W/G-3630-2014; de Barros, Pedro Victor
   Renault/AAA-4514-2020; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Cilli, Eduardo
   Maffud/0000-0002-4767-0904; Tinoco, Luzineide W/0000-0002-1299-6242; de
   Barros, Pedro Victor Renault/0000-0002-5649-3057; Almeida,
   Fabio/0000-0001-6046-7006
CR Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X
   Almeida FCL, 1997, J MAGN RESON, V124, P509, DOI 10.1006/jmre.1996.1091
   Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Berendsen H. J. C., 1969, NATURE, V224, P175
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bertini I, 2001, METHOD ENZYMOL, V339, P314, DOI 10.1016/S0076-6879(01)39320-5
   Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Carlson HA, 2000, MOL PHARMACOL, V57, P213
   Cavanagh J, 2001, NAT STRUCT BIOL, V8, P912, DOI 10.1038/nsb1101-912
   CHENG H, 1995, ANNU REV BIOPH BIOM, V24, P209, DOI 10.1146/annurev.biophys.24.1.209
   da Silva A, 2002, MOL BIOCHEM PARASIT, V120, P53, DOI 10.1016/S0166-6851(01)00439-X
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007
   Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   Gunasekaran K, 2007, J MOL BIOL, V365, P257, DOI 10.1016/j.jmb.2006.09.062
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   Israelachvili J. N., 1992, INTERMOLECULAR SURFA
   James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d
   Karplus M, 1999, PROTEIN ENG, V12, P185, DOI 10.1093/protein/12.3.185
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j
   Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   NAKAIE CR, 1983, BIOCHIM BIOPHYS ACTA, V742, P63, DOI 10.1016/0167-4838(83)90359-X
   Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121
   Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748
   Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8
   Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200
   Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813
   Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012
   Ramamoorthy A, 2004, ANNU REP NMR SPECTRO, V52, P1, DOI 10.1016/S0066-4103(04)52001-X
   Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890
   Ramamoorthy A, 2006, BBA-BIOMEMBRANES, V1758, P154, DOI 10.1016/j.bbamem.2006.02.014
   Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   SUBBARAO NK, 1991, BIOCHIM BIOPHYS ACTA, V1063, P147, DOI 10.1016/0005-2736(91)90364-E
   Tamm LK, 2006, PROG NUCL MAG RES SP, V48, P201, DOI 10.1016/j.pnmrs.2006.05.005
   Tinoco LW, 2002, J BIOL CHEM, V277, P36351, DOI 10.1074/jbc.M204225200
   TINOCO LW, IN PRESS J BIOMOL NM
   Toniolo C, 1998, BIOPOLYMERS, V47, P153, DOI 10.1002/(SICI)1097-0282(1998)47:2<153::AID-BIP4>3.0.CO;2-T
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Werten PJL, 2002, FEBS LETT, V529, P65, DOI 10.1016/S0014-5793(02)03290-8
   Whitehead TL, 2004, J BIOMOL STRUCT DYN, V21, P567, DOI 10.1080/07391102.2004.10506949
   WOLFWATZ M, 2004, BIOCHEMISTRY-US, V40, P11423
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
NR 65
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 1879-2642
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD DEC
PY 2007
VL 1768
IS 12
BP 3182
EP 3192
DI 10.1016/j.bbamem.2007.08.022
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 253AH
UT WOS:000252488900025
PM 17927950
OA Green Published
DA 2020-12-01
ER

PT J
AU Tinoco, LW
   Gomes-Neto, F
   Valente, AP
   Almeida, FCL
AF Tinoco, Luzineide W.
   Gomes-Neto, Francisco
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Effect of micelle interface on the binding of anticoccidial PW2 peptide
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE avian coccidiosis; antimicrobial peptide; Eimeria; membrane; NMR;
   structure
ID CECROPIN A(1-8)-MAGAININ 2(1-12); ANTIMICROBIAL PEPTIDES; HINGE REGION;
   SDS MICELLES; MEMBRANE; NMR; ANALOGS; DISPLAY; ANTIBACTERIAL;
   DIASTEREOMERS
AB PW2 is an anticoccidial peptide active against Eimeria acervulina and Eimeria tenella. We determined the structure of PW2 in dodecylphosphocholine micelles. The structure showed two distinct regions: an amphipathic N-terminal 3(10) helix and an aromatic region containing WWR interface-binding motif. The aromatic region acted as a scaffold of the protein in the interface and shared the same structure in both DPC and SDS micelles. N-terminal helix interacted with DPC but not with SDS interface. Chemical shift change was slow when SDS was added to PW2 in DPC and fast when DPC was added to PW2 in SDS, indicating that interaction with DPC micelles was kinetically more stable than with SDS micelles. Also, DPC interface was able to accommodate PW2, but it maintained the conformational arrangement in the aromatic region observed for SDS micelles. This behavior, which is different from that observed for other antimicrobial peptides with WWR motif, may be associated with the absence of PW2 antibacterial activity and its selectivity for Eimeria parasites.
C1 Univ Fed Rio de Janeiro, Program Biol Estrutural, Inst Bioquim Med, Ctr Nacl Ressonacia Magnet Nucl Jiri Jonas, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Nucl Pesquisas Product Nat, BR-21941590 Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Program Biol Estrutural, Inst Bioquim Med, Ctr Nacl Ressonacia Magnet Nucl Jiri Jonas, BR-21941 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Tinoco, Luzineide W/G-3630-2014; Almeida, Fabio/O-4989-2018; Valente,
   Ana Paula/J-3010-2017
OI Tinoco, Luzineide W/0000-0002-1299-6242; Almeida,
   Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123
CR Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002
   Baleja JD, 2001, ANAL BIOCHEM, V288, P1, DOI 10.1006/abio.2000.4815
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   da Silva A, 2002, MOL BIOCHEM PARASIT, V120, P53, DOI 10.1016/S0166-6851(01)00439-X
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035
   Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9
   Hicks RP, 2003, BIOPOLYMERS, V68, P459, DOI 10.1002/bip.10325
   Hong J, 1999, BIOCHEMISTRY-US, V38, P16963, DOI 10.1021/bi991850y
   Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KALLICK DA, 1995, J MAGN RESON SER B, V109, P60, DOI 10.1006/jmrb.1995.1146
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lee A, 2001, CURR BIOL, V11, pR811, DOI 10.1016/S0960-9822(01)00491-2
   Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7
   MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206
   Martin A, 1999, PARASITOL RES, V85, P331, DOI 10.1007/s004360050557
   Neidigh JW, 2002, BIOPOLYMERS, V65, P354, DOI 10.1002/bip.10272
   NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425
   Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g
   Oh JE, 2000, BIOCHEM J, V352, P659, DOI 10.1042/0264-6021:3520659
   Palian MM, 2003, J AM CHEM SOC, V125, P5823, DOI 10.1021/ja0268635
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Rilfors L, 2002, COLLOID SURFACE B, V26, P112, DOI 10.1016/S0927-7765(01)00310-1
   Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c
   Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305
   Shin SY, 2000, BBA-BIOMEMBRANES, V1463, P209, DOI 10.1016/S0005-2736(99)00210-2
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Subbalakshmi C, 1996, FEBS LETT, V395, P48, DOI 10.1016/0014-5793(96)00996-9
   Tinoco LW, 2002, J BIOL CHEM, V277, P36351, DOI 10.1074/jbc.M204225200
   Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5
   Whitehead TL, 2004, J BIOMOL STRUCT DYN, V21, P567, DOI 10.1080/07391102.2004.10506949
   Whitehead TL, 2001, BIOPOLYMERS, V58, P593, DOI 10.1002/1097-0282(200106)58:7<593::AID-BIP1033>3.0.CO;2-P
   Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yu K, 2001, J BIOMOL STRUCT DYN, V18, P595, DOI 10.1080/07391102.2001.10506691
   ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U
NR 41
TC 9
Z9 9
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD DEC
PY 2007
VL 39
IS 4
BP 315
EP 322
DI 10.1007/s10858-007-9202-6
PG 8
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 226ZC
UT WOS:000250626000006
PM 17926009
DA 2020-12-01
ER

PT J
AU Freitas, MS
   Gaspar, LP
   Lorenzoni, M
   Almeida, FCL
   Tinoco, LW
   Almeida, MS
   Maia, LF
   Degreve, L
   Valente, AP
   Silva, JL
AF Freitas, Monica S.
   Gaspar, Luciane P.
   Lorenzoni, Marcos
   Almeida, Fabio C. L.
   Tinoco, Luzineide W.
   Almeida, Marcius S.
   Maia, Lenize F.
   Degreve, Leo
   Valente, Ana Paula
   Silva, Jerson L.
TI Structure of the Ebola fusion peptide in a membrane-mimetic environment
   and the interaction with lipid rafts
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID VIRUS GLYCOPROTEIN; INFLUENZA HEMAGGLUTININ; PROTEIN; SIMULATION;
   DOMAIN; SUBUNIT; GP2; PH
AB The fusion peptide EBO16 (GAAIGLAWIPYFGPAA) comprises the fusion domain of an internal sequence located in the envelope fusion glycoprotein (GP2) of the Ebola virus. This region interacts with the cellular membrane of the host and leads to membrane fusion. To gain insight into the mechanism of the peptide-membrane interaction and fusion, insertion of the peptide was modeled by experiments in which the tryptophan fluorescence and (HNMR)-H-1 were monitored in the presence of sodium dodecyl sulfate micelles or in the presence of detergent-resistant membrane fractions. In the presence of SDS micelles, EBO16 undergoes a random coil-helix transition, showing a tendency to self-associate. The three-dimensional structure displays a 3(10)-helix in the central part of molecule, similar to the fusion peptides of many known membrane fusion proteins. Our results also reveal that EBO16 can interact with detergent-resistant membrane fractions and strongly suggest that Trp-8 and Phe-12 are important for structure maintenance within the membrane bilayer. Replacement of tryptophan 8 with alanine (W8A) resulted in dramatic loss of helical structure, proving the importance of the aromatic ring in stabilizing the helix. Molecular dynamics studies of the interaction between the peptide and the target membrane also corroborated the crucial participation of these aromatic residues. The aromatic-aromatic interaction may provide a mechanism for the free energy coupling between random coil-helical transition and membrane anchoring. Our data shed light on the structural "domains" of fusion peptides and provide a clue for the development of a drug that might block the early steps of viral infection.
C1 Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Programa biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz, Dept Virol, BR-21040360 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
   Univ Fed Rio de Janeiro, Lab Analise & Desenvolvimento Inibidores, BR-21941590 Rio De Janeiro, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Programa biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
EM jerson@bioqmed.ufrj.br
RI Tinoco, Luzineide W/G-3630-2014; Valente, Ana Paula/J-3010-2017; Silva,
   Jerson/J-8984-2014; de Freitas, Monica Santos/E-8540-2015; Almeida,
   Fabio/O-4989-2018
OI Tinoco, Luzineide W/0000-0002-1299-6242; Valente, Ana
   Paula/0000-0001-7219-1123; Silva, Jerson/0000-0001-9523-9441; de
   Freitas, Monica Santos/0000-0003-3105-7918; Almeida,
   Fabio/0000-0001-6046-7006; almeida, marcius/0000-0003-4921-8185
CR Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306
   Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Feldmann H, 1993, Arch Virol Suppl, V7, P81
   GORDON JA, 1991, METHOD ENZYMOL, V201, P477
   Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434
   Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200
   Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662
   Malashkevich VN, 2001, P NATL ACAD SCI USA, V98, P8502, DOI 10.1073/pnas.151254798
   MILLHAUSER GL, 1995, BIOCHEMISTRY-US, V34, P3873, DOI 10.1021/bi00012a001
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Peter CJ, 1996, FIELDS VIROLOGY, P1161
   Ruiz-Arguello MB, 1998, J VIROL, V72, P1775
   Schweighofer KJ, 1997, J PHYS CHEM B, V101, P3793, DOI 10.1021/jp963460g
   SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L
   SHEINERMAN FB, 1995, J AM CHEM SOC, V117, P10098, DOI 10.1021/ja00145a022
   Suarez T, 2003, FEBS LETT, V535, P23, DOI 10.1016/S0014-5793(02)03847-4
   Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261
   Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f
   Weissenhorn W, 1998, P NATL ACAD SCI USA, V95, P6032, DOI 10.1073/pnas.95.11.6032
   Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   Wong TC, 2003, BBA-BIOMEMBRANES, V1609, P45, DOI 10.1016/S0005-2736(02)00652-1
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yao Y, 2003, VIROLOGY, V310, P319, DOI 10.1016/S0042-6822(03)00146-6
NR 33
TC 40
Z9 40
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 14
PY 2007
VL 282
IS 37
BP 27306
EP 27314
DI 10.1074/jbc.M611864200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 208FJ
UT WOS:000249304900072
PM 17545161
OA Bronze
DA 2020-12-01
ER

PT J
AU Amorim, GC
   Pinheiro, AS
   Netto, LES
   Valente, AP
   Almeida, FCL
AF Amorim, Gisele Cardoso
   Pinheiro, Anderson Sa
   Soares Netto, Luis Eduardo
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI NMR solution structure of the reduced form of thioredoxin 2 from
   Saccharomyces cerevisiae
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE NMR; Saccharomyces cerevisiae; structure; thioredoxin 2; yeast
ID NF-KAPPA-B; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RESOLUTION; SYSTEM;
   PROGRAM; COMPLEX; GROWTH
C1 Univ Fed Rio de Janeiro, CCS, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil.
RP Almeida, FCL (corresponding author), Ave Brigadeiro Trompowski,Cidade Univ,S-N,CCS,Blo, BR-21941590 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017; Amorim,
   Gisele/O-9231-2019; Netto, Luis/A-3783-2008; Pinheiro, Anderson
   S/B-6350-2014; Amorim, Gisele/D-7876-2013
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123; Amorim, Gisele/0000-0003-4348-9515; Netto,
   Luis/0000-0002-4250-9177; Amorim, Gisele/0000-0003-4348-9515; Pinheiro,
   Anderson/0000-0001-5118-6931
CR Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194
   BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Doublie S, 1998, NATURE, V391, P251
   FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069
   FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7
   HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321
   JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297
   KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   LAURENT TC, 1964, J BIOL CHEM, V239, P3436
   Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065
   Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851
   MONTEFORTE M, 1990, SERIE CIENTIFICA, V1, P13
   Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987
   Pinheiro AS, 2006, J BIOMOL NMR, V36, P35, DOI 10.1007/s10858-006-0025-7
   QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9
   QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4
   SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Wahl MC, 2005, J MOL BIOL, V345, P1119, DOI 10.1016/j.jmb.2004.11.004
NR 28
TC 12
Z9 13
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD MAY
PY 2007
VL 38
IS 1
BP 99
EP 104
DI 10.1007/s10858-007-9144-z
PG 6
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 164IE
UT WOS:000246226300011
PM 17340205
DA 2020-12-01
ER

PT J
AU Moreau, VH
   Valente, AP
   Almeida, FCL
AF Moreau, Vitor Hugo
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI Prediction of the amount of secondary structure of proteins using
   unassigned NMR spectra: A tool for target selection in structural
   proteomics
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Article
DE chemical shift dispersion; PASSNMR; prediction of secondary structure;
   structural proteomics; target selection
ID CHEMICAL-SHIFT INDEX; FOLD RECOGNITION; ESCHERICHIA-COLI; SOLID-STATE;
   CONFORMATION; BACKBONE; RESTRAINTS; DATABASE
AB With the advent of structural genomics, the need for fast structural information about unknown proteins has increased. We describe a new methodology, based on C-13, N-15 and H-1 chemical shift dispersion to predict the amount of secondary structure of unassigned proteins from their N-15- and/or C-13-edited heteronuclear single quantum coherence (HSQC) spectra. This methodology has been coded into a software called PASSNMR (Prediction of the Amount of Secondary Structure by Nuclear Magnetic Resonance), which can be accessed directly from the Internet. PASSNMR program is a powerful tool for screening proteins for proteomic or structural genomic investigations when used with recent methodologies that take advantage of the use of the antibiotic rifampicin to selectively label the heterologous proteins expressed in E. coli. PASSNMR analysis can be useful as a first approach to predict the amount of secondary structure in proteins to structural genomics. Information about the secondary structure of proteins can be obtained even before protein purification, with small quantities of protein, just by performing two simple nuclear magnetic resonance (NMR) experiments and using PASSNMR program.
C1 Fac Tecnol & Ciencias, BR-41820785 Salvador, BA, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941 Rio De Janeiro, Brazil.
RP Moreau, VH (corresponding author), Fac Tecnol & Ciencias, Av Luis Viano Filho 8812,Mod 3,Saia 110, BR-41820785 Salvador, BA, Brazil.
EM vhmoreau@yahoo.com.br
RI Moreau, Vitor Hugo/J-4829-2015; Valente, Ana Paula/J-3010-2017; Moreau,
   Vitor Hugo/B-8865-2009; Almeida, Fabio/O-4989-2018
OI Moreau, Vitor Hugo/0000-0002-5393-0645; Valente, Ana
   Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006
CR Almeida FCL, 2001, J MAGN RESON, V148, P142, DOI 10.1006/jmre.2000.2213
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ANDERSON TW, 1996, NEW STAT ANAL DATA
   ANDO I, 1984, MACROMOLECULES, V17, P457, DOI 10.1021/ma00133a036
   Ayers DJ, 1999, PROTEIN SCI, V8, P1127, DOI 10.1110/ps.8.5.1127
   Bhaduri A, 2004, PROTEINS, V54, P657, DOI 10.1002/prot.10638
   Brenner SE, 2000, NAT STRUCT BIOL, V7, P967, DOI 10.1038/80747
   Bujnicki JM, 2001, PROTEIN ENG, V14, P717, DOI 10.1093/protein/14.10.717
   Campos-Olivas R, 1999, J BIOMOL NMR, V15, P267, DOI 10.1023/A:1008327130654
   Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L
   Christendat D, 2000, NAT STRUCT BIOL, V7, P903
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Galvao-Botton LMP, 2003, FEBS LETT, V552, P207, DOI 10.1016/S0014-5793(03)00926-8
   Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Jung JW, 2004, J BIOCHEM MOL BIOL, V37, P28
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Li QZ, 2001, J THEOR BIOL, V213, P493, DOI 10.1006/jtbi.2001.2441
   Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002
   Liu Xin, 2004, J Bioinform Comput Biol, V2, P343, DOI 10.1142/S0219720004000594
   Meiler J, 2000, J BIOMOL NMR, V17, P283, DOI 10.1023/A:1008362931964
   MOREAU VH, 2004, BIOCHEMISTRY-US, V43, P142
   Onyango P, 2004, CURR CANCER DRUG TAR, V4, P111, DOI 10.2174/1568009043481588
   OSAPAY K, 1994, J BIOMOL NMR, V4, P215
   PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x
   PASTORE A, 1990, J MAGN RESON, V90, P165, DOI 10.1016/0022-2364(90)90375-J
   Pellecchia M, 1998, J BIOMOL NMR, V11, P229, DOI 10.1023/A:1008207111214
   Prestegard JH, 2001, BIOCHEMISTRY-US, V40, P8677, DOI 10.1021/bi0102095
   Rychlewski L, 1999, PROTEIN SCI, V8, P614
   SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002
   SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107
   SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516
   Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528
   Smith CV, 2003, CURR OPIN STRUC BIOL, V13, P658, DOI 10.1016/j.sbi.2003.10.004
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Thompson MJ, 1997, PROTEIN SCI, V6, P1963, DOI 10.1002/pro.5560060917
   Tjandra N, 1997, J AM CHEM SOC, V119, P9576, DOI 10.1021/ja9721374
   WILLIAMSON MP, 1990, BIOPOLYMERS, V29, P1428
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   WISHART DS, 1991, FEBS LETT, V293, P72, DOI 10.1016/0014-5793(91)81155-2
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
NR 43
TC 5
Z9 5
U1 0
U2 7
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PD DEC
PY 2006
VL 29
IS 4
BP 762
EP 770
DI 10.1590/S1415-47572006000400030
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 114JP
UT WOS:000242662800030
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Maia, LF
   Soares, MR
   Valente, AP
   Almeida, FCL
   Oliveira, AC
   Gomes, AMO
   Freitas, MS
   Schneemann, A
   Johnson, JE
   Silva, JL
AF Maia, Lenize F.
   Soares, Marcia R.
   Valente, Ana P.
   Almeida, Fabio C. L.
   Oliveira, Andrea C.
   Gomes, Andre M. O.
   Freitas, Monica S.
   Schneemann, Anette
   Johnson, John E.
   Silva, Jerson L.
TI Structure of a membrane-binding domain from a non-enveloped animal virus
   - Insights into the mechanism of membrane permeability and cellular
   entry
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FUSION PEPTIDE; FUNCTIONAL IMPLICATIONS; PORE FORMATION; HEMAGGLUTININ;
   SPECTROSCOPY; PROGRAM; MODELS; HELIX
AB The gamma 1-peptide is a 21-residue lipid-binding domain from the non-enveloped Flock House virus (FHV). Unlike enveloped viruses, the entry of non-enveloped viruses into cells is believed to occur without membrane fusion. In this study, we performed NMR experiments to establish the solution structure of a membrane-binding peptide from a small non-enveloped icosahedral virus. The three-dimensional structure of the FHV gamma(1)-domain was determined at pH 6.5 and 4.0 in a hydrophobic environment. The secondary and tertiary structures were evaluated in the context of the capacity of the peptide for permeabilizing membrane vesicles of different lipid composition, as measured by fluorescence assays. At both pH values, the peptide has a kinked structure, similar to the fusion domain from the enveloped viruses. The secondary structure was similar in three different hydrophobic environments as follows: water/trifluoroethanol, SDS, and membrane vesicles of different compositions. The ability of the peptide to induce vesicle leakage was highly dependent on the membrane composition. Although the gamma-peptide shares some structural properties to fusion domains of enveloped viruses, it did not induce membrane fusion. Our results suggest that small protein components such as the gamma-peptide in nodaviruses (such as FHV) and VP4 in picornaviruses have a crucial role in conducting nucleic acids through cellular membranes and that their structures resemble the fusion domains of membrane proteins from enveloped viruses.
C1 Univ Fed Rio de Janeiro, Programa Biol Estrutrural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941590 Rio De Janeiro, Brazil.
   Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutrural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM jerson@bioqmed.ufrj.br
RI Gomes, Andre/C-4009-2014; Almeida, Fabio/O-4989-2018; de Freitas, Monica
   Santos/E-8540-2015; Silva, Jerson/J-8984-2014; Valente, Ana
   Paula/J-3010-2017
OI Gomes, Andre/0000-0003-1052-8004; Almeida, Fabio/0000-0001-6046-7006; de
   Freitas, Monica Santos/0000-0003-3105-7918; Silva,
   Jerson/0000-0001-9523-9441; Valente, Ana Paula/0000-0001-7219-1123
CR AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9
   Chang DK, 1997, J VIROL, V71, P6593, DOI 10.1128/JVI.71.9.6593-6602.1997
   CHENG RH, 1994, STRUCTURE, V2, P271
   Corcoran JA, 2004, J BIOL CHEM, V279, P51386, DOI 10.1074/jbc.M406990200
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005
   Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X
   FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0
   FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990
   Glaser RW, 1999, BIOCHEMISTRY-US, V38, P2560, DOI 10.1021/bi982130e
   Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434
   Harrison Stephen C., 1996, P59
   Hinz A, 2005, EUR BIOPHYS J BIOPHY, V34, P285, DOI 10.1007/s00249-004-0450-z
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   Hsu CH, 2002, J BIOL CHEM, V277, P22725, DOI 10.1074/jbc.M200089200
   Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099
   Janshoff A, 1999, BIOCHEMISTRY-US, V38, P5328, DOI 10.1021/bi982976i
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200
   LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923
   Li YM, 2005, P NATL ACAD SCI USA, V102, P7529, DOI 10.1073/pnas.0408749102
   Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   MILLHAUSER GL, 1995, BIOCHEMISTRY-US, V34, P3873, DOI 10.1021/bi00012a001
   Nicol F, 2000, BIOPHYS J, V78, P818, DOI 10.1016/S0006-3495(00)76639-2
   Nieva JL, 2003, BBA-BIOMEMBRANES, V1614, P104, DOI 10.1016/S0005-2736(03)00168-8
   Oliveira AC, 2000, J BIOL CHEM, V275, P16037, DOI 10.1074/jbc.M910145199
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9
   Rohl CA, 1996, PROTEIN SCI, V5, P1687, DOI 10.1002/pro.5560050822
   Rossmann MG, 2000, VIROLOGY, V269, P239, DOI 10.1006/viro.2000.0258
   Schievano E, 2004, BIOCHEMISTRY-US, V43, P9343, DOI 10.1021/bi0496438
   Schneemann A, 1998, J VIROL, V72, P8738, DOI 10.1128/JVI.72.11.8738-8746.1998
   SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992
   Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X
   Schwarcz WD, 2004, CELL MOL BIOL, V50, P419
   Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238
   Wang LT, 2005, PROTEIN SCI, V14, P1661, DOI 10.1110/ps.051390405
   WUTHRICK K, 1986, PROTEINS NUCL ACIDS
NR 47
TC 24
Z9 24
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 29
PY 2006
VL 281
IS 39
BP 29278
EP 29286
DI 10.1074/jbc.M604689200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 086NO
UT WOS:000240680500083
PM 16861222
OA Bronze
DA 2020-12-01
ER

PT J
AU Cruzeiro-Silva, C
   Albernaz, FP
   Valente, AP
   Almeida, FCL
AF Cruzeiro-Silva, C
   Albernaz, FP
   Valente, AP
   Almeida, FCL
TI In-cell NMR spectroscopy - Inhibition of autologous protein expression
   reduces Escherichia coli lysis
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT 1st Latin-American-Protein-Society Meeting
CY NOV 08-12, 2004
CL Angra dos Reis, BRAZIL
SP Latin Amer Protein Soc
DE in-cell NMR; cell lysis; rifampicin; programmed cell death; thioredoxin;
   structure
ID MAGNETIC-RESONANCE-SPECTROSCOPY; DEATH; STATE; VIVO
AB Structural studies by in-cell nuclear magnetic resonance are a developing new field of research, and their objective is to obtain structural information of proteins and other biological macromolecules in the cytoplasm of Escherichia coli cells. The major limitation of in-cell experiments is cell lysis that occurs during the experiments. In this article, we describe how inhibition of autologous expression by rifampicin at a high concentration decreases cell lysis in E. coh. We suggest that rifampicin is acting in the programmed cell death gene system MazEF, which is triggered by stress conditions and ultimately leads to cell lysis.
C1 UFRJ, Programa Biol Estrutural, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas CNRMN, Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), UFRJ, Programa Biol Estrutural, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas CNRMN, Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006
CR Almeida FCL, 2001, J MAGN RESON, V148, P142, DOI 10.1006/jmre.2000.2213
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Galvao-Botton LMP, 2003, FEBS LETT, V552, P207, DOI 10.1016/S0014-5793(03)00926-8
   Hubbard JA, 2003, MOL MICROBIOL, V49, P1191, DOI 10.1046/j.1365-2958.2003.03628.x
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000
   Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984
   Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001
   Serber Z, 2004, J AM CHEM SOC, V126, P7119, DOI 10.1021/ja049977k
   Serber Z, 2001, J AM CHEM SOC, V123, P8895, DOI 10.1021/ja0112846
   Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w
   Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528
   Shimba N, 2003, BIOCHEMISTRY-US, V42, P9227, DOI 10.1021/bi0344679
   Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004
NR 14
TC 12
Z9 13
U1 1
U2 5
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2006
VL 44
IS 3
BP 497
EP 502
DI 10.1385/CBB:44:3:497
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 040TR
UT WOS:000237403800020
PM 16679537
DA 2020-12-01
ER

PT J
AU Valente, AP
   Miyamoto, CA
   Almeida, FCL
AF Valente, A. P.
   Miyamoto, C. A.
   Almeida, F. C. L.
TI Implications of protein conformational diversity for binding and
   development of new biological active compounds
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
ID RESIDUAL DIPOLAR COUPLINGS; PHAGE DISPLAY LIBRARIES; BACKBONE DYNAMICS;
   CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; ALLOSTERIC MECHANISM; DOMAIN
   FLEXIBILITY; ALPHA-SYNUCLEIN; MODEL; RELAXATION
AB The new generation of biologically active compounds developed during the 20(th) century relied on knowledge of enzymology and protein structure, and were based initially, on the understanding that protein-protein and small molecule-protein interactions occurred through a lock-and-key mechanism. Later, evidence suggested that this mechanism was usually followed by a conformational change, known as induced fit. Recent studies on protein dynamics, mainly by nuclear magnetic resonance (NMR) relaxation measurements, have shown that proteins are not structured in a unique conformation. Rather, they frequently have regions of conformational diversity.
   In the present review we will discuss a novel view of binding, put forward in by several research groups in the last 5 to 10 years. In the free state, protein regions displaying conformational diversity exhibit equilibria among pre-existing conformations. In the presence of a ligand, one of these conformations is stabilized. so that the ligand does not need to induce a new conformation. Upon ligand binding there is a population shift toward the bound conformational state. Conformational diversity of binding sites of several proteins has been measured and has important practical as well as thermodynamical consequences: binding sites can be mapped without prior knowledge of the ligand and also evolution of binding sites depends mostly on the free state, occurring at least partially independently of the ligand.
C1 Fed Univ Rio De Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Program Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), Fed Univ Rio De Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Program Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123
CR Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3
   Alberts IL, 2005, J MED CHEM, V48, P6585, DOI 10.1021/jm050196j
   Almeida FCL, 1997, J MAGN RESON, V124, P509, DOI 10.1006/jmre.1996.1091
   Almeida FCL, 1997, J MOL BIOL, V270, P481, DOI 10.1006/jmbi.1997.1114
   Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802
   Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006
   Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m
   Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e
   Giedroc DP, 2001, J BIOL CHEM, V276, P42322, DOI 10.1074/jbc.M106517200
   Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Kay LE, 1998, BIOCHEM CELL BIOL, V76, P145, DOI 10.1139/bcb-76-2-3-145
   Korzhnev DM, 2003, PROTEIN SCI, V12, P56, DOI 10.1110/ps.0225403
   Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Lippens G, 2006, PROTEIN PEPTIDE LETT, V13, P235, DOI 10.2174/092986606775338461
   Liu DJ, 2001, J MOL BIOL, V314, P543, DOI 10.1006/jmbi.2001.5146
   Lu JY, 2003, J MOL BIOL, V330, P799, DOI 10.1016/S0022-2836(03)00629-6
   McKercher SR, 2003, P NATL ACAD SCI USA, V100, P511, DOI 10.1073/pnas.0136910100
   Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y
   Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Ramboarina S, 2002, J MOL BIOL, V316, P611, DOI 10.1006/jmbi.2001.5379
   Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200
   Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c
   Seeliger MA, 2005, J BIOL CHEM, V280, P30448, DOI 10.1074/jbc.M501450200
   Shapiro YE, 2002, BIOCHEMISTRY-US, V41, P6271, DOI 10.1021/bi012132q
   Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200
   Soares MR, 2004, FEBS LETT, V560, P134, DOI 10.1016/S0014-5793(04)00088-2
   Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947
   Tinoco LW, 2002, J BIOL CHEM, V277, P36351, DOI 10.1074/jbc.M204225200
   Tugarinov V, 2002, J MOL BIOL, V315, P155, DOI 10.1006/jmbi.2001.5231
   Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f
   Venkitaramani DV, 2005, PROTEIN SCI, V14, P1894, DOI 10.1110/ps.051412605
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001
   Wang CY, 2003, MAGN RESON CHEM, V41, P866, DOI 10.1002/mrc.1262
   Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819
   Yao SG, 2004, BIOCHEMISTRY-US, V43, P11187, DOI 10.1021/bi049456+
   Yuan Y, 2002, J MOL BIOL, V321, P863, DOI 10.1016/S0022-2836(02)00704-0
   Zurita AJ, 2003, J CONTROL RELEASE, V91, P183, DOI 10.1016/S0168-3659(03)00236-0
NR 48
TC 36
Z9 37
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2006
VL 13
IS 30
BP 3697
EP 3703
DI 10.2174/092986706779026147
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 105AW
UT WOS:000242002700006
PM 17168731
DA 2020-12-01
ER

PT J
AU Pinheiro, AS
   Amorim, GC
   Netto, LES
   Valente, AP
   Almeida, FCL
AF Pinheiro, Anderson S.
   Amorim, Gisele C.
   Netto, Luis E. S.
   Valente, Ana Paula
   Almeida, Fabio C. L.
TI H-1, C-13 and N-15 resonance assignments for the reduced forms of
   thioredoxin 1 and 2 from S-cerevisiae
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941590 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Biociencias, BR-05508 Sao Paulo, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, BR-21941590 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Pinheiro, Anderson S/B-6350-2014; Netto, Luis/A-3783-2008; Valente, Ana
   Paula/J-3010-2017; Amorim, Gisele/D-7876-2013; Almeida,
   Fabio/O-4989-2018; Amorim, Gisele/O-9231-2019
OI Netto, Luis/0000-0002-4250-9177; Valente, Ana Paula/0000-0001-7219-1123;
   Amorim, Gisele/0000-0003-4348-9515; Almeida, Fabio/0000-0001-6046-7006;
   Amorim, Gisele/0000-0003-4348-9515; Pinheiro,
   Anderson/0000-0001-5118-6931
CR Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102
NR 1
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PY 2006
VL 36
SU 1
BP 35
EP 35
DI 10.1007/s10858-006-0025-7
PG 1
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 116XG
UT WOS:000242836500035
PM 16609834
DA 2020-12-01
ER

PT J
AU Ferrao-Gonzales, AD
   Robbs, BK
   Moreau, VH
   Ferreira, A
   Juliano, L
   Valente, AP
   Almeida, FCL
   Silva, JL
   Foguel, D
AF Ferrao-Gonzales, AD
   Robbs, BK
   Moreau, VH
   Ferreira, A
   Juliano, L
   Valente, AP
   Almeida, FCL
   Silva, JL
   Foguel, D
TI Controlling beta-amyloid oligomerization by the use of naphthalene
   sulfonates - Trapping low molecular weight oligomeric species
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ALZHEIMERS-DISEASE; FIBRIL FORMATION; COMMON MECHANISM; DYES ATTENUATE;
   PRION PROTEIN; PEPTIDE; AGGREGATION; DEPOSITION; INHIBITION; TOXICITY
AB Aggregation of proteins and peptides has been shown to be responsible for several diseases known as amyloidoses, which include Alzheimer disease ( AD), prion diseases, among several others. AD is a neurodegenerative disorder caused primarily by the aggregation of beta-amyloid peptide (A beta). Here we describe the stabilization of small oligomers of A beta by the use of sulfonated hydrophobic molecules such as AMNS (1-amino-5-naphthalene sulfonate); 1,8-ANS (1-anilinonaphthalene-8-sulfonate) and bis-ANS (4,4'-dianilino1,1'-binaphthyl-5,5'-disulfonate). The experiments were performed with either A beta-1-42 or with A beta-13-23, a shorter version of A beta that is still able to form amyloid fibrils in vitro and contains amino acid residues 16 - 20, previously shown to be essential to peptide-peptide interaction and fibril formation. All sulfonated molecules tested were able to prevent A beta aggregation in a concentration dependent fashion in the following order of efficacy: 1,8ANS< AMNS< bis-ANS. Size exclusion chromatography revealed that in the presence of bis-ANS, A beta forms a heterogeneous population of low molecular weight species that proved to be toxic to cell cultures. Since the ANS compounds all have apolar rings and negative charges ( sulfonate groups), both hydrophobic and electrostatic interactions may contribute to interpeptide contacts that lead to aggregation. We also performed NMR experiments to investigate the structure of A beta-13-23 in SDSmicelles and found features of an alpha-helix from Lys(16) to Phe(20). H-1 TOCSY spectra of A beta-13 - 23 in the presence of AMNS displayed a chemical-shift dispersion quite similar to that observed in SDS, which suggests that in the presence of AMNS this peptide might adopt a conformation similar to that reported in the presence of SDS. Taken together, our studies provide evidence for the crucial role of small oligomers and their stabilization by sulfonate hydrophobic compounds.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Sao Paulo, Dept Biofis, BR-04023900 Sao Paulo, Brazil.
RP Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Av Bauhinia 400, BR-21941590 Rio De Janeiro, Brazil.
EM foguel@bioqmed.ufrj.br
RI Robbs, Bruno/H-5553-2013; Valente, Ana Paula/J-3010-2017; Juliano,
   Luiz/D-7204-2012; Silva, Jerson/J-8984-2014; Moreau, Vitor
   Hugo/B-8865-2009; Moreau, Vitor Hugo/J-4829-2015; Gonzales, Astria Dias
   Ferrao-/D-3288-2015; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Juliano,
   Luiz/0000-0002-5589-2822; Silva, Jerson/0000-0001-9523-9441; Moreau,
   Vitor Hugo/0000-0002-5393-0645; Gonzales, Astria Dias
   Ferrao-/0000-0003-4144-5244; Almeida, Fabio/0000-0001-6046-7006; Robbs,
   Bruno/0000-0002-3972-5530; Foguel, Debora/0000-0001-7312-7115
CR Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f
   Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200
   Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200
   De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200
   Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002
   Dong MQ, 1996, J BIOL CHEM, V271, P28875, DOI 10.1074/jbc.271.46.28875
   Esler WP, 1997, NAT BIOTECHNOL, V15, P258, DOI 10.1038/nbt0397-258
   Fletcher TG, 1997, PROTEIN SCI, V6, P666
   Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361
   Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100
   GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8
   Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283
   Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999
   JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x
   JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328
   KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503
   KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143
   Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010
   Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g
   LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106
   Li LP, 1999, BIOPHYS J, V76, P2871, DOI 10.1016/S0006-3495(99)77442-4
   Liu YB, 1997, J NEUROCHEM, V69, P2285
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   MAY PC, 1992, NEUROBIOL AGING, V13, P605, DOI 10.1016/0197-4580(92)90064-5
   MAZUMDAR M, 1992, BIOCHEMISTRY-US, V31, P6470, DOI 10.1021/bi00143a016
   Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x
   Nakagami Y, 2002, EUR J PHARMACOL, V457, P11, DOI 10.1016/S0014-2999(02)02657-2
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I
   POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T
   Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a
   Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x
   Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631
   Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066
   Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6
   SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0
   SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1
   Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109
   STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x
   SUMNERMAKIN O, 2005, P NATL ACAD SCI USA, V102, P315
   TALAFOUS J, 1994, BIOCHEMISTRY-US, V33, P7788, DOI 10.1021/bi00191a006
   TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10658, DOI 10.1021/bi00091a016
   Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545
   Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619
   Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101
   Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9
   Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364
   WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003
NR 67
TC 57
Z9 58
U1 0
U2 16
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 14
PY 2005
VL 280
IS 41
BP 34747
EP 34754
DI 10.1074/jbc.M501651200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 971SD
UT WOS:000232403900046
PM 16041062
OA Bronze
DA 2020-12-01
ER

PT J
AU Giordano, RJ
   Anobom, CD
   Cardo-Veila, M
   Kalil, J
   Valente, AP
   Pasqualini, R
   Almeida, FCL
   Arap, W
AF Giordano, RJ
   Anobom, CD
   Cardo-Veila, M
   Kalil, J
   Valente, AP
   Pasqualini, R
   Almeida, FCL
   Arap, W
TI Structural basis for the interaction of a vascular endothelial growth
   factor mimic peptide motif and its corresponding receptors
SO CHEMISTRY & BIOLOGY
LA English
DT Article
ID VEGF; BINDING; ANGIOGENESIS; NEUROPILIN-1; TARGET; CANCER; NEUROGENESIS;
   SPECTROSCOPY; BEVACIZUMAB; DISCOVERY
AB Vascular endothelial growth factor (VEGF) is central to the survival and development of the vascular and nervous systems. We screened phage display libraries and built a peptide-based ligand-receptor map of binding sites within the VEGF family. We then validated a cyclic peptide, CPQPRPLC, as a VEGF-mimic that binds specifically to neuropilin-1 and VEGF receptor-1. Here, we use NMR spectroscopy to understand the structural basis of the interaction between our mimic peptide and the VEGF receptors. We show that: (1) CPQPRPLC has multiple interactive conformations; (2) receptor binding is mediated by the motif Arg-Pro-Leu; and (3) the Pro residue within Arg-Pro-Leu participates in binding to neuropilin-1 but not to VEGF receptor-1, perhaps representing an evolutionary gain-of-function. Therefore, Arg-Pro-Leu is a differential ligand motif to VEGF receptors and a candidate peptidomimetic lead for VEGF pathway modulation.
C1 Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA.
   Univ Fed Rio de Janeiro, Inst Med Biochem, Natl Ctr Nucl Magnet Resonance, BR-21941 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Sch Med, Inst Heart, BR-05403 Sao Paulo, SP, Brazil.
RP Pasqualini, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA.
EM rpasqual@mdanderson.org; falmeida@cnrmn.bioqmed.ufrj.br;
   warap@mdanderson.org
RI Bom, Cristiane Dinis Ano/X-9461-2019; Valente, Ana Paula/J-3010-2017;
   Almeida, Fabio/O-4989-2018; Giordano, Ricardo/A-2074-2010; KALIL,
   JORGE/C-8029-2012
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Giordano, Ricardo/0000-0001-8116-6771; KALIL,
   JORGE/0000-0001-8415-4274
CR ABRAGAM A, 1961, INT SERIES MONOGRAPH, V32, P264
   Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121
   Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Burg MA, 1999, CANCER RES, V59, P2869
   Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   COOKE RM, 1996, NMR DRUG DESIGN, P245
   Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008
   Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3
   Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Folkman J, 2003, CANCER BIOL THER, V2, pS127
   Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499
   Kawasaki T, 1999, DEVELOPMENT, V126, P4895
   Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731
   Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217
   Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X
   Pasqualini R, 2000, CANCER RES, V60, P722
   Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72
   Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140
   Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3
   Vogel G, 2005, SCIENCE, V307, P665, DOI 10.1126/science.307.5710.665
   Weinstein BM, 2005, CELL, V120, P299, DOI 10.1016/j.cell.2005.01.010
   Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491
   Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293
NR 34
TC 36
Z9 36
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-5521
EI 1879-1301
J9 CHEM BIOL
JI Chem. Biol.
PD OCT
PY 2005
VL 12
IS 10
BP 1075
EP 1083
DI 10.1016/j.chembiol.2005.07.008
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 981GZ
UT WOS:000233077000006
PM 16242650
OA Bronze
DA 2020-12-01
ER

PT J
AU Valente, AP
   Almeida, FCL
   Nakaie, CR
   Schreier, S
   Crusca, E
   Cilli, EM
AF Valente, AP
   Almeida, FCL
   Nakaie, CR
   Schreier, S
   Crusca, E
   Cilli, EM
TI Study of the effect of the peptide loading and solvent system in SPPS by
   HRMAS-NMR
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE NMR; high-resolution magic angle spinning; solid-phase synthesis; resin;
   peptide
ID SOLID-PHASE-SYNTHESIS; HIGH-RESOLUTION H-1-NMR; ORGANIC-SYNTHESIS;
   SECONDARY STRUCTURE; CHAIN AGGREGATION; SOLVATION; SPECTRA; RESINS;
   MODEL; EPR
AB The SPPS methodology has continuously been investigated as a valuable model to monitor the solvation properties of polymeric materials. In this connection, the present work applied HRMAS-NMR spectroscopy to examine the dynamics of an aggregating peptide sequence attached to a resin core with varying peptide loading (up to 80%) and solvent system. Low and high substituted BHAR were used for assembling the VQAAIDYING sequence and some of its minor fragments. The HRMAS-NMR results were in agreement with the swelling of each resin, i.e. there was an improved resolution of resonance peaks in the better solvated conditions. Moreover, the peptide loading and the attached peptide sequence also affected the spectra. Strong peptide chain aggregation was observed mainly in highly peptide loaded resins when solvated in CDCl3. Conversely, due to the better swelling of these highly loaded resins in DMSO, improved NMR spectra were acquired in this polar aprotic solvent, thus enabling the detection of relevant sequence-dependent conformational alterations. The more prominent aggregation was displayed by the VQAAIDYING segment and not by any of its intermediary fragments and these findings were also corroborated by EPR studies of these peptide-resins labelled properly with an amino acid-type spin probe. Copyright (c) 2005 European Peptide Society and John Wiley & Sons, Ltd.
C1 UNESP, Dept Biochem & Chem Technol, BR-14800900 Araraquara, SP, Brazil.
   Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05599970 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Dept Biophys, BR-04044020 Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Dept Med Biochem, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Rio de Janeiro, Brazil.
RP Cilli, EM (corresponding author), UNESP, Dept Biochem & Chem Technol, Rua Prof Francisco Degnt S-N Bairro Quitandinha, BR-14800900 Araraquara, SP, Brazil.
EM cilli@iq.unesp.br
RI Valente, Ana Paula/J-3010-2017; Schreier, Shirley/F-7001-2014; Nakaie,
   Clovis R./B-3444-2014; Crusca, Edson/B-3370-2013; Cilli, Eduardo
   Maffud/K-1857-2019; Cilli, Eduardo Maffud/B-9130-2012; Almeida,
   Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Cilli, Eduardo
   Maffud/0000-0002-4767-0904; Almeida, Fabio/0000-0001-6046-7006; Crusca,
   Edson/0000-0002-7519-049X
CR Barany G, 1980, PEPTIDES ANAL SYNTHE
   Berliner LJ, 1989, BIOL MAGNETIC RESONA
   BEYERMANN M, 1992, TETRAHEDRON LETT, V33, P3745, DOI 10.1016/S0040-4039(00)92003-3
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Cilli EM, 1999, J ORG CHEM, V64, P9118, DOI 10.1021/jo991035o
   Cilli EM, 2000, J BRAZIL CHEM SOC, V11, P474
   Cilli EM, 1997, TETRAHEDRON LETT, V38, P517, DOI 10.1016/S0040-4039(96)02363-5
   Cilli EM, 1996, J ORG CHEM, V61, P8992, DOI 10.1021/jo9611632
   Dhalluin C, 1997, J AM CHEM SOC, V119, P10494, DOI 10.1021/ja971795l
   DIMROTH K, 1963, LIEBIGS ANN CHEM, V661, P1
   FITCH WL, 1994, J ORG CHEM, V59, P7955, DOI 10.1021/jo00105a006
   Furrer J, 2002, MAGN RESON CHEM, V40, P123, DOI 10.1002/mrc.970
   Furrer J, 2001, J AM CHEM SOC, V123, P4130, DOI 10.1021/ja003566w
   GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001
   HANCOCK WS, 1973, J ORG CHEM, V38, P774, DOI 10.1021/jo00944a033
   HENDRIX JC, 1990, J ORG CHEM, V55, P4517, DOI 10.1021/jo00302a009
   Henkel B, 1998, J PEPT SCI, V4, P461, DOI 10.1002/(SICI)1099-1387(199812)4:8<461::AID-PSC165>3.3.CO;2-3
   Jelinek R, 1997, J MAGN RESON, V125, P185, DOI 10.1006/jmre.1996.1099
   Keifer PA, 1996, J ORG CHEM, V61, P1558, DOI 10.1021/jo952001t
   KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521
   Lancelot N, 2003, CHEM-EUR J, V9, P1317, DOI 10.1002/chem.200390151
   Lippens G, 2002, J MAGN RESON, V156, P242, DOI 10.1006/jmre.2002.2561
   LUDWICK AG, 1986, J AM CHEM SOC, V108, P6493, DOI 10.1021/ja00281a007
   Malavolta L, 2002, TETRAHEDRON, V58, P4383, DOI 10.1016/S0040-4020(02)00417-9
   MARCHETTO R, 1993, J AM CHEM SOC, V115, P11042, DOI 10.1021/ja00076a093
   MARCHETTO R, 1992, J BRAZIL CHEM SOC, V3, P30
   MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025
   Oliveira E, 2002, EUR J ORG CHEM, V2002, P3686
   PIETTA PG, 1974, J ORG CHEM, V39, P44, DOI 10.1021/jo00915a008
   PILLAI VNR, 1981, ACCOUNTS CHEM RES, V14, P122, DOI 10.1021/ar00064a005
   Pinciroli V, 2001, J COMB CHEM, V3, P434, DOI 10.1021/cc000101t
   Pop IE, 1996, TETRAHEDRON, V52, P12209, DOI 10.1016/0040-4020(96)00701-6
   Rahman SS, 1998, J ORG CHEM, V63, P6196, DOI 10.1021/jo980258w
   Ribeiro SCF, 2001, TETRAHEDRON LETT, V42, P3243, DOI 10.1016/S0040-4039(01)00414-2
   Rousselot-Pailley P, 2001, J COMB CHEM, V3, P559, DOI 10.1021/cc010019d
   Rousselot-Pailley P, 2003, J PEPT SCI, V9, P47, DOI 10.1002/psc.431
   Sasikumar PG, 2003, J PEPT RES, V62, P1, DOI 10.1034/j.1399-3011.2003.00057.x
   SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   STEWART JM, 1984, SOLID PHASE PEPTIDE
   Vaino AR, 2000, J COMB CHEM, V2, P330, DOI 10.1021/cc000007c
   Warrass R, 2000, J AM CHEM SOC, V122, P1789, DOI 10.1021/ja993718r
   Warrass R, 2000, J ORG CHEM, V65, P2946, DOI 10.1021/jo9914824
NR 43
TC 9
Z9 10
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD SEP
PY 2005
VL 11
IS 9
BP 556
EP 563
DI 10.1002/psc.659
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 963UE
UT WOS:000231830700005
PM 15880628
DA 2020-12-01
ER

PT J
AU Nadra, AD
   Eliseo, T
   Mok, YK
   Almeida, FCL
   Bycroft, M
   Paci, M
   Prat-Gay, G
   Cicero, DO
AF Nadra, AD
   Eliseo, T
   Mok, YK
   Almeida, FCL
   Bycroft, M
   Paci, M
   Prat-Gay, G
   Cicero, DO
TI Solution structure of the HPV-16 E2 DNA binding domain, a
   transcriptional regulator with a dimeric beta-barrel fold
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Letter
DE dimer protein structure; E2 DNA binding domain; papillomavirus; RDC
ID RESIDUAL DIPOLAR COUPLINGS; HUMAN-PAPILLOMAVIRUS; NMR; PROTEINS;
   DISCRIMINATION; REFINEMENT; LEUCINE
C1 Fac Ciencias Exactas & Nat UBA, CONICET, Inst Invest Bioquim Fdn Leloir, RA-1405 Buenos Aires, DF, Argentina.
   Univ Roma La Sapienza, Dipt Chim, Rome, Italy.
   Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, Ctr Nacl Ressonan Magnet Nucl, BR-21914590 Rio De Janeiro, Brazil.
   Hong Kong Univ Sci & Technol, Clear Water Bay, Hong Kong, Kowloon, Peoples R China.
   MRC Ctr Protein Engn, MRC Lab Molec Biol, Cambridge CB2 2QH, England.
   Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Prat-Gay, G (corresponding author), Fac Ciencias Exactas & Nat UBA, CONICET, Inst Invest Bioquim Fdn Leloir, Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
EM gpratgay@leloir.org.ar; cicero@scienze.uniroma2.it
RI Mok, Yu Keung/H-8019-2012; Bycroft, Mark/D-9446-2017; Almeida,
   Fabio/O-4989-2018; Nadra, Alejandro/A-5668-2009
OI Mok, Yu Keung/0000-0002-2829-4878; Almeida, Fabio/0000-0001-6046-7006;
   Nadra, Alejandro/0000-0002-7860-3245; Prat Gay,
   Gonzalo/0000-0001-5748-6863
CR BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070
   Bewley CA, 2000, J AM CHEM SOC, V122, P6009, DOI 10.1021/ja000858o
   Bussiere DE, 1998, ACTA CRYSTALLOGR D, V54, P1367, DOI 10.1107/S0907444998005587
   Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345
   Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k
   Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827
   Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009
   Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r
   HEDGE RS, 1992, NATURE, V359, P505
   HEDGE RS, 2002, ANNU REV BIOPH BIOM, V31, P343
   Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200
   Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w
   Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711
   NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003
   ODonoghue SI, 1996, J BIOMOL NMR, V8, P193, DOI 10.1007/BF00211165
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   VANDIJK AA, 1992, BIOCHEMISTRY-US, V31, P9063, DOI 10.1021/bi00152a050
   Veeraraghavan S, 1999, BIOCHEMISTRY-US, V38, P16115, DOI 10.1021/bi991633x
   Vermeulen A, 2000, J AM CHEM SOC, V122, P9638, DOI 10.1021/ja001919l
NR 19
TC 24
Z9 25
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD OCT
PY 2004
VL 30
IS 2
BP 211
EP 214
DI 10.1023/B:JNMR.0000048942.96866.76
PG 4
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 872PJ
UT WOS:000225219400013
PM 15702528
DA 2020-12-01
ER

PT J
AU Moreau, VH
   da Silva, AC
   Siloto, RMP
   Valente, AP
   Leite, A
   Almeida, FCL
AF Moreau, VH
   da Silva, AC
   Siloto, RMP
   Valente, AP
   Leite, A
   Almeida, FCL
TI The bZIP region of the plant transcription factor opaque-2 forms stable
   homodimers in solution and retains its helical structure upon subunit
   dissociation
SO BIOCHEMISTRY
LA English
DT Article
ID LEUCINE-ZIPPER; COILED COILS; PROTEIN; DOMAIN; BINDING; GENE;
   TRANSITION; MAIZE; GCN4; DNA
AB Opaque-2 (O2) is a plant bZIP transcription factor that regulates the expression of alpha and beta prolamines, the main storage proteins in seeds of cereals such as maize and Coix. One of the main processes modulating O2 activity is the heterodimerization with other bZIP transcription factors, but the primary mechanism underlying the partner choice is still unknown. In this paper, we have characterized the bZIP domain of O2 by nuclear magnetic resonance (NMR), circular dichroism (CD), and size-exclusion chromatography. Results obtained from CD measurements suggested that the native O2bZIP has about 40 of its 49 leucine-zipper residues in helical structure, while the DNA-binding domain is completely unstructured. Diffusion-ordered NMR spectroscopy and size-exclusion chromatography showed that O2 forms homodimers in solution. Thermal denaturation experiments indicate that O2 reversibly undergoes dissociation and unfolding in a process that is fully dependent on the protein concentration. Subunit dissociation of O2bZIP dimers, upon dilution of the protein, led to partially folded monomers that retained similar to80% of the native CD ellipticity at 222 net. We believe that the existence of partially folded monomers could decrease the entropic penalty for helix formation involved in the DNA binding and in the subunit association of O2bZIP. Stabilization of partially folded monomers may also play a significant role in the dimerization of O2 with other bZIP transcription factors and, consequently, can be important for the regulation of the biological functions of O2 in plants.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, CNRMN, Rio De Janeiro, Brazil.
   Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Campinas, Brazil.
RP Moreau, VH (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, CNRMN, Rio De Janeiro, Brazil.
EM vitorhm@bioqmed.ufrj.br
RI Moreau, Vitor Hugo/B-8865-2009; Scott, M. Paul/E-3291-2010; Almeida,
   Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017; Moreau, Vitor
   Hugo/J-4829-2015
OI Almeida, Fabio/0000-0001-6046-7006; Valente, Ana
   Paula/0000-0001-7219-1123; Moreau, Vitor Hugo/0000-0002-5393-0645
CR Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r
   Arruda P, 2000, TRENDS PLANT SCI, V5, P324, DOI 10.1016/S1360-1385(00)01688-5
   Bosshard HR, 2001, BIOCHEMISTRY-US, V40, P3544, DOI 10.1021/bi002161l
   Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033
   Boysen RI, 2002, J BIOL CHEM, V277, P23, DOI 10.1074/jbc.M104556200
   Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2708, DOI 10.1021/bi9923555
   Cantor C. R., 1980, TECHNIQUES STUDY BIO
   d'Avignon DA, 1999, BIOPHYS J, V76, P2752
   Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e
   Durr E, 2000, BIOCHEMISTRY-US, V39, P4472, DOI 10.1021/bi992948f
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235
   Grossmann JG, 2001, BIOCHEMISTRY-US, V40, P6267, DOI 10.1021/bi0028946
   HVIDT S, 1985, BIOPOLYMERS, V24, P1647, DOI 10.1002/bip.360240902
   Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3
   Jean-Francois N, 2003, J MOL BIOL, V326, P1577, DOI 10.1016/S0022-2836(03)00029-9
   Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663
   Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762
   LEHRER SS, 1991, BIOCHEMISTRY-US, V30, P5682, DOI 10.1021/bi00237a007
   Loening NM, 2001, J MAGN RESON, V153, P103, DOI 10.1006/jmre.2001.2423
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Mohanty D, 1999, BIOPHYS J, V77, P54, DOI 10.1016/S0006-3495(99)76872-4
   MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071
   Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9
   NETO GC, 1995, PLANT MOL BIOL, V27, P1015, DOI 10.1007/BF00037028
   ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017
   OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3
   PYSH LD, 1993, PLANT CELL, V5, P227, DOI 10.1105/tpc.5.2.227
   SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P1310, DOI 10.1021/bi00219a022
   SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   Stone JR, 2002, J BIOL CHEM, V277, P5448, DOI 10.1074/jbc.M109815200
   Vettore AL, 1998, PLANT MOL BIOL, V36, P249, DOI 10.1023/A:1005995806897
   Vincentz M, 1997, PLANT MOL BIOL, V34, P879, DOI 10.1023/A:1005874404706
   WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Zeng X, 1997, P NATL ACAD SCI USA, V94, P3673, DOI 10.1073/pnas.94.8.3673
NR 41
TC 9
Z9 10
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 27
PY 2004
VL 43
IS 16
BP 4862
EP 4868
DI 10.1021/bi035905e
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 814IH
UT WOS:000220967900025
PM 15096055
DA 2020-12-01
ER

PT J
AU Soares, MR
   Bisch, PM
   de Carvalho, ACC
   Valente, AP
   Almeida, FCL
AF Soares, MR
   Bisch, PM
   de Carvalho, ACC
   Valente, AP
   Almeida, FCL
TI Correlation between conformation and antibody binding: NMR structure of
   cross-reactive peptides from T. cruzi, human and L-braziliensis
SO FEBS LETTERS
LA English
DT Article
DE ribosomal P protein; Chagas' disease; nuclear magnetic resonance;
   molecular recognition
ID CHAGAS HEART-DISEASE; RIBOSOMAL P-PROTEINS; TRYPANOSOMA-CRUZI; EPITOPE;
   AUTOANTIBODIES; AUTOIMMUNITY; SPECTROSCOPY; RECEPTOR; ANTIGEN; PROGRAM
AB The structure of peptides corresponding to the C-terminal residues from Trypanosoma cruzi (R13), human (H13) and Leishmania braziliensis (A13) ribosomal proteins were determined using nuclear magnetic resonance. Although there is only one amino acid difference between them, the peptides present distinct structures in solution: R13 adopts a random coil conformation while H13 and A13 form a bend. Interaction of these peptides with polyclonal antibodies from chronic Chagas' disease patients and a monoclonal antibody raised against T. cruzi ribosomal P2beta protein was probed by transferred NOE. The results show that the flexibility of R13 is fundamental for the binding to the antibody. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Fed Rio de Janeiro, ICB, CCS, Dept Bioquim Med,Ctr Nacl Ressonancia Magnet Nucl, BR-21941950 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941950 Rio De Janeiro, Brazil.
   Albert Einstein Coll Med, Bronx, NY 10461 USA.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, ICB, CCS, Dept Bioquim Med,Ctr Nacl Ressonancia Magnet Nucl, Av Brigadeiro Trompowiski S-N,CCS Bloco E Sala 10, BR-21941950 Rio De Janeiro, Brazil.
EM falmeida@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; de Carvalho, Antonio Campos/A-3152-2008;
   Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; de Carvalho, Antonio
   Campos/0000-0002-0062-3043; Almeida, Fabio/0000-0001-6046-7006
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [1R01 HL 073732-01] Funding Source: Medline; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [R01HL073732, R01HL073732,
   R01HL073732, R01HL073732, R01HL073732, R01HL073732, R01HL073732,
   R01HL073732] Funding Source: NIH RePORTER
CR BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BORDA E, 1984, CLIN EXP IMMUNOL, V57, P679
   BRENER Z, 1979, TRYPANOSOMA CRUZI
   BRENER Z, 1992, IMMUNE RESPONSE IMMU
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1
   CHURCHILL MEA, 1994, J MOL BIOL, V241, P534, DOI 10.1006/jmbi.1994.1530
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   CUNHANETO E, 1995, REV SOC CARDIOL, V5, P217
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   FERRARI I, 1995, J EXP MED, V182, P59, DOI 10.1084/jem.182.1.59
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Leon JS, 2001, INT J PARASITOL, V31, P555, DOI 10.1016/S0020-7519(01)00163-1
   LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530
   LEVIN MJ, 1990, MEM I OSWALDO CRUZ, V85, P539, DOI 10.1590/S0074-02761990000400028
   LEVITUS G, 1991, CLIN EXP IMMUNOL, V85, P413, DOI 10.1111/j.1365-2249.1991.tb05741.x
   Mahler E, 2001, EUR J IMMUNOL, V31, P2210, DOI 10.1002/1521-4141(200107)31:7&lt;2210::AID-IMMU2210&gt;3.0.CO;2-J
   Masuda MO, 1998, FASEB J, V12, P1551
   Mayo KH, 1997, METHOD ENZYMOL, V289, P646
   MESRI EA, 1990, J CLIN MICROBIOL, V28, P1219, DOI 10.1128/JCM.28.6.1219-1224.1990
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3
   Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 31
TC 14
Z9 15
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD FEB 27
PY 2004
VL 560
IS 1-3
BP 134
EP 140
DI 10.1016/S0014-5793(04)00088-2
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 779YA
UT WOS:000189328900026
PM 14988012
DA 2020-12-01
ER

PT J
AU Ishimaru, D
   Maia, LF
   Maiolino, LM
   Quesado, PA
   Lopez, PCM
   Almeida, FCL
   Valente, AP
   Silva, JL
AF Ishimaru, D
   Maia, LF
   Maiolino, LM
   Quesado, PA
   Lopez, PCM
   Almeida, FCL
   Valente, AP
   Silva, JL
TI Conversion of wild-type p53 core domain into a conformation that mimics
   a hot-spot mutant
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE tumor suppressor protein; metastable state; folding intermediate; NMR;
   high hydrostatic pressure
ID HIGH HYDROSTATIC-PRESSURE; DNA-BINDING DOMAIN; STRUCTURAL-CHANGES;
   PROTEIN; DISSOCIATION; STABILITY; STATE; TEMPERATURE; RESCUE;
   METASTABILITY
AB The wild-type p53 protein can be driven into a conformation corresponding to that adopted by structural mutant forms by heterodimerization with a mutant subunit. To seek partially folded states of the wild-type p53 core domain (p53C) we used high hydrostatic pressure (HP) and subzero temperatures. Aggregation of the protein was observed in parallel with its pressure denaturation at 25 and 37 degreesC. However, when HP experiments were performed at 4 degreesC, the extent of denaturation and aggregation was significantly less pronounced. On the other hand, subzero temperatures under pressure led to cold denaturation and yielded a non-aggregated, alternative conformation of p53C. Nuclear magnetic resonance ((HN)-H-1-N-15-NMR) data showed that the alternative p53C conformation resembled that of the hot-spot oncogenic mutant R248Q. This alternative state was as susceptible to denaturation and aggregation as the mutant R248Q when subjected to HP at 25 degreesC. Together these data demonstrate that wild-type p53C adopts an alternative conformation with a mutant-like stability, consistent with the dominant-negative effect caused by many mutants. This alternative conformation is likely related to inactive forms that appear in vivo, usually driven by interaction with mutant proteins. Therefore, it can be a valuable target in the search for ways to interfere with protein misfolding and hence to prevent tumor development. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Nacl Ressonancia Magnet Nucl Macromol, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Nacl Ressonancia Magnet Nucl Macromol, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Valente, Ana Paula/J-3010-2017; Silva, Jerson/J-8984-2014; Almeida,
   Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Silva,
   Jerson/0000-0001-9523-9441; Almeida, Fabio/0000-0001-6046-7006
CR Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4
   Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3
   Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434
   Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338
   CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157
   CIONI P, 1994, J MOL BIOL, V242, P291, DOI 10.1006/jmbi.1994.1579
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   FARRIS FJ, 1978, J AM CHEM SOC, V100, P4469, DOI 10.1021/ja00482a026
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244
   FOGUEL D, 1995, J BIOL CHEM, V270, P28759, DOI 10.1074/jbc.270.48.28759
   Foguel D, 1996, P NATL ACAD SCI USA, V93, P10642, DOI 10.1073/pnas.93.20.10642
   FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003
   Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507
   Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998
   Gaspar LP, 2002, J BIOL CHEM, V277, P8433, DOI 10.1074/jbc.M106096200
   Hall RI, 1996, CAN J FISH AQUAT SCI, V53, P1, DOI 10.1139/f95-171
   HERNANDEZBOUSSA.T, 1999, HUM MUTAT, V14, pR5
   HONEYCUTT JD, 1990, P NATL ACAD SCI USA, V87, P3526, DOI 10.1073/pnas.87.9.3526
   Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781
   Inoue K, 2000, NAT STRUCT BIOL, V7, P547
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kinsho T, 2002, EUR J BIOCHEM, V269, P4666, DOI 10.1046/j.1432-1033.2002.03167.x
   Lane DP, 2002, TRENDS MOL MED, V8, pS38, DOI 10.1016/S1471-4914(02)02309-2
   Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727
   Lima LMTR, 2000, P NATL ACAD SCI USA, V97, P14289, DOI 10.1073/pnas.250352197
   McLure KG, 1999, EMBO J, V18, P763, DOI 10.1093/emboj/18.3.763
   MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B
   Nichols NM, 2001, BIOCHEM BIOPH RES CO, V288, P111, DOI 10.1006/bbrc.2001.5764
   Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Panda M, 2001, J BIOL CHEM, V276, P6253, DOI 10.1074/jbc.M009530200
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Prives C, 1999, J PATHOL, V187, P112
   Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Smeller L, 1999, BIOCHEMISTRY-US, V38, P3816, DOI 10.1021/bi981693n
   SUN Y, 1993, FASEB J, V7, P944
   VISSER AJWG, 1977, BIOCHEMISTRY-US, V16, P4879, DOI 10.1021/bi00641a020
   WEBER G, 1986, BIOCHEMISTRY-US, V25, P3626, DOI 10.1021/bi00360a022
   WEBER G, 1993, NATO ADV SCI INST SE, V401, P471
   Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438
   ZHANG J, 1995, BIOCHEMISTRY-US, V34, P8631, DOI 10.1021/bi00027a012
NR 47
TC 32
Z9 33
U1 0
U2 3
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 17
PY 2003
VL 333
IS 2
BP 443
EP 451
DI 10.1016/j.jmb.2003.08.026
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 730VZ
UT WOS:000185852000017
PM 14529628
DA 2020-12-01
ER

PT J
AU Galvao-Botton, LMP
   Katsuyama, AM
   Guzzo, CR
   Almeida, FCL
   Farah, CS
   Valente, AP
AF Galvao-Botton, LMP
   Katsuyama, AM
   Guzzo, CR
   Almeida, FCL
   Farah, CS
   Valente, AP
TI High-throughput screening of structural proteomics targets using NMR
SO FEBS LETTERS
LA English
DT Article
DE structural proteomics; NMR; X-ray; protein screening; target ORF;
   Xanthomonas citri
ID PROTON-EXCHANGE; CLEANEX-PM; PROTEIN; GENOMICS; SPECTROSCOPY;
   EXPRESSION; RESONANCE; ASSIGNMENT
AB We applied a high-throughput strategy for the screening of targets for structural proteomics of Xanthoynonas axonopodis pv citri. This strategy is based on the rapid H-1-N-15 HSQC NMR analysis of bacterial lysates containing selectively 15N-labelled heterologous proteins. Our analysis permitted us to classify the 19 soluble candidates in terms of 'foldedness', that is, the extent to which they present a well-folded solution structure, as reflected by the quality of their NMR spectra. This classification allowed us to define a priority list to be used as a guide to select protein candidates for further structural studies. (C) 2003 Published by Elsevier B.V.
C1 Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508900 Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB, CCS, BR-21941590 Rio De Janeiro, Brazil.
RP Valente, AP (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508900 Sao Paulo, Brazil.
EM chsfarah@iq.usp.br; valente@cnrmn.bioqmed.ufrj.br
RI Almeida, Fabio/O-4989-2018; Farah, Chuck S/G-5565-2012; Valente, Ana
   Paula/J-3010-2017; Carvalho, Cristiane R. G/K-2855-2016
OI Almeida, Fabio/0000-0001-6046-7006; Farah, Chuck S/0000-0003-3110-6302;
   Valente, Ana Paula/0000-0001-7219-1123; Carvalho, Cristiane R.
   G/0000-0002-5664-8055
CR Almeida FCL, 2001, J MAGN RESON, V148, P142, DOI 10.1006/jmre.2000.2213
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bhattacharyya S, 2002, BIOCHEMISTRY-US, V41, P4760, DOI 10.1021/bi0115176
   Bhavesh NS, 2001, BIOCHEMISTRY-US, V40, P14727, DOI 10.1021/bi015683p
   Boettner M, 2002, J BIOTECHNOL, V99, P51, DOI 10.1016/S0168-1656(02)00157-8
   Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574
   Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697
   Christendat D, 2002, PROTEIN SCI, V11, P1409, DOI 10.1110/ps.4720102
   Christendat D, 2000, NAT STRUCT BIOL, V7, P903
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   Dalvit C, 1995, J MAGN RESON SER B, V109, P334, DOI 10.1006/jmrb.1995.9984
   Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602
   Guignard L, 2002, FEBS LETT, V524, P159, DOI 10.1016/S0014-5793(02)03048-X
   Huynen M, 1998, J MOL BIOL, V280, P323, DOI 10.1006/jmbi.1998.1884
   Hwang TL, 1997, J AM CHEM SOC, V119, P6203, DOI 10.1021/ja970160j
   Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875
   Jackson RM, 2001, COMPUT CHEM, V26, P31, DOI 10.1016/S0097-8485(01)00097-3
   Jaren OR, 2002, BIOCHEMISTRY-US, V41, P14158, DOI 10.1021/bi026340+
   Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2
   Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d
   Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763
   Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399
   Mittl PRE, 2001, CURR OPIN CHEM BIOL, V5, P402, DOI 10.1016/S1367-5931(00)00221-0
   Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768
   Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X
   Prestegard JH, 2001, BIOCHEMISTRY-US, V40, P8677, DOI 10.1021/bi0102095
   Rehm T, 2002, STRUCTURE, V10, P1613, DOI 10.1016/S0969-2126(02)00894-8
   Service RF, 2002, SCIENCE, V298, P948, DOI 10.1126/science.298.5595.948
   Shimba N, 2002, ANAL BIOCHEM, V301, P123, DOI 10.1006/abio.2001.5485
   Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   Szyperski T, 2002, P NATL ACAD SCI USA, V99, P8009, DOI 10.1073/pnas.122224599
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Villasenor A, 2002, BIOTECHNIQUES, V32, P184, DOI 10.2144/02321dd05
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599
   Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4
   Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831
   Zweckstetter M, 2001, J AM CHEM SOC, V123, P9490, DOI 10.1021/ja016496h
NR 39
TC 24
Z9 26
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD SEP 25
PY 2003
VL 552
IS 2-3
BP 207
EP 213
DI 10.1016/S0014-5793(03)00926-8
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 726DK
UT WOS:000185583000026
PM 14527688
OA Bronze
DA 2020-12-01
ER

PT J
AU Cabral, KMS
   Almeida, MS
   Valente, AP
   Almeida, FCL
   Kurtenbach, E
AF Cabral, KMS
   Almeida, MS
   Valente, AP
   Almeida, FCL
   Kurtenbach, E
TI Production of the active antifungal Pisum sativum defensin 1 (Psd1) in
   Pichia pastoris: overcoming the inefficiency of the STE13 protease
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE antifungal protein; Pichia pastoris; heterologous expression; circular
   dichroism; NMR; Pisum sativum defensin
ID PLANT DEFENSINS; EXPRESSION; PEPTIDES; NMR; PROTEINS; DNA
AB Plant defensins are small cysteine-rich proteins that present high activity against fungi and bacteria and inhibition of insect proteases and alpha-amylases. Here, we present the expression in Pichia pastoris, purification and characterization of the recombinant Pisum sativum defensin I (rPsd1); a pea defensin which presents four disulfide bridges and high antifungal activity. For this, we had to overcome the inefficiency of the STE13 protease. Our strategy was to clone the corresponding cDNA directly in-frame with a variant of the widely used secretion signal from the Saccharomyces cerevisiae alpha-mating factor, devoid of the STE13 proteolytic signal cleavage sequence. Using an optimized expression protocol, which included a buffered basal salt media formulation, it was possible to obtain about 63.0 mg/L of N-15-labeled and unlabeled rPsd1. The recombinants were purified to homogeneity by gel filtration chromatography, followed by reversed-phase HPLC. Mass spectrometry of native and recombinant Psd1 revealed that the protein expressed heterologously was post-translationally processed to the same mature protein as the native one. Circular dichroism and nuclear magnetic resonance spectroscopy analysis indicated that the recombinant protein had the same folding when compared to native Psd1. In addition, the rPsd1 was fully active against Aspergillus niger, if compared with native Psd1. To our knowledge, this is the first heterologous expression of a fully active plant defensin in a high-yield flask. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Fed Rio de Janeiro, ICB, CCS,Ctr Nacl Ressonancia Magnet Nucl, Dept Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Almeida, MS (corresponding author), Univ Fed Rio de Janeiro, ICB, CCS,Ctr Nacl Ressonancia Magnet Nucl, Dept Bioquim Med, Cidade Univ,Sala 05,Bloco D Sub Solo, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM msalmeida@bioqmed.ufrj.br
RI Kurtenbach, Eleonora/L-4148-2016; Almeida, Fabio/O-4989-2018; Valente,
   Ana Paula/J-3010-2017
OI Kurtenbach, Eleonora/0000-0002-2141-518X; Almeida,
   Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123;
   almeida, marcius/0000-0003-4921-8185
CR Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Almeida MS, 2001, ARCH BIOCHEM BIOPHYS, V395, P199, DOI 10.1006/abbi.2001.2564
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI 10.1016/S0378-1097(98)00477-7
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x
   CHIANG CC, 1991, MOL PLANT MICROBE IN, V4, P324, DOI 10.1094/MPMI-4-324
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0
   FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470
   Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436
   Garcia-Olmedo F, 2001, FEBS LETT, V498, P219, DOI 10.1016/S0014-5793(01)02456-5
   KOBAYASHI Y, 1991, BIOPOLYMERS, V31, P1213, DOI 10.1002/bip.360311009
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Manners JM, 1998, PLANT MOL BIOL, V38, P1071, DOI 10.1023/A:1006070413843
   MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2
   OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9
   Rodriguez E, 2001, J BIOCHEM-TOKYO, V130, P19, DOI 10.1093/oxfordjournals.jbchem.a002957
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x
   SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2
   SONI R, 1994, ANAL BIOCHEM, V218, P474, DOI 10.1006/abio.1994.1214
   Thevissen K, 1997, J BIOL CHEM, V272, P32176, DOI 10.1074/jbc.272.51.32176
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
NR 26
TC 79
Z9 92
U1 1
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD SEP
PY 2003
VL 31
IS 1
BP 115
EP 122
DI 10.1016/S1046-5928(03)00136-0
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 725QM
UT WOS:000185553900014
PM 12963348
DA 2020-12-01
ER

PT J
AU Anobom, CD
   Albuquerque, SC
   Albernaz, FP
   Oliveira, AC
   Silva, JL
   Peabody, DS
   Valente, AP
   Almeida, FCL
AF Anobom, CD
   Albuquerque, SC
   Albernaz, FP
   Oliveira, AC
   Silva, JL
   Peabody, DS
   Valente, AP
   Almeida, FCL
TI Structural studies of MS2 bacteriophage virus particle disassembly by
   nuclear magnetic resonance relaxation measurements
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MODEL-FREE APPROACH; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; TIME SCALES;
   FG LOOP; PROTEIN; CAPSIDS; MOTIONS; BINDING; DOMAIN
AB In this article we studied, by nuclear magnetic resonance relaxation measurements, the disassembly of a virus particle-the MS2 bacteriophage. MS2 is one of the single-stranded RNA bacteriophages that infect Escherichia coli. At pH 4.5, the phage turns to a metastable state, as is indicated by an increase in the observed nuclear magnetic resonance signal intensity upon decreasing the pH from 7.0 to 4.5. Steady-state fluorescence and circular dichroism spectra at pH 4.5 show that the difference in conformation and secondary structure is not pronounced if compared with the phage at pH 7.0. At pH 4.5, two-dimensional N-15-H-1 heteronuclear multiple quantum coherence (HMQC) spectrum shows similar to40 crosspeaks, corresponding to the most mobile residues of MS2 coat protein at pH 4.5. The N-15 linewidth is similar to30 Hz, which is consistent with an intermediate with a rotational relaxation time of 100 ns. The average spin lattice relaxation time (T-1) of the mobile residues was measured at different temperatures, clearly distinguishing between the dimer and the equilibrium intermediate. The results show, for the first time, the presence of intermediates in the process of dissociation of the MS2 bacteriophage.
C1 Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, ICB, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.
   Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA.
RP Valente, AP (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias, Av Brig Trompowiski S-N,Saude Bioco E Sala 10,Cid, BR-21941590 Rio De Janeiro, Brazil.
RI Bom, Cristiane Dinis Ano/X-9461-2019; Valente, Ana Paula/J-3010-2017;
   Silva, Jerson/J-8984-2014; Almeida, Fabio/O-4989-2018
OI Valente, Ana Paula/0000-0001-7219-1123; Silva,
   Jerson/0000-0001-9523-9441; Almeida, Fabio/0000-0001-6046-7006
CR Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r
   Almeida FCL, 1997, J MAGN RESON, V124, P509, DOI 10.1006/jmre.1996.1091
   Almeida FCL, 1997, J MOL BIOL, V270, P481, DOI 10.1006/jmbi.1997.1114
   ATKINS PW, 1997, PHYSICAL CHEM
   Axblom C, 1998, VIROLOGY, V249, P80, DOI 10.1006/viro.1998.9279
   BERGLUND H, 1992, BIOCHEMISTRY-US, V31, P12001, DOI 10.1021/bi00163a007
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006
   CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070
   DAPOIAN AT, 1993, J MOL BIOL, V231, P999, DOI 10.1006/jmbi.1993.1347
   GOLMOHAMMADI R, 1993, J MOL BIOL, V234, P620, DOI 10.1006/jmbi.1993.1616
   Johnson JE, 2000, CURR OPIN STRUC BIOL, V10, P229, DOI 10.1016/S0959-440X(00)00073-7
   JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lago H, 2001, J MOL BIOL, V305, P1131, DOI 10.1006/jmbi.2000.4355
   Liljas Lars, 1999, Current Opinion in Structural Biology, V9, P129, DOI 10.1016/S0959-440X(99)80017-7
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k
   NI CZ, 1995, STRUCTURE, V3, P255, DOI 10.1016/S0969-2126(01)00156-3
   NIRMALA NR, 1988, J AM CHEM SOC, V110, P7557, DOI 10.1021/ja00230a057
   PEABODY DS, 1992, NUCLEIC ACIDS RES, V20, P1649, DOI 10.1093/nar/20.7.1649
   Phelps DK, 2000, CURR OPIN STRUC BIOL, V10, P170, DOI 10.1016/S0959-440X(00)00064-6
   Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280
   STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003
   Stonehouse NJ, 1996, J MOL BIOL, V256, P330, DOI 10.1006/jmbi.1996.0089
   SUGIYAMA T, 1967, J MOL BIOL, V25, P455, DOI 10.1016/0022-2836(67)90198-2
   Tuma R, 1996, J MOL BIOL, V257, P87, DOI 10.1006/jmbi.1996.0149
   VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0
   van Vlijmen HWT, 1998, J MOL BIOL, V275, P295, DOI 10.1006/jmbi.1997.1418
   WAGNER G, 1993, QUAR REV BIOPHYS, V16, P1
   Wagner G., 1993, NMR PROTEINS, P220
NR 31
TC 3
Z9 3
U1 0
U2 3
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUN
PY 2003
VL 84
IS 6
BP 3894
EP 3903
DI 10.1016/S0006-3495(03)75117-0
PG 10
WC Biophysics
SC Biophysics
GA 683CL
UT WOS:000183129800035
PM 12770895
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Katsuyama, AM
   Farah, CS
   Galvao-Botton, LMP
   Almeida, FCL
   Valente, AP
   Spisni, A
   Pertinhez, TA
AF Katsuyama, AM
   Farah, CS
   Galvao-Botton, LMP
   Almeida, FCL
   Valente, AP
   Spisni, A
   Pertinhez, TA
TI Structural genomics of phytopatogen Xanthomonas axonopodis pv. citri -
   NMR characterization of ApaG/CorD protein
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Biophysical-Society
CY MAR 01-05, 2003
CL SAN ANTONIO, TEXAS
SP Biophys Soc, Axon Instruments, ALA Sci Instruments
C1 USP, IQ, BR-05513970 Sao Paulo, Brazil.
   UFRJ, BR-21941590 Rio De Janeiro, Brazil.
RI Farah, Chuck S/G-5565-2012; Spisni, Alberto/AAY-7778-2020
OI Farah, Chuck S/0000-0003-3110-6302; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2003
VL 84
IS 2
SU S
BP 174A
EP 174A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 682ZW
UT WOS:000183123800850
DA 2020-12-01
ER

PT J
AU Vieira, RFF
   Sousa, K
   Nakaie, CR
   Almeida, FCL
   Valente, AP
AF Vieira, RFF
   Sousa, K
   Nakaie, CR
   Almeida, FCL
   Valente, AP
TI NMR structure investigation of alpha-MSH using TOAC labeling
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 18th American Peptide Symposium
CY JUL 19-23, 2003
CL BOSTON, MA
C1 Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, Dept Med Biochem, BR-21941590 Rio De Janeiro, Brazil.
CR Barbosa SR, 1999, FEBS LETT, V446, P45, DOI 10.1016/S0014-5793(99)00172-6
   Hansen DF, 2001, J MAGN RESON, V151, P339, DOI 10.1006/jmre.2001.2376
NR 2
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PY 2003
VL 71
IS 3
MA P332
BP 375
EP 376
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 696GG
UT WOS:000183878800454
DA 2020-12-01
ER

PT J
AU Tinoco, LW
   da Silva, A
   Leite, A
   Valente, AP
   Almeida, FCL
AF Tinoco, LW
   da Silva, A
   Leite, A
   Valente, AP
   Almeida, FCL
TI NMR structure of PW2 bound to SDS micelles - A tryptophan-rich
   anticoccidial peptide selected from phage display libraries
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ANTIMICROBIAL PEPTIDE; CIRCULAR-DICHROISM; INDOLICIDIN; PROTEIN;
   ANTIBACTERIAL; SPECTROSCOPY; NEUTROPHILS; MEMBRANES; PROGRAM
AB PW2 (HPLKQYWWRPSI) was selected from phage display libraries through an alternative panning method using living sporozoites of Eimeria acervulina as target. Synthetic PW2 shows anticoccidial activity against E. acervulina and Eimeria tenella with very low hemolytic activity. It also displays antifungal activity but no activity against bacteria. We present the solution structure of the PW2 bound to SDS micelles. In the absence of an interface, PW2 is in random coil conformation. In micelles, structural calculation shows that Trp-7 forms the hydrophobic core that is important for the peptide folding. Lys-4, Tyr-6, Trp-8, and Arg-9 are in the same surface, possibly facing the micelle interface. This possibility was supported by the fact that chemical shift differences for these residues were more pronounced when compared with PW2 in water and in SDS. PW2 gains structure upon binding to SDS micelles. Lys-4, Tyr-6, Trp-8, and Arg-9 were found to bind to the micelle. Trp-7, Trp-8, and Arg-9 composed the WW+ consensus found in the sequence of the peptides selected with the phage display technique against E. acervulina sporozoites. This suggested that Trp-7, Trp-8, and Arg-9 are probably key residues not only for the peptide interaction with SDS micelles but also for the interaction with E. acervulina sporozoites surface.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-23083970 Campinas, SP, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM valente@cnrmn.bioqmed.ufrj.br
RI Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; Tinoco,
   Luzineide W/G-3630-2014
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Tinoco, Luzineide W/0000-0002-1299-6242
CR AHMAD I, 1995, BBA-BIOMEMBRANES, V1237, P109, DOI 10.1016/0005-2736(95)00087-J
   ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067
   Bihan TL, 1996, BIOCHEMISTRY-US, V35, P12712, DOI 10.1021/bi960869n
   BLOCHET JE, 1993, FEBS LETT, V329, P336, DOI 10.1016/0014-5793(93)80249-T
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cammue Bruno Philippe Angelo, 1995, Plant Physiology (Rockville), V109, P445, DOI 10.1104/pp.109.2.445
   da Silva A, 2002, MOL BIOCHEM PARASIT, V120, P53, DOI 10.1016/S0166-6851(01)00439-X
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Friedrich CL, 2001, J BIOL CHEM, V276, P24015, DOI 10.1074/jbc.M009691200
   GATINEAU E, 1987, BIOCHEMISTRY-US, V26, P8046, DOI 10.1021/bi00399a004
   HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lawyer C, 1996, FEBS LETT, V390, P95, DOI 10.1016/0014-5793(96)00637-0
   Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Robinson WE, 1998, J LEUKOCYTE BIOL, V63, P94
   Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m
   Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c
   SELSTED ME, 1992, J BIOL CHEM, V267, P4292
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Subbalakshmi C, 1996, FEBS LETT, V395, P48, DOI 10.1016/0014-5793(96)00996-9
   Tassin S, 1998, BIOCHEMISTRY-US, V37, P3623, DOI 10.1021/bi9723515
   WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597
   WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575
   Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   YANG JJ, 1994, BIOCHEMISTRY-US, V33, P7345, DOI 10.1021/bi00189a040
   Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200
   Zhao HX, 2001, BIOPHYS J, V81, P2979, DOI 10.1016/S0006-3495(01)75938-3
NR 37
TC 36
Z9 36
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 27
PY 2002
VL 277
IS 39
BP 36351
EP 36356
DI 10.1074/jbc.M204225200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 598KN
UT WOS:000178275100073
PM 12130641
OA Bronze
DA 2020-12-01
ER

PT J
AU Alonso, LG
   Garcia-Alai, MM
   Nadra, AD
   Lapena, AN
   Almeida, FL
   Gualfetti, P
   de Prat-Gay, G
AF Alonso, LG
   Garcia-Alai, MM
   Nadra, AD
   Lapena, AN
   Almeida, FL
   Gualfetti, P
   de Prat-Gay, G
TI High-risk (HPV16) human papillomavirus E7 oncoprotein is highly stable
   and extended, with conformational transitions that could explain its
   multiple cellular binding partners
SO BIOCHEMISTRY
LA English
DT Article
ID RETINOBLASTOMA GENE-PRODUCT; ESCHERICHIA-COLI; ZINC-BINDING; PROTEIN;
   COMPLEX; ADENOVIRUS-E1A; TRANSFORMATION; CAPACITY; FORM
AB High-risk papillomaviruses are known to exert their transforming activity mainly through E7, one of their two oncoproteins. Despite its relevance, no structural information has been obtained that could explain the apparent broad binding specificity of E7. Recombinant E7 from HPV-16 purified to near homogeneity showed two species in gel filtration chromatography, one of these corresponding to a dimer with a molecular weight of 22 kDa, determined by multiangle light scattering. The E7 dimer was isolated for characterization and was shown to undergo a substantial conformational transition when changing from pH 7.0 to 5.0, with an increase in helical structure and increased solvent accessibility to hydrophobic surfaces. The protein was resistant to thermal denaturation even in the presence of SDS, and we show that persistent residual structure in the monomer is responsible for its reported anomalous electrophoretic behavior. The dimer also displays a nonglobular hydrodynamic volume based on gel filtration experiments and becomes more globular in the presence of 0.3 M guanidinium chloride, with hydrophobic surfaces becoming accessible to the solvent, as indicated by the large increase in ANS binding. At low protein concentration, dissociation of the globular E7 dimer was observed, preceding the cooperative unfolding of the structured and extended monomer. Although E7 bears properties that resemble natively unfolded polypeptides, its far-UV circular dichroism spectrum, cooperative unfolding, and exposure of ANS binding sites support a folded and extended, as opposed to disordered and fluctuating, conformation. The large increase in solvent accessibility to hydrophobic surfaces upon small pH decrease within physiological range and in mild denaturant concentrations suggests conformational properties that could have evolved to enable protein-protein recognition of the large number of cellular binding partners reported.
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Leloir, RA-1405 Buenos Aires, DF, Argentina.
   Genencor Int Inc, Palo Alto, CA 94304 USA.
   Univ Fed Rio de Janeiro, Ctr Nacl Resonancia Magnet Nucl, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP de Prat-Gay, G (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Leloir, Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
RI Almeida, Fabio/O-4989-2018; Nadra, Alejandro/A-5668-2009
OI Almeida, Fabio/0000-0001-6046-7006; Nadra,
   Alejandro/0000-0002-7860-3245; Prat Gay, Gonzalo/0000-0001-5748-6863
CR ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569
   BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989
   Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449
   BROKAW JL, 1994, VIROLOGY, V205, P603, DOI 10.1006/viro.1994.1688
   CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549
   Clements A, 2000, BIOCHEMISTRY-US, V39, P16033, DOI 10.1021/bi002111g
   COLE ST, 1987, J MOL BIOL, V193, P599, DOI 10.1016/0022-2836(87)90343-3
   DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532
   Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197
   HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9
   IMAI Y, 1991, J VIROL, V65, P4966, DOI 10.1128/JVI.65.9.4966-4972.1991
   Jelesarov I, 1998, BIOCHEMISTRY-US, V37, P7539, DOI 10.1021/bi972977v
   Kirk WR, 1996, BIOPHYS J, V70, P69, DOI 10.1016/S0006-3495(96)79592-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Massimi P, 1997, VIROLOGY, V227, P255, DOI 10.1006/viro.1996.8315
   Mauricio L, 1997, J BIOL CHEM, V272, P19295, DOI 10.1074/jbc.272.31.19295
   Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247
   McIntyre MC, 1996, VIROLOGY, V215, P73, DOI 10.1006/viro.1996.0008
   MCINTYRE MC, 1993, J VIROL, V67, P3142, DOI 10.1128/JVI.67.6.3142-3150.1993
   MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x
   MUNGER K, 1995, HPV SEQUENCE DATABAS
   PAHEL G, 1993, J BIOL CHEM, V268, P26018
   PATRICK DR, 1992, J BIOL CHEM, V267, P6910
   PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3
   SANG BC, 1992, P NATL ACAD SCI USA, V89, P8063, DOI 10.1073/pnas.89.17.8063
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   TOMMASINO M, 1993, ONCOGENE, V8, P195
   TOMMASINO M, 1995, BIOESSAYS, V17, P509, DOI 10.1002/bies.950170607
   TOURMADJE A, 1995, J AM CHEM SOC, V117, P7023
   Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z
   Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n
   ZurHausen H, 1996, BIOCHIM BIOPHYS ACTA, V1288, P55
   Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291
NR 34
TC 48
Z9 51
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD AUG 20
PY 2002
VL 41
IS 33
BP 10510
EP 10518
DI 10.1021/bi025579n
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 583WY
UT WOS:000177435100017
PM 12173938
DA 2020-12-01
ER

PT J
AU Almeida, MS
   Cabral, KMS
   Kurtenbach, E
   Almeida, FCL
   Valente, AP
AF Almeida, MS
   Cabral, KMS
   Kurtenbach, E
   Almeida, FCL
   Valente, AP
TI Solution structure of Pisum sativum defensin 1 by high resolution NMR:
   Plant defensins, identical backbone with different mechanisms of action
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE plant defensin; antifungal; surface analysis; NMR spectroscopy; 3D
   structure
ID 3-DIMENSIONAL SOLUTION STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; DAHLIA
   DAHLIA-MERCKII; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL ACTIVITY; WHEAT
   ENDOSPERM; CHEMICAL-SHIFTS; PROTEIN; COMMON; TOXIN
AB Pisum sativum defensin 1 (Psd1) is a 46 amino acid residue plant defensin isolated from seeds of pea. The three-dimensional structure in solution of Psd1 was determined by two-dimensional NMR data recorded at 600 MHz. Experimental restraints were used for structure calculation using CNS and torsion-angle molecular dynamics. The 20 lowest energy structures were selected and further subjected to minimization, giving a root-mean-square deviation of 0.78(+/-0.22) Angstrom in the backbone and 1.91(+/-0.60) Angstrom for over all atoms of the molecule. The protein has a globular fold with a triple-stranded antiparalell beta-sheet and an alpha-helix (from residue Asn17 to Leu27). Psd1 presents the so called "cysteine stabilized alpha/beta motif" and presents identical three-dimensional topology in the backbone with other defensins and neurotoxins. Comparison of the electrostatic surface potential among proteins with high three-dimensional (selected using the softwares TOP and DALI) topology gave insights into the mode of action of Psd1. The surface topologies between proteins that present antifungal activity or sodium channel inhibiting activity are different. On the other hand the surface topology presents several common features with potassium channel inhibitors, suggesting that Psd1 presents this activity. Other common features with potassium channel inhibitors were found including the presence of a lysine residue essential for inhibitory activity. The identity of Psd1 in primary sequence is not enough to infer a mechanism of action, in contrast with the strategy proposed here. (C) 2002 Academic Press.
C1 UFRJ, CCS, ICB,Dept Bioquim Med, Dept Bioquim,Ctr Nacl Ressonancia Magnet, BR-21941590 Rio De Janeiro, Brazil.
   UFRJ, CCS, ICB, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Almeida, FCL (corresponding author), UFRJ, CCS, ICB,Dept Bioquim Med, Dept Bioquim,Ctr Nacl Ressonancia Magnet, BR-21941590 Rio De Janeiro, Brazil.
RI Kurtenbach, Eleonora/L-4148-2016; Valente, Ana Paula/J-3010-2017;
   Almeida, Fabio/O-4989-2018
OI Kurtenbach, Eleonora/0000-0002-2141-518X; Valente, Ana
   Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006; almeida,
   marcius/0000-0003-4921-8185
CR Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Almeida MS, 2001, ARCH BIOCHEM BIOPHYS, V395, P199, DOI 10.1006/abbi.2001.2564
   BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3
   Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148
   BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   CASE DA, 1994, METHOD ENZYMOL, V239, P392
   CHIANG CC, 1990, MOL PLANT MICROBE IN, V3, P78, DOI 10.1094/MPMI-3-078
   COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0
   DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767
   Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.3.CO;2-6
   Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436
   Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701
   HEINZ DW, 1991, J MOL BIOL, V217, P353, DOI 10.1016/0022-2836(91)90549-L
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Jaravine VA, 1997, BIOCHEMISTRY-US, V36, P1223, DOI 10.1021/bi9614390
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KHARRAT R, 1989, EUR J BIOCHEM, V181, P381, DOI 10.1111/j.1432-1033.1989.tb14735.x
   Klenk KC, 2000, PROTEINS, V38, P441, DOI 10.1002/(SICI)1097-0134(20000301)38:4&lt;441::AID-PROT9&gt;3.0.CO;2-L
   KOBAYASHI Y, 1991, BIOPOLYMERS, V31, P1213, DOI 10.1002/bip.360311009
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805
   Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908
   Landon C, 1996, EUR J BIOCHEM, V236, P395, DOI 10.1111/j.1432-1033.1996.00395.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339
   MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x
   MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2
   MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159
   Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x
   Segura A, 1998, FEBS LETT, V435, P159, DOI 10.1016/S0014-5793(98)01060-6
   Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027
   TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573
   TERRAS FRG, 1992, J BIOL CHEM, V267, P15302
   Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451
   Thevissen K, 2000, MOL PLANT MICROBE IN, V13, P54, DOI 10.1094/MPMI.2000.13.1.54
   Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797
   Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054
   Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1
   Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835
NR 48
TC 106
Z9 112
U1 1
U2 20
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 25
PY 2002
VL 315
IS 4
BP 749
EP 757
DI 10.1006/jmbi.2001.5252
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 521JL
UT WOS:000173836800021
PM 11812144
DA 2020-12-01
ER

PT J
AU Almeida, MS
   Cabral, KS
   de Medeiros, LN
   Valente, AP
   Almeida, FCL
   Kurtenbach, E
AF Almeida, MS
   Cabral, KS
   de Medeiros, LN
   Valente, AP
   Almeida, FCL
   Kurtenbach, E
TI cDNA cloning and heterologous expression of functional cysteine-rich
   antifungal protein Psd1 in the yeast Pichia pastoris
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE plant defensins; antifungal peptides; Pichia pastoris; circular
   dichroism; intrinsic fluorescence; NMR; Pisum sativum
ID 3-DIMENSIONAL SOLUTION STRUCTURE; PLANT DEFENSINS; PEPTIDES; SITES; DNA
AB In the present work, we describe the cDNA cloning, expression in Pichia pastoris, purification, and characterization of the recombinant Pisum sativum defensin 1 (rPsd1), a novel Cys-rich protein presenting four disulfide bridges and high antifungal activity. Several parameters that affect the level of protein expression were assayed. The best condition yielded 13.8 mg/L (1.50 mug/10(8) cells) of active rPsd1. The recombinant rPsd1 was purified to homogeneity by cation exchange, followed by reversed-phase HPLC, and subjected to automated amino acid sequencing, which revealed four additional amino acids (EAEA) at the N-terminal region. Circular dichroism, intrinsic fluorescence, and nuclear magnetic resonance spectroscopy analysis indicated that the recombinant protein has a very similar folding and a correct disulfide-bonding pattern when compared to native Psd1. Nevertheless, the rPsd1 presented a more species-specific antifungal activity. The importance of the Nand C-termini for Psd1 activity is pointed out. (C) 2001 Academic Press.
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil.
RP Kurtenbach, E (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim Med, Inst Ciencias Biomed, Cidade Univ, BR-21941 Rio De Janeiro, Brazil.
EM kurten@bioqmed.ufrj.br
RI Kurtenbach, Eleonora/L-4148-2016; Valente, Ana Paula/J-3010-2017;
   Almeida, Fabio/O-4989-2018; Medeiros, Luciano/E-5572-2012
OI Kurtenbach, Eleonora/0000-0002-2141-518X; Valente, Ana
   Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006; Medeiros,
   Luciano/0000-0001-7423-5177; almeida, marcius/0000-0003-4921-8185
CR Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   ALVES ALV, 1994, FEBS LETT, V348, P228
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642
   BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI 10.1016/S0378-1097(98)00477-7
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W
   Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x
   CHIANG CC, 1991, MOL PLANT MICROBE IN, V4, P324, DOI 10.1094/MPMI-4-324
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0
   DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171
   Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767
   FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470
   Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436
   Garcia-Olmedo F, 2001, FEBS LETT, V498, P219, DOI 10.1016/S0014-5793(01)02456-5
   GUARRO J, 1992, MYCOSES, V35, P109, DOI 10.1111/j.1439-0507.1992.tb00830.x
   Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748
   KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438
   KOBAYASHI Y, 1991, BIOPOLYMERS, V31, P1213, DOI 10.1002/bip.360311009
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manners JM, 1998, PLANT MOL BIOL, V38, P1071, DOI 10.1023/A:1006070413843
   OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x
   SONI R, 1994, ANAL BIOCHEM, V218, P474, DOI 10.1006/abio.1994.1214
   Thevissen K, 1997, J BIOL CHEM, V272, P32176, DOI 10.1074/jbc.272.51.32176
   Wood MJ, 1999, J BIOMOL NMR, V13, P149, DOI 10.1023/A:1008398313350
NR 31
TC 55
Z9 57
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2001
VL 395
IS 2
BP 199
EP 207
DI 10.1006/abbi.2001.2564
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 493DL
UT WOS:000172206700008
PM 11697857
DA 2020-12-01
ER

PT J
AU Almeida, FCL
   Amorim, GC
   Moreau, VH
   Sousa, VO
   Creazola, AT
   Americo, TA
   Pais, APN
   Leite, A
   Netto, LES
   Giordano, RJ
   Valente, AP
AF Almeida, FCL
   Amorim, GC
   Moreau, VH
   Sousa, VO
   Creazola, AT
   Americo, TA
   Pais, APN
   Leite, A
   Netto, LES
   Giordano, RJ
   Valente, AP
TI Selectively labeling the heterologous protein in Escherichia coli for
   NMR studies: A strategy to speed up NMR spectroscopy
SO JOURNAL OF MAGNETIC RESONANCE
LA English
DT Article
DE NMR; Opaque 2; rifampicin; selective labeling; thioredoxin
ID EXPRESSED PROTEINS
AB Nuclear magnetic resonance is an important tool for high-resolution structural studies of proteins. It demands high protein concentration and high purity; however, the expression of proteins at high levels often leads to protein aggregation and the protein purification step can correspond to a high percentage of the overall time in the structural determination process, In the present article we show that the step of sample optimization can be simplified by selective labeling the heterologous protein expressed in Escherichia coli by the use of rifampicin, Yeast thioredoxin and a coix transcription factor Opaque 2 leucine zipper (LZ) were used to show the effectiveness of the protocol. The H-1/N-15 heteronuclear correlation two-dimensional NMR spectrum (HMQC) of the selective N-15-labeled thioredoxin without any purification is remarkably similar to the spectrum of the purified protein, The method has high yields and a good H-1/N-15 HMQC spectrum can be obtained with 50 mi of Mo growth medium. Opaque 2 LZ, a difficult protein due to the lower expression level and high hydrophobicity, was also probed. The N-15-edited spectrum of Opaque 2 LZ showed only the resonances of the protein of heterologous expression (Opaque 2 LZ) while the H-1 spectrum shows several other resonances from other proteins of the cell lysate, The demand for a fast methodology for structural determination is increasing with the advent of genome/proteome projects. Selective labeling the heterologous protein can speed up NMR structural studies as well as NMR-based drug screening. This methodology is especially effective for difficult proteins such as hydrophobic transcription factors, membrane proteins, and others, (C) 2001 Academic Press.
C1 Univ Fed Rio de Janeiro, CCS, ICB, Dept Bioquim Med,Ctr Nacl Ressonancia Magnet Nucl, BR-21941590 Rio De Janeiro, Brazil.
   UNICAMP, Campinas, SP, Brazil.
   Univ Sao Paulo, Inst Biol, Sao Paulo, Brazil.
   Univ Texas, MD Anderson Canc Ctr, GU Med Oncol Dept, Houston, TX 77030 USA.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, CCS, ICB, Dept Bioquim Med,Ctr Nacl Ressonancia Magnet Nucl, Av Brigadeiro Trompowiski S-N,Bloco E Sala 10,Cid, BR-21941590 Rio De Janeiro, Brazil.
RI Almeida, Fabio/O-4989-2018; Amorim, Gisele/O-9231-2019; Amorim,
   Gisele/D-7876-2013; Netto, Luis/A-3783-2008; Moreau, Vitor
   Hugo/B-8865-2009; Giordano, Ricardo/A-2074-2010; Valente, Ana
   Paula/J-3010-2017; Moreau, Vitor Hugo/J-4829-2015
OI Almeida, Fabio/0000-0001-6046-7006; Amorim, Gisele/0000-0003-4348-9515;
   Amorim, Gisele/0000-0003-4348-9515; Netto, Luis/0000-0002-4250-9177;
   Giordano, Ricardo/0000-0001-8116-6771; Valente, Ana
   Paula/0000-0001-7219-1123; Moreau, Vitor Hugo/0000-0002-5393-0645
CR Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429
   Gao WW, 1997, FASEB J, V11, P1153
   Gronenborn AM, 1996, PROTEIN SCI, V5, P174
   HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583
   LEE KM, 1995, J BIOMOL NMR, V5, P93, DOI 10.1007/BF00227474
   MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Sambrook J, 1989, MOL CLONING LAB MANU
   SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2
   TRAVERS A, 1971, NATURE-NEW BIOL, V229, P69
   Vettore AL, 1998, PLANT MOL BIOL, V36, P249, DOI 10.1023/A:1005995806897
   Wang CC, 1998, ACTA BIOCH BIOPH SIN, V30, P533
NR 14
TC 19
Z9 19
U1 1
U2 11
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1090-7807
J9 J MAGN RESON
JI J. Magn. Reson.
PD JAN
PY 2001
VL 148
IS 1
BP 142
EP 146
DI 10.1006/jmre.2000.2213
PG 5
WC Biochemical Research Methods; Physics, Atomic, Molecular & Chemical;
   Spectroscopy
SC Biochemistry & Molecular Biology; Physics; Spectroscopy
GA 390XL
UT WOS:000166325000018
PM 11133287
DA 2020-12-01
ER

PT J
AU Oliveira, AC
   Gomes, AMO
   Almeida, FCL
   Mohana-Borges, R
   Valente, AP
   Reddy, VS
   Johnson, JE
   Silva, JL
AF Oliveira, AC
   Gomes, AMO
   Almeida, FCL
   Mohana-Borges, R
   Valente, AP
   Reddy, VS
   Johnson, JE
   Silva, JL
TI Virus maturation targets the protein capsid to concerted disassembly and
   unfolding
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FLOCK-HOUSE VIRUS; INFLUENZA HEMAGGLUTININ; FUNCTIONAL IMPLICATIONS;
   3-DIMENSIONAL STRUCTURE; PRESSURE DENATURATION; MEMBRANE-FUSION; ARC
   REPRESSOR; MOSAIC-VIRUS; STABILITY; PICORNAVIRUSES
AB Many animal viruses undergo post-assembly proteolytic cleavage that is required for infectivity, The role of maturation cleavage on Flock House virus was evaluated by comparing wild type (wt) and cleavage-defective mutant (D75N) Flock House virus virus-like particles. A concerted dissociation and unfolding of the mature wt particle was observed under treatment by urea, whereas the cleavage-defective mutant dissociated to folded subunits as determined by steady-state and dynamic fluorescence spectroscopy, circular dichroism, and nuclear magnetic resonance. The folded D75N a subunit could reassemble into capsids, whereas the yield of reassembly from unfolded cleaved alpha subunits was very low. Overall, our results demonstrate that the maturation/cleavage process targets the particle for an "off pathway" disassembly, because dissociation is coupled to unfolding. The increased motions in the cleaved capsid, revealed by fluorescence and NMR, and the concerted nature of dissociation/unfolding may be crucial to make the mature particle infectious.
C1 Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Silva, Jerson/J-8984-2014; Almeida, Fabio/O-4989-2018; Borges, Ronaldo S
   Mohana/C-5575-2013; Gomes, Andre/C-4009-2014; Valente, Ana
   Paula/J-3010-2017
OI Silva, Jerson/0000-0001-9523-9441; Almeida, Fabio/0000-0001-6046-7006;
   Gomes, Andre/0000-0003-1052-8004; Valente, Ana Paula/0000-0001-7219-1123
CR ALCALA JR, 1985, ANAL INSTRUM, V14, P225
   Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X
   BAVASAPPA R, 1994, PROTEIN SCI, V3, P1651
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9
   Bothner B, 1999, NAT STRUCT BIOL, V6, P114
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6
   CHENG RH, 1994, STRUCTURE, V2, P271
   COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740
   DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034
   Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2
   FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P120
   GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988
   Gaspar LP, 1997, J MOL BIOL, V273, P456, DOI 10.1006/jmbi.1997.1299
   GRATTON E, 1986, BIOCHEM SOC T, V14, P835, DOI 10.1042/bst0140835
   Harrison Stephen C., 1996, P59
   HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218
   Janshoff A, 1999, BIOCHEMISTRY-US, V38, P5328, DOI 10.1021/bi982976i
   Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27
   LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010
   Mohana-Borges R, 1999, J BIOL CHEM, V274, P7732, DOI 10.1074/jbc.274.12.7732
   Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   Robinson CR, 1996, BIOCHEMISTRY-US, V35, P13878, DOI 10.1021/bi961375t
   Robinson CR, 1995, METHOD ENZYMOL, V259, P395
   ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010
   ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0
   ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533
   RUECKERT RR, 1996, FIELDS VIROLOGY, P609
   Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X
   SCHNEEMANN A, 1994, J VIROL, V68, P4547, DOI 10.1128/JVI.68.7.4547-4556.1994
   SCHNEEMANN A, 1993, J VIROL, V67, P2756, DOI 10.1128/JVI.67.5.2756-2763.1993
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Smith TJ, 1999, ADV VIRUS RES, V52, P1, DOI 10.1016/S0065-3527(08)60297-3
   WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014
   ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680
NR 44
TC 26
Z9 27
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 26
PY 2000
VL 275
IS 21
BP 16037
EP 16043
DI 10.1074/jbc.M910145199
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 318NX
UT WOS:000087291400059
PM 10748191
OA Bronze
DA 2020-12-01
ER

PT J
AU Moreau, VH
   Amorin, G
   Souza, VO
   Americo, TA
   Creazola, AT
   Giordano, RJ
   Almeida, FC
   Valente, AP
AF Moreau, VH
   Amorin, G
   Souza, VO
   Americo, TA
   Creazola, AT
   Giordano, RJ
   Almeida, FC
   Valente, AP
TI NMR structural studies using selective labeling of the heterologous
   protein.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 UFRJ, Ctr Nacl RMN Macromol, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Burnham Inst, San Diego, CA USA.
RI Moreau, Vitor Hugo/B-8865-2009; Moreau, Vitor Hugo/J-4829-2015
OI Moreau, Vitor Hugo/0000-0002-5393-0645
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2000
VL 78
IS 1
MA 183Pos
BP 32A
EP 32A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 274RR
UT WOS:000084779300184
DA 2020-12-01
ER

PT S
AU Oliveira, AC
   Valente, AP
   Almeida, FCL
   Lima, SMB
   Ishimaru, D
   Goncalves, RB
   Peabody, D
   Foguel, D
   Silva, JL
AF Oliveira, AC
   Valente, AP
   Almeida, FCL
   Lima, SMB
   Ishimaru, D
   Goncalves, RB
   Peabody, D
   Foguel, D
   Silva, JL
BE Winter, R
   Jonas, J
TI Hydrostatic pressure as a tool to study virus assembly:
   Pressure-inactivation of viruses by formation of fusion intermediate
   states
SO HIGH PRESSURE MOLECULAR SCIENCE
SE NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES E, APPLIED SCIENCES
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on High Pressure
   Molecular Science
CY SEP 27-OCT 11, 1998
CL IL CIOCCO, ITALY
SP NATO, Sci Affairs Div
ID MOSAIC-VIRUS; 3-DIMENSIONAL STRUCTURE; INFLUENZA HEMAGGLUTININ; INDUCED
   DISSOCIATION; LOW-TEMPERATURE; COAT PROTEIN; STABILITY; DENATURATION;
   VACCINES; PICORNAVIRUSES
AB The contribution of protein folding and protein-nucleic acid interactions to virus assembly has been measured in several bacterial, plant and animal viruses, using hydrostatic pressure as thermodynamic variable. By comparing the pressure stability among native wild-type viruses, single-amino acid mutants or empty particles, we have gained new insights about virus assembly and disassembly. We find that the isolated capsid proteins and the assembly intermediates are not fully folded, and that association of 60 or more subunits into an icosahedral particle is coupled to progressive folding of the coat protein and also to changes in interactions with the nucleic acid. Using pressure, we have detected the presence of a ribonucleoprotein intermediate, where the coat protein is partially unfolded but bound to RNA. These intermediates are potential targets for antiviral compounds. Pressure studies on viruses have direct biotechnological applications. The ability of pressure to inactivate viruses has been evaluated with a view toward the applications of vaccine development and virus sterilization. We demonstrate that pressure causes virus inactivation while preserving the immunogenic properties. There are substantial evidence that a high pressure cycle traps a virus in the "fusion intermediate state", not infectious but highly immunogenic. Pressure inactivation has been successful with viruses that cause disease in animals, especially foot-and-mouth disease virus (FMDV) and bovine rotavirus and humans, such as rhinoviruses, adenoviruses, alphaviruses, influenza and retroviruses.
C1 Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
RP Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
RI Goncalves, Rafael/C-3978-2014; Oliveira, Adelcio/L-1669-2013; Silva,
   Jerson/J-8984-2014
OI Silva, Jerson/0000-0001-9523-9441
CR ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0
   Bloom BR, 1996, SCIENCE, V272, P1888, DOI 10.1126/science.272.5270.1888
   Bonafe CFS, 1998, BIOCHEMISTRY-US, V37, P11097, DOI 10.1021/bi980349n
   BUDOWSKY EI, 1991, ADV VIRUS RES, V39, P255
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0
   DaPoian AT, 1996, P NATL ACAD SCI USA, V93, P8268, DOI 10.1073/pnas.93.16.8268
   DAPOIAN AT, 1994, BIOCHEMISTRY-US, V33, P8339, DOI 10.1021/bi00193a022
   DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034
   DAPOIAN AT, 1993, J MOL BIOL, V231, P999, DOI 10.1006/jmbi.1993.1347
   FOGUEL D, 1995, J BIOL CHEM, V270, P28759, DOI 10.1074/jbc.270.48.28759
   FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003
   FOGUEL D, 1999, UNPUB MIMICRY FUSION
   Gaspar LP, 1997, J MOL BIOL, V273, P456, DOI 10.1006/jmbi.1997.1299
   GIRANDA VL, 1992, P NATL ACAD SCI USA, V89, P10213, DOI 10.1073/pnas.89.21.10213
   Harrison Stephen C., 1996, P59
   HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218
   Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27
   JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935
   LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357
   Lauffer MA, 1941, J BIOL CHEM, V140, P509
   MOZHAEV VV, 1994, TRENDS BIOTECHNOL, V12, P493, DOI 10.1016/0167-7799(94)90057-4
   NAKAGAMI T, 1992, J VIROL METHODS, V38, P255, DOI 10.1016/0166-0934(92)90115-T
   Nash DP, 1997, BIOCHEMISTRY-US, V36, P14375, DOI 10.1021/bi970881v
   Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5
   PONTES L, 1997, PRESSURE INACTIVATIO, P91
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010
   ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0
   RUECKERT RR, 1996, FIELDS VIROLOGY, P609
   SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513
   SILVA JL, 1993, NATO ADV SCI INST SE, V401, P561
   SOUZA PC, 1999, IN PRESS J MOL BIOL
   VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0
   WEBER G, 1993, NATO ADV SCI INST SE, V401, P471
NR 39
TC 11
Z9 12
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0168-132X
BN 0-7923-5806-6
J9 NATO ADV SCI I E-APP
PY 1999
VL 358
BP 497
EP 513
PG 17
WC Biophysics; Chemistry, Physical; Physics, Atomic, Molecular & Chemical;
   Physics, Condensed Matter
SC Biophysics; Chemistry; Physics
GA BQ03H
UT WOS:000086915400025
DA 2020-12-01
ER

PT J
AU Almeida, FCL
   Valente, AP
   Chaimovich, H
AF Almeida, FCL
   Valente, AP
   Chaimovich, H
TI Stability and activity modulation of chymotrypsins in AOT reversed
   micelles by protein-interface interaction - Interaction of
   alpha-chymotrypsin with a negative interface leads to a cooperative
   breakage of a salt bridge that keeps the catalytic active conformation
   (IIe(16)-Asp(194))
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE chymotrypsin; enzyme stability; reversed micelles; interface
ID DELTA-CHYMOTRYPSIN; ORGANIC-SOLVENTS
AB The stability of alpha-chymotrypsin and delta-chymotrypsin was studied in reversed micelles of sodium bis(2-ethylhexyl)sulfosuccinate (AOT) in isooctane, alpha-Chymotrypsin is inactivated at the interface and at the water pool, while delta-chymotrypsin is inactivated only at the water pool. The mechanism of inactivation at the interface is related to the interaction of N-terminal group alanine 149 (absent in delta-chymotrypsin) with the negative interface. The dependence of enzyme activity on water content of these two enzymes in reversed micelles of AOT is also related with the interface interaction, since delta-chymotrypsin does not have a bell-shaped curve as observed for alpha-chymotrypsin. (C) 1998 John Wiley & Sons, Inc.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498970 Sao Paulo, SP, Brazil.
RP Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM falmeida@server.bioqmed.ufrj.br
RI Chaimovich, Hernan/B-8393-2009; Valente, Ana Paula/J-3010-2017;
   Chaimovich, Hernan/B-5006-2011; Almeida, Fabio/O-4989-2018
OI Chaimovich, Hernan/0000-0001-9380-2157; Valente, Ana
   Paula/0000-0001-7219-1123; Chaimovich, Hernan/0000-0001-9380-2157;
   Almeida, Fabio/0000-0001-6046-7006
CR BARBARIC S, 1981, J AM CHEM SOC, V103, P4239, DOI 10.1021/ja00404a044
   Blow D, 1971, ENZYMES, V3, P185, DOI DOI 10.1016/S1874-6047(08)60397-2
   FLETCHER PDI, 1984, COLLOID SURFACE, V10, P193, DOI 10.1016/0166-6622(84)80020-7
   GARCIACARMONA F, 1992, BIOMOLECULES ORGANIC, P163
   GHELIS C, 1970, BIOCHEMISTRY-US, V9, P3902, DOI 10.1021/bi00822a008
   GUPTA MN, 1992, EUR J BIOCHEM, V203, P25, DOI 10.1111/j.1432-1033.1992.tb19823.x
   HESS GP, 1971, ENZYMES, V3, P213
   KRAUT J, 1972, ENZYMES, V3, P165
   LUISI PL, 1987, METHOD ENZYMOL, V136, P188
   LUISI PL, 1988, BIOCHIM BIOPHYS ACTA, V947, P209, DOI 10.1016/0304-4157(88)90025-1
   OPPENHEIMER HL, 1966, J BIOL CHEM, V241, P2720
   PILENI MP, 1989, STRUCTURE REACTIVITY
   RUCKENSTEIN E, 1990, J COLLOID INTERF SCI, V139, P408, DOI 10.1016/0021-9797(90)90115-5
   SHARMA SK, 1978, J BIOL CHEM, V253, P3055
   SHARMA SK, 1982, EUR J BIOCHEM, V129, P87, DOI 10.1111/j.1432-1033.1982.tb07024.x
   SHARMA SK, 1979, BIOCHEMISTRY-US, V18, P1008, DOI 10.1021/bi00573a012
   Stryer L., 1988, BIOCHEMISTRY
   VALENTE AP, 1994, THESIS U SAO PAULO S
   VALENZUELA P, 1970, BIOCHEMISTRY-US, V9, P2440, DOI 10.1021/bi00814a008
   VALENZUELA P, 1973, J BIOL CHEM, V348, P4909
NR 20
TC 9
Z9 9
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG 5
PY 1998
VL 59
IS 3
BP 360
EP 363
DI 10.1002/(SICI)1097-0290(19980805)59:3<360::AID-BIT12>3.0.CO;2-I
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA ZV932
UT WOS:000074356300012
PM 10099347
DA 2020-12-01
ER

PT J
AU Almeida, FCL
   Opella, SJ
AF Almeida, FCL
   Opella, SJ
TI fd coat protein structure in membrane environments: Structural dynamics
   of the loop between the hydrophobic trans-membrane helix and the
   amphipathic in-plane helix
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE membrane protein; NMR spectroscopy; molecular dynamics simulations; fd
   coat protein; protein dynamics
ID PHOTOSYNTHETIC REACTION CENTER; NUCLEAR-MAGNETIC-RESONANCE; N-15
   NMR-SPECTROSCOPY; MODEL-FREE APPROACH; BACKBONE DYNAMICS;
   HYDROGEN-EXCHANGE; COUPLING-CONSTANTS; SOLID-STATE; M13; ASSIGNMENT
AB By performing multidimensional solution NMX experiments on micelle samples it was possible to determine the structure of the membrane-bound form of fd coat protein based on short-range distance and dihedral angle constraints using distance geometry and simulated annealing calculations. Its dynamics were described by N-15 relaxation measurements (T-1, T-2, heteronuclear nuclear Overhauser enhancement (NOE)) fitted with the Lipari-Szabo model-free formalism adapted for the transmembrane and in-plane helices of a membrane protein. The overall correlation time of the protein in micelles was found to be similar to 9 ns, and the local motion of each backbone N-H vector was described by an order parameter and an effective correlation time. The 50 residue protein has an amphipathic alpha-helix (residues 7 to 16) and a hydrophobic alpha-helix (residues 27 to 44), which were found to be approximately perpendicular on the basis of NOEs in the residues that connect the two helices. The residues connecting the helices are of particular interest in membrane proteins, and in this case the loop consists of two turns. The relaxation data show the presence of an extra motion in the amphipathic alpha-helix on the nanosecond timescale and additional flexibility of several residues in the loop connecting the two helices. (C) 1997 Academic Press Limited.
C1 DREXEL UNIV,DEPT CHEM,PHILADELPHIA,PA 19104.
RI Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI020770, R01AI020770, R01AI020770, R01AI020770, R01AI020770,
   R01AI020770, R01AI020770, R01AI020770, R01AI020770, R01AI020770,
   R01AI020770, R01AI020770, R01AI020770] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R37GM024266,
   R37GM024266, R37GM024266, R37GM024266, R37GM024266, R37GM024266,
   R37GM024266, R37GM024266, R37GM024266, R37GM024266, R37GM024266,
   R37GM024266] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI20770] Funding Source: Medline; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R37GM24266] Funding Source: Medline
CR Almeida FCL, 1997, J MAGN RESON, V124, P509, DOI 10.1006/jmre.1996.1091
   BLACKLEDGE MJ, 1993, BIOCHEMISTRY-US, V32, P10960, DOI 10.1021/bi00092a005
   BOGUSKY MJ, 1987, J MAGN RESON, V72, P186, DOI 10.1016/0022-2364(87)90187-9
   BOVIN MJJ, 1996, J BIOMOL NMR, V7, P72
   BOVIN MJJ, 1995, J MOL BIOL, V250, P80
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   BRUNGER AT, 1992, XPLOR 3 1 SYSTEM XRA
   CHANG CH, 1991, BIOCHEMISTRY-US, V30, P5352, DOI 10.1021/bi00236a005
   CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006
   CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070
   COWAN SW, 1995, STRUCTURE, V15, P1041
   DATEMA KP, 1989, SCIENCE, V245, P1463
   DELLWO MJ, 1989, J AM CHEM SOC, V111, P4571, DOI 10.1021/ja00195a007
   GLUCKSMAN MJ, 1992, J MOL BIOL, V226, P455, DOI 10.1016/0022-2836(92)90960-R
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   HEMMINGA MA, 1992, PROG LIPID RES, V31, P301, DOI 10.1016/0163-7827(92)90011-7
   HENRY GD, 1992, BIOCHEMISTRY-US, V31, P5284, DOI 10.1021/bi00138a007
   HENRY GD, 1987, BIOCHEMISTRY-US, V26, P3619, DOI 10.1021/bi00386a055
   HENRY GD, 1986, BIOCHEMISTRY-US, V25, P590, DOI 10.1021/bi00351a012
   HENRY GD, 1990, BIOCHEMISTRY-US, V29, P6303, DOI 10.1021/bi00478a027
   IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0
   KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   KENIRY MA, 1984, NATURE, V307, P383, DOI 10.1038/307383a0
   KITE J, 1982, J MOL BIOL, V157, P105
   LEO GC, 1987, BIOCHEMISTRY-US, V26, P854, DOI 10.1021/bi00377a029
   LEVITT MH, 1982, J MAGN RESON, V50, P157, DOI 10.1016/0022-2364(82)90042-7
   LEVITT MH, 1982, J MAGN RESON, V47, P328, DOI 10.1016/0022-2364(82)90124-X
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   MARASSI FM, 1997, IN PRESS P NATL ACAD
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004
   MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2
   MARVIN DA, 1994, J MOL BIOL, V235, P260, DOI 10.1016/S0022-2836(05)80032-4
   MCDONNELL PA, 1993, J MAGN RESON SER B, V102, P120, DOI 10.1006/jmrb.1993.1073
   MCDONNELL PA, 1993, J MOL BIOL, V233, P447, DOI 10.1006/jmbi.1993.1523
   NAMBUDRIPAD R, 1991, SCIENCE, V252, P1305, DOI 10.1126/science.1925543
   NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3
   ONEIL JDJ, 1989, BIOCHEMISTRY-US, V28, P6736, DOI 10.1021/bi00442a029
   OPELLA SJ, 1987, Q REV BIOPHYS, V19, P7, DOI 10.1017/S0033583500004017
   OPELLA SJ, 1994, METHOD ENZYMOL, V239, P536
   PAPAVOINE CHM, 1994, BIOCHEMISTRY-US, V33, P12990, DOI 10.1021/bi00248a007
   PAPAVOINE CHM, 1995, EUR J BIOCHEM, V232, P490, DOI 10.1111/j.1432-1033.1995.tb20835.x
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Press W., 1992, NUMERICAL RECIPES AR
   REES DC, 1989, ANNU REV BIOCHEM, V58, P607
   RUSSEL M, 1991, MOL MICROBIOL, V5, P1607, DOI 10.1111/j.1365-2958.1991.tb01907.x
   SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2
   SHON KJ, 1991, BIOTECHNOLOGY : BRIDGING RESEARCH AND APPLICATIONS, P109
   SHON KJ, 1991, SCIENCE, V252, P1303, DOI 10.1126/science.1925542
   TOBIAS DJ, 1995, J MOL BIOL, V253, P391, DOI 10.1006/jmbi.1995.0561
   TSAKIHARA T, 1996, SCIENCE, V272, P1136
   VANDEVEN FJM, 1993, BIOCHEMISTRY-US, V32, P8322, DOI 10.1021/bi00083a036
   VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   YEAGLE PL, 1995, BIOCHEMISTRY-US, V34, P14621, DOI 10.1021/bi00045a002
NR 57
TC 104
Z9 106
U1 0
U2 1
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 18
PY 1997
VL 270
IS 3
BP 481
EP 495
DI 10.1006/jmbi.1997.1114
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA XM193
UT WOS:A1997XM19300015
PM 9237913
DA 2020-12-01
ER

PT J
AU Almeida, FCL
   Opella, SJ
AF Almeida, FCL
   Opella, SJ
TI Measurement of H-1 T-1 rho in a uniformly N-15-labeled protein in
   solution with heteronuclear two-dimensional spectroscopy
SO JOURNAL OF MAGNETIC RESONANCE
LA English
DT Article
ID SPECTRA; SCHEME
RP Almeida, FCL (corresponding author), UNIV PENN,DEPT CHEM,PHILADELPHIA,PA 19104, USA.
RI Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI20770] Funding Source: Medline; NIGMS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R37GM24266] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI020770, R01AI020770, R01AI020770, R01AI020770, R01AI020770,
   R01AI020770, R01AI020770, R01AI020770, R01AI020770, R01AI020770,
   R01AI020770, R01AI020770, R01AI020770] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R37GM024266,
   R37GM024266, R37GM024266, R37GM024266, R37GM024266, R37GM024266,
   R37GM024266, R37GM024266, R37GM024266, R37GM024266, R37GM024266,
   R37GM024266] Funding Source: NIH RePORTER
CR Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r
   ALMEIDA FCL, UNPUB
   BLACKLEDGE MJ, 1993, BIOCHEMISTRY-US, V32, P10960, DOI 10.1021/bi00092a005
   DATEMA KP, 1987, BIOCHEMISTRY-US, V26, P6145, DOI 10.1021/bi00393a030
   MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2
   MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109
   PENG JW, 1991, J MAGN RESON, V95, P421, DOI 10.1016/0022-2364(91)90233-J
   SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2
   Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132
NR 9
TC 7
Z9 7
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 1090-7807
J9 J MAGN RESON
JI J. Magn. Reson.
PD FEB
PY 1997
VL 124
IS 2
BP 509
EP 511
DI 10.1006/jmre.1996.1091
PG 3
WC Biochemical Research Methods; Physics, Atomic, Molecular & Chemical;
   Spectroscopy
SC Biochemistry & Molecular Biology; Physics; Spectroscopy
GA WP821
UT WOS:A1997WP82100028
PM 9169225
DA 2020-12-01
ER

PT J
AU ALMEIDA, FCL
   TOSCANO, VG
   DOSSANTOS, O
   POLITI, MJ
   NEUMANN, MG
   FO, PB
AF ALMEIDA, FCL
   TOSCANO, VG
   DOSSANTOS, O
   POLITI, MJ
   NEUMANN, MG
   FO, PB
TI SOLVENT-INDUCED CHANGES IN THE PHOTOPHYSICAL PROPERTIES OF
   N-ALKYLPHTHALIMIDES .2. TEMPERATURE AND ACIDITY EFFECTS
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
LA English
DT Article
AB The fluorescence quantum yields of N-propylphthalimide were determined in methyl, ethyl, isopropyl and butyl alcohols, water and aqueous solutions of HClO4.  An increase in the protic nature and polarity of the solvent resulted in higher fluorescence yields.  Temperature effects were similar in water and ethanol.  Solvent and temperature effects are interpreted in terms of electronic energy distribution, the increase in fluorescence quantum yield being ascribed to the mixing of the pi-pi* and n-pi* states.  Prototropic equilibrium is shown to be present only in the ground state.
C1 UNIV SAO PAULO,INST FIS & QUIM SAO CARLOS,POB 369,BR-13560 SAO CARLOS,SP,BRAZIL.
   UNIV SAO PAULO,INST QUIM,BR-13560 SAO CARLOS,SP,BRAZIL.
RI Politi, Mario J/F-2605-2016; Almeida, Fabio/O-4989-2018
OI Almeida, Fabio/0000-0001-6046-7006
CR BARLTROP JA, 1978, PRINCIPLES PHOTOCHEM, pCH2
   BOWEN M, 1977, THESIS U MARYLAND
   BRIDGES JW, 1981, STANDARDS FLUORESCEN, V2, pCH7
   CATALANI LH, 1987, J AM CHEM SOC, V109, P7458, DOI 10.1021/ja00258a033
   COYLE JD, 1978, J CHEM SOC PERK T 2, P133, DOI 10.1039/p29780000133
   COYLE JD, 1979, J CHEM SOC P2, P779
   FO PB, 1988, J PHOTOCH PHOTOBIO A, V43, P51
   FO PB, 1988, J PHOTOCH PHOTOBIO A, V45, P265
   KANAOKA Y, 1972, TETRAHEDRON LETT, P4517
   LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, pCH7
   MATAGA N, 1970, MOL INTERACTIONS ELE, pCH7
NR 11
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 1010-6030
J9 J PHOTOCH PHOTOBIO A
JI J. Photochem. Photobiol. A-Chem.
PD JUN 10
PY 1991
VL 58
IS 3
BP 289
EP 294
DI 10.1016/1010-6030(91)87047-Y
PG 6
WC Chemistry, Physical
SC Chemistry
GA FR617
UT WOS:A1991FR61700002
DA 2020-12-01
ER

EF